id	sid	tid	token	lemma	pos
bjp-25731	1	1	introduction	introduction	NOUN
bjp-25731	1	2	over	over	ADP
bjp-25731	1	3	the	the	DET
bjp-25731	1	4	years	year	NOUN
bjp-25731	1	5	,	,	PUNCT
bjp-25731	1	6	heterocyclic	heterocyclic	ADJ
bjp-25731	1	7	chemistry	chemistry	NOUN
bjp-25731	1	8	has	have	AUX
bjp-25731	1	9	gained	gain	VERB
bjp-25731	1	10	tremendous	tremendous	ADJ
bjp-25731	1	11	attention	attention	NOUN
bjp-25731	1	12	because	because	SCONJ
bjp-25731	1	13	of	of	ADP
bjp-25731	1	14	its	its	PRON
bjp-25731	1	15	unavoidable	unavoidable	ADJ
bjp-25731	1	16	pharmacological	pharmacological	ADJ
bjp-25731	1	17	diversity	diversity	NOUN
bjp-25731	1	18	in	in	ADP
bjp-25731	1	19	medicinal	medicinal	ADJ
bjp-25731	1	20	chemistry	chemistry	NOUN
bjp-25731	1	21	research	research	NOUN
bjp-25731	1	22	.	.	PUNCT
bjp-25731	2	1	there	there	PRON
bjp-25731	2	2	has	have	AUX
bjp-25731	2	3	been	be	AUX
bjp-25731	2	4	considerable	considerable	ADJ
bjp-25731	2	5	attention	attention	NOUN
bjp-25731	2	6	on	on	ADP
bjp-25731	2	7	the	the	DET
bjp-25731	2	8	preparation	preparation	NOUN
bjp-25731	2	9	of	of	ADP
bjp-25731	2	10	useful	useful	ADJ
bjp-25731	2	11	heterocyclic	heterocyclic	ADJ
bjp-25731	2	12	compounds	compound	NOUN
bjp-25731	2	13	in	in	ADP
bjp-25731	2	14	organic	organic	ADJ
bjp-25731	2	15	synthesis	synthesis	NOUN
bjp-25731	2	16	(	(	PUNCT
bjp-25731	2	17	ajani	ajani	NOUN
bjp-25731	2	18	and	and	CCONJ
bjp-25731	2	19	nwinyi	nwinyi	NOUN
bjp-25731	2	20	,	,	PUNCT
bjp-25731	2	21	2009	2009	NUM
bjp-25731	2	22	)	)	PUNCT
bjp-25731	2	23	.	.	PUNCT
bjp-25731	3	1	these	these	DET
bjp-25731	3	2	structures	structure	NOUN
bjp-25731	3	3	can	can	AUX
bjp-25731	3	4	either	either	CCONJ
bjp-25731	3	5	be	be	AUX
bjp-25731	3	6	aromatic	aromatic	ADJ
bjp-25731	3	7	or	or	CCONJ
bjp-25731	3	8	non	non	ADJ
bjp-25731	3	9	-	-	ADJ
bjp-25731	3	10	aromatic	aromatic	ADJ
bjp-25731	3	11	rings	ring	NOUN
bjp-25731	3	12	(	(	PUNCT
bjp-25731	3	13	joule	joule	NOUN
bjp-25731	3	14	and	and	CCONJ
bjp-25731	3	15	mills	mill	NOUN
bjp-25731	3	16	,	,	PUNCT
bjp-25731	3	17	2000	2000	NUM
bjp-25731	3	18	)	)	PUNCT
bjp-25731	3	19	.	.	PUNCT
bjp-25731	4	1	pyrimidine	pyrimidine	NOUN
bjp-25731	4	2	falls	fall	VERB
bjp-25731	4	3	under	under	ADP
bjp-25731	4	4	the	the	DET
bjp-25731	4	5	common	common	ADJ
bjp-25731	4	6	azines	azine	NOUN
bjp-25731	4	7	6	6	NUM
bjp-25731	4	8	-	-	PUNCT
bjp-25731	4	9	membered	membere	VERB
bjp-25731	4	10	aromatic	aromatic	ADJ
bjp-25731	4	11	nitrogen	nitrogen	NOUN
bjp-25731	4	12	heterocycles	heterocycle	NOUN
bjp-25731	4	13	(	(	PUNCT
bjp-25731	4	14	eicher	eicher	PROPN
bjp-25731	4	15	and	and	CCONJ
bjp-25731	4	16	hauptmann	hauptmann	PROPN
bjp-25731	4	17	,	,	PUNCT
bjp-25731	4	18	2003	2003	NUM
bjp-25731	4	19	)	)	PUNCT
bjp-25731	4	20	,	,	PUNCT
bjp-25731	4	21	while	while	SCONJ
bjp-25731	4	22	quinazoline	quinazoline	NOUN
bjp-25731	4	23	falls	fall	VERB
bjp-25731	4	24	under	under	ADP
bjp-25731	4	25	the	the	DET
bjp-25731	4	26	category	category	NOUN
bjp-25731	4	27	of	of	ADP
bjp-25731	4	28	benzo	benzo	NOUN
bjp-25731	4	29	-	-	PUNCT
bjp-25731	4	30	fused	fuse	VERB
bjp-25731	4	31	azines	azine	NOUN
bjp-25731	4	32	because	because	SCONJ
bjp-25731	4	33	it	it	PRON
bjp-25731	4	34	resulted	result	VERB
bjp-25731	4	35	from	from	ADP
bjp-25731	4	36	the	the	DET
bjp-25731	4	37	fusion	fusion	NOUN
bjp-25731	4	38	of	of	ADP
bjp-25731	4	39	a	a	DET
bjp-25731	4	40	benzene	benzene	NOUN
bjp-25731	4	41	ring	ring	NOUN
bjp-25731	4	42	and	and	CCONJ
bjp-25731	4	43	a	a	DET
bjp-25731	4	44	pyrimidine	pyrimidine	NOUN
bjp-25731	4	45	atom	atom	NOUN
bjp-25731	4	46	(	(	PUNCT
bjp-25731	4	47	asif	asif	NOUN
bjp-25731	4	48	,	,	PUNCT
bjp-25731	4	49	2014	2014	NUM
bjp-25731	4	50	)	)	PUNCT
bjp-25731	4	51	.	.	PUNCT
bjp-25731	5	1	heterocyclic	heterocyclic	ADJ
bjp-25731	5	2	frameworks	framework	NOUN
bjp-25731	5	3	constitute	constitute	VERB
bjp-25731	5	4	most	most	ADJ
bjp-25731	5	5	of	of	ADP
bjp-25731	5	6	the	the	DET
bjp-25731	5	7	active	active	ADJ
bjp-25731	5	8	ingredients	ingredient	NOUN
bjp-25731	5	9	and	and	CCONJ
bjp-25731	5	10	building	building	NOUN
bjp-25731	5	11	blocks	block	NOUN
bjp-25731	5	12	of	of	ADP
bjp-25731	5	13	many	many	ADJ
bjp-25731	5	14	pharmaceuticals	pharmaceutical	NOUN
bjp-25731	5	15	,	,	PUNCT
bjp-25731	5	16	agrochemicals	agrochemical	NOUN
bjp-25731	5	17	and	and	CCONJ
bjp-25731	5	18	veterinary	veterinary	ADJ
bjp-25731	5	19	products	product	NOUN
bjp-25731	5	20	(	(	PUNCT
bjp-25731	5	21	ouahrouch	ouahrouch	PROPN
bjp-25731	5	22	et	et	PROPN
bjp-25731	5	23	al	al	PROPN
bjp-25731	5	24	.	.	PROPN
bjp-25731	5	25	,	,	PUNCT
bjp-25731	5	26	2014	2014	NUM
bjp-25731	5	27	;	;	PUNCT
bjp-25731	5	28	murgan	murgan	NOUN
bjp-25731	5	29	et	et	PROPN
bjp-25731	5	30	al	al	PROPN
bjp-25731	5	31	.	.	PROPN
bjp-25731	5	32	,	,	PUNCT
bjp-25731	5	33	2003	2003	NUM
bjp-25731	5	34	)	)	PUNCT
bjp-25731	5	35	.	.	PUNCT
bjp-25731	6	1	in	in	ADP
bjp-25731	6	2	comparison	comparison	NOUN
bjp-25731	6	3	with	with	ADP
bjp-25731	6	4	our	our	PRON
bjp-25731	6	5	earlier	early	ADJ
bjp-25731	6	6	review	review	NOUN
bjp-25731	6	7	,	,	PUNCT
bjp-25731	6	8	quinazoline	quinazoline	PROPN
bjp-25731	6	9	is	be	AUX
bjp-25731	6	10	an	an	DET
bjp-25731	6	11	heterocycle	heterocycle	NOUN
bjp-25731	6	12	which	which	PRON
bjp-25731	6	13	belongs	belong	VERB
bjp-25731	6	14	to	to	ADP
bjp-25731	6	15	benzodiazine	benzodiazine	PROPN
bjp-25731	6	16	family	family	NOUN
bjp-25731	6	17	with	with	ADP
bjp-25731	6	18	its	its	PRON
bjp-25731	6	19	heteroatomic	heteroatomic	ADJ
bjp-25731	6	20	nitrogen	nitrogen	NOUN
bjp-25731	6	21	located	locate	VERB
bjp-25731	6	22	at	at	ADP
bjp-25731	6	23	1and	1and	PROPN
bjp-25731	6	24	3positions	3positions	PROPN
bjp-25731	6	25	(	(	PUNCT
bjp-25731	6	26	ajani	ajani	PROPN
bjp-25731	6	27	,	,	PUNCT
bjp-25731	6	28	2014	2014	NUM
bjp-25731	6	29	)	)	PUNCT
bjp-25731	6	30	.	.	PUNCT
bjp-25731	7	1	evolution	evolution	NOUN
bjp-25731	7	2	of	of	ADP
bjp-25731	7	3	quinazolines	quinazoline	NOUN
bjp-25731	7	4	began	begin	VERB
bjp-25731	7	5	only	only	ADV
bjp-25731	7	6	with	with	ADP
bjp-25731	7	7	discovery	discovery	NOUN
bjp-25731	7	8	of	of	ADP
bjp-25731	7	9	febrifugine	febrifugine	NOUN
bjp-25731	7	10	,	,	PUNCT
bjp-25731	7	11	a	a	DET
bjp-25731	7	12	‘	'	PUNCT
bjp-25731	7	13	quinazolinone	quinazolinone	NOUN
bjp-25731	7	14	alkaloid	alkaloid	NOUN
bjp-25731	7	15	”	"	PUNCT
bjp-25731	7	16	,	,	PUNCT
bjp-25731	7	17	which	which	PRON
bjp-25731	7	18	was	be	AUX
bjp-25731	7	19	isolated	isolate	VERB
bjp-25731	7	20	from	from	ADP
bjp-25731	7	21	the	the	DET
bjp-25731	7	22	chinese	chinese	ADJ
bjp-25731	7	23	plant	plant	NOUN
bjp-25731	7	24	aseru	aseru	PROPN
bjp-25731	7	25	(	(	PUNCT
bjp-25731	7	26	dichroa	dichroa	PROPN
bjp-25731	7	27	febrifuga	febrifuga	X
bjp-25731	7	28	lour	lour	NOUN
bjp-25731	7	29	)	)	PUNCT
bjp-25731	7	30	and	and	CCONJ
bjp-25731	7	31	was	be	AUX
bjp-25731	7	32	reported	report	VERB
bjp-25731	7	33	to	to	ADP
bjp-25731	7	34	possessing	possess	VERB
bjp-25731	7	35	antimalarial	antimalarial	ADJ
bjp-25731	7	36	potential	potential	NOUN
bjp-25731	7	37	.	.	PUNCT
bjp-25731	8	1	it	it	PRON
bjp-25731	8	2	was	be	AUX
bjp-25731	8	3	first	first	ADV
bjp-25731	8	4	synthesized	synthesize	VERB
bjp-25731	8	5	by	by	ADP
bjp-25731	8	6	gabrial	gabrial	NOUN
bjp-25731	8	7	in	in	ADP
bjp-25731	8	8	the	the	DET
bjp-25731	8	9	year	year	NOUN
bjp-25731	8	10	1903	1903	NUM
bjp-25731	8	11	and	and	CCONJ
bjp-25731	8	12	was	be	AUX
bjp-25731	8	13	first	first	ADV
bjp-25731	8	14	isolated	isolate	VERB
bjp-25731	8	15	from	from	ADP
bjp-25731	8	16	the	the	DET
bjp-25731	8	17	chinese	chinese	ADJ
bjp-25731	8	18	plant	plant	NOUN
bjp-25731	8	19	aseru	aseru	NOUN
bjp-25731	8	20	(	(	PUNCT
bjp-25731	8	21	selvam	selvam	PROPN
bjp-25731	8	22	and	and	CCONJ
bjp-25731	8	23	kumar	kumar	PROPN
bjp-25731	8	24	,	,	PUNCT
bjp-25731	8	25	2011	2011	NUM
bjp-25731	8	26	)	)	PUNCT
bjp-25731	8	27	.	.	PUNCT
bjp-25731	9	1	quinazoline	quinazoline	PROPN
bjp-25731	9	2	is	be	AUX
bjp-25731	9	3	the	the	DET
bjp-25731	9	4	most	most	ADV
bjp-25731	9	5	commonly	commonly	ADV
bjp-25731	9	6	experienced	experienced	ADJ
bjp-25731	9	7	heterocyclic	heterocyclic	ADJ
bjp-25731	9	8	core	core	NOUN
bjp-25731	9	9	in	in	ADP
bjp-25731	9	10	medicinal	medicinal	ADJ
bjp-25731	9	11	research	research	NOUN
bjp-25731	9	12	,	,	PUNCT
bjp-25731	9	13	owing	owe	VERB
bjp-25731	9	14	to	to	ADP
bjp-25731	9	15	its	its	PRON
bjp-25731	9	16	wide	wide	ADJ
bjp-25731	9	17	spectrum	spectrum	NOUN
bjp-25731	9	18	of	of	ADP
bjp-25731	9	19	pharmacological	pharmacological	ADJ
bjp-25731	9	20	potential	potential	NOUN
bjp-25731	9	21	(	(	PUNCT
bjp-25731	9	22	luo	luo	PROPN
bjp-25731	9	23	et	et	PROPN
bjp-25731	9	24	al	al	PROPN
bjp-25731	9	25	.	.	PROPN
bjp-25731	9	26	,	,	PUNCT
bjp-25731	9	27	2014	2014	NUM
bjp-25731	9	28	;	;	PUNCT
bjp-25731	9	29	selvam	selvam	PROPN
bjp-25731	9	30	et	et	PROPN
bjp-25731	9	31	al	al	PROPN
bjp-25731	9	32	.	.	PROPN
bjp-25731	9	33	,	,	PUNCT
bjp-25731	9	34	2008	2008	NUM
bjp-25731	9	35	)	)	PUNCT
bjp-25731	9	36	and	and	CCONJ
bjp-25731	9	37	a	a	DET
bjp-25731	9	38	huge	huge	ADJ
bjp-25731	9	39	amount	amount	NOUN
bjp-25731	9	40	of	of	ADP
bjp-25731	9	41	its	its	PRON
bjp-25731	9	42	derivatives	derivative	NOUN
bjp-25731	9	43	are	be	AUX
bjp-25731	9	44	referred	refer	VERB
bjp-25731	9	45	to	to	PART
bjp-25731	9	46	be	be	AUX
bjp-25731	9	47	salient	salient	ADJ
bjp-25731	9	48	structural	structural	ADJ
bjp-25731	9	49	synthons	synthon	NOUN
bjp-25731	9	50	of	of	ADP
bjp-25731	9	51	numerous	numerous	ADJ
bjp-25731	9	52	physiological	physiological	ADJ
bjp-25731	9	53	relevance	relevance	NOUN
bjp-25731	9	54	and	and	CCONJ
bjp-25731	9	55	pharmaceutical	pharmaceutical	NOUN
bjp-25731	9	56	applications	application	NOUN
bjp-25731	9	57	(	(	PUNCT
bjp-25731	9	58	luo	luo	PROPN
bjp-25731	9	59	et	et	PROPN
bjp-25731	9	60	al	al	PROPN
bjp-25731	9	61	.	.	PROPN
bjp-25731	9	62	,	,	PUNCT
bjp-25731	9	63	2014	2014	NUM
bjp-25731	9	64	)	)	PUNCT
bjp-25731	9	65	.	.	PUNCT
bjp-25731	10	1	these	these	PRON
bjp-25731	10	2	include	include	VERB
bjp-25731	10	3	usage	usage	NOUN
bjp-25731	10	4	in	in	ADP
bjp-25731	10	5	drug	drug	NOUN
bjp-25731	10	6	design	design	NOUN
bjp-25731	10	7	and	and	CCONJ
bjp-25731	10	8	medicinal	medicinal	ADJ
bjp-25731	10	9	researches	research	NOUN
bjp-25731	10	10	because	because	SCONJ
bjp-25731	10	11	they	they	PRON
bjp-25731	10	12	have	have	AUX
bjp-25731	10	13	been	be	AUX
bjp-25731	10	14	reported	report	VERB
bjp-25731	10	15	to	to	PART
bjp-25731	10	16	display	display	VERB
bjp-25731	10	17	anti	anti	ADJ
bjp-25731	10	18	-	-	ADJ
bjp-25731	10	19	tobacco	tobacco	ADJ
bjp-25731	10	20	mosaic	mosaic	ADJ
bjp-25731	10	21	virus	virus	NOUN
bjp-25731	10	22	(	(	PUNCT
bjp-25731	10	23	anti	anti	ADJ
bjp-25731	10	24	-	-	ADJ
bjp-25731	10	25	tmv	tmv	ADJ
bjp-25731	10	26	)	)	PUNCT
bjp-25731	10	27	,	,	PUNCT
bjp-25731	10	28	anti	anti	ADJ
bjp-25731	10	29	-	-	ADJ
bjp-25731	10	30	hiv	hiv	ADJ
bjp-25731	10	31	,	,	PUNCT
bjp-25731	10	32	anti	anti	ADJ
bjp-25731	10	33	-	-	ADJ
bjp-25731	10	34	cancer	cancer	ADJ
bjp-25731	10	35	,	,	PUNCT
bjp-25731	10	36	antimicrobial	antimicrobial	ADJ
bjp-25731	10	37	,	,	PUNCT
bjp-25731	10	38	antifungal	antifungal	PROPN
bjp-25731	10	39	(	(	PUNCT
bjp-25731	10	40	patel	patel	NOUN
bjp-25731	10	41	and	and	CCONJ
bjp-25731	10	42	patel	patel	PROPN
bjp-25731	10	43	,	,	PUNCT
bjp-25731	10	44	2011	2011	NUM
bjp-25731	10	45	)	)	PUNCT
bjp-25731	10	46	,	,	PUNCT
bjp-25731	10	47	anti	anti	ADJ
bjp-25731	10	48	-	-	ADJ
bjp-25731	10	49	inflammatory	inflammatory	ADJ
bjp-25731	10	50	(	(	PUNCT
bjp-25731	10	51	kumar	kumar	PROPN
bjp-25731	10	52	et	et	PROPN
bjp-25731	10	53	al	al	PROPN
bjp-25731	10	54	.	.	PROPN
bjp-25731	10	55	,	,	PUNCT
bjp-25731	10	56	2010	2010	NUM
bjp-25731	10	57	)	)	PUNCT
bjp-25731	10	58	,	,	PUNCT
bjp-25731	10	59	anti	anti	ADJ
bjp-25731	10	60	-	-	ADJ
bjp-25731	10	61	hypertensive	hypertensive	ADJ
bjp-25731	10	62	,	,	PUNCT
bjp-25731	10	63	antimalarial	antimalarial	NOUN
bjp-25731	10	64	(	(	PUNCT
bjp-25731	10	65	werbel	werbel	NOUN
bjp-25731	10	66	and	and	CCONJ
bjp-25731	10	67	degnan	degnan	NOUN
bjp-25731	10	68	,	,	PUNCT
bjp-25731	10	69	1987	1987	NUM
bjp-25731	10	70	)	)	PUNCT
bjp-25731	10	71	and	and	CCONJ
bjp-25731	10	72	anti	anti	ADJ
bjp-25731	10	73	-	-	ADJ
bjp-25731	10	74	convulsant	convulsant	ADJ
bjp-25731	10	75	(	(	PUNCT
bjp-25731	10	76	aly	aly	PROPN
bjp-25731	10	77	et	et	PROPN
bjp-25731	10	78	al	al	PROPN
bjp-25731	10	79	.	.	PROPN
bjp-25731	10	80	,	,	PUNCT
bjp-25731	10	81	2010	2010	NUM
bjp-25731	10	82	)	)	PUNCT
bjp-25731	10	83	activities	activity	NOUN
bjp-25731	10	84	among	among	ADP
bjp-25731	10	85	others	other	NOUN
bjp-25731	10	86	.	.	PUNCT
bjp-25731	11	1	furthermore	furthermore	ADV
bjp-25731	11	2	,	,	PUNCT
bjp-25731	11	3	quinazoline	quinazoline	NOUN
bjp-25731	11	4	and	and	CCONJ
bjp-25731	11	5	quinazolinone	quinazolinone	PROPN
bjp-25731	11	6	compounds	compound	NOUN
bjp-25731	11	7	are	be	AUX
bjp-25731	11	8	also	also	ADV
bjp-25731	11	9	used	use	VERB
bjp-25731	11	10	in	in	ADP
bjp-25731	11	11	the	the	DET
bjp-25731	11	12	preparation	preparation	NOUN
bjp-25731	11	13	of	of	ADP
bjp-25731	11	14	various	various	ADJ
bjp-25731	11	15	functional	functional	ADJ
bjp-25731	11	16	materials	material	NOUN
bjp-25731	11	17	for	for	ADP
bjp-25731	11	18	synthetic	synthetic	ADJ
bjp-25731	11	19	chemistry	chemistry	NOUN
bjp-25731	11	20	and	and	CCONJ
bjp-25731	11	21	also	also	ADV
bjp-25731	11	22	present	present	ADJ
bjp-25731	11	23	in	in	ADP
bjp-25731	11	24	various	various	ADJ
bjp-25731	11	25	drugs	drug	NOUN
bjp-25731	11	26	molecule	molecule	NOUN
bjp-25731	11	27	(	(	PUNCT
bjp-25731	11	28	rajput	rajput	PROPN
bjp-25731	11	29	and	and	CCONJ
bjp-25731	11	30	mishra	mishra	PROPN
bjp-25731	11	31	,	,	PUNCT
bjp-25731	11	32	a	a	DET
bjp-25731	11	33	journal	journal	NOUN
bjp-25731	11	34	of	of	ADP
bjp-25731	11	35	the	the	DET
bjp-25731	11	36	bangladesh	bangladesh	NOUN
bjp-25731	11	37	pharmacological	pharmacological	ADJ
bjp-25731	11	38	society	society	NOUN
bjp-25731	11	39	(	(	PUNCT
bjp-25731	11	40	bdps	bdps	NOUN
bjp-25731	11	41	)	)	PUNCT
bjp-25731	11	42	bangladesh	bangladesh	PROPN
bjp-25731	11	43	j	j	PROPN
bjp-25731	11	44	pharmacol	pharmacol	PROPN
bjp-25731	11	45	2016	2016	NUM
bjp-25731	11	46	;	;	PUNCT
bjp-25731	11	47	11	11	NUM
bjp-25731	11	48	:	:	PUNCT
bjp-25731	11	49	716	716	NUM
bjp-25731	11	50	-	-	SYM
bjp-25731	11	51	733	733	NUM
bjp-25731	11	52	journal	journal	NOUN
bjp-25731	11	53	homepage	homepage	NOUN
bjp-25731	11	54	:	:	PUNCT
bjp-25731	11	55	www.banglajol.info	www.banglajol.info	PROPN
bjp-25731	11	56	abstracted	abstract	VERB
bjp-25731	11	57	/	/	SYM
bjp-25731	11	58	indexed	index	VERB
bjp-25731	11	59	in	in	ADP
bjp-25731	11	60	academic	academic	ADJ
bjp-25731	11	61	search	search	NOUN
bjp-25731	11	62	complete	complete	ADJ
bjp-25731	11	63	,	,	PUNCT
bjp-25731	11	64	asia	asia	PROPN
bjp-25731	11	65	journals	journal	NOUN
bjp-25731	11	66	online	online	ADV
bjp-25731	11	67	,	,	PUNCT
bjp-25731	11	68	bangladesh	bangladesh	NOUN
bjp-25731	11	69	journals	journal	NOUN
bjp-25731	11	70	online	online	ADV
bjp-25731	11	71	,	,	PUNCT
bjp-25731	11	72	biological	biological	ADJ
bjp-25731	11	73	abstracts	abstract	NOUN
bjp-25731	11	74	,	,	PUNCT
bjp-25731	11	75	biosis	biosis	NOUN
bjp-25731	11	76	previews	preview	NOUN
bjp-25731	11	77	,	,	PUNCT
bjp-25731	11	78	cab	cab	NOUN
bjp-25731	11	79	abstracts	abstract	NOUN
bjp-25731	11	80	,	,	PUNCT
bjp-25731	11	81	current	current	ADJ
bjp-25731	11	82	abstracts	abstract	NOUN
bjp-25731	11	83	,	,	PUNCT
bjp-25731	11	84	embase	embase	NOUN
bjp-25731	11	85	/	/	SYM
bjp-25731	11	86	excerpta	excerpta	NOUN
bjp-25731	11	87	medica	medica	NOUN
bjp-25731	11	88	,	,	PUNCT
bjp-25731	11	89	google	google	PROPN
bjp-25731	11	90	scholar	scholar	NOUN
bjp-25731	11	91	,	,	PUNCT
bjp-25731	11	92	hinari	hinari	X
bjp-25731	11	93	(	(	PUNCT
bjp-25731	11	94	who	who	PRON
bjp-25731	11	95	)	)	PUNCT
bjp-25731	11	96	,	,	PUNCT
bjp-25731	11	97	international	international	ADJ
bjp-25731	11	98	pharmaceutical	pharmaceutical	ADJ
bjp-25731	11	99	abstracts	abstract	NOUN
bjp-25731	11	100	,	,	PUNCT
bjp-25731	11	101	open	open	ADJ
bjp-25731	11	102	j	j	PROPN
bjp-25731	11	103	-	-	PUNCT
bjp-25731	11	104	gate	gate	NOUN
bjp-25731	11	105	,	,	PUNCT
bjp-25731	11	106	science	science	NOUN
bjp-25731	11	107	citation	citation	NOUN
bjp-25731	11	108	index	index	NOUN
bjp-25731	11	109	expanded	expand	VERB
bjp-25731	11	110	,	,	PUNCT
bjp-25731	11	111	scopus	scopus	NOUN
bjp-25731	11	112	and	and	CCONJ
bjp-25731	11	113	social	social	ADJ
bjp-25731	11	114	sciences	sciences	PROPN
bjp-25731	11	115	citation	citation	NOUN
bjp-25731	11	116	index	index	NOUN
bjp-25731	11	117	;	;	PUNCT
bjp-25731	11	118	issn	issn	PROPN
bjp-25731	11	119	:	:	PUNCT
bjp-25731	11	120	1991	1991	NUM
bjp-25731	11	121	-	-	SYM
bjp-25731	11	122	0088	0088	NUM
bjp-25731	11	123	abstract	abstract	NOUN
bjp-25731	11	124	this	this	DET
bjp-25731	11	125	present	present	ADJ
bjp-25731	11	126	study	study	NOUN
bjp-25731	11	127	comprehensively	comprehensively	ADV
bjp-25731	11	128	expatiates	expatiate	VERB
bjp-25731	11	129	the	the	DET
bjp-25731	11	130	functionalized	functionalized	ADJ
bjp-25731	11	131	utilization	utilization	NOUN
bjp-25731	11	132	of	of	ADP
bjp-25731	11	133	quinazoline	quinazoline	NOUN
bjp-25731	11	134	scaffolds	scaffold	NOUN
bjp-25731	11	135	in	in	ADP
bjp-25731	11	136	drug	drug	NOUN
bjp-25731	11	137	development	development	NOUN
bjp-25731	11	138	and	and	CCONJ
bjp-25731	11	139	furnishes	furnish	VERB
bjp-25731	11	140	latest	late	ADJ
bjp-25731	11	141	updates	update	NOUN
bjp-25731	11	142	in	in	ADP
bjp-25731	11	143	pharmacological	pharmacological	NOUN
bjp-25731	11	144	appositeness	appositeness	NOUN
bjp-25731	11	145	of	of	ADP
bjp-25731	11	146	its	its	PRON
bjp-25731	11	147	derivatives	derivative	NOUN
bjp-25731	11	148	in	in	ADP
bjp-25731	11	149	order	order	NOUN
bjp-25731	11	150	to	to	PART
bjp-25731	11	151	reveal	reveal	VERB
bjp-25731	11	152	novel	novel	ADJ
bjp-25731	11	153	pathways	pathway	NOUN
bjp-25731	11	154	for	for	ADP
bjp-25731	11	155	therapeutic	therapeutic	ADJ
bjp-25731	11	156	targets	target	NOUN
bjp-25731	11	157	.	.	PUNCT
bjp-25731	12	1	it	it	PRON
bjp-25731	12	2	traverses	traverse	VERB
bjp-25731	12	3	numerous	numerous	ADJ
bjp-25731	12	4	biological	biological	ADJ
bjp-25731	12	5	potentials	potential	NOUN
bjp-25731	12	6	of	of	ADP
bjp-25731	12	7	quinazoline	quinazoline	NOUN
bjp-25731	12	8	in	in	ADP
bjp-25731	12	9	the	the	DET
bjp-25731	12	10	contemporary	contemporary	ADJ
bjp-25731	12	11	time	time	NOUN
bjp-25731	12	12	to	to	PART
bjp-25731	12	13	allow	allow	VERB
bjp-25731	12	14	researchers	researcher	NOUN
bjp-25731	12	15	’	'	PUNCT
bjp-25731	12	16	unhindered	unhindered	ADJ
bjp-25731	12	17	access	access	NOUN
bjp-25731	12	18	to	to	ADP
bjp-25731	12	19	the	the	DET
bjp-25731	12	20	beneficial	beneficial	ADJ
bjp-25731	12	21	role	role	NOUN
bjp-25731	12	22	of	of	ADP
bjp-25731	12	23	quinazoline	quinazoline	NOUN
bjp-25731	12	24	in	in	ADP
bjp-25731	12	25	fighting	fight	VERB
bjp-25731	12	26	infectious	infectious	ADJ
bjp-25731	12	27	diseases	disease	NOUN
bjp-25731	12	28	for	for	ADP
bjp-25731	12	29	future	future	ADJ
bjp-25731	12	30	drug	drug	NOUN
bjp-25731	12	31	discovery	discovery	NOUN
bjp-25731	12	32	.	.	PUNCT
bjp-25731	13	1	this	this	DET
bjp-25731	13	2	work	work	NOUN
bjp-25731	13	3	provides	provide	VERB
bjp-25731	13	4	broad	broad	ADJ
bjp-25731	13	5	overview	overview	NOUN
bjp-25731	13	6	of	of	ADP
bjp-25731	13	7	medicinal	medicinal	ADJ
bjp-25731	13	8	survey	survey	NOUN
bjp-25731	13	9	of	of	ADP
bjp-25731	13	10	quinazoline	quinazoline	ADJ
bjp-25731	13	11	chemistry	chemistry	NOUN
bjp-25731	13	12	valuable	valuable	ADJ
bjp-25731	13	13	in	in	ADP
bjp-25731	13	14	the	the	DET
bjp-25731	13	15	discovery	discovery	NOUN
bjp-25731	13	16	of	of	ADP
bjp-25731	13	17	more	more	ADV
bjp-25731	13	18	efficient	efficient	ADJ
bjp-25731	13	19	clinical	clinical	ADJ
bjp-25731	13	20	trials	trial	NOUN
bjp-25731	13	21	and	and	CCONJ
bjp-25731	13	22	to	to	PART
bjp-25731	13	23	summarize	summarize	VERB
bjp-25731	13	24	the	the	DET
bjp-25731	13	25	most	most	ADV
bjp-25731	13	26	promising	promising	ADJ
bjp-25731	13	27	molecular	molecular	ADJ
bjp-25731	13	28	targets	target	NOUN
bjp-25731	13	29	for	for	ADP
bjp-25731	13	30	drug	drug	NOUN
bjp-25731	13	31	design	design	NOUN
bjp-25731	13	32	.	.	PUNCT
bjp-25731	14	1	article	article	NOUN
bjp-25731	14	2	info	info	NOUN
bjp-25731	14	3	received	receive	VERB
bjp-25731	14	4	:	:	PUNCT
bjp-25731	14	5	16	16	NUM
bjp-25731	14	6	november	november	PROPN
bjp-25731	14	7	2015	2015	NUM
bjp-25731	14	8	accepted	accept	VERB
bjp-25731	14	9	:	:	PUNCT
bjp-25731	14	10	16	16	NUM
bjp-25731	14	11	july	july	PROPN
bjp-25731	14	12	2016	2016	NUM
bjp-25731	14	13	available	available	ADJ
bjp-25731	14	14	online	online	ADV
bjp-25731	14	15	:	:	PUNCT
bjp-25731	14	16	15	15	NUM
bjp-25731	14	17	august	august	PROPN
bjp-25731	14	18	2016	2016	NUM
bjp-25731	14	19	doi	doi	NOUN
bjp-25731	14	20	:	:	PUNCT
bjp-25731	14	21	10.3329	10.3329	NUM
bjp-25731	14	22	/	/	SYM
bjp-25731	14	23	bjp.v11i3.25731	bjp.v11i3.25731	PROPN
bjp-25731	14	24	cite	cite	VERB
bjp-25731	14	25	this	this	DET
bjp-25731	14	26	article	article	NOUN
bjp-25731	14	27	:	:	PUNCT
bjp-25731	14	28	ajani	ajani	VERB
bjp-25731	14	29	oo	oo	PROPN
bjp-25731	14	30	,	,	PUNCT
bjp-25731	14	31	aderohunmu	aderohunmu	PROPN
bjp-25731	14	32	dv	dv	PROPN
bjp-25731	14	33	,	,	PUNCT
bjp-25731	14	34	umeokoro	umeokoro	PROPN
bjp-25731	14	35	en	en	PROPN
bjp-25731	14	36	,	,	PUNCT
bjp-25731	14	37	olomieja	olomieja	ADJ
bjp-25731	14	38	ao	ao	PROPN
bjp-25731	14	39	.	.	PUNCT
bjp-25731	15	1	quinazoline	quinazoline	VERB
bjp-25731	15	2	pharmacophore	pharmacophore	NOUN
bjp-25731	15	3	in	in	ADP
bjp-25731	15	4	therapeutic	therapeutic	ADJ
bjp-25731	15	5	medicine	medicine	NOUN
bjp-25731	15	6	.	.	PUNCT
bjp-25731	16	1	bangladesh	bangladesh	PROPN
bjp-25731	16	2	j	j	PROPN
bjp-25731	16	3	pharmacol	pharmacol	PROPN
bjp-25731	16	4	.	.	PROPN
bjp-25731	17	1	2016	2016	NUM
bjp-25731	17	2	;	;	PUNCT
bjp-25731	17	3	11	11	NUM
bjp-25731	17	4	:	:	PUNCT
bjp-25731	17	5	716	716	NUM
bjp-25731	17	6	-	-	SYM
bjp-25731	17	7	33	33	NUM
bjp-25731	17	8	.	.	PUNCT
bjp-25731	18	1	quinazoline	quinazoline	PROPN
bjp-25731	18	2	pharmacophore	pharmacophore	NOUN
bjp-25731	18	3	in	in	ADP
bjp-25731	18	4	therapeutic	therapeutic	ADJ
bjp-25731	18	5	medicine	medicine	NOUN
bjp-25731	18	6	olayinka	olayinka	ADJ
bjp-25731	18	7	oyewale	oyewale	PROPN
bjp-25731	18	8	ajani1	ajani1	PROPN
bjp-25731	18	9	,	,	PUNCT
bjp-25731	18	10	damilola	damilola	PROPN
bjp-25731	18	11	victoria	victoria	PROPN
bjp-25731	18	12	aderohunmu1	aderohunmu1	PROPN
bjp-25731	18	13	,	,	PUNCT
bjp-25731	18	14	ejike	ejike	NOUN
bjp-25731	18	15	nzube	nzube	NOUN
bjp-25731	18	16	umeokoro1	umeokoro1	PROPN
bjp-25731	18	17	and	and	CCONJ
bjp-25731	18	18	ayodele	ayodele	PROPN
bjp-25731	18	19	ojo	ojo	PROPN
bjp-25731	18	20	olomieja2	olomieja2	PROPN
bjp-25731	19	1	1department	1department	NUM
bjp-25731	19	2	of	of	ADP
bjp-25731	19	3	chemistry	chemistry	NOUN
bjp-25731	19	4	,	,	PUNCT
bjp-25731	19	5	covenant	covenant	ADJ
bjp-25731	19	6	university	university	PROPN
bjp-25731	19	7	,	,	PUNCT
bjp-25731	19	8	cst	cst	PROPN
bjp-25731	19	9	,	,	PUNCT
bjp-25731	19	10	canaanland	canaanland	PROPN
bjp-25731	19	11	,	,	PUNCT
bjp-25731	19	12	km	km	PROPN
bjp-25731	19	13	10	10	NUM
bjp-25731	19	14	idiroko	idiroko	NOUN
bjp-25731	19	15	road	road	NOUN
bjp-25731	19	16	,	,	PUNCT
bjp-25731	19	17	p.m.b	p.m.b	ADJ
bjp-25731	19	18	.	.	PROPN
bjp-25731	19	19	1023	1023	NUM
bjp-25731	19	20	,	,	PUNCT
bjp-25731	19	21	ota	ota	PROPN
bjp-25731	19	22	,	,	PUNCT
bjp-25731	19	23	ogun	ogun	PROPN
bjp-25731	19	24	state	state	PROPN
bjp-25731	19	25	,	,	PUNCT
bjp-25731	19	26	nigeria	nigeria	PROPN
bjp-25731	19	27	;	;	PUNCT
bjp-25731	19	28	2department	2department	NUM
bjp-25731	19	29	of	of	ADP
bjp-25731	19	30	chemistry	chemistry	NOUN
bjp-25731	19	31	,	,	PUNCT
bjp-25731	19	32	ogun	ogun	PROPN
bjp-25731	19	33	state	state	PROPN
bjp-25731	19	34	institute	institute	PROPN
bjp-25731	19	35	of	of	ADP
bjp-25731	19	36	technology	technology	PROPN
bjp-25731	19	37	,	,	PUNCT
bjp-25731	19	38	igbesa	igbesa	NOUN
bjp-25731	19	39	,	,	PUNCT
bjp-25731	19	40	ogun	ogun	PROPN
bjp-25731	19	41	state	state	PROPN
bjp-25731	19	42	,	,	PUNCT
bjp-25731	19	43	nigeria	nigeria	PROPN
bjp-25731	19	44	.	.	PUNCT
bjp-25731	20	1	m	m	VERB
bjp-25731	20	2	in	in	ADP
bjp-25731	20	3	i	i	PROPN
bjp-25731	20	4	-	-	PUNCT
bjp-25731	20	5	r	r	NOUN
bjp-25731	20	6	ev	ev	X
bjp-25731	20	7	ie	ie	X
bjp-25731	20	8	w	w	NOUN
bjp-25731	20	9	http://www.bioxbio.com/if/html/bangl-j-pharmacol.html	http://www.bioxbio.com/if/html/bangl-j-pharmacol.html	NOUN
bjp-25731	20	10	2012	2012	NUM
bjp-25731	20	11	)	)	PUNCT
bjp-25731	20	12	.	.	PUNCT
bjp-25731	21	1	novel	novel	ADJ
bjp-25731	21	2	quinazoline	quinazoline	NOUN
bjp-25731	21	3	-	-	PUNCT
bjp-25731	21	4	urea	urea	NOUN
bjp-25731	21	5	analogues	analogue	NOUN
bjp-25731	21	6	were	be	AUX
bjp-25731	21	7	recently	recently	ADV
bjp-25731	21	8	reported	report	VERB
bjp-25731	21	9	as	as	ADP
bjp-25731	21	10	modulators	modulator	NOUN
bjp-25731	21	11	for	for	ADP
bjp-25731	21	12	a	a	DET
bjp-25731	21	13	-induced	-induce	VERB
bjp-25731	21	14	mitochondrial	mitochondrial	ADJ
bjp-25731	21	15	dysfunction	dysfunction	NOUN
bjp-25731	21	16	making	make	VERB
bjp-25731	21	17	them	they	PRON
bjp-25731	21	18	valuable	valuable	ADJ
bjp-25731	21	19	template	template	NOUN
bjp-25731	21	20	in	in	ADP
bjp-25731	21	21	the	the	DET
bjp-25731	21	22	treatment	treatment	NOUN
bjp-25731	21	23	of	of	ADP
bjp-25731	21	24	various	various	ADJ
bjp-25731	21	25	neurodegenerative	neurodegenerative	ADJ
bjp-25731	21	26	disorders	disorder	NOUN
bjp-25731	21	27	(	(	PUNCT
bjp-25731	21	28	elkamhawy	elkamhawy	PROPN
bjp-25731	21	29	et	et	PROPN
bjp-25731	21	30	al	al	PROPN
bjp-25731	21	31	.	.	PROPN
bjp-25731	21	32	,	,	PUNCT
bjp-25731	21	33	2014	2014	NUM
bjp-25731	21	34	)	)	PUNCT
bjp-25731	21	35	.	.	PUNCT
bjp-25731	22	1	sulfonamides	sulfonamide	NOUN
bjp-25731	22	2	containing	contain	VERB
bjp-25731	22	3	quinazoline	quinazoline	NOUN
bjp-25731	22	4	core	core	NOUN
bjp-25731	22	5	structure	structure	NOUN
bjp-25731	22	6	was	be	AUX
bjp-25731	22	7	reported	report	VERB
bjp-25731	22	8	to	to	PART
bjp-25731	22	9	be	be	AUX
bjp-25731	22	10	suitable	suitable	ADJ
bjp-25731	22	11	toolbox	toolbox	NOUN
bjp-25731	22	12	for	for	ADP
bjp-25731	22	13	better	well	ADJ
bjp-25731	22	14	comprehension	comprehension	NOUN
bjp-25731	22	15	of	of	ADP
bjp-25731	22	16	the	the	DET
bjp-25731	22	17	usefulness	usefulness	NOUN
bjp-25731	22	18	of	of	ADP
bjp-25731	22	19	bacterial	bacterial	ADJ
bjp-25731	22	20	carbonic	carbonic	ADJ
bjp-25731	22	21	anhydrases	anhydrase	NOUN
bjp-25731	22	22	in	in	ADP
bjp-25731	22	23	pathogenesis	pathogenesis	NOUN
bjp-25731	22	24	(	(	PUNCT
bjp-25731	22	25	alafeefy	alafeefy	PROPN
bjp-25731	22	26	et	et	PROPN
bjp-25731	22	27	al	al	PROPN
bjp-25731	22	28	.	.	PROPN
bjp-25731	22	29	,	,	PUNCT
bjp-25731	22	30	2014	2014	NUM
bjp-25731	22	31	)	)	PUNCT
bjp-25731	22	32	.	.	PUNCT
bjp-25731	23	1	quinazolinyloxybiaryl	quinazolinyloxybiaryl	PROPN
bjp-25731	23	2	urea	urea	PROPN
bjp-25731	23	3	was	be	AUX
bjp-25731	23	4	identified	identify	VERB
bjp-25731	23	5	as	as	ADP
bjp-25731	23	6	a	a	DET
bjp-25731	23	7	new	new	ADJ
bjp-25731	23	8	class	class	NOUN
bjp-25731	23	9	of	of	ADP
bjp-25731	23	10	inhibitor	inhibitor	NOUN
bjp-25731	23	11	against	against	ADP
bjp-25731	23	12	sumo	sumo	NOUN
bjp-25731	23	13	activating	activate	VERB
bjp-25731	23	14	enzyme	enzyme	NOUN
bjp-25731	23	15	1	1	NUM
bjp-25731	23	16	which	which	PRON
bjp-25731	23	17	is	be	AUX
bjp-25731	23	18	an	an	DET
bjp-25731	23	19	excellent	excellent	ADJ
bjp-25731	23	20	oncology	oncology	NOUN
bjp-25731	23	21	target	target	NOUN
bjp-25731	23	22	(	(	PUNCT
bjp-25731	23	23	kumar	kumar	PROPN
bjp-25731	23	24	et	et	PROPN
bjp-25731	23	25	al	al	PROPN
bjp-25731	23	26	.	.	PROPN
bjp-25731	23	27	,	,	PUNCT
bjp-25731	23	28	2013	2013	NUM
bjp-25731	23	29	)	)	PUNCT
bjp-25731	23	30	.	.	PUNCT
bjp-25731	24	1	quinazoline	quinazoline	PROPN
bjp-25731	24	2	core	core	NOUN
bjp-25731	24	3	was	be	AUX
bjp-25731	24	4	not	not	PART
bjp-25731	24	5	left	leave	VERB
bjp-25731	24	6	out	out	ADP
bjp-25731	24	7	in	in	ADP
bjp-25731	24	8	the	the	DET
bjp-25731	24	9	new	new	ADJ
bjp-25731	24	10	advancement	advancement	NOUN
bjp-25731	24	11	in	in	ADP
bjp-25731	24	12	phenoclustering	phenoclustere	VERB
bjp-25731	24	13	of	of	ADP
bjp-25731	24	14	diverse	diverse	ADJ
bjp-25731	24	15	model	model	NOUN
bjp-25731	24	16	systems	system	NOUN
bjp-25731	24	17	as	as	ADP
bjp-25731	24	18	an	an	DET
bjp-25731	24	19	option	option	NOUN
bjp-25731	24	20	for	for	ADP
bjp-25731	24	21	the	the	DET
bjp-25731	24	22	recognition	recognition	NOUN
bjp-25731	24	23	of	of	ADP
bjp-25731	24	24	targeted	target	VERB
bjp-25731	24	25	site	site	NOUN
bjp-25731	24	26	in	in	ADP
bjp-25731	24	27	drug	drug	NOUN
bjp-25731	24	28	development	development	NOUN
bjp-25731	24	29	(	(	PUNCT
bjp-25731	24	30	williams	williams	PROPN
bjp-25731	24	31	and	and	CCONJ
bjp-25731	24	32	hong	hong	PROPN
bjp-25731	24	33	,	,	PUNCT
bjp-25731	24	34	2013	2013	NUM
bjp-25731	24	35	)	)	PUNCT
bjp-25731	24	36	.	.	PUNCT
bjp-25731	25	1	linear	linear	PROPN
bjp-25731	25	2	and	and	CCONJ
bjp-25731	25	3	angular	angular	ADJ
bjp-25731	25	4	4’,5’-dimethylfuroquinazolines	4’,5’-dimethylfuroquinazolines	NUM
bjp-25731	25	5	proved	prove	VERB
bjp-25731	25	6	to	to	PART
bjp-25731	25	7	intercalate	intercalate	VERB
bjp-25731	25	8	within	within	ADP
bjp-25731	25	9	the	the	DET
bjp-25731	25	10	dna	dna	PROPN
bjp-25731	25	11	double	double	ADJ
bjp-25731	25	12	helix	helix	NOUN
bjp-25731	25	13	,	,	PUNCT
bjp-25731	25	14	however	however	ADV
bjp-25731	25	15	they	they	PRON
bjp-25731	25	16	could	could	AUX
bjp-25731	25	17	not	not	PART
bjp-25731	25	18	photo	photo	NOUN
bjp-25731	25	19	-	-	PUNCT
bjp-25731	25	20	bind	bind	ADJ
bjp-25731	25	21	dna	dna	NOUN
bjp-25731	25	22	bases	basis	NOUN
bjp-25731	25	23	in	in	ADP
bjp-25731	25	24	the	the	DET
bjp-25731	25	25	presence	presence	NOUN
bjp-25731	25	26	of	of	ADP
bjp-25731	25	27	ultraviolet	ultraviolet	ADJ
bjp-25731	25	28	radiation	radiation	NOUN
bjp-25731	25	29	(	(	PUNCT
bjp-25731	25	30	miolo	miolo	ADV
bjp-25731	25	31	et	et	PROPN
bjp-25731	25	32	al	al	PROPN
bjp-25731	25	33	.	.	PROPN
bjp-25731	25	34	,	,	PUNCT
bjp-25731	25	35	2014	2014	NUM
bjp-25731	25	36	)	)	PUNCT
bjp-25731	25	37	.	.	PUNCT
bjp-25731	26	1	fluorescence	fluorescence	NOUN
bjp-25731	26	2	relays	relay	NOUN
bjp-25731	26	3	increased	increase	VERB
bjp-25731	26	4	sequential	sequential	ADJ
bjp-25731	26	5	identification	identification	NOUN
bjp-25731	26	6	of	of	ADP
bjp-25731	26	7	cu2	cu2	NOUN
bjp-25731	26	8	+	+	CCONJ
bjp-25731	26	9	and	and	CCONJ
bjp-25731	26	10	cn−	cn−	VERB
bjp-25731	26	11	through	through	ADP
bjp-25731	26	12	effect	effect	NOUN
bjp-25731	26	13	of	of	ADP
bjp-25731	26	14	novel	novel	ADJ
bjp-25731	26	15	quinazoline	quinazoline	NOUN
bjp-25731	26	16	scaffold	scaffold	NOUN
bjp-25731	26	17	(	(	PUNCT
bjp-25731	26	18	liu	liu	PROPN
bjp-25731	26	19	et	et	PROPN
bjp-25731	26	20	al	al	PROPN
bjp-25731	26	21	.	.	PROPN
bjp-25731	26	22	,	,	PUNCT
bjp-25731	26	23	2013	2013	NUM
bjp-25731	26	24	;	;	PUNCT
bjp-25731	26	25	tang	tang	X
bjp-25731	26	26	et	et	PROPN
bjp-25731	26	27	al	al	PROPN
bjp-25731	26	28	.	.	PROPN
bjp-25731	26	29	,	,	PUNCT
bjp-25731	26	30	2013	2013	NUM
bjp-25731	26	31	)	)	PUNCT
bjp-25731	26	32	and	and	CCONJ
bjp-25731	26	33	their	their	PRON
bjp-25731	26	34	role	role	NOUN
bjp-25731	26	35	as	as	ADP
bjp-25731	26	36	turn	turn	VERB
bjp-25731	26	37	on	on	ADP
bjp-25731	26	38	fluorescence	fluorescence	NOUN
bjp-25731	26	39	for	for	ADP
bjp-25731	26	40	cysteine	cysteine	NOUN
bjp-25731	26	41	and	and	CCONJ
bjp-25731	26	42	chemodosimeter	chemodosimeter	NOUN
bjp-25731	26	43	for	for	ADP
bjp-25731	26	44	no	no	PRON
bjp-25731	26	45	has	have	AUX
bjp-25731	26	46	also	also	ADV
bjp-25731	26	47	been	be	AUX
bjp-25731	26	48	reported	report	VERB
bjp-25731	26	49	(	(	PUNCT
bjp-25731	26	50	anand	anand	PROPN
bjp-25731	26	51	et	et	PROPN
bjp-25731	26	52	al	al	PROPN
bjp-25731	26	53	.	.	PROPN
bjp-25731	26	54	,	,	PUNCT
bjp-25731	26	55	2014	2014	NUM
bjp-25731	26	56	)	)	PUNCT
bjp-25731	26	57	.	.	PUNCT
bjp-25731	27	1	some	some	DET
bjp-25731	27	2	quinazoline	quinazoline	ADJ
bjp-25731	27	3	motifs	motif	NOUN
bjp-25731	27	4	were	be	AUX
bjp-25731	27	5	shown	show	VERB
bjp-25731	27	6	to	to	PART
bjp-25731	27	7	display	display	VERB
bjp-25731	27	8	bronchodilatory	bronchodilatory	ADJ
bjp-25731	27	9	effect	effect	NOUN
bjp-25731	27	10	at	at	ADP
bjp-25731	27	11	low	low	ADJ
bjp-25731	27	12	micromolar	micromolar	ADJ
bjp-25731	27	13	concentrations	concentration	NOUN
bjp-25731	27	14	on	on	ADP
bjp-25731	27	15	isolated	isolated	ADJ
bjp-25731	27	16	rat	rat	NOUN
bjp-25731	27	17	trachea	trachea	NOUN
bjp-25731	27	18	,	,	PUNCT
bjp-25731	27	19	and	and	CCONJ
bjp-25731	27	20	low	low	ADJ
bjp-25731	27	21	toxicity	toxicity	NOUN
bjp-25731	27	22	both	both	CCONJ
bjp-25731	27	23	on	on	ADP
bjp-25731	27	24	balb	balb	ADJ
bjp-25731	27	25	/	/	SYM
bjp-25731	27	26	c	c	NOUN
bjp-25731	27	27	3t3	3t3	NUM
bjp-25731	27	28	mouse	mouse	NOUN
bjp-25731	27	29	fibroblast	fibroblast	ADJ
bjp-25731	27	30	cells	cell	NOUN
bjp-25731	27	31	and	and	CCONJ
bjp-25731	27	32	in	in	ADP
bjp-25731	27	33	mice	mouse	NOUN
bjp-25731	27	34	(	(	PUNCT
bjp-25731	27	35	špulák	špulák	VERB
bjp-25731	27	36	et	et	PROPN
bjp-25731	27	37	al	al	PROPN
bjp-25731	27	38	.	.	PROPN
bjp-25731	27	39	,	,	PUNCT
bjp-25731	27	40	2014	2014	NUM
bjp-25731	27	41	)	)	PUNCT
bjp-25731	27	42	.	.	PUNCT
bjp-25731	28	1	some	some	DET
bjp-25731	28	2	valuable	valuable	ADJ
bjp-25731	28	3	quinazoline	quinazoline	NOUN
bjp-25731	28	4	-	-	PUNCT
bjp-25731	28	5	based	base	VERB
bjp-25731	28	6	compounds	compound	NOUN
bjp-25731	28	7	include	include	VERB
bjp-25731	28	8	antitumor	antitumor	PROPN
bjp-25731	28	9	erlotinib	erlotinib	NOUN
bjp-25731	28	10	1	1	NUM
bjp-25731	28	11	,	,	PUNCT
bjp-25731	28	12	anti	anti	ADJ
bjp-25731	28	13	-	-	ADJ
bjp-25731	28	14	cancer	cancer	ADJ
bjp-25731	28	15	iressa	iressa	NOUN
bjp-25731	28	16	2	2	NUM
bjp-25731	28	17	and	and	CCONJ
bjp-25731	28	18	kinase	kinase	PROPN
bjp-25731	28	19	inhibitor	inhibitor	PROPN
bjp-25731	28	20	lapatinib	lapatinib	VERB
bjp-25731	28	21	3	3	NUM
bjp-25731	28	22	(	(	PUNCT
bjp-25731	28	23	sharma	sharma	PROPN
bjp-25731	28	24	et	et	PROPN
bjp-25731	28	25	al	al	PROPN
bjp-25731	28	26	.	.	PROPN
bjp-25731	28	27	,	,	PUNCT
bjp-25731	28	28	2013a	2013a	NUM
bjp-25731	28	29	;	;	PUNCT
bjp-25731	29	1	garofalo	garofalo	PROPN
bjp-25731	29	2	et	et	PROPN
bjp-25731	29	3	al	al	PROPN
bjp-25731	29	4	.	.	PROPN
bjp-25731	29	5	,	,	PUNCT
bjp-25731	29	6	2011	2011	NUM
bjp-25731	29	7	)	)	PUNCT
bjp-25731	29	8	as	as	SCONJ
bjp-25731	29	9	presented	present	VERB
bjp-25731	29	10	in	in	ADP
bjp-25731	29	11	figure	figure	NOUN
bjp-25731	29	12	1	1	NUM
bjp-25731	29	13	.	.	PUNCT
bjp-25731	30	1	physical	physical	ADJ
bjp-25731	30	2	properties	property	NOUN
bjp-25731	30	3	quinazoline	quinazoline	VERB
bjp-25731	30	4	is	be	AUX
bjp-25731	30	5	a	a	DET
bjp-25731	30	6	nitrogen	nitrogen	NOUN
bjp-25731	30	7	-	-	PUNCT
bjp-25731	30	8	based	base	VERB
bjp-25731	30	9	heterocyclic	heterocyclic	ADJ
bjp-25731	30	10	entity	entity	NOUN
bjp-25731	30	11	which	which	PRON
bjp-25731	30	12	contains	contain	VERB
bjp-25731	30	13	a	a	DET
bjp-25731	30	14	fusion	fusion	NOUN
bjp-25731	30	15	of	of	ADP
bjp-25731	30	16	benzene	benzene	NOUN
bjp-25731	30	17	structure	structure	NOUN
bjp-25731	30	18	on	on	ADP
bjp-25731	30	19	a	a	DET
bjp-25731	30	20	pyrimidine	pyrimidine	NOUN
bjp-25731	30	21	heterocycle	heterocycle	NOUN
bjp-25731	30	22	.	.	PUNCT
bjp-25731	31	1	hence	hence	ADV
bjp-25731	31	2	,	,	PUNCT
bjp-25731	31	3	it	it	PRON
bjp-25731	31	4	qualifies	qualify	VERB
bjp-25731	31	5	to	to	PART
bjp-25731	31	6	be	be	AUX
bjp-25731	31	7	called	call	VERB
bjp-25731	31	8	benzopyrimidine	benzopyrimidine	NOUN
bjp-25731	31	9	.	.	PUNCT
bjp-25731	32	1	it	it	PRON
bjp-25731	32	2	is	be	AUX
bjp-25731	32	3	a	a	DET
bjp-25731	32	4	yellow	yellow	ADJ
bjp-25731	32	5	colored	colored	ADJ
bjp-25731	32	6	solid	solid	ADJ
bjp-25731	32	7	compound	compound	NOUN
bjp-25731	32	8	having	have	VERB
bjp-25731	32	9	the	the	DET
bjp-25731	32	10	chemical	chemical	ADJ
bjp-25731	32	11	formular	formular	NOUN
bjp-25731	32	12	c8h6n2	c8h6n2	NOUN
bjp-25731	32	13	and	and	CCONJ
bjp-25731	32	14	a	a	DET
bjp-25731	32	15	molecular	molecular	ADJ
bjp-25731	32	16	mass	mass	NOUN
bjp-25731	32	17	of	of	ADP
bjp-25731	32	18	130.1	130.1	NUM
bjp-25731	32	19	g	g	NOUN
bjp-25731	32	20	/	/	SYM
bjp-25731	32	21	mol	mol	NOUN
bjp-25731	32	22	.	.	PUNCT
bjp-25731	33	1	it	it	PRON
bjp-25731	33	2	is	be	AUX
bjp-25731	33	3	usually	usually	ADV
bjp-25731	33	4	found	find	VERB
bjp-25731	33	5	in	in	ADP
bjp-25731	33	6	crystalline	crystalline	NOUN
bjp-25731	33	7	state	state	NOUN
bjp-25731	33	8	and	and	CCONJ
bjp-25731	33	9	it	it	PRON
bjp-25731	33	10	is	be	AUX
bjp-25731	33	11	isomeric	isomeric	ADJ
bjp-25731	33	12	with	with	ADP
bjp-25731	33	13	other	other	ADJ
bjp-25731	33	14	naphthyridines	naphthyridine	NOUN
bjp-25731	33	15	including	include	VERB
bjp-25731	33	16	quinoxaline	quinoxaline	ADJ
bjp-25731	33	17	,	,	PUNCT
bjp-25731	33	18	phthalazine	phthalazine	ADJ
bjp-25731	33	19	and	and	CCONJ
bjp-25731	33	20	cinnoline	cinnoline	PROPN
bjp-25731	33	21	(	(	PUNCT
bjp-25731	33	22	selvam	selvam	PROPN
bjp-25731	33	23	et	et	PROPN
bjp-25731	33	24	al	al	PROPN
bjp-25731	33	25	.	.	PROPN
bjp-25731	33	26	,	,	PUNCT
bjp-25731	33	27	2008	2008	NUM
bjp-25731	33	28	)	)	PUNCT
bjp-25731	33	29	.	.	PUNCT
bjp-25731	34	1	natural	natural	ADJ
bjp-25731	34	2	occurrence	occurrence	NOUN
bjp-25731	34	3	quinazoline	quinazoline	PROPN
bjp-25731	34	4	occurs	occur	VERB
bjp-25731	34	5	mostly	mostly	ADV
bjp-25731	34	6	as	as	ADP
bjp-25731	34	7	alkaloid	alkaloid	NOUN
bjp-25731	34	8	in	in	ADP
bjp-25731	34	9	root	root	NOUN
bjp-25731	34	10	and	and	CCONJ
bjp-25731	34	11	leaves	leave	NOUN
bjp-25731	34	12	of	of	ADP
bjp-25731	34	13	some	some	DET
bjp-25731	34	14	medicinal	medicinal	ADJ
bjp-25731	34	15	plants	plant	NOUN
bjp-25731	34	16	such	such	ADJ
bjp-25731	34	17	as	as	ADP
bjp-25731	34	18	dichroa	dichroa	NOUN
bjp-25731	34	19	febrifuga	febrifuga	NOUN
bjp-25731	34	20	(	(	PUNCT
bjp-25731	34	21	also	also	ADV
bjp-25731	34	22	called	call	VERB
bjp-25731	34	23	chinese	chinese	ADJ
bjp-25731	34	24	quinine	quinine	NOUN
bjp-25731	34	25	)	)	PUNCT
bjp-25731	34	26	which	which	PRON
bjp-25731	34	27	belongs	belong	VERB
bjp-25731	34	28	to	to	ADP
bjp-25731	34	29	the	the	DET
bjp-25731	34	30	saxifragaceae	saxifragaceae	PROPN
bjp-25731	34	31	family	family	NOUN
bjp-25731	34	32	(	(	PUNCT
bjp-25731	34	33	mclaughlin	mclaughlin	PROPN
bjp-25731	34	34	et	et	PROPN
bjp-25731	34	35	al	al	PROPN
bjp-25731	34	36	.	.	PROPN
bjp-25731	34	37	,	,	PUNCT
bjp-25731	34	38	2014	2014	NUM
bjp-25731	34	39	)	)	PUNCT
bjp-25731	34	40	.	.	PUNCT
bjp-25731	35	1	they	they	PRON
bjp-25731	35	2	are	be	AUX
bjp-25731	35	3	present	present	ADJ
bjp-25731	35	4	there	there	ADV
bjp-25731	35	5	as	as	ADP
bjp-25731	35	6	isomeric	isomeric	ADJ
bjp-25731	35	7	alkaloids	alkaloid	NOUN
bjp-25731	35	8	(	(	PUNCT
bjp-25731	35	9	+	+	ADJ
bjp-25731	35	10	)	)	PUNCT
bjp-25731	35	11	-febrifugine	-febrifugine	NOUN
bjp-25731	35	12	4a	4a	NOUN
bjp-25731	35	13	and	and	CCONJ
bjp-25731	35	14	(	(	PUNCT
bjp-25731	35	15	+	+	ADJ
bjp-25731	35	16	)	)	PUNCT
bjp-25731	35	17	-isofebrifugine	-isofebrifugine	ADJ
bjp-25731	35	18	4b	4b	PROPN
bjp-25731	35	19	.	.	PUNCT
bjp-25731	36	1	the	the	DET
bjp-25731	36	2	recent	recent	ADJ
bjp-25731	36	3	review	review	NOUN
bjp-25731	36	4	summarized	summarize	VERB
bjp-25731	36	5	historical	historical	ADJ
bjp-25731	36	6	isolation	isolation	NOUN
bjp-25731	36	7	information	information	NOUN
bjp-25731	36	8	and	and	CCONJ
bjp-25731	36	9	the	the	DET
bjp-25731	36	10	chemistry	chemistry	NOUN
bjp-25731	36	11	studies	study	NOUN
bjp-25731	36	12	which	which	PRON
bjp-25731	36	13	culminated	culminate	VERB
bjp-25731	36	14	in	in	ADP
bjp-25731	36	15	the	the	DET
bjp-25731	36	16	correct	correct	ADJ
bjp-25731	36	17	structural	structural	ADJ
bjp-25731	36	18	elucidation	elucidation	NOUN
bjp-25731	36	19	of	of	ADP
bjp-25731	36	20	this	this	PRON
bjp-25731	36	21	naturally	naturally	ADV
bjp-25731	36	22	occurring	occur	VERB
bjp-25731	36	23	quinazoline	quinazoline	NOUN
bjp-25731	36	24	-	-	PUNCT
bjp-25731	36	25	based	base	VERB
bjp-25731	36	26	alkaloid	alkaloid	NOUN
bjp-25731	36	27	called	call	VERB
bjp-25731	36	28	febrifugine	febrifugine	PROPN
bjp-25731	36	29	and	and	CCONJ
bjp-25731	36	30	its	its	PRON
bjp-25731	36	31	isomer	isomer	PROPN
bjp-25731	36	32	,	,	PUNCT
bjp-25731	36	33	isofebrifugine	isofebrifugine	NOUN
bjp-25731	36	34	(	(	PUNCT
bjp-25731	36	35	mclaughlin	mclaughlin	PROPN
bjp-25731	36	36	et	et	PROPN
bjp-25731	36	37	al	al	PROPN
bjp-25731	36	38	.	.	PROPN
bjp-25731	36	39	,	,	PUNCT
bjp-25731	36	40	2014	2014	NUM
bjp-25731	36	41	)	)	PUNCT
bjp-25731	36	42	.	.	PUNCT
bjp-25731	37	1	hydrachine	hydrachine	VERB
bjp-25731	37	2	a	a	DET
bjp-25731	37	3	5	5	NUM
bjp-25731	37	4	,	,	PUNCT
bjp-25731	37	5	a	a	DET
bjp-25731	37	6	natural	natural	ADJ
bjp-25731	37	7	quinazoline	quinazoline	NOUN
bjp-25731	37	8	-	-	PUNCT
bjp-25731	37	9	core	core	NOUN
bjp-25731	37	10	,	,	PUNCT
bjp-25731	37	11	was	be	AUX
bjp-25731	37	12	isolated	isolate	VERB
bjp-25731	37	13	from	from	ADP
bjp-25731	37	14	the	the	DET
bjp-25731	37	15	roots	root	NOUN
bjp-25731	37	16	of	of	ADP
bjp-25731	37	17	hydrangea	hydrangea	NOUN
bjp-25731	37	18	chinensis	chinensis	NOUN
bjp-25731	37	19	(	(	PUNCT
bjp-25731	37	20	chang	chang	PROPN
bjp-25731	37	21	et	et	PROPN
bjp-25731	37	22	al	al	PROPN
bjp-25731	37	23	.	.	PROPN
bjp-25731	37	24	,	,	PUNCT
bjp-25731	37	25	2003	2003	NUM
bjp-25731	37	26	)	)	PUNCT
bjp-25731	37	27	.	.	PUNCT
bjp-25731	38	1	the	the	DET
bjp-25731	38	2	structures	structure	NOUN
bjp-25731	38	3	of	of	ADP
bjp-25731	38	4	these	these	PRON
bjp-25731	38	5	naturally	naturally	ADV
bjp-25731	38	6	occurring	occur	VERB
bjp-25731	38	7	quinazoline	quinazoline	ADJ
bjp-25731	38	8	motifs	motif	NOUN
bjp-25731	38	9	are	be	AUX
bjp-25731	38	10	as	as	SCONJ
bjp-25731	38	11	shown	show	VERB
bjp-25731	38	12	in	in	ADP
bjp-25731	38	13	figure	figure	NOUN
bjp-25731	38	14	2	2	NUM
bjp-25731	38	15	.	.	PUNCT
bjp-25731	38	16	structure	structure	NOUN
bjp-25731	38	17	of	of	ADP
bjp-25731	38	18	quinazoline	quinazoline	NOUN
bjp-25731	38	19	/	/	SYM
bjp-25731	38	20	auinazolinone	auinazolinone	NOUN
bjp-25731	38	21	in	in	ADP
bjp-25731	38	22	quinazoline	quinazoline	NOUN
bjp-25731	38	23	structure	structure	NOUN
bjp-25731	38	24	,	,	PUNCT
bjp-25731	38	25	the	the	DET
bjp-25731	38	26	reactivity	reactivity	NOUN
bjp-25731	38	27	behaviour	behaviour	NOUN
bjp-25731	38	28	of	of	ADP
bjp-25731	38	29	heteroatomic	heteroatomic	ADJ
bjp-25731	38	30	six	six	NUM
bjp-25731	38	31	-	-	PUNCT
bjp-25731	38	32	membered	membere	VERB
bjp-25731	38	33	ring	ring	NOUN
bjp-25731	38	34	is	be	AUX
bjp-25731	38	35	significantly	significantly	ADV
bjp-25731	38	36	affected	affect	VERB
bjp-25731	38	37	by	by	ADP
bjp-25731	38	38	the	the	DET
bjp-25731	38	39	incorporated	incorporated	ADJ
bjp-25731	38	40	benzene	benzene	NOUN
bjp-25731	38	41	nucleus	nucleus	NOUN
bjp-25731	38	42	.	.	PUNCT
bjp-25731	39	1	the	the	DET
bjp-25731	39	2	two	two	NUM
bjp-25731	39	3	nheteroatoms	nheteroatom	NOUN
bjp-25731	39	4	are	be	AUX
bjp-25731	39	5	slightly	slightly	ADV
bjp-25731	39	6	different	different	ADJ
bjp-25731	39	7	in	in	ADP
bjp-25731	39	8	their	their	PRON
bjp-25731	39	9	reaction	reaction	NOUN
bjp-25731	39	10	,	,	PUNCT
bjp-25731	39	11	and	and	CCONJ
bjp-25731	39	12	the	the	DET
bjp-25731	39	13	existed	existed	ADJ
bjp-25731	39	14	polarization	polarization	NOUN
bjp-25731	39	15	of	of	ADP
bjp-25731	39	16	the	the	DET
bjp-25731	39	17	π	π	PROPN
bjp-25731	39	18	bond	bond	NOUN
bjp-25731	39	19	at	at	ADP
bjp-25731	39	20	3,4	3,4	NUM
bjp-25731	39	21	-	-	PUNCT
bjp-25731	39	22	position	position	NOUN
bjp-25731	39	23	is	be	AUX
bjp-25731	39	24	unveiled	unveil	VERB
bjp-25731	39	25	in	in	ADP
bjp-25731	39	26	the	the	DET
bjp-25731	39	27	marked	mark	VERB
bjp-25731	39	28	reactions	reaction	NOUN
bjp-25731	39	29	of	of	ADP
bjp-25731	39	30	quinazoline	quinazoline	NOUN
bjp-25731	39	31	.	.	PUNCT
bjp-25731	40	1	the	the	DET
bjp-25731	40	2	substituted	substitute	VERB
bjp-25731	40	3	quinazolines	quinazoline	NOUN
bjp-25731	40	4	nature	nature	NOUN
bjp-25731	40	5	is	be	AUX
bjp-25731	40	6	mainly	mainly	ADV
bjp-25731	40	7	determined	determine	VERB
bjp-25731	40	8	by	by	ADP
bjp-25731	40	9	position	position	NOUN
bjp-25731	40	10	of	of	ADP
bjp-25731	40	11	substituents	substituent	NOUN
bjp-25731	40	12	attachment	attachment	NOUN
bjp-25731	40	13	,	,	PUNCT
bjp-25731	40	14	i.e.	i.e.	X
bjp-25731	40	15	if	if	SCONJ
bjp-25731	40	16	they	they	PRON
bjp-25731	40	17	are	be	AUX
bjp-25731	40	18	either	either	ADV
bjp-25731	40	19	attached	attach	VERB
bjp-25731	40	20	to	to	ADP
bjp-25731	40	21	the	the	DET
bjp-25731	40	22	heteroatomic	heteroatomic	ADJ
bjp-25731	40	23	ring	ring	NOUN
bjp-25731	40	24	portion	portion	NOUN
bjp-25731	40	25	or	or	CCONJ
bjp-25731	40	26	benzene	benzene	NOUN
bjp-25731	40	27	nucleus	nucleus	NOUN
bjp-25731	40	28	.	.	PUNCT
bjp-25731	41	1	another	another	DET
bjp-25731	41	2	factor	factor	NOUN
bjp-25731	41	3	has	have	VERB
bjp-25731	41	4	to	to	PART
bjp-25731	41	5	do	do	VERB
bjp-25731	41	6	with	with	ADP
bjp-25731	41	7	whether	whether	SCONJ
bjp-25731	41	8	there	there	PRON
bjp-25731	41	9	is	be	VERB
bjp-25731	41	10	complete	complete	ADJ
bjp-25731	41	11	conjugation	conjugation	NOUN
bjp-25731	41	12	in	in	ADP
bjp-25731	41	13	the	the	DET
bjp-25731	41	14	pyrimidine	pyrimidine	NOUN
bjp-25731	41	15	ring	ring	NOUN
bjp-25731	41	16	or	or	CCONJ
bjp-25731	41	17	not	not	PART
bjp-25731	41	18	(	(	PUNCT
bjp-25731	41	19	vijayakumar	vijayakumar	PROPN
bjp-25731	41	20	et	et	PROPN
bjp-25731	41	21	al	al	PROPN
bjp-25731	41	22	.	.	PROPN
bjp-25731	41	23	,	,	PUNCT
bjp-25731	41	24	2013	2013	NUM
bjp-25731	41	25	)	)	PUNCT
bjp-25731	41	26	.	.	PUNCT
bjp-25731	42	1	bangladesh	bangladesh	PROPN
bjp-25731	42	2	j	j	PROPN
bjp-25731	42	3	pharmacol	pharmacol	PROPN
bjp-25731	42	4	2016	2016	NUM
bjp-25731	42	5	;	;	PUNCT
bjp-25731	42	6	11	11	NUM
bjp-25731	42	7	:	:	PUNCT
bjp-25731	42	8	716	716	NUM
bjp-25731	42	9	-	-	SYM
bjp-25731	42	10	733	733	NUM
bjp-25731	42	11	717	717	NUM
bjp-25731	42	12	figure	figure	NOUN
bjp-25731	42	13	1	1	NUM
bjp-25731	42	14	:	:	PUNCT
bjp-25731	42	15	selected	select	VERB
bjp-25731	42	16	commercially	commercially	ADV
bjp-25731	42	17	available	available	ADJ
bjp-25731	42	18	drug	drug	NOUN
bjp-25731	42	19	bearing	bear	VERB
bjp-25731	42	20	quinazoline	quinazoline	NOUN
bjp-25731	42	21	core	core	NOUN
bjp-25731	42	22	figure	figure	NOUN
bjp-25731	42	23	2	2	NUM
bjp-25731	42	24	:	:	PUNCT
bjp-25731	42	25	structural	structural	ADJ
bjp-25731	42	26	identity	identity	NOUN
bjp-25731	42	27	of	of	ADP
bjp-25731	42	28	some	some	PRON
bjp-25731	42	29	naturally	naturally	ADV
bjp-25731	42	30	occurring	occur	VERB
bjp-25731	42	31	quinazoline	quinazoline	ADJ
bjp-25731	42	32	motifs	motif	NOUN
bjp-25731	42	33	classification	classification	NOUN
bjp-25731	42	34	of	of	ADP
bjp-25731	42	35	quinazolinones	quinazolinone	NOUN
bjp-25731	42	36	based	base	VERB
bjp-25731	42	37	on	on	ADP
bjp-25731	42	38	substitution	substitution	NOUN
bjp-25731	42	39	pattern	pattern	NOUN
bjp-25731	42	40	of	of	ADP
bjp-25731	42	41	its	its	PRON
bjp-25731	42	42	ring	ring	NOUN
bjp-25731	42	43	system	system	NOUN
bjp-25731	42	44	,	,	PUNCT
bjp-25731	42	45	quinazolinones	quinazolinone	NOUN
bjp-25731	42	46	can	can	AUX
bjp-25731	42	47	be	be	AUX
bjp-25731	42	48	classified	classify	VERB
bjp-25731	42	49	into	into	ADP
bjp-25731	42	50	the	the	DET
bjp-25731	42	51	following	follow	VERB
bjp-25731	42	52	categories	category	NOUN
bjp-25731	42	53	:	:	PUNCT
bjp-25731	42	54	2	2	NUM
bjp-25731	42	55	-	-	PUNCT
bjp-25731	42	56	substituted-4(3h)-quinazolinones	substituted-4(3h)-quinazolinone	NOUN
bjp-25731	42	57	6	6	NUM
bjp-25731	42	58	,	,	PUNCT
bjp-25731	42	59	3substituted	3substituted	NUM
bjp-25731	42	60	one	one	NUM
bjp-25731	42	61	7	7	NUM
bjp-25731	42	62	,	,	PUNCT
bjp-25731	42	63	4	4	NUM
bjp-25731	42	64	-	-	PUNCT
bjp-25731	42	65	substituted	substitute	VERB
bjp-25731	42	66	one	one	NUM
bjp-25731	42	67	8	8	NUM
bjp-25731	42	68	and	and	CCONJ
bjp-25731	42	69	2,3	2,3	NUM
bjp-25731	42	70	-	-	PUNCT
bjp-25731	42	71	disubstituted	disubstitute	VERB
bjp-25731	42	72	type	type	NOUN
bjp-25731	42	73	9	9	NUM
bjp-25731	42	74	(	(	PUNCT
bjp-25731	42	75	mhaske	mhaske	ADJ
bjp-25731	42	76	and	and	CCONJ
bjp-25731	42	77	argade	argade	NOUN
bjp-25731	42	78	,	,	PUNCT
bjp-25731	42	79	2006	2006	NUM
bjp-25731	42	80	)	)	PUNCT
bjp-25731	42	81	as	as	SCONJ
bjp-25731	42	82	shown	show	VERB
bjp-25731	42	83	in	in	ADP
bjp-25731	42	84	figure	figure	NOUN
bjp-25731	42	85	3	3	NUM
bjp-25731	42	86	.	.	PUNCT
bjp-25731	42	87	based	base	VERB
bjp-25731	42	88	on	on	ADP
bjp-25731	42	89	the	the	DET
bjp-25731	42	90	location	location	NOUN
bjp-25731	42	91	of	of	ADP
bjp-25731	42	92	oxo	oxo	NOUN
bjp-25731	42	93	group	group	NOUN
bjp-25731	42	94	,	,	PUNCT
bjp-25731	42	95	quinazoline	quinazoline	PROPN
bjp-25731	42	96	could	could	AUX
bjp-25731	42	97	be	be	AUX
bjp-25731	42	98	further	far	ADV
bjp-25731	42	99	categorized	categorize	VERB
bjp-25731	42	100	into	into	ADP
bjp-25731	42	101	three	three	NUM
bjp-25731	42	102	other	other	ADJ
bjp-25731	42	103	classes	class	NOUN
bjp-25731	42	104	which	which	PRON
bjp-25731	42	105	include	include	VERB
bjp-25731	42	106	:	:	PUNCT
bjp-25731	42	107	quinazolin-2(1h)-ones	quinazolin-2(1h)-one	NOUN
bjp-25731	42	108	,	,	PUNCT
bjp-25731	42	109	quinazolin-4(3h)-ones	quinazolin-4(3h)-one	NOUN
bjp-25731	42	110	and	and	CCONJ
bjp-25731	42	111	quinazoline-2,4(1h,3h)dione	quinazoline-2,4(1h,3h)dione	NOUN
bjp-25731	42	112	(	(	PUNCT
bjp-25731	42	113	mahato	mahato	PROPN
bjp-25731	42	114	et	et	PROPN
bjp-25731	42	115	al	al	PROPN
bjp-25731	42	116	.	.	PROPN
bjp-25731	42	117	,	,	PUNCT
bjp-25731	42	118	2011	2011	NUM
bjp-25731	42	119	)	)	PUNCT
bjp-25731	42	120	.	.	PUNCT
bjp-25731	43	1	it	it	PRON
bjp-25731	43	2	is	be	AUX
bjp-25731	43	3	worthy	worthy	ADJ
bjp-25731	43	4	to	to	PART
bjp-25731	43	5	note	note	VERB
bjp-25731	43	6	that	that	SCONJ
bjp-25731	43	7	,	,	PUNCT
bjp-25731	43	8	of	of	ADP
bjp-25731	43	9	all	all	DET
bjp-25731	43	10	the	the	DET
bjp-25731	43	11	templates	template	NOUN
bjp-25731	43	12	,	,	PUNCT
bjp-25731	43	13	quinazolin-4(3h)-ones	quinazolin-4(3h)-one	NOUN
bjp-25731	43	14	are	be	AUX
bjp-25731	43	15	the	the	DET
bjp-25731	43	16	commonest	commonest	NOUN
bjp-25731	43	17	privileged	privileged	ADJ
bjp-25731	43	18	in	in	ADP
bjp-25731	43	19	terms	term	NOUN
bjp-25731	43	20	of	of	ADP
bjp-25731	43	21	naturally	naturally	ADV
bjp-25731	43	22	occurring	occur	VERB
bjp-25731	43	23	molecular	molecular	ADJ
bjp-25731	43	24	features	feature	NOUN
bjp-25731	43	25	or	or	CCONJ
bjp-25731	43	26	intermediates	intermediate	NOUN
bjp-25731	43	27	in	in	ADP
bjp-25731	43	28	numerous	numerous	ADJ
bjp-25731	43	29	reported	report	VERB
bjp-25731	43	30	construction	construction	NOUN
bjp-25731	43	31	route	route	NOUN
bjp-25731	43	32	in	in	ADP
bjp-25731	43	33	biosyn	biosyn	NOUN
bjp-25731	43	34	-	-	PUNCT
bjp-25731	43	35	thesis	thesis	NOUN
bjp-25731	43	36	(	(	PUNCT
bjp-25731	43	37	mahato	mahato	NOUN
bjp-25731	43	38	et	et	PROPN
bjp-25731	43	39	al	al	PROPN
bjp-25731	43	40	.	.	PROPN
bjp-25731	43	41	,	,	PUNCT
bjp-25731	43	42	2011	2011	NUM
bjp-25731	43	43	)	)	PUNCT
bjp-25731	43	44	.	.	PUNCT
bjp-25731	44	1	justification	justification	NOUN
bjp-25731	44	2	for	for	ADP
bjp-25731	44	3	expository	expository	ADJ
bjp-25731	44	4	study	study	NOUN
bjp-25731	44	5	on	on	ADP
bjp-25731	44	6	quinazoline	quinazoline	NOUN
bjp-25731	44	7	derivatives	derivative	NOUN
bjp-25731	44	8	the	the	DET
bjp-25731	44	9	recent	recent	ADJ
bjp-25731	44	10	development	development	NOUN
bjp-25731	44	11	in	in	ADP
bjp-25731	44	12	the	the	DET
bjp-25731	44	13	medicinal	medicinal	ADJ
bjp-25731	44	14	importance	importance	NOUN
bjp-25731	44	15	of	of	ADP
bjp-25731	44	16	quinazoline	quinazoline	NOUN
bjp-25731	44	17	derivatives	derivative	NOUN
bjp-25731	44	18	has	have	AUX
bjp-25731	44	19	necessitated	necessitate	VERB
bjp-25731	44	20	strong	strong	ADJ
bjp-25731	44	21	international	international	ADJ
bjp-25731	44	22	effort	effort	NOUN
bjp-25731	44	23	for	for	ADP
bjp-25731	44	24	the	the	DET
bjp-25731	44	25	development	development	NOUN
bjp-25731	44	26	of	of	ADP
bjp-25731	44	27	new	new	ADJ
bjp-25731	44	28	and	and	CCONJ
bjp-25731	44	29	better	well	ADJ
bjp-25731	44	30	synthetic	synthetic	ADJ
bjp-25731	44	31	strategies	strategy	NOUN
bjp-25731	44	32	for	for	ADP
bjp-25731	44	33	their	their	PRON
bjp-25731	44	34	preparations	preparation	NOUN
bjp-25731	44	35	.	.	PUNCT
bjp-25731	45	1	the	the	DET
bjp-25731	45	2	relinquishable	relinquishable	ADJ
bjp-25731	45	3	attribute	attribute	NOUN
bjp-25731	45	4	of	of	ADP
bjp-25731	45	5	its	its	PRON
bjp-25731	45	6	characteristic	characteristic	NOUN
bjp-25731	45	7	offers	offer	VERB
bjp-25731	45	8	an	an	DET
bjp-25731	45	9	effective	effective	ADJ
bjp-25731	45	10	justification	justification	NOUN
bjp-25731	45	11	for	for	ADP
bjp-25731	45	12	the	the	DET
bjp-25731	45	13	discovery	discovery	NOUN
bjp-25731	45	14	of	of	ADP
bjp-25731	45	15	these	these	DET
bjp-25731	45	16	techniques	technique	NOUN
bjp-25731	45	17	(	(	PUNCT
bjp-25731	45	18	portela	portela	NOUN
bjp-25731	45	19	-	-	ADJ
bjp-25731	45	20	cubillo	cubillo	NOUN
bjp-25731	45	21	et	et	PROPN
bjp-25731	45	22	al	al	PROPN
bjp-25731	45	23	.	.	PROPN
bjp-25731	45	24	,	,	PUNCT
bjp-25731	45	25	2009	2009	NUM
bjp-25731	45	26	)	)	PUNCT
bjp-25731	45	27	.	.	PUNCT
bjp-25731	46	1	synthetic	synthetic	ADJ
bjp-25731	46	2	chemists	chemist	NOUN
bjp-25731	46	3	are	be	AUX
bjp-25731	46	4	continuously	continuously	ADV
bjp-25731	46	5	engaging	engage	VERB
bjp-25731	46	6	the	the	DET
bjp-25731	46	7	preparation	preparation	NOUN
bjp-25731	46	8	of	of	ADP
bjp-25731	46	9	quinazoline	quinazoline	NOUN
bjp-25731	46	10	and	and	CCONJ
bjp-25731	46	11	its	its	PRON
bjp-25731	46	12	derivatives	derivative	NOUN
bjp-25731	46	13	by	by	ADP
bjp-25731	46	14	simple	simple	ADJ
bjp-25731	46	15	and	and	CCONJ
bjp-25731	46	16	effective	effective	ADJ
bjp-25731	46	17	methods	method	NOUN
bjp-25731	46	18	because	because	SCONJ
bjp-25731	46	19	of	of	ADP
bjp-25731	46	20	its	its	PRON
bjp-25731	46	21	diverse	diverse	ADJ
bjp-25731	46	22	biological	biological	ADJ
bjp-25731	46	23	applications	application	NOUN
bjp-25731	46	24	such	such	ADJ
bjp-25731	46	25	as	as	ADP
bjp-25731	46	26	anti	anti	ADJ
bjp-25731	46	27	-	-	ADJ
bjp-25731	46	28	cancer	cancer	ADJ
bjp-25731	46	29	,	,	PUNCT
bjp-25731	46	30	antiviral	antiviral	ADJ
bjp-25731	46	31	and	and	CCONJ
bjp-25731	46	32	antitubercular	antitubercular	ADJ
bjp-25731	46	33	agents	agent	NOUN
bjp-25731	46	34	.	.	PUNCT
bjp-25731	47	1	the	the	DET
bjp-25731	47	2	quinazoline	quinazoline	PROPN
bjp-25731	47	3	unit	unit	NOUN
bjp-25731	47	4	is	be	AUX
bjp-25731	47	5	represented	represent	VERB
bjp-25731	47	6	in	in	ADP
bjp-25731	47	7	a	a	DET
bjp-25731	47	8	number	number	NOUN
bjp-25731	47	9	of	of	ADP
bjp-25731	47	10	useful	useful	ADJ
bjp-25731	47	11	natural	natural	ADJ
bjp-25731	47	12	product	product	NOUN
bjp-25731	47	13	scaffolds	scaffold	NOUN
bjp-25731	47	14	with	with	ADP
bjp-25731	47	15	laudable	laudable	ADJ
bjp-25731	47	16	activities	activity	NOUN
bjp-25731	47	17	against	against	ADP
bjp-25731	47	18	numerous	numerous	ADJ
bjp-25731	47	19	pharmacological	pharmacological	ADJ
bjp-25731	47	20	disorders	disorder	NOUN
bjp-25731	47	21	.	.	PUNCT
bjp-25731	48	1	on	on	ADP
bjp-25731	48	2	this	this	DET
bjp-25731	48	3	note	note	NOUN
bjp-25731	48	4	,	,	PUNCT
bjp-25731	48	5	quinazoline	quinazoline	ADJ
bjp-25731	48	6	moieties	moiety	NOUN
bjp-25731	48	7	are	be	AUX
bjp-25731	48	8	one	one	NUM
bjp-25731	48	9	of	of	ADP
bjp-25731	48	10	the	the	DET
bjp-25731	48	11	strongest	strong	ADJ
bjp-25731	48	12	ever	ever	ADV
bjp-25731	48	13	reported	report	VERB
bjp-25731	48	14	inhibitors	inhibitor	NOUN
bjp-25731	48	15	cellular	cellular	ADJ
bjp-25731	48	16	phosphorylation	phosphorylation	NOUN
bjp-25731	48	17	and	and	CCONJ
bjp-25731	48	18	tyrosine	tyrosine	PROPN
bjp-25731	48	19	kinase	kinase	PROPN
bjp-25731	48	20	.	.	PUNCT
bjp-25731	49	1	these	these	DET
bjp-25731	49	2	heterocycles	heterocycle	NOUN
bjp-25731	49	3	have	have	AUX
bjp-25731	49	4	functioned	function	VERB
bjp-25731	49	5	as	as	ADP
bjp-25731	49	6	common	common	ADJ
bjp-25731	49	7	ligands	ligand	NOUN
bjp-25731	49	8	in	in	ADP
bjp-25731	49	9	deoxyribonucleic	deoxyribonucleic	ADJ
bjp-25731	49	10	acid	acid	NOUN
bjp-25731	49	11	,	,	PUNCT
bjp-25731	49	12	which	which	PRON
bjp-25731	49	13	link	link	VERB
bjp-25731	49	14	to	to	PART
bjp-25731	49	15	adenosine	adenosine	VERB
bjp-25731	49	16	receptors	receptor	NOUN
bjp-25731	49	17	,	,	PUNCT
bjp-25731	49	18	as	as	ADV
bjp-25731	49	19	well	well	ADV
bjp-25731	49	20	as	as	ADP
bjp-25731	49	21	being	be	AUX
bjp-25731	49	22	efficacious	efficacious	ADJ
bjp-25731	49	23	as	as	ADP
bjp-25731	49	24	tough	tough	ADJ
bjp-25731	49	25	antibacterial	antibacterial	ADJ
bjp-25731	49	26	agents	agent	NOUN
bjp-25731	49	27	(	(	PUNCT
bjp-25731	49	28	portela	portela	NOUN
bjp-25731	49	29	-	-	ADJ
bjp-25731	49	30	cubillo	cubillo	NOUN
bjp-25731	49	31	et	et	PROPN
bjp-25731	49	32	al	al	PROPN
bjp-25731	49	33	.	.	PROPN
bjp-25731	49	34	,	,	PUNCT
bjp-25731	49	35	2009	2009	NUM
bjp-25731	49	36	)	)	PUNCT
bjp-25731	49	37	.	.	PUNCT
bjp-25731	50	1	no	no	DET
bjp-25731	50	2	wonder	wonder	NOUN
bjp-25731	50	3	their	their	PRON
bjp-25731	50	4	frameworks	framework	NOUN
bjp-25731	50	5	serve	serve	VERB
bjp-25731	50	6	as	as	ADP
bjp-25731	50	7	the	the	DET
bjp-25731	50	8	foundation	foundation	NOUN
bjp-25731	50	9	in	in	ADP
bjp-25731	50	10	the	the	DET
bjp-25731	50	11	application	application	NOUN
bjp-25731	50	12	that	that	PRON
bjp-25731	50	13	have	have	VERB
bjp-25731	50	14	to	to	PART
bjp-25731	50	15	do	do	VERB
bjp-25731	50	16	with	with	ADP
bjp-25731	50	17	lots	lot	NOUN
bjp-25731	50	18	of	of	ADP
bjp-25731	50	19	pharmaceutical	pharmaceutical	NOUN
bjp-25731	50	20	,	,	PUNCT
bjp-25731	50	21	agrochemical	agrochemical	NOUN
bjp-25731	50	22	,	,	PUNCT
bjp-25731	50	23	and	and	CCONJ
bjp-25731	50	24	veterinary	veterinary	ADJ
bjp-25731	50	25	products	product	NOUN
bjp-25731	50	26	(	(	PUNCT
bjp-25731	50	27	portela	portela	NOUN
bjp-25731	50	28	-	-	ADJ
bjp-25731	50	29	cubillo	cubillo	NOUN
bjp-25731	50	30	et	et	PROPN
bjp-25731	50	31	al	al	PROPN
bjp-25731	50	32	.	.	PROPN
bjp-25731	50	33	,	,	PUNCT
bjp-25731	50	34	2009	2009	NUM
bjp-25731	50	35	)	)	PUNCT
bjp-25731	50	36	.	.	PUNCT
bjp-25731	51	1	the	the	DET
bjp-25731	51	2	increasing	increase	VERB
bjp-25731	51	3	significance	significance	NOUN
bjp-25731	51	4	of	of	ADP
bjp-25731	51	5	quinazolines	quinazoline	NOUN
bjp-25731	51	6	around	around	ADP
bjp-25731	51	7	therapeutic	therapeutic	ADJ
bjp-25731	51	8	research	research	NOUN
bjp-25731	51	9	has	have	AUX
bjp-25731	51	10	been	be	AUX
bjp-25731	51	11	noticed	notice	VERB
bjp-25731	51	12	based	base	VERB
bjp-25731	51	13	on	on	ADP
bjp-25731	51	14	the	the	DET
bjp-25731	51	15	reported	report	VERB
bjp-25731	51	16	highly	highly	ADV
bjp-25731	51	17	voluminous	voluminous	ADJ
bjp-25731	51	18	selling	selling	NOUN
bjp-25731	51	19	of	of	ADP
bjp-25731	51	20	the	the	DET
bjp-25731	51	21	quinazoline	quinazoline	NOUN
bjp-25731	51	22	-	-	PUNCT
bjp-25731	51	23	based	base	VERB
bjp-25731	51	24	drugs	drug	NOUN
bjp-25731	51	25	called	call	VERB
bjp-25731	51	26	erlotinib	erlotinib	NOUN
bjp-25731	51	27	1	1	NUM
bjp-25731	51	28	,	,	PUNCT
bjp-25731	51	29	which	which	PRON
bjp-25731	51	30	serves	serve	VERB
bjp-25731	51	31	a	a	DET
bjp-25731	51	32	well	well	ADV
bjp-25731	51	33	-	-	PUNCT
bjp-25731	51	34	recognized	recognize	VERB
bjp-25731	51	35	curing	cure	VERB
bjp-25731	51	36	agent	agent	NOUN
bjp-25731	51	37	for	for	ADP
bjp-25731	51	38	various	various	ADJ
bjp-25731	51	39	kinds	kind	NOUN
bjp-25731	51	40	of	of	ADP
bjp-25731	51	41	tumours	tumours	PROPN
bjp-25731	51	42	(	(	PUNCT
bjp-25731	51	43	fung	fung	PROPN
bjp-25731	51	44	and	and	CCONJ
bjp-25731	51	45	grandis	grandis	PROPN
bjp-25731	51	46	,	,	PUNCT
bjp-25731	51	47	2010	2010	NUM
bjp-25731	51	48	;	;	PUNCT
bjp-25731	51	49	portelacubillo	portelacubillo	PROPN
bjp-25731	51	50	et	et	PROPN
bjp-25731	51	51	al	al	PROPN
bjp-25731	51	52	.	.	PROPN
bjp-25731	51	53	,	,	PUNCT
bjp-25731	51	54	2009	2009	NUM
bjp-25731	51	55	)	)	PUNCT
bjp-25731	51	56	and	and	CCONJ
bjp-25731	51	57	prazosin	prazosin	PROPN
bjp-25731	51	58	,	,	PUNCT
bjp-25731	51	59	which	which	PRON
bjp-25731	51	60	serves	serve	VERB
bjp-25731	51	61	as	as	ADP
bjp-25731	51	62	a	a	DET
bjp-25731	51	63	blocking	block	VERB
bjp-25731	51	64	agent	agent	NOUN
bjp-25731	51	65	for	for	ADP
bjp-25731	51	66	r	r	NOUN
bjp-25731	51	67	-	-	PUNCT
bjp-25731	51	68	adrenergic	adrenergic	ADJ
bjp-25731	51	69	blocker	blocker	NOUN
bjp-25731	51	70	.	.	PUNCT
bjp-25731	52	1	in	in	ADP
bjp-25731	52	2	the	the	DET
bjp-25731	52	3	same	same	ADJ
bjp-25731	52	4	vein	vein	NOUN
bjp-25731	52	5	,	,	PUNCT
bjp-25731	52	6	iressa	iressa	ADJ
bjp-25731	52	7	2	2	NUM
bjp-25731	52	8	,	,	PUNCT
bjp-25731	52	9	which	which	PRON
bjp-25731	52	10	serves	serve	VERB
bjp-25731	52	11	as	as	ADP
bjp-25731	52	12	an	an	DET
bjp-25731	52	13	inhibitor	inhibitor	NOUN
bjp-25731	52	14	of	of	ADP
bjp-25731	52	15	egfr	egfr	NOUN
bjp-25731	52	16	,	,	PUNCT
bjp-25731	52	17	has	have	AUX
bjp-25731	52	18	been	be	AUX
bjp-25731	52	19	certified	certify	VERB
bjp-25731	52	20	by	by	ADP
bjp-25731	52	21	the	the	DET
bjp-25731	52	22	united	united	PROPN
bjp-25731	52	23	state	state	PROPN
bjp-25731	52	24	food	food	PROPN
bjp-25731	52	25	and	and	CCONJ
bjp-25731	52	26	drug	drug	NOUN
bjp-25731	52	27	administration	administration	NOUN
bjp-25731	52	28	for	for	ADP
bjp-25731	52	29	the	the	DET
bjp-25731	52	30	treatment	treatment	NOUN
bjp-25731	52	31	of	of	ADP
bjp-25731	52	32	lung	lung	NOUN
bjp-25731	52	33	cancer	cancer	NOUN
bjp-25731	52	34	(	(	PUNCT
bjp-25731	52	35	portela	portela	INTJ
bjp-25731	52	36	-cubillo	-cubillo	PROPN
bjp-25731	52	37	et	et	NOUN
bjp-25731	52	38	al	al	PROPN
bjp-25731	52	39	.	.	PROPN
bjp-25731	52	40	,	,	PUNCT
bjp-25731	52	41	2009	2009	NUM
bjp-25731	52	42	)	)	PUNCT
bjp-25731	52	43	.	.	PUNCT
bjp-25731	53	1	prozosin	prozosin	PROPN
bjp-25731	53	2	,	,	PUNCT
bjp-25731	53	3	which	which	PRON
bjp-25731	53	4	is	be	AUX
bjp-25731	53	5	another	another	DET
bjp-25731	53	6	radrenergic	radrenergic	NOUN
bjp-25731	53	7	blocker	blocker	NOUN
bjp-25731	53	8	,	,	PUNCT
bjp-25731	53	9	is	be	AUX
bjp-25731	53	10	a	a	DET
bjp-25731	53	11	popular	popular	ADJ
bjp-25731	53	12	drug	drug	NOUN
bjp-25731	53	13	bearing	bear	VERB
bjp-25731	53	14	the	the	DET
bjp-25731	53	15	quinazoline	quinazoline	NOUN
bjp-25731	53	16	unit	unit	NOUN
bjp-25731	53	17	.	.	PUNCT
bjp-25731	54	1	quinazolin-4(3h)-one	quinazolin-4(3h)-one	PROPN
bjp-25731	54	2	bearing	bear	VERB
bjp-25731	54	3	a	a	DET
bjp-25731	54	4	benzyl	benzyl	NOUN
bjp-25731	54	5	functionality	functionality	NOUN
bjp-25731	54	6	at	at	ADP
bjp-25731	54	7	2	2	NUM
bjp-25731	54	8	-	-	PUNCT
bjp-25731	54	9	position	position	NOUN
bjp-25731	54	10	has	have	AUX
bjp-25731	54	11	been	be	AUX
bjp-25731	54	12	reported	report	VERB
bjp-25731	54	13	to	to	PART
bjp-25731	54	14	have	have	VERB
bjp-25731	54	15	selective	selective	ADJ
bjp-25731	54	16	inhibitory	inhibitory	ADJ
bjp-25731	54	17	efficiency	efficiency	NOUN
bjp-25731	54	18	on	on	ADP
bjp-25731	54	19	human	human	ADJ
bjp-25731	54	20	leucocyte	leucocyte	NOUN
bjp-25731	54	21	elastase	elastase	NOUN
bjp-25731	54	22	as	as	ADV
bjp-25731	54	23	well	well	ADV
bjp-25731	54	24	as	as	ADP
bjp-25731	54	25	on	on	ADP
bjp-25731	54	26	serine	serine	NOUN
bjp-25731	54	27	protease	protease	NOUN
bjp-25731	54	28	while	while	SCONJ
bjp-25731	54	29	1,3	1,3	NUM
bjp-25731	54	30	-	-	PUNCT
bjp-25731	54	31	dimethyl	dimethyl	NOUN
bjp-25731	54	32	-1	-1	PUNCT
bjp-25731	55	1	h	h	PROPN
bjp-25731	55	2	-	-	PUNCT
bjp-25731	55	3	quinazoline-2,4	quinazoline-2,4	NOUN
bjp-25731	55	4	-	-	PUNCT
bjp-25731	55	5	dione	dione	NOUN
bjp-25731	55	6	did	do	AUX
bjp-25731	55	7	not	not	PART
bjp-25731	55	8	only	only	ADV
bjp-25731	55	9	act	act	VERB
bjp-25731	55	10	against	against	ADP
bjp-25731	55	11	inflammation	inflammation	NOUN
bjp-25731	55	12	but	but	CCONJ
bjp-25731	55	13	also	also	ADV
bjp-25731	55	14	showed	show	VERB
bjp-25731	55	15	strong	strong	ADJ
bjp-25731	55	16	and	and	CCONJ
bjp-25731	55	17	encouraging	encourage	VERB
bjp-25731	55	18	analgesic	analgesic	NOUN
bjp-25731	55	19	as	as	ADV
bjp-25731	55	20	well	well	ADV
bjp-25731	55	21	as	as	ADP
bjp-25731	55	22	anticonvulsant	anticonvulsant	ADJ
bjp-25731	55	23	potentials	potential	NOUN
bjp-25731	55	24	(	(	PUNCT
bjp-25731	55	25	connolly	connolly	PROPN
bjp-25731	55	26	et	et	PROPN
bjp-25731	55	27	al	al	PROPN
bjp-25731	55	28	.	.	PROPN
bjp-25731	55	29	,	,	PUNCT
bjp-25731	55	30	2005	2005	NUM
bjp-25731	55	31	;	;	PUNCT
bjp-25731	56	1	maskey	maskey	NOUN
bjp-25731	56	2	et	et	PROPN
bjp-25731	56	3	al	al	PROPN
bjp-25731	56	4	.	.	PROPN
bjp-25731	56	5	,	,	PUNCT
bjp-25731	56	6	2004	2004	NUM
bjp-25731	56	7	)	)	PUNCT
bjp-25731	56	8	.	.	PUNCT
bjp-25731	57	1	4(3h)-quinazoline	4(3h)-quinazoline	NUM
bjp-25731	57	2	derivatives	derivative	NOUN
bjp-25731	57	3	possess	possess	VERB
bjp-25731	57	4	a	a	DET
bjp-25731	57	5	broad	broad	ADJ
bjp-25731	57	6	spectrum	spectrum	NOUN
bjp-25731	57	7	of	of	ADP
bjp-25731	57	8	biological	biological	ADJ
bjp-25731	57	9	activities	activity	NOUN
bjp-25731	57	10	and	and	CCONJ
bjp-25731	57	11	have	have	AUX
bjp-25731	57	12	been	be	AUX
bjp-25731	57	13	identified	identify	VERB
bjp-25731	57	14	as	as	ADP
bjp-25731	57	15	antidiabetic	antidiabetic	ADJ
bjp-25731	57	16	and	and	CCONJ
bjp-25731	57	17	cns	cns	NOUN
bjp-25731	57	18	depressants	depressant	NOUN
bjp-25731	57	19	(	(	PUNCT
bjp-25731	57	20	ding	ding	NOUN
bjp-25731	57	21	et	et	PROPN
bjp-25731	57	22	al	al	PROPN
bjp-25731	57	23	.	.	PROPN
bjp-25731	57	24	,	,	PUNCT
bjp-25731	57	25	2004	2004	NUM
bjp-25731	57	26	)	)	PUNCT
bjp-25731	57	27	.	.	PUNCT
bjp-25731	58	1	due	due	ADP
bjp-25731	58	2	to	to	ADP
bjp-25731	58	3	the	the	DET
bjp-25731	58	4	existence	existence	NOUN
bjp-25731	58	5	of	of	ADP
bjp-25731	58	6	microorganisms	microorganism	NOUN
bjp-25731	58	7	’	'	PUNCT
bjp-25731	58	8	resistance	resistance	NOUN
bjp-25731	58	9	phenomenon	phenomenon	NOUN
bjp-25731	58	10	to	to	ADP
bjp-25731	58	11	drugs	drug	NOUN
bjp-25731	58	12	currently	currently	ADV
bjp-25731	58	13	available	available	ADJ
bjp-25731	58	14	in	in	ADP
bjp-25731	58	15	the	the	DET
bjp-25731	58	16	market	market	NOUN
bjp-25731	58	17	and	and	CCONJ
bjp-25731	58	18	consistent	consistent	ADJ
bjp-25731	58	19	increase	increase	NOUN
bjp-25731	58	20	in	in	ADP
bjp-25731	58	21	the	the	DET
bjp-25731	58	22	outbreak	outbreak	NOUN
bjp-25731	58	23	of	of	ADP
bjp-25731	58	24	new	new	ADJ
bjp-25731	58	25	diseases	disease	NOUN
bjp-25731	58	26	,	,	PUNCT
bjp-25731	58	27	it	it	PRON
bjp-25731	58	28	is	be	AUX
bjp-25731	58	29	highly	highly	ADV
bjp-25731	58	30	imperative	imperative	ADJ
bjp-25731	58	31	and	and	CCONJ
bjp-25731	58	32	necessary	necessary	ADJ
bjp-25731	58	33	to	to	PART
bjp-25731	58	34	continuously	continuously	ADV
bjp-25731	58	35	design	design	VERB
bjp-25731	58	36	and	and	CCONJ
bjp-25731	58	37	prepare	prepare	VERB
bjp-25731	58	38	novel	novel	ADJ
bjp-25731	58	39	heterocyclic	heterocyclic	ADJ
bjp-25731	58	40	scaffolds	scaffold	NOUN
bjp-25731	58	41	which	which	PRON
bjp-25731	58	42	display	display	VERB
bjp-25731	58	43	improved	improve	VERB
bjp-25731	58	44	druggability	druggability	NOUN
bjp-25731	58	45	relevance	relevance	NOUN
bjp-25731	58	46	for	for	ADP
bjp-25731	58	47	medicinal	medicinal	ADJ
bjp-25731	58	48	research	research	NOUN
bjp-25731	58	49	(	(	PUNCT
bjp-25731	58	50	ajani	ajani	PROPN
bjp-25731	58	51	,	,	PUNCT
bjp-25731	58	52	2014	2014	NUM
bjp-25731	58	53	)	)	PUNCT
bjp-25731	58	54	.	.	PUNCT
bjp-25731	59	1	therefore	therefore	ADV
bjp-25731	59	2	,	,	PUNCT
bjp-25731	59	3	the	the	DET
bjp-25731	59	4	main	main	ADJ
bjp-25731	59	5	goal	goal	NOUN
bjp-25731	59	6	of	of	ADP
bjp-25731	59	7	this	this	DET
bjp-25731	59	8	review	review	NOUN
bjp-25731	59	9	herein	herein	NOUN
bjp-25731	59	10	is	be	AUX
bjp-25731	59	11	to	to	PART
bjp-25731	59	12	harness	harness	VERB
bjp-25731	59	13	the	the	DET
bjp-25731	59	14	valuable	valuable	ADJ
bjp-25731	59	15	updated	update	VERB
bjp-25731	59	16	information	information	NOUN
bjp-25731	59	17	in	in	ADP
bjp-25731	59	18	the	the	DET
bjp-25731	59	19	medicinal	medicinal	ADJ
bjp-25731	59	20	applications	application	NOUN
bjp-25731	59	21	and	and	CCONJ
bjp-25731	59	22	pharmacological	pharmacological	ADJ
bjp-25731	59	23	expertise	expertise	NOUN
bjp-25731	59	24	of	of	ADP
bjp-25731	59	25	quinazoline	quinazoline	ADJ
bjp-25731	59	26	motifs	motif	NOUN
bjp-25731	59	27	so	so	SCONJ
bjp-25731	59	28	as	as	SCONJ
bjp-25731	59	29	to	to	PART
bjp-25731	59	30	unfold	unfold	VERB
bjp-25731	59	31	novel	novel	ADJ
bjp-25731	59	32	routes	route	NOUN
bjp-25731	59	33	toward	toward	ADP
bjp-25731	59	34	active	active	ADJ
bjp-25731	59	35	targets	target	NOUN
bjp-25731	59	36	in	in	ADP
bjp-25731	59	37	drug	drug	NOUN
bjp-25731	59	38	development	development	NOUN
bjp-25731	59	39	.	.	PUNCT
bjp-25731	60	1	synthetic	synthetic	ADJ
bjp-25731	60	2	methods	method	NOUN
bjp-25731	60	3	quinazoline	quinazoline	VERB
bjp-25731	60	4	is	be	AUX
bjp-25731	60	5	relatively	relatively	ADV
bjp-25731	60	6	easy	easy	ADJ
bjp-25731	60	7	to	to	PART
bjp-25731	60	8	prepare	prepare	VERB
bjp-25731	60	9	and	and	CCONJ
bjp-25731	60	10	many	many	ADJ
bjp-25731	60	11	derivatives	derivative	NOUN
bjp-25731	60	12	have	have	AUX
bjp-25731	60	13	been	be	AUX
bjp-25731	60	14	synthesized	synthesize	VERB
bjp-25731	60	15	in	in	ADP
bjp-25731	60	16	order	order	NOUN
bjp-25731	60	17	to	to	PART
bjp-25731	60	18	obtain	obtain	VERB
bjp-25731	60	19	biologically	biologically	ADV
bjp-25731	60	20	active	active	ADJ
bjp-25731	60	21	motifs	motif	NOUN
bjp-25731	60	22	.	.	PUNCT
bjp-25731	61	1	medicinal	medicinal	ADJ
bjp-25731	61	2	chemistry	chemistry	NOUN
bjp-25731	61	3	researchers	researcher	NOUN
bjp-25731	61	4	have	have	AUX
bjp-25731	61	5	designed	design	VERB
bjp-25731	61	6	series	series	NOUN
bjp-25731	61	7	of	of	ADP
bjp-25731	61	8	quinazoline	quinazoline	NOUN
bjp-25731	61	9	templates	template	NOUN
bjp-25731	61	10	having	have	VERB
bjp-25731	61	11	diverse	diverse	ADJ
bjp-25731	61	12	bioactivities	bioactivitie	NOUN
bjp-25731	61	13	by	by	ADP
bjp-25731	61	14	incorporating	incorporate	VERB
bjp-25731	61	15	and	and	CCONJ
bjp-25731	61	16	attaching	attach	VERB
bjp-25731	61	17	several	several	ADJ
bjp-25731	61	18	active	active	ADJ
bjp-25731	61	19	functionalities	functionality	NOUN
bjp-25731	61	20	to	to	ADP
bjp-25731	61	21	the	the	DET
bjp-25731	61	22	quinazoline	quinazoline	NOUN
bjp-25731	61	23	core	core	NOUN
bjp-25731	61	24	with	with	ADP
bjp-25731	61	25	the	the	DET
bjp-25731	61	26	aid	aid	NOUN
bjp-25731	61	27	of	of	ADP
bjp-25731	61	28	improved	improved	ADJ
bjp-25731	61	29	synthetic	synthetic	ADJ
bjp-25731	61	30	figure	figure	NOUN
bjp-25731	61	31	3	3	NUM
bjp-25731	61	32	:	:	PUNCT
bjp-25731	61	33	classification	classification	NOUN
bjp-25731	61	34	of	of	ADP
bjp-25731	61	35	quinazoline	quinazoline	NOUN
bjp-25731	61	36	and	and	CCONJ
bjp-25731	61	37	quinazolinone	quinazolinone	NOUN
bjp-25731	61	38	derivatives	derivative	NOUN
bjp-25731	61	39	718	718	NUM
bjp-25731	61	40	bangladesh	bangladesh	PROPN
bjp-25731	61	41	j	j	PROPN
bjp-25731	61	42	pharmacol	pharmacol	PROPN
bjp-25731	61	43	2016	2016	NUM
bjp-25731	61	44	;	;	PUNCT
bjp-25731	61	45	11	11	NUM
bjp-25731	61	46	:	:	PUNCT
bjp-25731	61	47	716	716	NUM
bjp-25731	61	48	-	-	SYM
bjp-25731	61	49	733	733	NUM
bjp-25731	61	50	methodologies	methodology	NOUN
bjp-25731	61	51	(	(	PUNCT
bjp-25731	61	52	wang	wang	PROPN
bjp-25731	61	53	and	and	CCONJ
bjp-25731	61	54	gao	gao	PROPN
bjp-25731	61	55	,	,	PUNCT
bjp-25731	61	56	2013	2013	NUM
bjp-25731	61	57	)	)	PUNCT
bjp-25731	61	58	.	.	PUNCT
bjp-25731	62	1	in	in	ADP
bjp-25731	62	2	an	an	DET
bjp-25731	62	3	earlier	early	ADJ
bjp-25731	62	4	review	review	NOUN
bjp-25731	62	5	,	,	PUNCT
bjp-25731	62	6	the	the	DET
bjp-25731	62	7	representative	representative	ADJ
bjp-25731	62	8	synthetic	synthetic	ADJ
bjp-25731	62	9	methods	method	NOUN
bjp-25731	62	10	for	for	ADP
bjp-25731	62	11	quinazoline	quinazoline	ADJ
bjp-25731	62	12	moieties	moiety	NOUN
bjp-25731	62	13	,	,	PUNCT
bjp-25731	62	14	either	either	CCONJ
bjp-25731	62	15	traditional	traditional	ADJ
bjp-25731	62	16	or	or	CCONJ
bjp-25731	62	17	novel	novel	NOUN
bjp-25731	62	18	were	be	AUX
bjp-25731	62	19	summarized	summarize	VERB
bjp-25731	62	20	,	,	PUNCT
bjp-25731	62	21	and	and	CCONJ
bjp-25731	62	22	they	they	PRON
bjp-25731	62	23	were	be	AUX
bjp-25731	62	24	classified	classify	VERB
bjp-25731	62	25	into	into	ADP
bjp-25731	62	26	five	five	NUM
bjp-25731	62	27	main	main	ADJ
bjp-25731	62	28	categories	category	NOUN
bjp-25731	62	29	which	which	PRON
bjp-25731	62	30	include	include	VERB
bjp-25731	62	31	:	:	PUNCT
bjp-25731	62	32	aza	aza	NOUN
bjp-25731	62	33	-	-	PUNCT
bjp-25731	62	34	reaction	reaction	NOUN
bjp-25731	62	35	,	,	PUNCT
bjp-25731	62	36	microwaveassisted	microwaveassisted	ADJ
bjp-25731	62	37	reaction	reaction	NOUN
bjp-25731	62	38	,	,	PUNCT
bjp-25731	62	39	metal	metal	NOUN
bjp-25731	62	40	-	-	PUNCT
bjp-25731	62	41	catalyzed	catalyze	VERB
bjp-25731	62	42	reaction	reaction	NOUN
bjp-25731	62	43	,	,	PUNCT
bjp-25731	62	44	ultrasoundpromoted	ultrasoundpromoted	ADJ
bjp-25731	62	45	reaction	reaction	NOUN
bjp-25731	62	46	and	and	CCONJ
bjp-25731	62	47	phase	phase	NOUN
bjp-25731	62	48	-	-	PUNCT
bjp-25731	62	49	transfer	transfer	NOUN
bjp-25731	62	50	catalysis	catalysis	NOUN
bjp-25731	62	51	(	(	PUNCT
bjp-25731	62	52	wang	wang	PROPN
bjp-25731	62	53	and	and	CCONJ
bjp-25731	62	54	gao	gao	PROPN
bjp-25731	62	55	,	,	PUNCT
bjp-25731	62	56	2013	2013	NUM
bjp-25731	62	57	)	)	PUNCT
bjp-25731	62	58	.	.	PUNCT
bjp-25731	63	1	first	first	ADJ
bjp-25731	63	2	quinazoline	quinazoline	NOUN
bjp-25731	63	3	compound	compound	NOUN
bjp-25731	63	4	,	,	PUNCT
bjp-25731	63	5	2	2	NUM
bjp-25731	63	6	-	-	PUNCT
bjp-25731	63	7	cyano3,4	cyano3,4	PROPN
bjp-25731	63	8	-	-	PUNCT
bjp-25731	63	9	dihydro-4	dihydro-4	NOUN
bjp-25731	63	10	-	-	ADJ
bjp-25731	63	11	oxoquinazoline	oxoquinazoline	ADJ
bjp-25731	63	12	(	(	PUNCT
bjp-25731	63	13	maheswari	maheswari	PROPN
bjp-25731	63	14	et	et	PROPN
bjp-25731	63	15	al	al	PROPN
bjp-25731	63	16	.	.	PROPN
bjp-25731	63	17	,	,	PUNCT
bjp-25731	63	18	2010	2010	NUM
bjp-25731	63	19	)	)	PUNCT
bjp-25731	63	20	,	,	PUNCT
bjp-25731	63	21	was	be	AUX
bjp-25731	63	22	prepared	prepare	VERB
bjp-25731	63	23	in	in	ADP
bjp-25731	63	24	1869	1869	NUM
bjp-25731	63	25	through	through	ADP
bjp-25731	63	26	the	the	DET
bjp-25731	63	27	reaction	reaction	NOUN
bjp-25731	63	28	of	of	ADP
bjp-25731	63	29	cyanogens	cyanogen	NOUN
bjp-25731	63	30	with	with	ADP
bjp-25731	63	31	anthranilic	anthranilic	NOUN
bjp-25731	63	32	acid	acid	NOUN
bjp-25731	63	33	and	and	CCONJ
bjp-25731	63	34	later	later	ADV
bjp-25731	63	35	documented	document	VERB
bjp-25731	63	36	by	by	ADP
bjp-25731	63	37	armarego	armarego	NOUN
bjp-25731	63	38	in	in	ADP
bjp-25731	63	39	1967	1967	NUM
bjp-25731	63	40	.	.	PUNCT
bjp-25731	64	1	biological	biological	ADJ
bjp-25731	64	2	importance	importance	NOUN
bjp-25731	64	3	of	of	ADP
bjp-25731	64	4	quinazoline	quinazoline	NOUN
bjp-25731	64	5	quinazoline	quinazoline	NOUN
bjp-25731	64	6	and	and	CCONJ
bjp-25731	64	7	its	its	PRON
bjp-25731	64	8	quinazolinone	quinazolinone	NOUN
bjp-25731	64	9	skeletons	skeleton	NOUN
bjp-25731	64	10	are	be	AUX
bjp-25731	64	11	recurrently	recurrently	ADV
bjp-25731	64	12	encountered	encounter	VERB
bjp-25731	64	13	heterocyclic	heterocyclic	ADJ
bjp-25731	64	14	compounds	compound	NOUN
bjp-25731	64	15	in	in	ADP
bjp-25731	64	16	therapeutic	therapeutic	ADJ
bjp-25731	64	17	medicine	medicine	NOUN
bjp-25731	64	18	’s	’s	PART
bjp-25731	64	19	literature	literature	NOUN
bjp-25731	64	20	with	with	ADP
bjp-25731	64	21	wide	wide	ADJ
bjp-25731	64	22	range	range	NOUN
bjp-25731	64	23	of	of	ADP
bjp-25731	64	24	utilization	utilization	NOUN
bjp-25731	64	25	including	include	VERB
bjp-25731	64	26	antidiabetic	antidiabetic	ADJ
bjp-25731	64	27	,	,	PUNCT
bjp-25731	64	28	antileishmanial	antileishmanial	ADJ
bjp-25731	64	29	,	,	PUNCT
bjp-25731	64	30	antihypertensive	antihypertensive	ADJ
bjp-25731	64	31	,	,	PUNCT
bjp-25731	64	32	cns	cns	NOUN
bjp-25731	64	33	depressant	depressant	NOUN
bjp-25731	64	34	,	,	PUNCT
bjp-25731	64	35	anticonvulsant	anticonvulsant	NOUN
bjp-25731	64	36	,	,	PUNCT
bjp-25731	64	37	antitubercular	antitubercular	ADJ
bjp-25731	64	38	,	,	PUNCT
bjp-25731	64	39	anti	anti	ADJ
bjp-25731	64	40	-	-	ADJ
bjp-25731	64	41	hiv	hiv	ADJ
bjp-25731	64	42	,	,	PUNCT
bjp-25731	64	43	antibacterial	antibacterial	ADJ
bjp-25731	64	44	,	,	PUNCT
bjp-25731	64	45	anti	anti	ADJ
bjp-25731	64	46	-	-	ADJ
bjp-25731	64	47	cancer	cancer	ADJ
bjp-25731	64	48	activities	activity	NOUN
bjp-25731	64	49	among	among	ADP
bjp-25731	64	50	others	other	NOUN
bjp-25731	64	51	.	.	PUNCT
bjp-25731	65	1	anti	anti	ADJ
bjp-25731	65	2	-	-	ADJ
bjp-25731	65	3	cancer	cancer	ADJ
bjp-25731	65	4	activity	activity	NOUN
bjp-25731	65	5	cancer	cancer	NOUN
bjp-25731	65	6	has	have	AUX
bjp-25731	65	7	continued	continue	VERB
bjp-25731	65	8	to	to	PART
bjp-25731	65	9	be	be	AUX
bjp-25731	65	10	topic	topic	NOUN
bjp-25731	65	11	of	of	ADP
bjp-25731	65	12	great	great	ADJ
bjp-25731	65	13	attention	attention	NOUN
bjp-25731	65	14	in	in	ADP
bjp-25731	65	15	all	all	DET
bjp-25731	65	16	regions	region	NOUN
bjp-25731	65	17	of	of	ADP
bjp-25731	65	18	the	the	DET
bjp-25731	65	19	world	world	NOUN
bjp-25731	65	20	due	due	ADP
bjp-25731	65	21	to	to	ADP
bjp-25731	65	22	its	its	PRON
bjp-25731	65	23	global	global	ADJ
bjp-25731	65	24	health	health	NOUN
bjp-25731	65	25	challenge	challenge	NOUN
bjp-25731	65	26	issue	issue	NOUN
bjp-25731	65	27	to	to	PART
bjp-25731	65	28	be	be	AUX
bjp-25731	65	29	a	a	DET
bjp-25731	65	30	leading	leading	ADJ
bjp-25731	65	31	health	health	NOUN
bjp-25731	65	32	problem	problem	NOUN
bjp-25731	65	33	in	in	ADP
bjp-25731	65	34	developed	develop	VERB
bjp-25731	65	35	as	as	ADV
bjp-25731	65	36	well	well	ADV
bjp-25731	65	37	as	as	ADP
bjp-25731	65	38	developing	develop	VERB
bjp-25731	65	39	countries	country	NOUN
bjp-25731	65	40	.	.	PUNCT
bjp-25731	66	1	it	it	PRON
bjp-25731	66	2	has	have	AUX
bjp-25731	66	3	been	be	AUX
bjp-25731	66	4	consistently	consistently	ADV
bjp-25731	66	5	associated	associate	VERB
bjp-25731	66	6	with	with	ADP
bjp-25731	66	7	high	high	ADJ
bjp-25731	66	8	mortality	mortality	NOUN
bjp-25731	66	9	rate	rate	NOUN
bjp-25731	66	10	due	due	ADP
bjp-25731	66	11	to	to	ADP
bjp-25731	66	12	various	various	ADJ
bjp-25731	66	13	worldwide	worldwide	ADJ
bjp-25731	66	14	factors	factor	NOUN
bjp-25731	66	15	(	(	PUNCT
bjp-25731	66	16	antonello	antonello	PROPN
bjp-25731	66	17	et	et	PROPN
bjp-25731	66	18	al	al	PROPN
bjp-25731	66	19	.	.	PROPN
bjp-25731	66	20	,	,	PUNCT
bjp-25731	66	21	2006	2006	NUM
bjp-25731	66	22	)	)	PUNCT
bjp-25731	66	23	.	.	PUNCT
bjp-25731	67	1	cancer	cancer	NOUN
bjp-25731	67	2	is	be	AUX
bjp-25731	67	3	an	an	DET
bjp-25731	67	4	abnormal	abnormal	ADJ
bjp-25731	67	5	cell	cell	NOUN
bjp-25731	67	6	growth	growth	NOUN
bjp-25731	67	7	which	which	PRON
bjp-25731	67	8	is	be	AUX
bjp-25731	67	9	identify	identify	VERB
bjp-25731	67	10	through	through	ADP
bjp-25731	67	11	a	a	DET
bjp-25731	67	12	shift	shift	NOUN
bjp-25731	67	13	in	in	ADP
bjp-25731	67	14	the	the	DET
bjp-25731	67	15	controlled	control	VERB
bjp-25731	67	16	mechanisms	mechanism	NOUN
bjp-25731	67	17	which	which	PRON
bjp-25731	67	18	guides	guide	VERB
bjp-25731	67	19	cell	cell	NOUN
bjp-25731	67	20	proliferation	proliferation	NOUN
bjp-25731	67	21	and	and	CCONJ
bjp-25731	67	22	differentiation	differentiation	NOUN
bjp-25731	67	23	(	(	PUNCT
bjp-25731	67	24	al	al	PROPN
bjp-25731	67	25	-	-	PUNCT
bjp-25731	67	26	omary	omary	NOUN
bjp-25731	67	27	et	et	PROPN
bjp-25731	67	28	al	al	PROPN
bjp-25731	67	29	.	.	PROPN
bjp-25731	67	30	,	,	PUNCT
bjp-25731	67	31	2012	2012	NUM
bjp-25731	67	32	)	)	PUNCT
bjp-25731	67	33	.	.	PUNCT
bjp-25731	68	1	quinazoline	quinazoline	PROPN
bjp-25731	68	2	bearing	bear	VERB
bjp-25731	68	3	sulfonamide	sulfonamide	NOUN
bjp-25731	68	4	functionalities	functionality	NOUN
bjp-25731	68	5	were	be	AUX
bjp-25731	68	6	recently	recently	ADV
bjp-25731	68	7	recognized	recognize	VERB
bjp-25731	68	8	as	as	ADP
bjp-25731	68	9	categories	category	NOUN
bjp-25731	68	10	of	of	ADP
bjp-25731	68	11	cancer	cancer	NOUN
bjp-25731	68	12	chemotherapeutics	chemotherapeutic	NOUN
bjp-25731	68	13	which	which	PRON
bjp-25731	68	14	exhibited	exhibit	VERB
bjp-25731	68	15	noticeable	noticeable	ADJ
bjp-25731	68	16	therapeutic	therapeutic	ADJ
bjp-25731	68	17	potentials	potential	NOUN
bjp-25731	68	18	on	on	ADP
bjp-25731	68	19	solid	solid	ADJ
bjp-25731	68	20	tumours	tumour	NOUN
bjp-25731	68	21	(	(	PUNCT
bjp-25731	68	22	mohamed	mohamed	PROPN
bjp-25731	68	23	et	et	PROPN
bjp-25731	68	24	al	al	PROPN
bjp-25731	68	25	.	.	PROPN
bjp-25731	68	26	,	,	PUNCT
bjp-25731	68	27	2015	2015	NUM
bjp-25731	68	28	)	)	PUNCT
bjp-25731	68	29	.	.	PUNCT
bjp-25731	69	1	4anilinoquinazoline	4anilinoquinazoline	NUM
bjp-25731	69	2	bearing	bear	VERB
bjp-25731	69	3	sulfonamide	sulfonamide	NOUN
bjp-25731	69	4	at	at	ADP
bjp-25731	69	5	6	6	NUM
bjp-25731	69	6	-	-	PUNCT
bjp-25731	69	7	position	position	NOUN
bjp-25731	69	8	was	be	AUX
bjp-25731	69	9	reported	report	VERB
bjp-25731	69	10	to	to	PART
bjp-25731	69	11	inhibit	inhibit	VERB
bjp-25731	69	12	the	the	DET
bjp-25731	69	13	breast	breast	NOUN
bjp-25731	69	14	cancer	cancer	NOUN
bjp-25731	69	15	cell	cell	NOUN
bjp-25731	69	16	line	line	NOUN
bjp-25731	69	17	growth	growth	NOUN
bjp-25731	69	18	at	at	ADP
bjp-25731	69	19	as	as	ADV
bjp-25731	69	20	low	low	ADJ
bjp-25731	69	21	as	as	ADP
bjp-25731	69	22	ic50	ic50	PROPN
bjp-25731	69	23	=	=	PROPN
bjp-25731	69	24	5.5	5.5	NUM
bjp-25731	69	25	μm	μm	NOUN
bjp-25731	69	26	based	base	VERB
bjp-25731	69	27	on	on	ADP
bjp-25731	69	28	the	the	DET
bjp-25731	69	29	result	result	NOUN
bjp-25731	69	30	of	of	ADP
bjp-25731	69	31	investigation	investigation	NOUN
bjp-25731	69	32	of	of	ADP
bjp-25731	69	33	the	the	DET
bjp-25731	69	34	screening	screening	NOUN
bjp-25731	69	35	carried	carry	VERB
bjp-25731	69	36	out	out	ADP
bjp-25731	69	37	by	by	ADP
bjp-25731	69	38	yassen	yassen	NOUN
bjp-25731	69	39	et	et	PROPN
bjp-25731	69	40	al	al	PROPN
bjp-25731	69	41	.	.	PROPN
bjp-25731	70	1	(	(	PUNCT
bjp-25731	70	2	2014	2014	NUM
bjp-25731	70	3	)	)	PUNCT
bjp-25731	70	4	whereas	whereas	SCONJ
bjp-25731	70	5	when	when	SCONJ
bjp-25731	70	6	the	the	DET
bjp-25731	70	7	sulfonamide	sulfonamide	NOUN
bjp-25731	70	8	was	be	AUX
bjp-25731	70	9	on	on	ADP
bjp-25731	70	10	para	para	ADJ
bjp-25731	70	11	position	position	NOUN
bjp-25731	70	12	of	of	ADP
bjp-25731	70	13	the	the	DET
bjp-25731	70	14	aniline	aniline	NOUN
bjp-25731	70	15	ring	ring	NOUN
bjp-25731	70	16	there	there	PRON
bjp-25731	70	17	was	be	VERB
bjp-25731	70	18	a	a	DET
bjp-25731	70	19	reduction	reduction	NOUN
bjp-25731	70	20	in	in	ADP
bjp-25731	70	21	anti	anti	ADJ
bjp-25731	70	22	-cancer	-cancer	NOUN
bjp-25731	70	23	activity	activity	NOUN
bjp-25731	70	24	to	to	ADP
bjp-25731	70	25	ic50	ic50	PROPN
bjp-25731	70	26	=	=	PUNCT
bjp-25731	71	1	77.9	77.9	NUM
bjp-25731	71	2	μm	μm	NOUN
bjp-25731	71	3	(	(	PUNCT
bjp-25731	71	4	ghorab	ghorab	PROPN
bjp-25731	71	5	et	et	PROPN
bjp-25731	71	6	al	al	PROPN
bjp-25731	71	7	.	.	PROPN
bjp-25731	71	8	,	,	PUNCT
bjp-25731	71	9	2016	2016	NUM
bjp-25731	71	10	)	)	PUNCT
bjp-25731	71	11	.	.	PUNCT
bjp-25731	72	1	quinazolinedione	quinazolinedione	NOUN
bjp-25731	72	2	-	-	PUNCT
bjp-25731	72	3	based	base	VERB
bjp-25731	72	4	redox	redox	ADJ
bjp-25731	72	5	modulators	modulator	NOUN
bjp-25731	72	6	,	,	PUNCT
bjp-25731	72	7	6-((3	6-((3	NUM
bjp-25731	72	8	-	-	PUNCT
bjp-25731	72	9	acetylphenyl)amino)quinazoline-5,8	acetylphenyl)amino)quinazoline-5,8	NOUN
bjp-25731	72	10	-	-	NOUN
bjp-25731	72	11	dione	dione	NOUN
bjp-25731	72	12	,	,	PUNCT
bjp-25731	72	13	was	be	AUX
bjp-25731	72	14	discovered	discover	VERB
bjp-25731	72	15	as	as	ADP
bjp-25731	72	16	therapy	therapy	NOUN
bjp-25731	72	17	for	for	ADP
bjp-25731	72	18	pancreatic	pancreatic	ADJ
bjp-25731	72	19	cancer	cancer	NOUN
bjp-25731	72	20	since	since	SCONJ
bjp-25731	72	21	the	the	DET
bjp-25731	72	22	oxidative	oxidative	ADJ
bjp-25731	72	23	stress	stress	NOUN
bjp-25731	72	24	enhanced	enhance	VERB
bjp-25731	72	25	through	through	ADP
bjp-25731	72	26	it	it	PRON
bjp-25731	72	27	,	,	PUNCT
bjp-25731	72	28	catalyzed	catalyze	VERB
bjp-25731	72	29	activation	activation	NOUN
bjp-25731	72	30	of	of	ADP
bjp-25731	72	31	stress	stress	NOUN
bjp-25731	72	32	kinases	kinase	NOUN
bjp-25731	72	33	(	(	PUNCT
bjp-25731	72	34	p38	p38	PROPN
bjp-25731	72	35	/	/	SYM
bjp-25731	72	36	jnk	jnk	PROPN
bjp-25731	72	37	)	)	PUNCT
bjp-25731	72	38	thereby	thereby	ADV
bjp-25731	72	39	leading	lead	VERB
bjp-25731	72	40	to	to	ADP
bjp-25731	72	41	cancer	cancer	NOUN
bjp-25731	72	42	cell	cell	NOUN
bjp-25731	72	43	death	death	NOUN
bjp-25731	72	44	(	(	PUNCT
bjp-25731	72	45	pathania	pathania	NOUN
bjp-25731	72	46	et	et	PROPN
bjp-25731	72	47	al	al	PROPN
bjp-25731	72	48	.	.	PROPN
bjp-25731	72	49	,	,	PUNCT
bjp-25731	72	50	2014	2014	NUM
bjp-25731	72	51	)	)	PUNCT
bjp-25731	72	52	.	.	PUNCT
bjp-25731	73	1	egfr	egfr	VERB
bjp-25731	73	2	inhibitory	inhibitory	ADJ
bjp-25731	73	3	activity	activity	NOUN
bjp-25731	73	4	comprehensive	comprehensive	ADJ
bjp-25731	73	5	clinical	clinical	ADJ
bjp-25731	73	6	studies	study	NOUN
bjp-25731	73	7	showed	show	VERB
bjp-25731	73	8	that	that	SCONJ
bjp-25731	73	9	inhibiting	inhibit	VERB
bjp-25731	73	10	egfr	egfr	ADJ
bjp-25731	73	11	family	family	NOUN
bjp-25731	73	12	receptor	receptor	NOUN
bjp-25731	73	13	tks	tks	PROPN
bjp-25731	73	14	represent	represent	VERB
bjp-25731	73	15	a	a	DET
bjp-25731	73	16	major	major	ADJ
bjp-25731	73	17	advance	advance	NOUN
bjp-25731	73	18	in	in	ADP
bjp-25731	73	19	the	the	DET
bjp-25731	73	20	treatment	treatment	NOUN
bjp-25731	73	21	of	of	ADP
bjp-25731	73	22	solid	solid	ADJ
bjp-25731	73	23	tumor	tumor	NOUN
bjp-25731	73	24	.	.	PUNCT
bjp-25731	74	1	gefitinib	gefitinib	NOUN
bjp-25731	74	2	and	and	CCONJ
bjp-25731	74	3	erlotinib	erlotinib	NOUN
bjp-25731	74	4	are	be	AUX
bjp-25731	74	5	quinazoline	quinazoline	NOUN
bjp-25731	74	6	-	-	PUNCT
bjp-25731	74	7	based	base	VERB
bjp-25731	74	8	compounds	compound	NOUN
bjp-25731	74	9	which	which	PRON
bjp-25731	74	10	happened	happen	VERB
bjp-25731	74	11	to	to	PART
bjp-25731	74	12	be	be	AUX
bjp-25731	74	13	earlier	early	ADV
bjp-25731	74	14	reported	report	VERB
bjp-25731	74	15	salient	salient	NOUN
bjp-25731	74	16	egfr	egfr	ADJ
bjp-25731	74	17	inhibitor	inhibitor	NOUN
bjp-25731	74	18	authorized	authorize	VERB
bjp-25731	74	19	for	for	ADP
bjp-25731	74	20	the	the	DET
bjp-25731	74	21	curing	curing	NOUN
bjp-25731	74	22	of	of	ADP
bjp-25731	74	23	diseases	disease	NOUN
bjp-25731	74	24	related	relate	VERB
bjp-25731	74	25	to	to	ADP
bjp-25731	74	26	nsclc	nsclc	NOUN
bjp-25731	74	27	(	(	PUNCT
bjp-25731	74	28	wang	wang	PROPN
bjp-25731	74	29	et	et	PROPN
bjp-25731	74	30	al	al	PROPN
bjp-25731	74	31	.	.	PROPN
bjp-25731	74	32	,	,	PUNCT
bjp-25731	74	33	2016	2016	NUM
bjp-25731	74	34	)	)	PUNCT
bjp-25731	74	35	.	.	PUNCT
bjp-25731	75	1	their	their	PRON
bjp-25731	75	2	mechanism	mechanism	NOUN
bjp-25731	75	3	of	of	ADP
bjp-25731	75	4	action	action	NOUN
bjp-25731	75	5	was	be	AUX
bjp-25731	75	6	through	through	ADP
bjp-25731	75	7	competitive	competitive	ADJ
bjp-25731	75	8	binding	binding	NOUN
bjp-25731	75	9	to	to	PART
bjp-25731	75	10	adenosine	adenosine	VERB
bjp-25731	75	11	triphosphate	triphosphate	NOUN
bjp-25731	75	12	(	(	PUNCT
bjp-25731	75	13	atp)-binding	atp)-binde	VERB
bjp-25731	75	14	pocket	pocket	NOUN
bjp-25731	75	15	of	of	ADP
bjp-25731	75	16	the	the	DET
bjp-25731	75	17	intracellular	intracellular	ADJ
bjp-25731	75	18	egfr	egfr	NOUN
bjp-25731	75	19	tk	tk	PROPN
bjp-25731	75	20	site	site	NOUN
bjp-25731	75	21	according	accord	VERB
bjp-25731	75	22	to	to	ADP
bjp-25731	75	23	docking	dock	VERB
bjp-25731	75	24	study	study	NOUN
bjp-25731	75	25	report	report	NOUN
bjp-25731	75	26	;	;	PUNCT
bjp-25731	75	27	hence	hence	ADV
bjp-25731	75	28	,	,	PUNCT
bjp-25731	75	29	effectively	effectively	ADV
bjp-25731	75	30	block	block	VERB
bjp-25731	75	31	the	the	DET
bjp-25731	75	32	aberrant	aberrant	NOUN
bjp-25731	75	33	egfr	egfr	NOUN
bjp-25731	75	34	down	down	ADP
bjp-25731	75	35	-	-	PUNCT
bjp-25731	75	36	stream	stream	NOUN
bjp-25731	75	37	signaling	signaling	NOUN
bjp-25731	75	38	required	require	VERB
bjp-25731	75	39	during	during	ADP
bjp-25731	75	40	tumor	tumor	NOUN
bjp-25731	75	41	survival	survival	NOUN
bjp-25731	75	42	as	as	ADV
bjp-25731	75	43	well	well	ADV
bjp-25731	75	44	as	as	ADP
bjp-25731	75	45	its	its	PRON
bjp-25731	75	46	proliferation	proliferation	NOUN
bjp-25731	75	47	(	(	PUNCT
bjp-25731	75	48	wang	wang	PROPN
bjp-25731	75	49	et	et	PROPN
bjp-25731	75	50	al	al	PROPN
bjp-25731	75	51	.	.	PROPN
bjp-25731	75	52	,	,	PUNCT
bjp-25731	75	53	2016	2016	NUM
bjp-25731	75	54	;	;	PUNCT
bjp-25731	75	55	hynes	hynes	PROPN
bjp-25731	75	56	and	and	CCONJ
bjp-25731	75	57	lane	lane	PROPN
bjp-25731	75	58	,	,	PUNCT
bjp-25731	75	59	2005	2005	NUM
bjp-25731	75	60	)	)	PUNCT
bjp-25731	75	61	.	.	PUNCT
bjp-25731	76	1	owing	owe	VERB
bjp-25731	76	2	to	to	ADP
bjp-25731	76	3	this	this	DET
bjp-25731	76	4	ability	ability	NOUN
bjp-25731	76	5	,	,	PUNCT
bjp-25731	76	6	structural	structural	ADJ
bjp-25731	76	7	modifications	modification	NOUN
bjp-25731	76	8	of	of	ADP
bjp-25731	76	9	earlier	early	ADJ
bjp-25731	76	10	discovered	discover	VERB
bjp-25731	76	11	gefitinib	gefitinib	NOUN
bjp-25731	76	12	and	and	CCONJ
bjp-25731	76	13	erlotinib	erlotinib	NOUN
bjp-25731	76	14	have	have	AUX
bjp-25731	76	15	been	be	AUX
bjp-25731	76	16	achieved	achieve	VERB
bjp-25731	76	17	to	to	PART
bjp-25731	76	18	produce	produce	VERB
bjp-25731	76	19	more	more	ADV
bjp-25731	76	20	effective	effective	ADJ
bjp-25731	76	21	egfr	egfr	ADJ
bjp-25731	76	22	inhibitors	inhibitor	NOUN
bjp-25731	76	23	.	.	PUNCT
bjp-25731	77	1	for	for	ADP
bjp-25731	77	2	instance	instance	NOUN
bjp-25731	77	3	,	,	PUNCT
bjp-25731	77	4	egfr	egfr	PROPN
bjp-25731	77	5	was	be	AUX
bjp-25731	77	6	reported	report	VERB
bjp-25731	77	7	clinically	clinically	ADV
bjp-25731	77	8	authenticated	authenticate	VERB
bjp-25731	77	9	during	during	ADP
bjp-25731	77	10	rational	rational	ADJ
bjp-25731	77	11	drug	drug	NOUN
bjp-25731	77	12	design	design	NOUN
bjp-25731	77	13	as	as	ADP
bjp-25731	77	14	targeted	target	VERB
bjp-25731	77	15	entity	entity	NOUN
bjp-25731	77	16	for	for	ADP
bjp-25731	77	17	cancer	cancer	NOUN
bjp-25731	77	18	chemotherapy	chemotherapy	NOUN
bjp-25731	77	19	.	.	PUNCT
bjp-25731	78	1	in	in	ADP
bjp-25731	78	2	addition	addition	NOUN
bjp-25731	78	3	,	,	PUNCT
bjp-25731	78	4	various	various	ADJ
bjp-25731	78	5	small	small	ADJ
bjp-25731	78	6	molecular	molecular	ADJ
bjp-25731	78	7	inhibitors	inhibitor	NOUN
bjp-25731	78	8	have	have	AUX
bjp-25731	78	9	been	be	AUX
bjp-25731	78	10	designed	design	VERB
bjp-25731	78	11	and	and	CCONJ
bjp-25731	78	12	made	make	VERB
bjp-25731	78	13	available	available	ADJ
bjp-25731	78	14	to	to	ADP
bjp-25731	78	15	members	member	NOUN
bjp-25731	78	16	of	of	ADP
bjp-25731	78	17	public	public	NOUN
bjp-25731	78	18	(	(	PUNCT
bjp-25731	78	19	zhang	zhang	X
bjp-25731	78	20	et	et	PROPN
bjp-25731	78	21	al	al	PROPN
bjp-25731	78	22	.	.	PROPN
bjp-25731	78	23	,	,	PUNCT
bjp-25731	78	24	2013a	2013a	NUM
bjp-25731	78	25	)	)	PUNCT
bjp-25731	78	26	as	as	ADP
bjp-25731	78	27	quinazoline	quinazoline	NOUN
bjp-25731	78	28	-	-	PUNCT
bjp-25731	78	29	based	base	VERB
bjp-25731	78	30	reversible	reversible	ADJ
bjp-25731	78	31	inhibitor	inhibitor	NOUN
bjp-25731	78	32	,	,	PUNCT
bjp-25731	78	33	e.g.	e.g.	ADV
bjp-25731	78	34	icotinib	icotinib	X
bjp-25731	78	35	(	(	PUNCT
bjp-25731	78	36	tan	tan	NOUN
bjp-25731	78	37	et	et	NOUN
bjp-25731	78	38	al	al	PROPN
bjp-25731	78	39	.	.	PROPN
bjp-25731	78	40	,	,	PUNCT
bjp-25731	78	41	2012	2012	NUM
bjp-25731	78	42	)	)	PUNCT
bjp-25731	78	43	and	and	CCONJ
bjp-25731	78	44	irreversible	irreversible	ADJ
bjp-25731	78	45	inhibitors	inhibitor	NOUN
bjp-25731	78	46	namely	namely	ADV
bjp-25731	78	47	;	;	PUNCT
bjp-25731	78	48	afatinib	afatinib	NOUN
bjp-25731	78	49	(	(	PUNCT
bjp-25731	78	50	minkovsky	minkovsky	NOUN
bjp-25731	78	51	and	and	CCONJ
bjp-25731	78	52	berezov	berezov	NOUN
bjp-25731	78	53	,	,	PUNCT
bjp-25731	78	54	2008	2008	NUM
bjp-25731	78	55	)	)	PUNCT
bjp-25731	78	56	,	,	PUNCT
bjp-25731	78	57	canertinib	canertinib	NOUN
bjp-25731	78	58	and	and	CCONJ
bjp-25731	78	59	newly	newly	ADV
bjp-25731	78	60	reported	report	VERB
bjp-25731	78	61	afatinib	afatinib	NOUN
bjp-25731	78	62	derivative	derivative	NOUN
bjp-25731	78	63	(	(	PUNCT
bjp-25731	78	64	zhang	zhang	X
bjp-25731	78	65	et	et	PROPN
bjp-25731	78	66	al	al	PROPN
bjp-25731	78	67	.	.	PROPN
bjp-25731	78	68	,	,	PUNCT
bjp-25731	78	69	2013a	2013a	NUM
bjp-25731	78	70	)	)	PUNCT
bjp-25731	78	71	.	.	PUNCT
bjp-25731	79	1	according	accord	VERB
bjp-25731	79	2	to	to	ADP
bjp-25731	79	3	results	result	NOUN
bjp-25731	79	4	of	of	ADP
bjp-25731	79	5	the	the	DET
bjp-25731	79	6	molecular	molecular	ADJ
bjp-25731	79	7	docking	docking	NOUN
bjp-25731	79	8	study	study	NOUN
bjp-25731	79	9	showed	show	VERB
bjp-25731	79	10	in	in	ADP
bjp-25731	79	11	figure	figure	NOUN
bjp-25731	79	12	4	4	NUM
bjp-25731	79	13	,	,	PUNCT
bjp-25731	79	14	the	the	DET
bjp-25731	79	15	comparison	comparison	NOUN
bjp-25731	79	16	between	between	ADP
bjp-25731	79	17	the	the	DET
bjp-25731	79	18	binding	bind	VERB
bjp-25731	79	19	modes	mode	NOUN
bjp-25731	79	20	of	of	ADP
bjp-25731	79	21	the	the	DET
bjp-25731	79	22	6,7dimethoxy	6,7dimethoxy	PROPN
bjp-25731	79	23	-	-	PUNCT
bjp-25731	79	24	derivative	derivative	NOUN
bjp-25731	79	25	of	of	ADP
bjp-25731	79	26	quinazoline	quinazoline	NOUN
bjp-25731	79	27	(	(	PUNCT
bjp-25731	79	28	lassbio-1814	lassbio-1814	NOUN
bjp-25731	79	29	;	;	PUNCT
bjp-25731	79	30	ic50	ic50	PROPN
bjp-25731	79	31	=	=	PROPN
bjp-25731	79	32	2.4	2.4	NUM
bjp-25731	79	33	μm	μm	NOUN
bjp-25731	79	34	for	for	ADP
bjp-25731	79	35	egfrwt	egfrwt	NOUN
bjp-25731	79	36	and	and	CCONJ
bjp-25731	79	37	1.02	1.02	NUM
bjp-25731	79	38	μm	μm	NOUN
bjp-25731	79	39	for	for	ADP
bjp-25731	79	40	vegfr-2	vegfr-2	NUM
bjp-25731	79	41	)	)	PUNCT
bjp-25731	79	42	and	and	CCONJ
bjp-25731	79	43	the	the	DET
bjp-25731	79	44	6,7	6,7	NUM
bjp-25731	79	45	-	-	PUNCT
bjp-25731	79	46	methylenedioxy	methylenedioxy	NOUN
bjp-25731	79	47	-	-	PUNCT
bjp-25731	79	48	derivative	derivative	NOUN
bjp-25731	79	49	of	of	ADP
bjp-25731	79	50	quinazoline	quinazoline	NOUN
bjp-25731	79	51	(	(	PUNCT
bjp-25731	79	52	lassbio-1815	lassbio-1815	NOUN
bjp-25731	79	53	;	;	PUNCT
bjp-25731	79	54	ic50	ic50	PROPN
bjp-25731	79	55	=	=	PUNCT
bjp-25731	79	56	34.6	34.6	NUM
bjp-25731	79	57	μm	μm	NOUN
bjp-25731	79	58	for	for	ADP
bjp-25731	79	59	egfrwt	egfrwt	NOUN
bjp-25731	79	60	and	and	CCONJ
bjp-25731	79	61	26.9	26.9	NUM
bjp-25731	79	62	μm	μm	NOUN
bjp-25731	79	63	for	for	ADP
bjp-25731	79	64	vegfr-2	vegfr-2	NUM
bjp-25731	79	65	)	)	PUNCT
bjp-25731	79	66	demonstrated	demonstrate	VERB
bjp-25731	79	67	that	that	SCONJ
bjp-25731	79	68	the	the	DET
bjp-25731	79	69	structural	structural	ADJ
bjp-25731	79	70	modification	modification	NOUN
bjp-25731	79	71	performed	perform	VERB
bjp-25731	79	72	led	lead	VERB
bjp-25731	79	73	to	to	ADP
bjp-25731	79	74	the	the	DET
bjp-25731	79	75	loss	loss	NOUN
bjp-25731	79	76	of	of	ADP
bjp-25731	79	77	important	important	ADJ
bjp-25731	79	78	hydrophobic	hydrophobic	NOUN
bjp-25731	79	79	interaction	interaction	NOUN
bjp-25731	79	80	with	with	ADP
bjp-25731	79	81	val726	val726	PROPN
bjp-25731	79	82	,	,	PUNCT
bjp-25731	79	83	leu718	leu718	PROPN
bjp-25731	79	84	and	and	CCONJ
bjp-25731	79	85	leu792	leu792	PROPN
bjp-25731	79	86	amino	amino	NOUN
bjp-25731	79	87	acid	acid	NOUN
bjp-25731	79	88	residues	residue	NOUN
bjp-25731	79	89	in	in	ADP
bjp-25731	79	90	egfrwt	egfrwt	ADJ
bjp-25731	79	91	binding	bind	VERB
bjp-25731	79	92	site	site	NOUN
bjp-25731	79	93	;	;	PUNCT
bjp-25731	79	94	and	and	CCONJ
bjp-25731	79	95	with	with	ADP
bjp-25731	79	96	val848	val848	PROPN
bjp-25731	79	97	,	,	PUNCT
bjp-25731	79	98	leu840	leu840	NOUN
bjp-25731	79	99	and	and	CCONJ
bjp-25731	79	100	phe918	phe918	PROPN
bjp-25731	79	101	amino	amino	NOUN
bjp-25731	79	102	acid	acid	NOUN
bjp-25731	79	103	residues	residue	NOUN
bjp-25731	79	104	in	in	ADP
bjp-25731	79	105	vegfr-2	vegfr-2	NUM
bjp-25731	79	106	binding	bind	VERB
bjp-25731	79	107	site	site	NOUN
bjp-25731	79	108	(	(	PUNCT
bjp-25731	79	109	barbosa	barbosa	PROPN
bjp-25731	79	110	et	et	PROPN
bjp-25731	79	111	al	al	PROPN
bjp-25731	79	112	.	.	PROPN
bjp-25731	79	113	,	,	PUNCT
bjp-25731	79	114	2014	2014	NUM
bjp-25731	79	115	)	)	PUNCT
bjp-25731	79	116	.	.	PUNCT
bjp-25731	80	1	anti	anti	ADJ
bjp-25731	80	2	-	-	ADJ
bjp-25731	80	3	proliferative	proliferative	ADJ
bjp-25731	80	4	activity	activity	NOUN
bjp-25731	80	5	over	over	ADP
bjp-25731	80	6	the	the	DET
bjp-25731	80	7	years	year	NOUN
bjp-25731	80	8	,	,	PUNCT
bjp-25731	80	9	it	it	PRON
bjp-25731	80	10	has	have	AUX
bjp-25731	80	11	been	be	AUX
bjp-25731	80	12	established	establish	VERB
bjp-25731	80	13	that	that	DET
bjp-25731	80	14	antiproliferative	antiproliferative	NOUN
bjp-25731	80	15	and	and	CCONJ
bjp-25731	80	16	cyctotoxic	cyctotoxic	PROPN
bjp-25731	80	17	drug	drug	NOUN
bjp-25731	80	18	serve	serve	VERB
bjp-25731	80	19	vital	vital	ADJ
bjp-25731	80	20	functions	function	NOUN
bjp-25731	80	21	in	in	ADP
bjp-25731	80	22	oncology	oncology	NOUN
bjp-25731	80	23	drug	drug	NOUN
bjp-25731	80	24	design	design	NOUN
bjp-25731	80	25	,	,	PUNCT
bjp-25731	80	26	either	either	CCONJ
bjp-25731	80	27	being	be	AUX
bjp-25731	80	28	used	use	VERB
bjp-25731	80	29	in	in	ADP
bjp-25731	80	30	isolation	isolation	NOUN
bjp-25731	80	31	or	or	CCONJ
bjp-25731	80	32	in	in	ADP
bjp-25731	80	33	conjunction	conjunction	NOUN
bjp-25731	80	34	with	with	ADP
bjp-25731	80	35	other	other	ADJ
bjp-25731	80	36	remedial	remedial	ADJ
bjp-25731	80	37	medical	medical	ADJ
bjp-25731	80	38	procedures	procedure	NOUN
bjp-25731	80	39	which	which	PRON
bjp-25731	80	40	include	include	VERB
bjp-25731	80	41	surgery	surgery	NOUN
bjp-25731	80	42	,	,	PUNCT
bjp-25731	80	43	radiation	radiation	NOUN
bjp-25731	80	44	and	and	CCONJ
bjp-25731	80	45	pharmacotherapy	pharmacotherapy	NOUN
bjp-25731	80	46	(	(	PUNCT
bjp-25731	80	47	arya	arya	PROPN
bjp-25731	80	48	et	et	PROPN
bjp-25731	80	49	al	al	PROPN
bjp-25731	80	50	.	.	PROPN
bjp-25731	80	51	,	,	PUNCT
bjp-25731	80	52	2014	2014	NUM
bjp-25731	80	53	;	;	PUNCT
bjp-25731	80	54	jabir	jabir	NOUN
bjp-25731	80	55	et	et	PROPN
bjp-25731	80	56	al	al	PROPN
bjp-25731	80	57	.	.	PROPN
bjp-25731	80	58	,	,	PUNCT
bjp-25731	80	59	2012	2012	NUM
bjp-25731	80	60	)	)	PUNCT
bjp-25731	80	61	.	.	PUNCT
bjp-25731	81	1	arya	arya	PROPN
bjp-25731	81	2	et	et	PROPN
bjp-25731	81	3	al	al	PROPN
bjp-25731	81	4	.	.	PROPN
bjp-25731	82	1	(	(	PUNCT
bjp-25731	82	2	2014	2014	NUM
bjp-25731	82	3	)	)	PUNCT
bjp-25731	82	4	reported	report	VERB
bjp-25731	82	5	that	that	SCONJ
bjp-25731	82	6	novel	novel	NOUN
bjp-25731	82	7	fluorinated	fluorinate	VERB
bjp-25731	82	8	benzothiazolo[2,3	benzothiazolo[2,3	PROPN
bjp-25731	82	9	-	-	NOUN
bjp-25731	82	10	b	b	NOUN
bjp-25731	82	11	]	]	PUNCT
bjp-25731	82	12	quinazoline	quinazoline	NOUN
bjp-25731	82	13	they	they	PRON
bjp-25731	82	14	synthesized	synthesize	VERB
bjp-25731	82	15	via	via	ADP
bjp-25731	82	16	greener	green	ADJ
bjp-25731	82	17	approach	approach	NOUN
bjp-25731	82	18	possessed	possess	VERB
bjp-25731	82	19	highly	highly	ADV
bjp-25731	82	20	promising	promising	ADJ
bjp-25731	82	21	photoanti	photoanti	ADJ
bjp-25731	82	22	-	-	ADJ
bjp-25731	82	23	proliferative	proliferative	ADJ
bjp-25731	82	24	activity	activity	NOUN
bjp-25731	82	25	upon	upon	SCONJ
bjp-25731	82	26	human	human	ADJ
bjp-25731	82	27	keratinocytes	keratinocyte	NOUN
bjp-25731	82	28	cell	cell	NOUN
bjp-25731	82	29	line	line	NOUN
bjp-25731	82	30	(	(	PUNCT
bjp-25731	82	31	arya	arya	PROPN
bjp-25731	82	32	et	et	PROPN
bjp-25731	82	33	al	al	PROPN
bjp-25731	82	34	.	.	PROPN
bjp-25731	82	35	,	,	PUNCT
bjp-25731	82	36	2014	2014	NUM
bjp-25731	82	37	)	)	PUNCT
bjp-25731	82	38	and	and	CCONJ
bjp-25731	82	39	carcinoma	carcinoma	NOUN
bjp-25731	82	40	cell	cell	NOUN
bjp-25731	82	41	line	line	NOUN
bjp-25731	82	42	such	such	ADJ
bjp-25731	82	43	as	as	ADP
bjp-25731	82	44	hl-60	hl-60	NOUN
bjp-25731	82	45	as	as	ADV
bjp-25731	82	46	well	well	ADV
bjp-25731	82	47	as	as	ADP
bjp-25731	82	48	lovo	lovo	PROPN
bjp-25731	82	49	cell	cell	NOUN
bjp-25731	82	50	lines	line	NOUN
bjp-25731	82	51	(	(	PUNCT
bjp-25731	82	52	arya	arya	PROPN
bjp-25731	82	53	et	et	PROPN
bjp-25731	82	54	al	al	PROPN
bjp-25731	82	55	.	.	PROPN
bjp-25731	82	56	,	,	PUNCT
bjp-25731	82	57	2014	2014	NUM
bjp-25731	82	58	)	)	PUNCT
bjp-25731	82	59	.	.	PUNCT
bjp-25731	83	1	novel	novel	ADJ
bjp-25731	83	2	array	array	NOUN
bjp-25731	83	3	of	of	ADP
bjp-25731	83	4	isatin	isatin	PROPN
bjp-25731	83	5	-	-	PUNCT
bjp-25731	83	6	based	base	VERB
bjp-25731	83	7	quinazolines	quinazoline	NOUN
bjp-25731	83	8	have	have	AUX
bjp-25731	83	9	been	be	AUX
bjp-25731	83	10	reported	report	VERB
bjp-25731	83	11	to	to	PART
bjp-25731	83	12	displayed	display	VERB
bjp-25731	83	13	distinctive	distinctive	ADJ
bjp-25731	83	14	selective	selective	ADJ
bjp-25731	83	15	growth	growth	NOUN
bjp-25731	83	16	inhibitory	inhibitory	ADJ
bjp-25731	83	17	effect	effect	NOUN
bjp-25731	83	18	(	(	PUNCT
bjp-25731	83	19	ic50	ic50	PROPN
bjp-25731	83	20	=	=	PROPN
bjp-25731	83	21	1.0	1.0	NUM
bjp-25731	83	22	 	 	SPACE
bjp-25731	83	23	±	±	NOUN
bjp-25731	83	24	 	 	SPACE
bjp-25731	83	25	0.2	0.2	NUM
bjp-25731	83	26	to	to	ADP
bjp-25731	83	27	2.4	2.4	NUM
bjp-25731	83	28	 	 	SPACE
bjp-25731	83	29	±	±	NOUN
bjp-25731	83	30	 	 	SPACE
bjp-25731	83	31	0.4	0.4	NUM
bjp-25731	83	32	 	 	SPACE
bjp-25731	83	33	μm	μm	NUM
bjp-25731	83	34	)	)	PUNCT
bjp-25731	83	35	by	by	ADP
bjp-25731	83	36	making	make	VERB
bjp-25731	83	37	use	use	NOUN
bjp-25731	83	38	of	of	ADP
bjp-25731	83	39	molecular	molecular	ADJ
bjp-25731	83	40	hybridization	hybridization	NOUN
bjp-25731	83	41	technique	technique	NOUN
bjp-25731	83	42	(	(	PUNCT
bjp-25731	83	43	fares	fare	NOUN
bjp-25731	83	44	et	et	PROPN
bjp-25731	83	45	al	al	PROPN
bjp-25731	83	46	.	.	PROPN
bjp-25731	83	47	,	,	PUNCT
bjp-25731	83	48	2015	2015	NUM
bjp-25731	83	49	)	)	PUNCT
bjp-25731	83	50	.	.	PUNCT
bjp-25731	84	1	anti	anti	ADJ
bjp-25731	84	2	-	-	ADJ
bjp-25731	84	3	tubercular	tubercular	ADJ
bjp-25731	84	4	activity	activity	NOUN
bjp-25731	84	5	tuberculosis	tuberculosis	NOUN
bjp-25731	84	6	(	(	PUNCT
bjp-25731	84	7	tb	tb	NOUN
bjp-25731	84	8	)	)	PUNCT
bjp-25731	84	9	is	be	AUX
bjp-25731	84	10	noted	note	VERB
bjp-25731	84	11	to	to	PART
bjp-25731	84	12	be	be	AUX
bjp-25731	84	13	one	one	NUM
bjp-25731	84	14	of	of	ADP
bjp-25731	84	15	the	the	DET
bjp-25731	84	16	oldest	old	ADJ
bjp-25731	84	17	and	and	CCONJ
bjp-25731	84	18	most	most	ADV
bjp-25731	84	19	-	-	PUNCT
bjp-25731	84	20	pervasive	pervasive	ADJ
bjp-25731	84	21	diseases	disease	NOUN
bjp-25731	84	22	in	in	ADP
bjp-25731	84	23	history	history	NOUN
bjp-25731	84	24	of	of	ADP
bjp-25731	84	25	mankind	mankind	NOUN
bjp-25731	84	26	(	(	PUNCT
bjp-25731	84	27	ankita	ankita	X
bjp-25731	84	28	et	et	PROPN
bjp-25731	84	29	al	al	PROPN
bjp-25731	84	30	.	.	PROPN
bjp-25731	84	31	,	,	PUNCT
bjp-25731	84	32	2014	2014	NUM
bjp-25731	84	33	;	;	PUNCT
bjp-25731	84	34	yves	yve	NOUN
bjp-25731	84	35	,	,	PUNCT
bjp-25731	84	36	2007	2007	NUM
bjp-25731	84	37	)	)	PUNCT
bjp-25731	84	38	.	.	PUNCT
bjp-25731	85	1	it	it	PRON
bjp-25731	85	2	has	have	AUX
bjp-25731	85	3	been	be	AUX
bjp-25731	85	4	projected	project	VERB
bjp-25731	85	5	that	that	SCONJ
bjp-25731	85	6	close	close	ADV
bjp-25731	85	7	to	to	ADP
bjp-25731	85	8	1000	1000	NUM
bjp-25731	85	9	million	million	NUM
bjp-25731	85	10	of	of	ADP
bjp-25731	85	11	world	world	NOUN
bjp-25731	85	12	population	population	NOUN
bjp-25731	85	13	will	will	AUX
bjp-25731	85	14	be	be	AUX
bjp-25731	85	15	newly	newly	ADV
bjp-25731	85	16	infected	infect	VERB
bjp-25731	85	17	,	,	PUNCT
bjp-25731	85	18	above	above	ADP
bjp-25731	85	19	150	150	NUM
bjp-25731	85	20	million	million	NUM
bjp-25731	85	21	individuals	individual	NOUN
bjp-25731	85	22	will	will	AUX
bjp-25731	85	23	develop	develop	VERB
bjp-25731	85	24	bangladesh	bangladesh	PROPN
bjp-25731	85	25	j	j	PROPN
bjp-25731	85	26	pharmacol	pharmacol	PROPN
bjp-25731	85	27	2016	2016	NUM
bjp-25731	85	28	;	;	PUNCT
bjp-25731	85	29	11	11	NUM
bjp-25731	85	30	:	:	PUNCT
bjp-25731	85	31	716	716	NUM
bjp-25731	85	32	-	-	SYM
bjp-25731	85	33	733	733	NUM
bjp-25731	85	34	719	719	NUM
bjp-25731	85	35	diseases	disease	NOUN
bjp-25731	85	36	and	and	CCONJ
bjp-25731	85	37	36	36	NUM
bjp-25731	85	38	million	million	NUM
bjp-25731	85	39	will	will	AUX
bjp-25731	85	40	die	die	VERB
bjp-25731	85	41	of	of	ADP
bjp-25731	85	42	tb	tb	NOUN
bjp-25731	85	43	,	,	PUNCT
bjp-25731	85	44	between	between	ADP
bjp-25731	85	45	2002	2002	NUM
bjp-25731	85	46	and	and	CCONJ
bjp-25731	85	47	2020	2020	NUM
bjp-25731	85	48	,	,	PUNCT
bjp-25731	85	49	if	if	SCONJ
bjp-25731	85	50	adequate	adequate	ADJ
bjp-25731	85	51	preventive	preventive	ADJ
bjp-25731	85	52	and	and	CCONJ
bjp-25731	85	53	proper	proper	ADJ
bjp-25731	85	54	control	control	NOUN
bjp-25731	85	55	measures	measure	NOUN
bjp-25731	85	56	are	be	AUX
bjp-25731	85	57	not	not	PART
bjp-25731	85	58	in	in	ADP
bjp-25731	85	59	place	place	NOUN
bjp-25731	85	60	(	(	PUNCT
bjp-25731	85	61	ankita	ankita	X
bjp-25731	85	62	et	et	PROPN
bjp-25731	85	63	al	al	PROPN
bjp-25731	85	64	.	.	PROPN
bjp-25731	85	65	,	,	PUNCT
bjp-25731	85	66	2014	2014	NUM
bjp-25731	85	67	;	;	PUNCT
bjp-25731	85	68	corbett	corbett	PROPN
bjp-25731	85	69	et	et	PROPN
bjp-25731	85	70	al	al	PROPN
bjp-25731	85	71	.	.	PROPN
bjp-25731	85	72	,	,	PUNCT
bjp-25731	85	73	2003	2003	NUM
bjp-25731	85	74	)	)	PUNCT
bjp-25731	85	75	.	.	PUNCT
bjp-25731	86	1	due	due	ADP
bjp-25731	86	2	to	to	ADP
bjp-25731	86	3	the	the	DET
bjp-25731	86	4	difficulty	difficulty	NOUN
bjp-25731	86	5	in	in	ADP
bjp-25731	86	6	the	the	DET
bjp-25731	86	7	treatment	treatment	NOUN
bjp-25731	86	8	of	of	ADP
bjp-25731	86	9	drug	drug	NOUN
bjp-25731	86	10	resistant	resistant	ADJ
bjp-25731	86	11	forms	form	NOUN
bjp-25731	86	12	of	of	ADP
bjp-25731	86	13	mycobacterium	mycobacterium	NOUN
bjp-25731	86	14	tuberculosis	tuberculosis	NOUN
bjp-25731	86	15	,	,	PUNCT
bjp-25731	86	16	the	the	DET
bjp-25731	86	17	development	development	NOUN
bjp-25731	86	18	of	of	ADP
bjp-25731	86	19	novel	novel	ADJ
bjp-25731	86	20	antituberculosis	antituberculosis	NOUN
bjp-25731	86	21	drug	drug	NOUN
bjp-25731	86	22	entities	entity	NOUN
bjp-25731	86	23	which	which	PRON
bjp-25731	86	24	exhibit	exhibit	VERB
bjp-25731	86	25	new	new	ADJ
bjp-25731	86	26	mechanisms	mechanism	NOUN
bjp-25731	86	27	of	of	ADP
bjp-25731	86	28	action	action	NOUN
bjp-25731	86	29	is	be	AUX
bjp-25731	86	30	urgently	urgently	ADV
bjp-25731	86	31	demanded	demand	VERB
bjp-25731	86	32	with	with	ADP
bjp-25731	86	33	the	the	DET
bjp-25731	86	34	aim	aim	NOUN
bjp-25731	86	35	of	of	ADP
bjp-25731	86	36	designing	design	VERB
bjp-25731	86	37	more	more	ADV
bjp-25731	86	38	potent	potent	ADJ
bjp-25731	86	39	combination	combination	NOUN
bjp-25731	86	40	therapy	therapy	NOUN
bjp-25731	86	41	(	(	PUNCT
bjp-25731	86	42	mathew	mathew	PROPN
bjp-25731	86	43	et	et	PROPN
bjp-25731	86	44	al	al	PROPN
bjp-25731	86	45	.	.	PROPN
bjp-25731	86	46	,	,	PUNCT
bjp-25731	86	47	2013	2013	NUM
bjp-25731	86	48	)	)	PUNCT
bjp-25731	86	49	.	.	PUNCT
bjp-25731	87	1	an	an	DET
bjp-25731	87	2	array	array	NOUN
bjp-25731	87	3	of	of	ADP
bjp-25731	87	4	new	new	ADJ
bjp-25731	87	5	2	2	NUM
bjp-25731	87	6	-	-	PUNCT
bjp-25731	87	7	trichloromethyl	trichloromethyl	PROPN
bjp-25731	87	8	quinazoline	quinazoline	NOUN
bjp-25731	87	9	moieties	moiety	NOUN
bjp-25731	87	10	containing	contain	VERB
bjp-25731	87	11	substituted	substitute	VERB
bjp-25731	87	12	secondary	secondary	ADJ
bjp-25731	87	13	amine	amine	ADJ
bjp-25731	87	14	side	side	NOUN
bjp-25731	87	15	chain	chain	NOUN
bjp-25731	87	16	at	at	ADP
bjp-25731	87	17	4th	4th	ADJ
bjp-25731	87	18	position	position	NOUN
bjp-25731	87	19	were	be	AUX
bjp-25731	87	20	designed	design	VERB
bjp-25731	87	21	and	and	CCONJ
bjp-25731	87	22	investigated	investigate	VERB
bjp-25731	87	23	via	via	ADP
bjp-25731	87	24	in	in	ADP
bjp-25731	87	25	vitro	vitro	X
bjp-25731	87	26	screening	screen	VERB
bjp-25731	87	27	for	for	ADP
bjp-25731	87	28	anti	anti	ADJ
bjp-25731	87	29	-	-	ADJ
bjp-25731	87	30	tubercular	tubercular	ADJ
bjp-25731	87	31	potential	potential	NOUN
bjp-25731	87	32	upon	upon	SCONJ
bjp-25731	87	33	m.	m.	NOUN
bjp-25731	87	34	tuberculosis	tuberculosis	NOUN
bjp-25731	87	35	h37rv	h37rv	PROPN
bjp-25731	87	36	atcc	atcc	NOUN
bjp-25731	87	37	(	(	PUNCT
bjp-25731	87	38	srivastav	srivastav	ADJ
bjp-25731	87	39	and	and	CCONJ
bjp-25731	87	40	shantakumar	shantakumar	ADJ
bjp-25731	87	41	,	,	PUNCT
bjp-25731	87	42	2013	2013	NUM
bjp-25731	87	43	)	)	PUNCT
bjp-25731	87	44	using	use	VERB
bjp-25731	87	45	alamar	alamar	PROPN
bjp-25731	87	46	blue	blue	PROPN
bjp-25731	87	47	assay	assay	VERB
bjp-25731	87	48	.	.	PUNCT
bjp-25731	88	1	8	8	NUM
bjp-25731	88	2	-	-	PUNCT
bjp-25731	88	3	methoxy-4-[4-[2-(1	methoxy-4-[4-[2-(1	NOUN
bjp-25731	88	4	-	-	ADJ
bjp-25731	88	5	piperidyl)ethoxy	piperidyl)ethoxy	NOUN
bjp-25731	88	6	]	]	X
bjp-25731	88	7	phenyl]-5,6	phenyl]-5,6	VERB
bjp-25731	88	8	-	-	PUNCT
bjp-25731	88	9	dihydrobenzo[h]quinazolin-2	dihydrobenzo[h]quinazolin-2	NOUN
bjp-25731	88	10	-	-	PUNCT
bjp-25731	88	11	amine	amine	NOUN
bjp-25731	88	12	exhibited	exhibit	VERB
bjp-25731	88	13	significant	significant	ADJ
bjp-25731	88	14	anti	anti	ADJ
bjp-25731	88	15	-	-	ADJ
bjp-25731	88	16	tubercular	tubercular	ADJ
bjp-25731	88	17	activity	activity	NOUN
bjp-25731	88	18	at	at	ADP
bjp-25731	88	19	mic	mic	ADJ
bjp-25731	88	20	values	value	NOUN
bjp-25731	88	21	50	50	NUM
bjp-25731	88	22	μm	μm	NOUN
bjp-25731	88	23	and	and	CCONJ
bjp-25731	88	24	the	the	DET
bjp-25731	88	25	in	in	ADV
bjp-25731	88	26	vitro	vitro	X
bjp-25731	88	27	cytotoxicity	cytotoxicity	NOUN
bjp-25731	88	28	data	datum	NOUN
bjp-25731	88	29	using	use	VERB
bjp-25731	88	30	thp-1	thp-1	ADJ
bjp-25731	88	31	cells	cell	NOUN
bjp-25731	88	32	indicated	indicate	VERB
bjp-25731	88	33	that	that	SCONJ
bjp-25731	88	34	it	it	PRON
bjp-25731	88	35	was	be	AUX
bjp-25731	88	36	safe	safe	ADJ
bjp-25731	88	37	as	as	SCONJ
bjp-25731	88	38	its	its	PRON
bjp-25731	88	39	mic	mic	ADJ
bjp-25731	88	40	value	value	NOUN
bjp-25731	88	41	was	be	AUX
bjp-25731	88	42	much	much	ADV
bjp-25731	88	43	lower	low	ADJ
bjp-25731	88	44	than	than	ADP
bjp-25731	88	45	the	the	DET
bjp-25731	88	46	cytotoxic	cytotoxic	ADJ
bjp-25731	88	47	value	value	NOUN
bjp-25731	88	48	as	as	SCONJ
bjp-25731	88	49	documented	document	VERB
bjp-25731	88	50	by	by	ADP
bjp-25731	88	51	maurya	maurya	PROPN
bjp-25731	88	52	et	et	PROPN
bjp-25731	88	53	al	al	PROPN
bjp-25731	88	54	.	.	PROPN
bjp-25731	89	1	(	(	PUNCT
bjp-25731	89	2	2013	2013	NUM
bjp-25731	89	3	)	)	PUNCT
bjp-25731	89	4	.	.	PUNCT
bjp-25731	90	1	anti	anti	ADJ
bjp-25731	90	2	-	-	ADJ
bjp-25731	90	3	inflammatory	inflammatory	ADJ
bjp-25731	90	4	activity	activity	NOUN
bjp-25731	90	5	for	for	ADP
bjp-25731	90	6	the	the	DET
bjp-25731	90	7	past	past	ADJ
bjp-25731	90	8	few	few	ADJ
bjp-25731	90	9	decades	decade	NOUN
bjp-25731	90	10	now	now	ADV
bjp-25731	90	11	,	,	PUNCT
bjp-25731	90	12	a	a	DET
bjp-25731	90	13	probable	probable	ADJ
bjp-25731	90	14	conjunction	conjunction	NOUN
bjp-25731	90	15	between	between	ADP
bjp-25731	90	16	the	the	DET
bjp-25731	90	17	application	application	NOUN
bjp-25731	90	18	of	of	ADP
bjp-25731	90	19	non	non	ADJ
bjp-25731	90	20	-	-	ADJ
bjp-25731	90	21	steroidal	steroidal	ADJ
bjp-25731	90	22	antiinflammatory	antiinflammatory	NOUN
bjp-25731	90	23	agents	agent	NOUN
bjp-25731	90	24	(	(	PUNCT
bjp-25731	90	25	nsaids	nsaids	PROPN
bjp-25731	90	26	)	)	PUNCT
bjp-25731	90	27	and	and	CCONJ
bjp-25731	90	28	modified	modify	VERB
bjp-25731	90	29	cases	case	NOUN
bjp-25731	90	30	of	of	ADP
bjp-25731	90	31	cancer	cancer	NOUN
bjp-25731	90	32	has	have	AUX
bjp-25731	90	33	continued	continue	VERB
bjp-25731	90	34	to	to	PART
bjp-25731	90	35	exist	exist	VERB
bjp-25731	90	36	as	as	ADP
bjp-25731	90	37	special	special	ADJ
bjp-25731	90	38	topic	topic	NOUN
bjp-25731	90	39	that	that	PRON
bjp-25731	90	40	needs	need	VERB
bjp-25731	90	41	intense	intense	ADJ
bjp-25731	90	42	evaluation	evaluation	NOUN
bjp-25731	90	43	and	and	CCONJ
bjp-25731	90	44	research	research	NOUN
bjp-25731	90	45	(	(	PUNCT
bjp-25731	90	46	chandrika	chandrika	X
bjp-25731	90	47	et	et	PROPN
bjp-25731	90	48	al	al	PROPN
bjp-25731	90	49	.	.	PROPN
bjp-25731	90	50	,	,	PUNCT
bjp-25731	90	51	2008	2008	NUM
bjp-25731	90	52	)	)	PUNCT
bjp-25731	90	53	.	.	PUNCT
bjp-25731	91	1	using	use	VERB
bjp-25731	91	2	nos	nos	PROPN
bjp-25731	91	3	-	-	NOUN
bjp-25731	91	4	ii	ii	NOUN
bjp-25731	91	5	as	as	ADP
bjp-25731	91	6	biomarker	biomarker	NOUN
bjp-25731	91	7	indicator	indicator	NOUN
bjp-25731	91	8	,	,	PUNCT
bjp-25731	91	9	generally	generally	ADV
bjp-25731	91	10	,	,	PUNCT
bjp-25731	91	11	quinazoline	quinazoline	ADJ
bjp-25731	91	12	motifs	motif	NOUN
bjp-25731	91	13	are	be	AUX
bjp-25731	91	14	well	well	ADV
bjp-25731	91	15	-	-	PUNCT
bjp-25731	91	16	known	know	VERB
bjp-25731	91	17	to	to	PART
bjp-25731	91	18	exhibit	exhibit	VERB
bjp-25731	91	19	significant	significant	ADJ
bjp-25731	91	20	anti	anti	ADJ
bjp-25731	91	21	-	-	ADJ
bjp-25731	91	22	inflammatory	inflammatory	ADJ
bjp-25731	91	23	properties	property	NOUN
bjp-25731	91	24	as	as	ADP
bjp-25731	91	25	inhibitors	inhibitor	NOUN
bjp-25731	91	26	of	of	ADP
bjp-25731	91	27	nosii	nosii	NOUN
bjp-25731	91	28	(	(	PUNCT
bjp-25731	91	29	farag	farag	PROPN
bjp-25731	91	30	et	et	PROPN
bjp-25731	91	31	al	al	PROPN
bjp-25731	91	32	.	.	PROPN
bjp-25731	91	33	,	,	PUNCT
bjp-25731	91	34	2013	2013	NUM
bjp-25731	91	35	;	;	PUNCT
bjp-25731	91	36	tinker	tinker	VERB
bjp-25731	91	37	et	et	PROPN
bjp-25731	91	38	al	al	PROPN
bjp-25731	91	39	.	.	PROPN
bjp-25731	91	40	,	,	PUNCT
bjp-25731	91	41	2003	2003	NUM
bjp-25731	91	42	)	)	PUNCT
bjp-25731	91	43	,	,	PUNCT
bjp-25731	91	44	nfkb	nfkb	PROPN
bjp-25731	91	45	,	,	PUNCT
bjp-25731	91	46	tnf	tnf	PROPN
bjp-25731	91	47	(	(	PUNCT
bjp-25731	91	48	serya	serya	NOUN
bjp-25731	91	49	et	et	PROPN
bjp-25731	91	50	al	al	PROPN
bjp-25731	91	51	.	.	PROPN
bjp-25731	91	52	,	,	PUNCT
bjp-25731	91	53	2015	2015	NUM
bjp-25731	91	54	)	)	PUNCT
bjp-25731	91	55	,	,	PUNCT
bjp-25731	91	56	impdh	impdh	NOUN
bjp-25731	91	57	-	-	PUNCT
bjp-25731	91	58	ii	ii	NOUN
bjp-25731	91	59	(	(	PUNCT
bjp-25731	91	60	rajput	rajput	PROPN
bjp-25731	91	61	and	and	CCONJ
bjp-25731	91	62	mishra	mishra	PROPN
bjp-25731	91	63	,	,	PUNCT
bjp-25731	91	64	2012	2012	NUM
bjp-25731	91	65	)	)	PUNCT
bjp-25731	91	66	,	,	PUNCT
bjp-25731	91	67	mapk	mapk	NOUN
bjp-25731	91	68	,	,	PUNCT
bjp-25731	91	69	il-6	il-6	NUM
bjp-25731	91	70	,	,	PUNCT
bjp-25731	91	71	pde-3	pde-3	PUNCT
bjp-25731	91	72	and	and	CCONJ
bjp-25731	91	73	pde-4	pde-4	PRON
bjp-25731	91	74	(	(	PUNCT
bjp-25731	91	75	serya	serya	NOUN
bjp-25731	91	76	et	et	PROPN
bjp-25731	91	77	al	al	PROPN
bjp-25731	91	78	.	.	PROPN
bjp-25731	91	79	,	,	PUNCT
bjp-25731	91	80	2015	2015	NUM
bjp-25731	91	81	)	)	PUNCT
bjp-25731	91	82	.	.	PUNCT
bjp-25731	92	1	a	a	DET
bjp-25731	92	2	series	series	NOUN
bjp-25731	92	3	of	of	ADP
bjp-25731	92	4	novel	novel	NOUN
bjp-25731	92	5	8/10	8/10	NUM
bjp-25731	92	6	trifluoromethylsubstituted	trifluoromethylsubstitute	VERB
bjp-25731	92	7	-	-	PUNCT
bjp-25731	92	8	imidazo[1,2	imidazo[1,2	NOUN
bjp-25731	92	9	-	-	PUNCT
bjp-25731	92	10	c	c	NOUN
bjp-25731	92	11	]	]	PUNCT
bjp-25731	92	12	quinazolines	quinazoline	NOUN
bjp-25731	92	13	were	be	AUX
bjp-25731	92	14	synthesized	synthesize	VERB
bjp-25731	92	15	and	and	CCONJ
bjp-25731	92	16	investigated	investigate	VERB
bjp-25731	92	17	in	in	ADP
bjp-25731	92	18	vivo	vivo	NOUN
bjp-25731	92	19	(	(	PUNCT
bjp-25731	92	20	rat	rat	NOUN
bjp-25731	92	21	paw	paw	PROPN
bjp-25731	92	22	edema	edema	PROPN
bjp-25731	92	23	)	)	PUNCT
bjp-25731	92	24	for	for	ADP
bjp-25731	92	25	their	their	PRON
bjp-25731	92	26	anti	anti	ADJ
bjp-25731	92	27	-	-	ADJ
bjp-25731	92	28	inflammatory	inflammatory	ADJ
bjp-25731	92	29	activity	activity	NOUN
bjp-25731	92	30	and	and	CCONJ
bjp-25731	92	31	in	in	ADP
bjp-25731	92	32	silico	silico	NOUN
bjp-25731	92	33	(	(	PUNCT
bjp-25731	92	34	docking	dock	VERB
bjp-25731	92	35	studies	study	NOUN
bjp-25731	92	36	)	)	PUNCT
bjp-25731	92	37	to	to	PART
bjp-25731	92	38	recognize	recognize	VERB
bjp-25731	92	39	the	the	DET
bjp-25731	92	40	hypothetical	hypothetical	ADJ
bjp-25731	92	41	binding	bind	VERB
bjp-25731	92	42	motif	motif	NOUN
bjp-25731	92	43	(	(	PUNCT
bjp-25731	92	44	rajput	rajput	PROPN
bjp-25731	92	45	and	and	CCONJ
bjp-25731	92	46	mishra	mishra	PROPN
bjp-25731	92	47	,	,	PUNCT
bjp-25731	92	48	2012	2012	NUM
bjp-25731	92	49	;	;	PUNCT
bjp-25731	92	50	kumar	kumar	PROPN
bjp-25731	92	51	et	et	PROPN
bjp-25731	92	52	al	al	PROPN
bjp-25731	92	53	.	.	PROPN
bjp-25731	92	54	,	,	PUNCT
bjp-25731	92	55	2003	2003	NUM
bjp-25731	92	56	)	)	PUNCT
bjp-25731	92	57	with	with	ADP
bjp-25731	92	58	the	the	DET
bjp-25731	92	59	cycloxygenase	cycloxygenase	NOUN
bjp-25731	92	60	enzymes	enzyme	NOUN
bjp-25731	92	61	(	(	PUNCT
bjp-25731	92	62	cox-1	cox-1	X
bjp-25731	92	63	and	and	CCONJ
bjp-25731	92	64	cox-2	cox-2	NOUN
bjp-25731	92	65	)	)	PUNCT
bjp-25731	92	66	employing	employ	VERB
bjp-25731	92	67	gold	gold	NOUN
bjp-25731	92	68	(	(	PUNCT
bjp-25731	92	69	ccdc	ccdc	PROPN
bjp-25731	92	70	,	,	PUNCT
bjp-25731	92	71	4.0.1	4.0.1	NUM
bjp-25731	92	72	version	version	NOUN
bjp-25731	92	73	)	)	PUNCT
bjp-25731	92	74	software	software	NOUN
bjp-25731	92	75	and	and	CCONJ
bjp-25731	92	76	found	find	VERB
bjp-25731	92	77	that	that	SCONJ
bjp-25731	92	78	compounds	compound	NOUN
bjp-25731	92	79	(	(	PUNCT
bjp-25731	92	80	rajput	rajput	PROPN
bjp-25731	92	81	and	and	CCONJ
bjp-25731	92	82	mishra	mishra	PROPN
bjp-25731	92	83	,	,	PUNCT
bjp-25731	92	84	2012	2012	NUM
bjp-25731	92	85	)	)	PUNCT
bjp-25731	92	86	figure	figure	NOUN
bjp-25731	92	87	4	4	NUM
bjp-25731	92	88	:	:	PUNCT
bjp-25731	92	89	(	(	PUNCT
bjp-25731	92	90	a	a	X
bjp-25731	92	91	)	)	PUNCT
bjp-25731	92	92	binding	bind	VERB
bjp-25731	92	93	interactions	interaction	NOUN
bjp-25731	92	94	of	of	ADP
bjp-25731	92	95	6,7	6,7	NUM
bjp-25731	92	96	-	-	PUNCT
bjp-25731	92	97	dimethoxy	dimethoxy	ADJ
bjp-25731	92	98	-	-	PUNCT
bjp-25731	92	99	derivative	derivative	NOUN
bjp-25731	92	100	of	of	ADP
bjp-25731	92	101	quinazoline	quinazoline	NOUN
bjp-25731	92	102	(	(	PUNCT
bjp-25731	92	103	yellow	yellow	ADJ
bjp-25731	92	104	)	)	PUNCT
bjp-25731	92	105	with	with	ADP
bjp-25731	92	106	egfrwt	egfrwt	NOUN
bjp-25731	92	107	.	.	PUNCT
bjp-25731	93	1	(	(	PUNCT
bjp-25731	93	2	b	b	X
bjp-25731	93	3	)	)	PUNCT
bjp-25731	93	4	binding	bind	VERB
bjp-25731	93	5	interactions	interaction	NOUN
bjp-25731	93	6	of	of	ADP
bjp-25731	93	7	methylenedioxy	methylenedioxy	NOUN
bjp-25731	93	8	-	-	PUNCT
bjp-25731	93	9	derivative	derivative	NOUN
bjp-25731	93	10	of	of	ADP
bjp-25731	93	11	quinazoline	quinazoline	NOUN
bjp-25731	93	12	(	(	PUNCT
bjp-25731	93	13	gray	gray	ADJ
bjp-25731	93	14	)	)	PUNCT
bjp-25731	93	15	with	with	ADP
bjp-25731	93	16	egfrwt	egfrwt	NOUN
bjp-25731	93	17	.	.	PUNCT
bjp-25731	94	1	(	(	PUNCT
bjp-25731	94	2	c	c	X
bjp-25731	94	3	)	)	PUNCT
bjp-25731	94	4	binding	bind	VERB
bjp-25731	94	5	interactions	interaction	NOUN
bjp-25731	94	6	of	of	ADP
bjp-25731	94	7	6,7	6,7	NUM
bjp-25731	94	8	-	-	PUNCT
bjp-25731	94	9	dimethoxy	dimethoxy	ADJ
bjp-25731	94	10	-	-	PUNCT
bjp-25731	94	11	derivative	derivative	NOUN
bjp-25731	94	12	of	of	ADP
bjp-25731	94	13	quinazoline	quinazoline	NOUN
bjp-25731	94	14	(	(	PUNCT
bjp-25731	94	15	yellow	yellow	ADJ
bjp-25731	94	16	)	)	PUNCT
bjp-25731	94	17	with	with	ADP
bjp-25731	94	18	vegfr-2	vegfr-2	NUM
bjp-25731	94	19	.	.	PUNCT
bjp-25731	95	1	(	(	PUNCT
bjp-25731	95	2	d	d	X
bjp-25731	95	3	)	)	PUNCT
bjp-25731	95	4	binding	bind	VERB
bjp-25731	95	5	interactions	interaction	NOUN
bjp-25731	95	6	of	of	ADP
bjp-25731	95	7	methylenedioxy	methylenedioxy	NOUN
bjp-25731	95	8	-	-	PUNCT
bjp-25731	95	9	derivative	derivative	NOUN
bjp-25731	95	10	of	of	ADP
bjp-25731	95	11	quinazoline	quinazoline	NOUN
bjp-25731	95	12	(	(	PUNCT
bjp-25731	95	13	gray	gray	ADJ
bjp-25731	95	14	)	)	PUNCT
bjp-25731	95	15	with	with	ADP
bjp-25731	95	16	vegfr-2	vegfr-2	NUM
bjp-25731	95	17	.	.	PUNCT
bjp-25731	96	1	docking	dock	VERB
bjp-25731	96	2	studies	study	NOUN
bjp-25731	96	3	were	be	AUX
bjp-25731	96	4	performed	perform	VERB
bjp-25731	96	5	with	with	ADP
bjp-25731	96	6	the	the	DET
bjp-25731	96	7	gold	gold	ADJ
bjp-25731	96	8	5.1	5.1	NUM
bjp-25731	96	9	program	program	NOUN
bjp-25731	96	10	.	.	PUNCT
bjp-25731	97	1	apolar	apolar	ADJ
bjp-25731	97	2	hydrogen	hydrogen	NOUN
bjp-25731	97	3	atoms	atom	NOUN
bjp-25731	97	4	were	be	AUX
bjp-25731	97	5	omitted	omit	VERB
bjp-25731	97	6	to	to	PART
bjp-25731	97	7	improve	improve	VERB
bjp-25731	97	8	clarity	clarity	NOUN
bjp-25731	97	9	.	.	PUNCT
bjp-25731	98	1	the	the	DET
bjp-25731	98	2	images	image	NOUN
bjp-25731	98	3	were	be	AUX
bjp-25731	98	4	generated	generate	VERB
bjp-25731	98	5	with	with	ADP
bjp-25731	98	6	pymol	pymol	PROPN
bjp-25731	98	7	software	software	NOUN
bjp-25731	98	8	(	(	PUNCT
bjp-25731	98	9	barbosa	barbosa	PROPN
bjp-25731	98	10	et	et	PROPN
bjp-25731	98	11	al	al	PROPN
bjp-25731	98	12	.	.	PROPN
bjp-25731	98	13	,	,	PUNCT
bjp-25731	98	14	2014	2014	NUM
bjp-25731	98	15	)	)	PUNCT
bjp-25731	98	16	720	720	NUM
bjp-25731	99	1	bangladesh	bangladesh	NOUN
bjp-25731	99	2	j	j	PROPN
bjp-25731	99	3	pharmacol	pharmacol	PROPN
bjp-25731	99	4	2016	2016	NUM
bjp-25731	99	5	;	;	PUNCT
bjp-25731	99	6	11	11	NUM
bjp-25731	99	7	:	:	PUNCT
bjp-25731	99	8	716	716	NUM
bjp-25731	99	9	-	-	SYM
bjp-25731	99	10	733	733	NUM
bjp-25731	99	11	http://www.sciencedirect.com/science/article/pii/s0223523407002607#bib19	http://www.sciencedirect.com/science/article/pii/s0223523407002607#bib19	NOUN
bjp-25731	99	12	showed	show	VERB
bjp-25731	99	13	good	good	ADJ
bjp-25731	99	14	anti	anti	ADJ
bjp-25731	99	15	-	-	ADJ
bjp-25731	99	16	inflammatory	inflammatory	ADJ
bjp-25731	99	17	activity	activity	NOUN
bjp-25731	99	18	against	against	ADP
bjp-25731	99	19	standard	standard	NOUN
bjp-25731	99	20	,	,	PUNCT
bjp-25731	99	21	indomethacin	indomethacin	PROPN
bjp-25731	99	22	.	.	PUNCT
bjp-25731	100	1	quinazoline	quinazoline	PROPN
bjp-25731	100	2	derivatives	derivative	NOUN
bjp-25731	100	3	are	be	AUX
bjp-25731	100	4	also	also	ADV
bjp-25731	100	5	found	find	VERB
bjp-25731	100	6	to	to	PART
bjp-25731	100	7	show	show	VERB
bjp-25731	100	8	bronco	bronco	NOUN
bjp-25731	100	9	-	-	PUNCT
bjp-25731	100	10	dilatory	dilatory	ADJ
bjp-25731	100	11	properties	property	NOUN
bjp-25731	100	12	(	(	PUNCT
bjp-25731	100	13	jindal	jindal	PROPN
bjp-25731	100	14	et	et	PROPN
bjp-25731	100	15	al	al	PROPN
bjp-25731	100	16	.	.	PROPN
bjp-25731	100	17	,	,	PUNCT
bjp-25731	100	18	2002	2002	NUM
bjp-25731	100	19	)	)	PUNCT
bjp-25731	100	20	.	.	PUNCT
bjp-25731	101	1	using	use	VERB
bjp-25731	101	2	tumor	tumor	NOUN
bjp-25731	101	3	necrosis	necrosis	NOUN
bjp-25731	101	4	factor	factor	NOUN
bjp-25731	101	5	-	-	PUNCT
bjp-25731	101	6	α	α	X
bjp-25731	101	7	(	(	PUNCT
bjp-25731	101	8	tnf	tnf	PROPN
bjp-25731	101	9	-	-	PUNCT
bjp-25731	101	10	α	α	NOUN
bjp-25731	101	11	)	)	PUNCT
bjp-25731	101	12	as	as	ADP
bjp-25731	101	13	the	the	DET
bjp-25731	101	14	biomedical	biomedical	ADJ
bjp-25731	101	15	pathway	pathway	NOUN
bjp-25731	101	16	,	,	PUNCT
bjp-25731	101	17	ethyl	ethyl	PROPN
bjp-25731	101	18	4-(2	4-(2	PROPN
bjp-25731	101	19	-	-	PUNCT
bjp-25731	101	20	carbamoyl	carbamoyl	PROPN
bjp-25731	101	21	anilino	anilino	PROPN
bjp-25731	101	22	)	)	PUNCT
bjp-25731	101	23	quinazoline-2	quinazoline-2	VERB
bjp-25731	101	24	-	-	PUNCT
bjp-25731	101	25	carboxylate	carboxylate	NOUN
bjp-25731	101	26	was	be	AUX
bjp-25731	101	27	discovered	discover	VERB
bjp-25731	101	28	to	to	PART
bjp-25731	101	29	be	be	AUX
bjp-25731	101	30	a	a	DET
bjp-25731	101	31	promising	promising	ADJ
bjp-25731	101	32	anti	anti	ADJ
bjp-25731	101	33	-	-	ADJ
bjp-25731	101	34	inflammatory	inflammatory	ADJ
bjp-25731	101	35	quinazoline	quinazoline	NOUN
bjp-25731	101	36	derivative	derivative	NOUN
bjp-25731	101	37	with	with	ADP
bjp-25731	101	38	68	68	NUM
bjp-25731	101	39	%	%	NOUN
bjp-25731	101	40	average	average	ADJ
bjp-25731	101	41	inhibition	inhibition	NOUN
bjp-25731	101	42	on	on	ADP
bjp-25731	101	43	pde4b	pde4b	NOUN
bjp-25731	101	44	enzyme	enzyme	NOUN
bjp-25731	101	45	at	at	ADP
bjp-25731	101	46	concentration	concentration	NOUN
bjp-25731	101	47	of	of	ADP
bjp-25731	101	48	10	10	NUM
bjp-25731	101	49	μm	μm	NOUN
bjp-25731	101	50	(	(	PUNCT
bjp-25731	101	51	serya	serya	NOUN
bjp-25731	101	52	et	et	PROPN
bjp-25731	101	53	al	al	PROPN
bjp-25731	101	54	.	.	PROPN
bjp-25731	101	55	,	,	PUNCT
bjp-25731	101	56	2015	2015	NUM
bjp-25731	101	57	)	)	PUNCT
bjp-25731	101	58	.	.	PUNCT
bjp-25731	102	1	antileishmanial	antileishmanial	ADJ
bjp-25731	102	2	activity	activity	NOUN
bjp-25731	102	3	leishmaniasis	leishmaniasis	NOUN
bjp-25731	102	4	,	,	PUNCT
bjp-25731	102	5	otherwise	otherwise	ADV
bjp-25731	102	6	known	know	VERB
bjp-25731	102	7	as	as	ADP
bjp-25731	102	8	african	african	ADJ
bjp-25731	102	9	trypanosomiasis	trypanosomiasis	NOUN
bjp-25731	102	10	or	or	CCONJ
bjp-25731	102	11	chagas	chagas	NOUN
bjp-25731	102	12	disease	disease	NOUN
bjp-25731	102	13	are	be	AUX
bjp-25731	102	14	vector	vector	NOUN
bjp-25731	102	15	-	-	PUNCT
bjp-25731	102	16	borne	borne	ADJ
bjp-25731	102	17	infectious	infectious	ADJ
bjp-25731	102	18	diseases	disease	NOUN
bjp-25731	102	19	whose	whose	DET
bjp-25731	102	20	causative	causative	ADJ
bjp-25731	102	21	agent	agent	NOUN
bjp-25731	102	22	are	be	AUX
bjp-25731	102	23	parasites	parasite	NOUN
bjp-25731	102	24	of	of	ADP
bjp-25731	102	25	the	the	DET
bjp-25731	102	26	kinetoplastida	kinetoplastida	PROPN
bjp-25731	102	27	order	order	NOUN
bjp-25731	102	28	(	(	PUNCT
bjp-25731	102	29	who	who	PRON
bjp-25731	102	30	,	,	PUNCT
bjp-25731	102	31	2016	2016	NUM
bjp-25731	102	32	;	;	PUNCT
bjp-25731	102	33	mendoza	mendoza	PROPN
bjp-25731	102	34	-	-	PUNCT
bjp-25731	102	35	martínez	martínez	PROPN
bjp-25731	102	36	et	et	PROPN
bjp-25731	102	37	al	al	PROPN
bjp-25731	102	38	.	.	PROPN
bjp-25731	102	39	,	,	PUNCT
bjp-25731	102	40	2015	2015	NUM
bjp-25731	102	41	)	)	PUNCT
bjp-25731	102	42	.	.	PUNCT
bjp-25731	103	1	it	it	PRON
bjp-25731	103	2	is	be	AUX
bjp-25731	103	3	quite	quite	ADV
bjp-25731	103	4	alarming	alarming	ADJ
bjp-25731	103	5	to	to	PART
bjp-25731	103	6	note	note	VERB
bjp-25731	103	7	that	that	SCONJ
bjp-25731	103	8	approximately	approximately	ADV
bjp-25731	103	9	1.5	1.5	NUM
bjp-25731	103	10	million	million	NUM
bjp-25731	103	11	of	of	ADP
bjp-25731	103	12	new	new	ADJ
bjp-25731	103	13	cases	case	NOUN
bjp-25731	103	14	of	of	ADP
bjp-25731	103	15	cutaneous	cutaneous	ADJ
bjp-25731	103	16	leishmaniasis	leishmaniasis	NOUN
bjp-25731	103	17	emerge	emerge	VERB
bjp-25731	103	18	every	every	DET
bjp-25731	103	19	year	year	NOUN
bjp-25731	103	20	while	while	SCONJ
bjp-25731	103	21	there	there	PRON
bjp-25731	103	22	is	be	VERB
bjp-25731	103	23	an	an	DET
bjp-25731	103	24	outbreak	outbreak	NOUN
bjp-25731	103	25	of	of	ADP
bjp-25731	103	26	about	about	ADV
bjp-25731	103	27	500	500	NUM
bjp-25731	103	28	000	000	NUM
bjp-25731	103	29	of	of	ADP
bjp-25731	103	30	new	new	ADJ
bjp-25731	103	31	cases	case	NOUN
bjp-25731	103	32	of	of	ADP
bjp-25731	103	33	visceral	visceral	ADJ
bjp-25731	103	34	diseases	disease	NOUN
bjp-25731	103	35	in	in	ADP
bjp-25731	103	36	similar	similar	ADJ
bjp-25731	103	37	vein	vein	NOUN
bjp-25731	103	38	.	.	PUNCT
bjp-25731	104	1	statistics	statistic	NOUN
bjp-25731	104	2	have	have	AUX
bjp-25731	104	3	shown	show	VERB
bjp-25731	104	4	that	that	SCONJ
bjp-25731	104	5	cutaneous	cutaneous	ADJ
bjp-25731	104	6	leishmaniasis	leishmaniasis	NOUN
bjp-25731	104	7	is	be	AUX
bjp-25731	104	8	endemic	endemic	ADJ
bjp-25731	104	9	over	over	ADP
bjp-25731	104	10	70	70	NUM
bjp-25731	104	11	countries	country	NOUN
bjp-25731	104	12	of	of	ADP
bjp-25731	104	13	the	the	DET
bjp-25731	104	14	world	world	NOUN
bjp-25731	104	15	today	today	NOUN
bjp-25731	104	16	(	(	PUNCT
bjp-25731	104	17	tiumana	tiumana	NOUN
bjp-25731	104	18	et	et	NOUN
bjp-25731	104	19	al	al	PROPN
bjp-25731	104	20	.	.	PROPN
bjp-25731	104	21	,	,	PUNCT
bjp-25731	104	22	2011	2011	NUM
bjp-25731	104	23	)	)	PUNCT
bjp-25731	104	24	.	.	PUNCT
bjp-25731	105	1	comprehensive	comprehensive	ADJ
bjp-25731	105	2	review	review	NOUN
bjp-25731	105	3	of	of	ADP
bjp-25731	105	4	anti	anti	ADJ
bjp-25731	105	5	-	-	ADJ
bjp-25731	105	6	leishmanial	leishmanial	ADJ
bjp-25731	105	7	drugs	drug	NOUN
bjp-25731	105	8	discovered	discover	VERB
bjp-25731	105	9	for	for	ADP
bjp-25731	105	10	the	the	DET
bjp-25731	105	11	last	last	ADJ
bjp-25731	105	12	decade	decade	NOUN
bjp-25731	105	13	projected	project	VERB
bjp-25731	105	14	quinazoline	quinazoline	NOUN
bjp-25731	105	15	as	as	ADP
bjp-25731	105	16	highly	highly	ADV
bjp-25731	105	17	promising	promising	ADJ
bjp-25731	105	18	in	in	ADP
bjp-25731	105	19	this	this	DET
bjp-25731	105	20	regard	regard	NOUN
bjp-25731	105	21	(	(	PUNCT
bjp-25731	105	22	sangshetti	sangshetti	NOUN
bjp-25731	105	23	et	et	NOUN
bjp-25731	105	24	al	al	PROPN
bjp-25731	105	25	.	.	PROPN
bjp-25731	105	26	,	,	PUNCT
bjp-25731	105	27	2015	2015	NUM
bjp-25731	105	28	)	)	PUNCT
bjp-25731	105	29	.	.	PUNCT
bjp-25731	106	1	a	a	DET
bjp-25731	106	2	series	series	NOUN
bjp-25731	106	3	of	of	ADP
bjp-25731	106	4	quina	quina	PROPN
bjp-25731	106	5	-	-	PUNCT
bjp-25731	106	6	zoline-2,4,6triamine	zoline-2,4,6triamine	PROPN
bjp-25731	106	7	were	be	AUX
bjp-25731	106	8	synthesized	synthesize	VERB
bjp-25731	106	9	and	and	CCONJ
bjp-25731	106	10	evaluated	evaluate	VERB
bjp-25731	106	11	in	in	ADP
bjp-25731	106	12	vitro	vitro	X
bjp-25731	106	13	against	against	ADP
bjp-25731	106	14	leishmania	leishmania	NOUN
bjp-25731	106	15	mexicana	mexicana	PROPN
bjp-25731	106	16	.	.	PUNCT
bjp-25731	107	1	among	among	ADP
bjp-25731	107	2	them	they	PRON
bjp-25731	107	3	,	,	PUNCT
bjp-25731	107	4	n6(ferrocenmethyl)quinazolin-2,4,6	n6(ferrocenmethyl)quinazolin-2,4,6	NOUN
bjp-25731	107	5	-	-	ADJ
bjp-25731	107	6	triamine	triamine	NOUN
bjp-25731	107	7	showed	show	VERB
bjp-25731	107	8	activity	activity	NOUN
bjp-25731	107	9	on	on	ADP
bjp-25731	107	10	promastigotes	promastigote	NOUN
bjp-25731	107	11	and	and	CCONJ
bjp-25731	107	12	intracellular	intracellular	ADJ
bjp-25731	107	13	amastigotes	amastigote	NOUN
bjp-25731	107	14	as	as	ADV
bjp-25731	107	15	well	well	ADV
bjp-25731	107	16	as	as	ADP
bjp-25731	107	17	low	low	ADJ
bjp-25731	107	18	cytotoxicity	cytotoxicity	NOUN
bjp-25731	107	19	in	in	ADP
bjp-25731	107	20	mammalian	mammalian	ADJ
bjp-25731	107	21	cells	cell	NOUN
bjp-25731	107	22	(	(	PUNCT
bjp-25731	107	23	mendoza	mendoza	PROPN
bjp-25731	107	24	-	-	PUNCT
bjp-25731	107	25	martínez	martínez	PROPN
bjp-25731	107	26	et	et	PROPN
bjp-25731	107	27	al	al	PROPN
bjp-25731	107	28	.	.	PROPN
bjp-25731	107	29	,	,	PUNCT
bjp-25731	107	30	2015	2015	NUM
bjp-25731	107	31	)	)	PUNCT
bjp-25731	107	32	as	as	SCONJ
bjp-25731	107	33	shown	show	VERB
bjp-25731	107	34	in	in	ADP
bjp-25731	107	35	figure	figure	NOUN
bjp-25731	107	36	5	5	NUM
bjp-25731	107	37	.	.	PUNCT
bjp-25731	108	1	in	in	ADP
bjp-25731	108	2	the	the	DET
bjp-25731	108	3	recent	recent	ADJ
bjp-25731	108	4	review	review	NOUN
bjp-25731	108	5	by	by	ADP
bjp-25731	108	6	sangshetti	sangshetti	NOUN
bjp-25731	108	7	et	et	PROPN
bjp-25731	108	8	al	al	PROPN
bjp-25731	108	9	.	.	PROPN
bjp-25731	109	1	(	(	PUNCT
bjp-25731	109	2	2015	2015	NUM
bjp-25731	109	3	)	)	PUNCT
bjp-25731	109	4	about	about	ADP
bjp-25731	109	5	anti	anti	ADJ
bjp-25731	109	6	-	-	ADJ
bjp-25731	109	7	leishmanial	leishmanial	ADJ
bjp-25731	109	8	drug	drug	NOUN
bjp-25731	109	9	discovery	discovery	NOUN
bjp-25731	109	10	,	,	PUNCT
bjp-25731	109	11	quinazoline	quinazoline	NOUN
bjp-25731	109	12	core	core	NOUN
bjp-25731	109	13	was	be	AUX
bjp-25731	109	14	not	not	PART
bjp-25731	109	15	left	leave	VERB
bjp-25731	109	16	out	out	ADP
bjp-25731	109	17	.	.	PUNCT
bjp-25731	110	1	antitumor	antitumor	PROPN
bjp-25731	110	2	activity	activity	NOUN
bjp-25731	110	3	literature	literature	NOUN
bjp-25731	110	4	survey	survey	NOUN
bjp-25731	110	5	revealed	reveal	VERB
bjp-25731	110	6	that	that	SCONJ
bjp-25731	110	7	4	4	NUM
bjp-25731	110	8	-	-	PUNCT
bjp-25731	110	9	anilinoquinazoline	anilinoquinazoline	NOUN
bjp-25731	110	10	and	and	CCONJ
bjp-25731	110	11	quinazolinone	quinazolinone	NOUN
bjp-25731	110	12	derivatives	derivative	NOUN
bjp-25731	110	13	are	be	AUX
bjp-25731	110	14	important	important	ADJ
bjp-25731	110	15	scaffold	scaffold	NOUN
bjp-25731	110	16	used	use	VERB
bjp-25731	110	17	in	in	ADP
bjp-25731	110	18	drug	drug	NOUN
bjp-25731	110	19	design	design	NOUN
bjp-25731	110	20	of	of	ADP
bjp-25731	110	21	effective	effective	ADJ
bjp-25731	110	22	antitumor	antitumor	NOUN
bjp-25731	110	23	agents	agent	NOUN
bjp-25731	110	24	(	(	PUNCT
bjp-25731	110	25	hassan	hassan	PROPN
bjp-25731	110	26	et	et	PROPN
bjp-25731	110	27	al	al	PROPN
bjp-25731	110	28	.	.	PROPN
bjp-25731	110	29	,	,	PUNCT
bjp-25731	110	30	2015	2015	NUM
bjp-25731	110	31	)	)	PUNCT
bjp-25731	110	32	.	.	PUNCT
bjp-25731	111	1	structure	structure	NOUN
bjp-25731	111	2	-	-	PUNCT
bjp-25731	111	3	activity	activity	NOUN
bjp-25731	111	4	relationship	relationship	NOUN
bjp-25731	111	5	studies	study	NOUN
bjp-25731	111	6	have	have	AUX
bjp-25731	111	7	revealed	reveal	VERB
bjp-25731	111	8	the	the	DET
bjp-25731	111	9	significant	significant	ADJ
bjp-25731	111	10	role	role	NOUN
bjp-25731	111	11	of	of	ADP
bjp-25731	111	12	4	4	NUM
bjp-25731	111	13	-	-	PUNCT
bjp-25731	111	14	anilino	anilino	NOUN
bjp-25731	111	15	substituent	substituent	NOUN
bjp-25731	111	16	in	in	ADP
bjp-25731	111	17	the	the	DET
bjp-25731	111	18	antitumor	antitumor	PROPN
bjp-25731	111	19	diversity	diversity	NOUN
bjp-25731	111	20	of	of	ADP
bjp-25731	111	21	quinazoline	quinazoline	ADJ
bjp-25731	111	22	motifs	motif	NOUN
bjp-25731	111	23	.	.	PUNCT
bjp-25731	111	24	from	from	ADP
bjp-25731	111	25	the	the	DET
bjp-25731	111	26	screening	screening	NOUN
bjp-25731	111	27	of	of	ADP
bjp-25731	111	28	a	a	DET
bjp-25731	111	29	series	series	NOUN
bjp-25731	111	30	of	of	ADP
bjp-25731	111	31	structurally	structurally	ADV
bjp-25731	111	32	related	relate	VERB
bjp-25731	111	33	4	4	NUM
bjp-25731	111	34	-	-	NOUN
bjp-25731	111	35	anilinoquinazoline	anilinoquinazoline	NOUN
bjp-25731	111	36	with	with	ADP
bjp-25731	111	37	n	n	X
bjp-25731	111	38	-	-	PUNCT
bjp-25731	111	39	adamantyl	adamantyl	NOUN
bjp-25731	111	40	formamide	formamide	ADV
bjp-25731	111	41	in	in	ADP
bjp-25731	111	42	4	4	NUM
bjp-25731	111	43	-	-	PUNCT
bjp-25731	111	44	position	position	NOUN
bjp-25731	111	45	10a	10a	NOUN
bjp-25731	111	46	-	-	SYM
bjp-25731	111	47	f	f	NOUN
bjp-25731	111	48	;	;	PUNCT
bjp-25731	111	49	specifically	specifically	ADV
bjp-25731	111	50	,	,	PUNCT
bjp-25731	111	51	compound	compound	NOUN
bjp-25731	111	52	10d	10d	NOUN
bjp-25731	111	53	(	(	PUNCT
bjp-25731	111	54	r1	r1	PROPN
bjp-25731	111	55	=	=	SYM
bjp-25731	111	56	h	h	NOUN
bjp-25731	111	57	;	;	PUNCT
bjp-25731	111	58	r2	r2	PROPN
bjp-25731	111	59	=	=	SYM
bjp-25731	111	60	cl	cl	NOUN
bjp-25731	111	61	;	;	PUNCT
bjp-25731	111	62	r3	r3	PROPN
bjp-25731	111	63	=	=	SYM
bjp-25731	111	64	4	4	NUM
bjp-25731	111	65	-	-	NUM
bjp-25731	111	66	morpholinyl-(ch2)3	morpholinyl-(ch2)3	PRON
bjp-25731	111	67	;	;	PUNCT
bjp-25731	111	68	r4	r4	PROPN
bjp-25731	111	69	=	=	SYM
bjp-25731	111	70	ch3	ch3	PROPN
bjp-25731	111	71	)	)	PUNCT
bjp-25731	111	72	,	,	PUNCT
bjp-25731	111	73	with	with	ADP
bjp-25731	111	74	an	an	DET
bjp-25731	111	75	ic50	ic50	PROPN
bjp-25731	111	76	value	value	NOUN
bjp-25731	111	77	of	of	ADP
bjp-25731	111	78	2.06	2.06	NUM
bjp-25731	111	79	μm	μm	NOUN
bjp-25731	111	80	against	against	ADP
bjp-25731	111	81	a431	a431	PROPN
bjp-25731	111	82	cells	cell	NOUN
bjp-25731	111	83	with	with	ADP
bjp-25731	111	84	the	the	DET
bjp-25731	111	85	wild	wild	ADJ
bjp-25731	111	86	-	-	PUNCT
bjp-25731	111	87	type	type	NOUN
bjp-25731	111	88	egfr	egfr	NOUN
bjp-25731	111	89	and	and	CCONJ
bjp-25731	111	90	of	of	ADP
bjp-25731	111	91	0.009	0.009	NUM
bjp-25731	111	92	μm	μm	NOUN
bjp-25731	111	93	against	against	ADP
bjp-25731	111	94	the	the	DET
bjp-25731	111	95	gefitinib	gefitinib	NOUN
bjp-25731	111	96	-	-	PUNCT
bjp-25731	111	97	sensitive	sensitive	ADJ
bjp-25731	111	98	cells	cell	NOUN
bjp-25731	111	99	(	(	PUNCT
bjp-25731	111	100	mendoza	mendoza	PROPN
bjp-25731	111	101	-	-	PUNCT
bjp-25731	111	102	martínez	martínez	PROPN
bjp-25731	111	103	et	et	PROPN
bjp-25731	111	104	al	al	PROPN
bjp-25731	111	105	.	.	PROPN
bjp-25731	111	106	,	,	PUNCT
bjp-25731	111	107	2015	2015	NUM
bjp-25731	111	108	)	)	PUNCT
bjp-25731	111	109	(	(	PUNCT
bjp-25731	111	110	figure	figure	VERB
bjp-25731	111	111	6	6	NUM
bjp-25731	111	112	)	)	PUNCT
bjp-25731	111	113	.	.	PUNCT
bjp-25731	112	1	it	it	PRON
bjp-25731	112	2	displayed	display	VERB
bjp-25731	112	3	efficacy	efficacy	NOUN
bjp-25731	112	4	that	that	PRON
bjp-25731	112	5	was	be	AUX
bjp-25731	112	6	about	about	ADV
bjp-25731	112	7	5	5	NUM
bjp-25731	112	8	-	-	ADJ
bjp-25731	112	9	fold	fold	VERB
bjp-25731	112	10	active	active	ADJ
bjp-25731	112	11	than	than	SCONJ
bjp-25731	112	12	the	the	DET
bjp-25731	112	13	lead	lead	NOUN
bjp-25731	112	14	compound	compound	VERB
bjp-25731	112	15	to	to	PART
bjp-25731	112	16	inhibit	inhibit	VERB
bjp-25731	112	17	the	the	DET
bjp-25731	112	18	growth	growth	NOUN
bjp-25731	112	19	of	of	ADP
bjp-25731	112	20	the	the	DET
bjp-25731	112	21	cells	cell	NOUN
bjp-25731	112	22	harboring	harbor	VERB
bjp-25731	112	23	the	the	DET
bjp-25731	112	24	egfr	egfr	NOUN
bjp-25731	112	25	(	(	PUNCT
bjp-25731	112	26	t790	t790	NUM
bjp-25731	112	27	m	m	NOUN
bjp-25731	112	28	)	)	PUNCT
bjp-25731	112	29	mutant	mutant	NOUN
bjp-25731	112	30	(	(	PUNCT
bjp-25731	112	31	yu	yu	PROPN
bjp-25731	112	32	et	et	PROPN
bjp-25731	112	33	al	al	PROPN
bjp-25731	112	34	.	.	PROPN
bjp-25731	112	35	,	,	PUNCT
bjp-25731	112	36	2016	2016	NUM
bjp-25731	112	37	;	;	PUNCT
bjp-25731	112	38	mendoza	mendoza	PROPN
bjp-25731	112	39	-	-	PUNCT
bjp-25731	112	40	martínez	martínez	PROPN
bjp-25731	112	41	et	et	PROPN
bjp-25731	112	42	al	al	PROPN
bjp-25731	112	43	.	.	PROPN
bjp-25731	112	44	,	,	PUNCT
bjp-25731	112	45	2015	2015	NUM
bjp-25731	112	46	)	)	PUNCT
bjp-25731	112	47	.	.	PUNCT
bjp-25731	113	1	the	the	DET
bjp-25731	113	2	synthesis	synthesis	NOUN
bjp-25731	113	3	,	,	PUNCT
bjp-25731	113	4	structural	structural	ADJ
bjp-25731	113	5	elucidation	elucidation	NOUN
bjp-25731	113	6	as	as	ADV
bjp-25731	113	7	well	well	ADV
bjp-25731	113	8	as	as	ADP
bjp-25731	113	9	in	in	ADP
bjp-25731	113	10	vitro	vitro	X
bjp-25731	113	11	antitumor	antitumor	NOUN
bjp-25731	113	12	properties	property	NOUN
bjp-25731	113	13	of	of	ADP
bjp-25731	113	14	ruthenium(ii	ruthenium(ii	NOUN
bjp-25731	113	15	)	)	PUNCT
bjp-25731	113	16	polypyridyl	polypyridyl	ADJ
bjp-25731	113	17	complexes	complex	NOUN
bjp-25731	113	18	of	of	ADP
bjp-25731	113	19	4anilinoquinazolines	4anilinoquinazolines	PROPN
bjp-25731	113	20	was	be	AUX
bjp-25731	113	21	recently	recently	ADV
bjp-25731	113	22	reported	report	VERB
bjp-25731	113	23	(	(	PUNCT
bjp-25731	113	24	du	du	PROPN
bjp-25731	113	25	et	et	PROPN
bjp-25731	113	26	al	al	PROPN
bjp-25731	113	27	.	.	PROPN
bjp-25731	113	28	,	,	PUNCT
bjp-25731	113	29	2016	2016	NUM
bjp-25731	113	30	)	)	PUNCT
bjp-25731	113	31	.	.	PUNCT
bjp-25731	114	1	the	the	DET
bjp-25731	114	2	reported	report	VERB
bjp-25731	114	3	complexes	complex	NOUN
bjp-25731	114	4	exhibited	exhibit	VERB
bjp-25731	114	5	substantial	substantial	ADJ
bjp-25731	114	6	enhancement	enhancement	NOUN
bjp-25731	114	7	in	in	ADP
bjp-25731	114	8	antitumor	antitumor	PROPN
bjp-25731	114	9	activity	activity	NOUN
bjp-25731	114	10	compared	compare	VERB
bjp-25731	114	11	to	to	ADP
bjp-25731	114	12	their	their	PRON
bjp-25731	114	13	precursor	precursor	NOUN
bjp-25731	114	14	ruthenium	ruthenium	NOUN
bjp-25731	114	15	polypyridyl	polypyridyl	ADJ
bjp-25731	114	16	moieties	moiety	NOUN
bjp-25731	114	17	.	.	PUNCT
bjp-25731	115	1	they	they	PRON
bjp-25731	115	2	also	also	ADV
bjp-25731	115	3	displayed	display	VERB
bjp-25731	115	4	a	a	DET
bjp-25731	115	5	dual	dual	ADV
bjp-25731	115	6	-	-	PUNCT
bjp-25731	115	7	targeting	target	VERB
bjp-25731	115	8	manner	manner	NOUN
bjp-25731	115	9	that	that	PRON
bjp-25731	115	10	can	can	AUX
bjp-25731	115	11	both	both	PRON
bjp-25731	115	12	bind	bind	VERB
bjp-25731	115	13	to	to	ADP
bjp-25731	115	14	the	the	DET
bjp-25731	115	15	dna	dna	PROPN
bjp-25731	115	16	minor	minor	ADJ
bjp-25731	115	17	groove	groove	NOUN
bjp-25731	115	18	and	and	CCONJ
bjp-25731	115	19	inhibit	inhibit	VERB
bjp-25731	115	20	egfr	egfr	NOUN
bjp-25731	115	21	(	(	PUNCT
bjp-25731	115	22	du	du	PROPN
bjp-25731	115	23	et	et	PROPN
bjp-25731	115	24	al	al	PROPN
bjp-25731	115	25	.	.	PROPN
bjp-25731	115	26	,	,	PUNCT
bjp-25731	115	27	2016	2016	NUM
bjp-25731	115	28	)	)	PUNCT
bjp-25731	115	29	.	.	PUNCT
bjp-25731	116	1	caspase-3	caspase-3	NUM
bjp-25731	116	2	activity	activity	NOUN
bjp-25731	116	3	and	and	CCONJ
bjp-25731	116	4	cell	cell	NOUN
bjp-25731	116	5	cycle	cycle	NOUN
bjp-25731	116	6	regulation	regulation	NOUN
bjp-25731	116	7	studies	study	NOUN
bjp-25731	116	8	revealed	reveal	VERB
bjp-25731	116	9	that	that	SCONJ
bjp-25731	116	10	4	4	NUM
bjp-25731	116	11	-	-	PUNCT
bjp-25731	116	12	anilinoquinazoline	anilinoquinazoline	NOUN
bjp-25731	116	13	11	11	NUM
bjp-25731	116	14	exerted	exert	VERB
bjp-25731	116	15	antitumor	antitumor	NOUN
bjp-25731	116	16	properties	property	NOUN
bjp-25731	116	17	with	with	ADP
bjp-25731	116	18	ic50	ic50	PROPN
bjp-25731	116	19	of	of	ADP
bjp-25731	116	20	3.4	3.4	NUM
bjp-25731	116	21	μm	μm	NOUN
bjp-25731	116	22	(	(	PUNCT
bjp-25731	116	23	palop	palop	NOUN
bjp-25731	116	24	et	et	PROPN
bjp-25731	116	25	al	al	PROPN
bjp-25731	116	26	.	.	PROPN
bjp-25731	116	27	,	,	PUNCT
bjp-25731	116	28	2013	2013	NUM
bjp-25731	116	29	)	)	PUNCT
bjp-25731	116	30	.	.	PUNCT
bjp-25731	117	1	compared	compare	VERB
bjp-25731	117	2	with	with	ADP
bjp-25731	117	3	the	the	DET
bjp-25731	117	4	parental	parental	ADJ
bjp-25731	117	5	dasatinib	dasatinib	NOUN
bjp-25731	117	6	,	,	PUNCT
bjp-25731	117	7	most	most	ADJ
bjp-25731	117	8	of	of	ADP
bjp-25731	117	9	the	the	DET
bjp-25731	117	10	new	new	ADJ
bjp-25731	117	11	compounds	compound	NOUN
bjp-25731	117	12	synthesized	synthesize	VERB
bjp-25731	117	13	by	by	ADP
bjp-25731	117	14	cai	cai	PROPN
bjp-25731	117	15	et	et	PROPN
bjp-25731	117	16	al	al	PROPN
bjp-25731	117	17	.	.	PROPN
bjp-25731	118	1	(	(	PUNCT
bjp-25731	118	2	2013	2013	NUM
bjp-25731	118	3	)	)	PUNCT
bjp-25731	118	4	,	,	PUNCT
bjp-25731	118	5	especially	especially	ADV
bjp-25731	118	6	2,4,6	2,4,6	NUM
bjp-25731	118	7	-	-	ADJ
bjp-25731	118	8	trimethylaniline	trimethylaniline	ADJ
bjp-25731	118	9	12	12	NUM
bjp-25731	118	10	,	,	PUNCT
bjp-25731	118	11	demonstrated	demonstrate	VERB
bjp-25731	118	12	significant	significant	ADJ
bjp-25731	118	13	antitumor	antitumor	NOUN
bjp-25731	118	14	activities	activity	NOUN
bjp-25731	118	15	against	against	ADP
bjp-25731	118	16	six	six	NUM
bjp-25731	118	17	cell	cell	NOUN
bjp-25731	118	18	lines	line	NOUN
bjp-25731	118	19	(	(	PUNCT
bjp-25731	118	20	figure	figure	NOUN
bjp-25731	118	21	7	7	NUM
bjp-25731	118	22	)	)	PUNCT
bjp-25731	118	23	.	.	PUNCT
bjp-25731	119	1	kinase	kinase	PROPN
bjp-25731	119	2	inhibitory	inhibitory	ADJ
bjp-25731	119	3	activity	activity	NOUN
bjp-25731	119	4	a	a	DET
bjp-25731	119	5	series	series	NOUN
bjp-25731	119	6	of	of	ADP
bjp-25731	119	7	benzimidazole	benzimidazole	PROPN
bjp-25731	119	8	-	-	PUNCT
bjp-25731	119	9	based	base	VERB
bjp-25731	119	10	quinazoline	quinazoline	NOUN
bjp-25731	119	11	derivatives	derivative	NOUN
bjp-25731	119	12	were	be	AUX
bjp-25731	119	13	reported	report	VERB
bjp-25731	119	14	to	to	PART
bjp-25731	119	15	serve	serve	VERB
bjp-25731	119	16	as	as	ADP
bjp-25731	119	17	active	active	ADJ
bjp-25731	119	18	inhibitor	inhibitor	NOUN
bjp-25731	119	19	of	of	ADP
bjp-25731	119	20	aurora	aurora	PROPN
bjp-25731	119	21	according	accord	VERB
bjp-25731	119	22	to	to	ADP
bjp-25731	119	23	the	the	DET
bjp-25731	119	24	investigation	investigation	NOUN
bjp-25731	119	25	carried	carry	VERB
bjp-25731	119	26	out	out	ADP
bjp-25731	119	27	through	through	ADP
bjp-25731	119	28	structure	structure	NOUN
bjp-25731	119	29	-	-	PUNCT
bjp-25731	119	30	activity	activity	NOUN
bjp-25731	119	31	relationship	relationship	NOUN
bjp-25731	119	32	(	(	PUNCT
bjp-25731	119	33	sar	sar	PROPN
bjp-25731	119	34	)	)	PUNCT
bjp-25731	119	35	and	and	CCONJ
bjp-25731	119	36	quantitative	quantitative	ADJ
bjp-25731	119	37	structure	structure	NOUN
bjp-25731	119	38	-	-	PUNCT
bjp-25731	119	39	activity	activity	NOUN
bjp-25731	119	40	relationship	relationship	NOUN
bjp-25731	119	41	(	(	PUNCT
bjp-25731	119	42	qsar	qsar	NOUN
bjp-25731	119	43	)	)	PUNCT
bjp-25731	119	44	figure	figure	NOUN
bjp-25731	119	45	5	5	NUM
bjp-25731	119	46	:	:	PUNCT
bjp-25731	119	47	molecular	molecular	ADJ
bjp-25731	119	48	docking	docking	NOUN
bjp-25731	119	49	study	study	NOUN
bjp-25731	119	50	n6-(ferrocenmethyl)quinazolin-2,4,6	n6-(ferrocenmethyl)quinazolin-2,4,6	NOUN
bjp-25731	119	51	-	-	NOUN
bjp-25731	119	52	triamine	triamine	NOUN
bjp-25731	119	53	as	as	ADP
bjp-25731	119	54	anti	anti	ADJ
bjp-25731	119	55	-	-	ADJ
bjp-25731	119	56	leishmanial	leishmanial	ADJ
bjp-25731	119	57	agent	agent	NOUN
bjp-25731	119	58	bangladesh	bangladesh	PROPN
bjp-25731	119	59	j	j	PROPN
bjp-25731	119	60	pharmacol	pharmacol	PROPN
bjp-25731	119	61	2016	2016	NUM
bjp-25731	119	62	;	;	PUNCT
bjp-25731	119	63	11	11	NUM
bjp-25731	119	64	:	:	PUNCT
bjp-25731	119	65	716	716	NUM
bjp-25731	119	66	-	-	SYM
bjp-25731	119	67	733	733	NUM
bjp-25731	119	68	721	721	NUM
bjp-25731	119	69	studies	study	NOUN
bjp-25731	119	70	(	(	PUNCT
bjp-25731	119	71	sharma	sharma	PROPN
bjp-25731	119	72	et	et	PROPN
bjp-25731	119	73	al	al	PROPN
bjp-25731	119	74	.	.	PROPN
bjp-25731	119	75	,	,	PUNCT
bjp-25731	119	76	2016	2016	NUM
bjp-25731	119	77	)	)	PUNCT
bjp-25731	119	78	.	.	PUNCT
bjp-25731	120	1	their	their	PRON
bjp-25731	120	2	noticed	noticed	ADJ
bjp-25731	120	3	activity	activity	NOUN
bjp-25731	120	4	depended	depend	VERB
bjp-25731	120	5	on	on	ADP
bjp-25731	120	6	the	the	DET
bjp-25731	120	7	nature	nature	NOUN
bjp-25731	120	8	of	of	ADP
bjp-25731	120	9	various	various	ADJ
bjp-25731	120	10	substitution	substitution	NOUN
bjp-25731	120	11	patterns	pattern	NOUN
bjp-25731	120	12	of	of	ADP
bjp-25731	120	13	the	the	DET
bjp-25731	120	14	amine	amine	NOUN
bjp-25731	120	15	which	which	PRON
bjp-25731	120	16	was	be	AUX
bjp-25731	120	17	present	present	ADJ
bjp-25731	120	18	in	in	ADP
bjp-25731	120	19	c2	c2	PROPN
bjp-25731	120	20	position	position	NOUN
bjp-25731	120	21	of	of	ADP
bjp-25731	120	22	this	this	DET
bjp-25731	120	23	heterocycles	heterocycle	NOUN
bjp-25731	120	24	(	(	PUNCT
bjp-25731	120	25	sharma	sharma	PROPN
bjp-25731	120	26	et	et	PROPN
bjp-25731	120	27	al	al	PROPN
bjp-25731	120	28	.	.	PROPN
bjp-25731	120	29	,	,	PUNCT
bjp-25731	120	30	2016	2016	NUM
bjp-25731	120	31	)	)	PUNCT
bjp-25731	120	32	.	.	PUNCT
bjp-25731	121	1	they	they	PRON
bjp-25731	121	2	were	be	AUX
bjp-25731	121	3	established	establish	VERB
bjp-25731	121	4	to	to	PART
bjp-25731	121	5	exhibit	exhibit	VERB
bjp-25731	121	6	improved	improved	ADJ
bjp-25731	121	7	efficacy	efficacy	NOUN
bjp-25731	121	8	as	as	ADP
bjp-25731	121	9	aurora	aurora	PROPN
bjp-25731	121	10	kinase	kinase	PROPN
bjp-25731	121	11	inhibitors	inhibitor	NOUN
bjp-25731	121	12	,	,	PUNCT
bjp-25731	121	13	with	with	ADP
bjp-25731	121	14	ic50	ic50	PROPN
bjp-25731	121	15	values	value	NOUN
bjp-25731	121	16	between	between	ADP
bjp-25731	121	17	0.035	0.035	NUM
bjp-25731	121	18	and	and	CCONJ
bjp-25731	121	19	0.532	0.532	NUM
bjp-25731	121	20	 	 	SPACE
bjp-25731	121	21	μm	μm	NOUN
bjp-25731	121	22	(	(	PUNCT
bjp-25731	121	23	sharma	sharma	PROPN
bjp-25731	121	24	et	et	PROPN
bjp-25731	121	25	al	al	PROPN
bjp-25731	121	26	.	.	PROPN
bjp-25731	121	27	,	,	PUNCT
bjp-25731	121	28	2016	2016	NUM
bjp-25731	121	29	)	)	PUNCT
bjp-25731	121	30	.	.	PUNCT
bjp-25731	122	1	the	the	DET
bjp-25731	122	2	erythropoietinreleasing	erythropoietinrelease	VERB
bjp-25731	122	3	hepatocellular	hepatocellular	NOUN
bjp-25731	122	4	(	(	PUNCT
bjp-25731	122	5	eph	eph	NOUN
bjp-25731	122	6	)	)	PUNCT
bjp-25731	122	7	receptor	receptor	NOUN
bjp-25731	122	8	tyrosine	tyrosine	NOUN
bjp-25731	122	9	kinases	kinase	NOUN
bjp-25731	122	10	was	be	AUX
bjp-25731	122	11	documented	document	VERB
bjp-25731	122	12	to	to	PART
bjp-25731	122	13	be	be	AUX
bjp-25731	122	14	of	of	ADP
bjp-25731	122	15	great	great	ADJ
bjp-25731	122	16	significance	significance	NOUN
bjp-25731	122	17	in	in	ADP
bjp-25731	122	18	many	many	ADJ
bjp-25731	122	19	physiological	physiological	ADJ
bjp-25731	122	20	and	and	CCONJ
bjp-25731	122	21	pathological	pathological	ADJ
bjp-25731	122	22	actions	action	NOUN
bjp-25731	122	23	(	(	PUNCT
bjp-25731	122	24	lim	lim	PROPN
bjp-25731	122	25	et	et	PROPN
bjp-25731	122	26	al	al	PROPN
bjp-25731	122	27	.	.	PROPN
bjp-25731	122	28	,	,	PUNCT
bjp-25731	122	29	2014	2014	NUM
bjp-25731	122	30	)	)	PUNCT
bjp-25731	122	31	.	.	PUNCT
bjp-25731	123	1	compound	compound	NOUN
bjp-25731	123	2	13	13	NUM
bjp-25731	123	3	provided	provide	VERB
bjp-25731	123	4	a	a	DET
bjp-25731	123	5	potent	potent	ADJ
bjp-25731	123	6	starting	starting	NOUN
bjp-25731	123	7	point	point	NOUN
bjp-25731	123	8	(	(	PUNCT
bjp-25731	123	9	ic50	ic50	PROPN
bjp-25731	123	10	=	=	PROPN
bjp-25731	123	11	12	12	NUM
bjp-25731	123	12	nm	nm	NOUN
bjp-25731	123	13	)	)	PUNCT
bjp-25731	123	14	for	for	ADP
bjp-25731	123	15	inhibition	inhibition	NOUN
bjp-25731	123	16	of	of	ADP
bjp-25731	123	17	mps1	mps1	PROPN
bjp-25731	123	18	kinase	kinase	PROPN
bjp-25731	123	19	with	with	ADP
bjp-25731	123	20	submicromolar	submicromolar	ADJ
bjp-25731	123	21	cellular	cellular	ADJ
bjp-25731	123	22	toxicity	toxicity	NOUN
bjp-25731	123	23	,	,	PUNCT
bjp-25731	123	24	reduced	reduce	VERB
bjp-25731	123	25	mw	mw	NOUN
bjp-25731	123	26	and	and	CCONJ
bjp-25731	123	27	tpsa	tpsa	PROPN
bjp-25731	123	28	,	,	PUNCT
bjp-25731	123	29	while	while	SCONJ
bjp-25731	123	30	14	14	NUM
bjp-25731	123	31	provided	provide	VERB
bjp-25731	123	32	a	a	DET
bjp-25731	123	33	further	further	ADJ
bjp-25731	123	34	boost	boost	NOUN
bjp-25731	123	35	in	in	ADP
bjp-25731	123	36	biochemical	biochemical	ADJ
bjp-25731	123	37	potency	potency	NOUN
bjp-25731	123	38	with	with	ADP
bjp-25731	123	39	ic50	ic50	PROPN
bjp-25731	123	40	=	=	SYM
bjp-25731	123	41	2	2	NUM
bjp-25731	123	42	nm	nm	NOUN
bjp-25731	123	43	(	(	PUNCT
bjp-25731	123	44	bursavich	bursavich	PROPN
bjp-25731	123	45	et	et	PROPN
bjp-25731	123	46	al	al	PROPN
bjp-25731	123	47	.	.	PROPN
bjp-25731	123	48	,	,	PUNCT
bjp-25731	123	49	2013	2013	NUM
bjp-25731	123	50	)	)	PUNCT
bjp-25731	123	51	.	.	PUNCT
bjp-25731	124	1	thus	thus	ADV
bjp-25731	124	2	,	,	PUNCT
bjp-25731	124	3	the	the	DET
bjp-25731	124	4	comparative	comparative	ADJ
bjp-25731	124	5	study	study	NOUN
bjp-25731	124	6	of	of	ADP
bjp-25731	124	7	the	the	DET
bjp-25731	124	8	two	two	NUM
bjp-25731	124	9	structurally	structurally	ADV
bjp-25731	124	10	related	relate	VERB
bjp-25731	124	11	quinazol	quinazol	PROPN
bjp-25731	124	12	ine	ine	PROPN
bjp-25731	124	13	revealed	reveal	VERB
bjp-25731	124	14	that	that	SCONJ
bjp-25731	124	15	presence	presence	NOUN
bjp-25731	124	16	of	of	ADP
bjp-25731	124	17	methylsulfonamide	methylsulfonamide	NOUN
bjp-25731	124	18	along	along	ADP
bjp-25731	124	19	the	the	DET
bjp-25731	124	20	axis	axis	NOUN
bjp-25731	124	21	of	of	ADP
bjp-25731	124	22	2	2	NUM
bjp-25731	124	23	-	-	PUNCT
bjp-25731	124	24	substitutent	substitutent	NOUN
bjp-25731	124	25	is	be	AUX
bjp-25731	124	26	crucial	crucial	ADJ
bjp-25731	124	27	for	for	ADP
bjp-25731	124	28	enhanced	enhanced	ADJ
bjp-25731	124	29	kinase	kinase	PROPN
bjp-25731	124	30	inhibitory	inhibitory	ADJ
bjp-25731	124	31	activity	activity	NOUN
bjp-25731	124	32	(	(	PUNCT
bjp-25731	124	33	figure	figure	NOUN
bjp-25731	124	34	8)	8)	NUM
bjp-25731	124	35	.	.	PUNCT
bjp-25731	125	1	anticonvulsant	anticonvulsant	ADJ
bjp-25731	125	2	activity	activity	NOUN
bjp-25731	125	3	epilepsy	epilepsy	NOUN
bjp-25731	125	4	is	be	AUX
bjp-25731	125	5	in	in	ADP
bjp-25731	125	6	fact	fact	NOUN
bjp-25731	125	7	several	several	ADJ
bjp-25731	125	8	disorderly	disorderly	ADJ
bjp-25731	125	9	phenomena	phenomenon	NOUN
bjp-25731	125	10	which	which	PRON
bjp-25731	125	11	is	be	AUX
bjp-25731	125	12	identified	identify	VERB
bjp-25731	125	13	through	through	ADP
bjp-25731	125	14	neuronal	neuronal	ADJ
bjp-25731	125	15	hyperexcitability	hyperexcitability	NOUN
bjp-25731	125	16	as	as	ADV
bjp-25731	125	17	well	well	ADV
bjp-25731	125	18	as	as	ADP
bjp-25731	125	19	neuronal	neuronal	ADJ
bjp-25731	125	20	firing	firing	NOUN
bjp-25731	125	21	.	.	PUNCT
bjp-25731	126	1	statistics	statistic	NOUN
bjp-25731	126	2	have	have	AUX
bjp-25731	126	3	shown	show	VERB
bjp-25731	126	4	it	it	PRON
bjp-25731	126	5	to	to	PART
bjp-25731	126	6	be	be	AUX
bjp-25731	126	7	a	a	DET
bjp-25731	126	8	terrible	terrible	ADJ
bjp-25731	126	9	menace	menace	NOUN
bjp-25731	126	10	affecting	affect	VERB
bjp-25731	126	11	one	one	NUM
bjp-25731	126	12	percentage	percentage	NOUN
bjp-25731	126	13	of	of	ADP
bjp-25731	126	14	global	global	ADJ
bjp-25731	126	15	population	population	NOUN
bjp-25731	126	16	(	(	PUNCT
bjp-25731	126	17	king	king	NOUN
bjp-25731	126	18	et	et	PROPN
bjp-25731	126	19	al	al	PROPN
bjp-25731	126	20	.	.	PROPN
bjp-25731	126	21	,	,	PUNCT
bjp-25731	126	22	2011	2011	NUM
bjp-25731	126	23	;	;	PUNCT
bjp-25731	126	24	chen	chen	PROPN
bjp-25731	126	25	et	et	PROPN
bjp-25731	126	26	al	al	PROPN
bjp-25731	126	27	.	.	PROPN
bjp-25731	126	28	,	,	PUNCT
bjp-25731	126	29	2007	2007	NUM
bjp-25731	126	30	)	)	PUNCT
bjp-25731	126	31	.	.	PUNCT
bjp-25731	127	1	the	the	DET
bjp-25731	127	2	anticonvulsants	anticonvulsant	NOUN
bjp-25731	127	3	used	use	VERB
bjp-25731	127	4	to	to	PART
bjp-25731	127	5	treat	treat	VERB
bjp-25731	127	6	this	this	DET
bjp-25731	127	7	condition	condition	NOUN
bjp-25731	127	8	are	be	AUX
bjp-25731	127	9	known	know	VERB
bjp-25731	127	10	as	as	ADP
bjp-25731	127	11	antiepileptic	antiepileptic	ADJ
bjp-25731	127	12	drugs	drug	NOUN
bjp-25731	127	13	and	and	CCONJ
bjp-25731	127	14	are	be	AUX
bjp-25731	127	15	among	among	ADP
bjp-25731	127	16	the	the	DET
bjp-25731	127	17	most	most	ADV
bjp-25731	127	18	widely	widely	ADV
bjp-25731	127	19	used	use	VERB
bjp-25731	127	20	drugs	drug	NOUN
bjp-25731	127	21	for	for	ADP
bjp-25731	127	22	the	the	DET
bjp-25731	127	23	treatment	treatment	NOUN
bjp-25731	127	24	of	of	ADP
bjp-25731	127	25	central	central	ADJ
bjp-25731	127	26	nervous	nervous	ADJ
bjp-25731	127	27	system	system	NOUN
bjp-25731	127	28	disorders	disorder	NOUN
bjp-25731	127	29	.	.	PUNCT
bjp-25731	128	1	new	new	ADJ
bjp-25731	128	2	fluorinated	fluorinate	VERB
bjp-25731	128	3	quinazolinone	quinazolinone	NOUN
bjp-25731	128	4	motifs	motif	NOUN
bjp-25731	128	5	have	have	AUX
bjp-25731	128	6	been	be	AUX
bjp-25731	128	7	reported	report	VERB
bjp-25731	128	8	as	as	ADP
bjp-25731	128	9	promising	promise	VERB
bjp-25731	128	10	anticonvulsant	anticonvulsant	NOUN
bjp-25731	128	11	in	in	ADP
bjp-25731	128	12	this	this	DET
bjp-25731	128	13	regard	regard	NOUN
bjp-25731	128	14	(	(	PUNCT
bjp-25731	128	15	zayed	zayed	ADJ
bjp-25731	128	16	,	,	PUNCT
bjp-25731	128	17	2014	2014	NUM
bjp-25731	128	18	)	)	PUNCT
bjp-25731	128	19	.	.	PUNCT
bjp-25731	129	1	the	the	DET
bjp-25731	129	2	outcome	outcome	NOUN
bjp-25731	129	3	of	of	ADP
bjp-25731	129	4	mes	me	NOUN
bjp-25731	129	5	and	and	CCONJ
bjp-25731	129	6	ptz	ptz	PROPN
bjp-25731	129	7	screening	screening	NOUN
bjp-25731	129	8	carried	carry	VERB
bjp-25731	129	9	out	out	ADP
bjp-25731	129	10	on	on	ADP
bjp-25731	129	11	n-(substituted)-1	n-(substituted)-1	NOUN
bjp-25731	129	12	-	-	PUNCT
bjp-25731	129	13	methyl-2,4d	methyl-2,4d	X
bjp-25731	129	14	i	i	PRON
bjp-25731	130	1	o	o	NOUN
bjp-25731	130	2	x	x	PUNCT
bjp-25731	130	3	o	o	NOUN
bjp-25731	130	4	1	1	NUM
bjp-25731	130	5	,	,	PUNCT
bjp-25731	130	6	2	2	NUM
bjp-25731	131	1	d	d	NOUN
bjp-25731	131	2	i	i	PRON
bjp-25731	131	3	h	h	VERB
bjp-25731	132	1	y	y	NOUN
bjp-25731	132	2	d	d	NOUN
bjp-25731	132	3	r	r	NOUN
bjp-25731	132	4	o	o	X
bjp-25731	132	5	q	q	X
bjp-25731	132	6	u	u	NOUN
bjp-25731	132	7	i	i	PRON
bjp-25731	132	8	n	n	CCONJ
bjp-25731	132	9	a	a	PRON
bjp-25731	132	10	z	z	NOUN
bjp-25731	132	11	o	o	NOUN
bjp-25731	133	1	l	l	NOUN
bjp-25731	134	1	i	i	PRON
bjp-25731	134	2	n	n	VERB
bjp-25731	134	3	e	e	NOUN
bjp-25731	134	4	3	3	NUM
bjp-25731	134	5	(	(	PUNCT
bjp-25731	134	6	4	4	NUM
bjp-25731	134	7	h	h	NOUN
bjp-25731	134	8	)	)	PUNCT
bjp-25731	134	9	carboxamides	carboxamide	VERB
bjp-25731	134	10	unveiled	unveil	VERB
bjp-25731	134	11	them	they	PRON
bjp-25731	134	12	to	to	PART
bjp-25731	134	13	possess	possess	VERB
bjp-25731	134	14	improved	improve	VERB
bjp-25731	134	15	and	and	CCONJ
bjp-25731	134	16	better	well	ADJ
bjp-25731	134	17	anticonvulsant	anticonvulsant	ADJ
bjp-25731	134	18	activity	activity	NOUN
bjp-25731	134	19	when	when	SCONJ
bjp-25731	134	20	compared	compare	VERB
bjp-25731	134	21	with	with	ADP
bjp-25731	134	22	clinical	clinical	ADJ
bjp-25731	134	23	standard	standard	ADJ
bjp-25731	134	24	drugs	drug	NOUN
bjp-25731	134	25	which	which	PRON
bjp-25731	134	26	are	be	AUX
bjp-25731	134	27	valproate	valproate	ADJ
bjp-25731	134	28	and	and	CCONJ
bjp-25731	134	29	methaqualone	methaqualone	NOUN
bjp-25731	134	30	(	(	PUNCT
bjp-25731	134	31	deepakumari	deepakumari	PROPN
bjp-25731	134	32	et	et	PROPN
bjp-25731	134	33	al	al	PROPN
bjp-25731	134	34	.	.	PROPN
bjp-25731	134	35	,	,	PUNCT
bjp-25731	134	36	2016	2016	NUM
bjp-25731	134	37	)	)	PUNCT
bjp-25731	134	38	.	.	PUNCT
bjp-25731	135	1	methaqualone	methaqualone	PROPN
bjp-25731	135	2	15	15	NUM
bjp-25731	135	3	as	as	ADP
bjp-25731	135	4	a	a	DET
bjp-25731	135	5	quinazoline	quinazoline	NOUN
bjp-25731	135	6	analog	analog	NOUN
bjp-25731	135	7	is	be	AUX
bjp-25731	135	8	an	an	DET
bjp-25731	135	9	important	important	ADJ
bjp-25731	135	10	landmark	landmark	NOUN
bjp-25731	135	11	in	in	ADP
bjp-25731	135	12	the	the	DET
bjp-25731	135	13	field	field	NOUN
bjp-25731	135	14	of	of	ADP
bjp-25731	135	15	synthetic	synthetic	ADJ
bjp-25731	135	16	anticonvulsants	anticonvulsant	NOUN
bjp-25731	135	17	(	(	PUNCT
bjp-25731	135	18	kashaw	kashaw	NOUN
bjp-25731	135	19	et	et	PROPN
bjp-25731	135	20	al	al	PROPN
bjp-25731	135	21	.	.	PROPN
bjp-25731	135	22	,	,	PUNCT
bjp-25731	135	23	2009	2009	NUM
bjp-25731	135	24	)	)	PUNCT
bjp-25731	135	25	.	.	PUNCT
bjp-25731	136	1	the	the	DET
bjp-25731	136	2	modification	modification	NOUN
bjp-25731	136	3	of	of	ADP
bjp-25731	136	4	15	15	NUM
bjp-25731	136	5	was	be	AUX
bjp-25731	136	6	carried	carry	VERB
bjp-25731	136	7	out	out	ADP
bjp-25731	136	8	by	by	ADP
bjp-25731	136	9	el	el	PROPN
bjp-25731	136	10	-	-	PROPN
bjp-25731	136	11	azab	azab	PROPN
bjp-25731	136	12	et	et	PROPN
bjp-25731	136	13	al	al	PROPN
bjp-25731	136	14	.	.	PROPN
bjp-25731	137	1	(	(	PUNCT
bjp-25731	137	2	2013	2013	NUM
bjp-25731	137	3	)	)	PUNCT
bjp-25731	138	1	to	to	PART
bjp-25731	138	2	obtain	obtain	VERB
bjp-25731	138	3	quinazolinone	quinazolinone	NUM
bjp-25731	138	4	scaffold	scaffold	NOUN
bjp-25731	138	5	16	16	NUM
bjp-25731	138	6	which	which	PRON
bjp-25731	138	7	proved	prove	VERB
bjp-25731	138	8	to	to	PART
bjp-25731	138	9	be	be	AUX
bjp-25731	138	10	2	2	NUM
bjp-25731	138	11	-	-	NOUN
bjp-25731	138	12	fold	fold	VERB
bjp-25731	138	13	more	more	ADV
bjp-25731	138	14	active	active	ADJ
bjp-25731	138	15	than	than	ADP
bjp-25731	138	16	anticonvulsant	anticonvulsant	ADJ
bjp-25731	138	17	drug	drug	NOUN
bjp-25731	138	18	sodium	sodium	NOUN
bjp-25731	138	19	valproate	valproate	VERB
bjp-25731	139	1	.	.	PUNCT
bjp-25731	140	1	according	accord	VERB
bjp-25731	140	2	to	to	ADP
bjp-25731	140	3	the	the	DET
bjp-25731	140	4	findings	finding	NOUN
bjp-25731	140	5	of	of	ADP
bjp-25731	140	6	el	el	PROPN
bjp-25731	140	7	-	-	PUNCT
bjp-25731	140	8	azab	azab	ADV
bjp-25731	140	9	and	and	CCONJ
bjp-25731	140	10	elfigure	elfigure	NOUN
bjp-25731	140	11	6	6	NUM
bjp-25731	140	12	:	:	PUNCT
bjp-25731	140	13	sar	sar	PROPN
bjp-25731	140	14	study	study	PROPN
bjp-25731	140	15	showing	show	VERB
bjp-25731	140	16	the	the	DET
bjp-25731	140	17	significant	significant	ADJ
bjp-25731	140	18	role	role	NOUN
bjp-25731	140	19	of	of	ADP
bjp-25731	140	20	4	4	NUM
bjp-25731	140	21	-	-	PUNCT
bjp-25731	140	22	anilinoquinazoline	anilinoquinazoline	NOUN
bjp-25731	140	23	as	as	ADP
bjp-25731	140	24	antitumor	antitumor	PROPN
bjp-25731	140	25	figure	figure	NOUN
bjp-25731	140	26	7	7	NUM
bjp-25731	140	27	:	:	PUNCT
bjp-25731	140	28	some	some	DET
bjp-25731	140	29	quinazoline	quinazoline	ADJ
bjp-25731	140	30	motifs	motif	NOUN
bjp-25731	140	31	with	with	ADP
bjp-25731	140	32	antitumor	antitumor	PROPN
bjp-25731	140	33	activity	activity	NOUN
bjp-25731	140	34	722	722	NUM
bjp-25731	140	35	bangladesh	bangladesh	NOUN
bjp-25731	140	36	j	j	PROPN
bjp-25731	140	37	pharmacol	pharmacol	PROPN
bjp-25731	140	38	2016	2016	NUM
bjp-25731	140	39	;	;	PUNCT
bjp-25731	140	40	11	11	NUM
bjp-25731	140	41	:	:	PUNCT
bjp-25731	140	42	716	716	NUM
bjp-25731	140	43	-	-	SYM
bjp-25731	140	44	733	733	NUM
bjp-25731	140	45	tahir	tahir	NOUN
bjp-25731	140	46	,	,	PUNCT
bjp-25731	140	47	(	(	PUNCT
bjp-25731	140	48	2012	2012	NUM
bjp-25731	140	49	)	)	PUNCT
bjp-25731	140	50	,	,	PUNCT
bjp-25731	140	51	8	8	NUM
bjp-25731	140	52	-	-	SYM
bjp-25731	140	53	substituted-4(3h)-quinazolinone	substituted-4(3h)-quinazolinone	NOUN
bjp-25731	140	54	17	17	NUM
bjp-25731	140	55	demonstrated	demonstrate	VERB
bjp-25731	140	56	a	a	DET
bjp-25731	140	57	better	well	ADJ
bjp-25731	140	58	anticonvulsant	anticonvulsant	ADJ
bjp-25731	140	59	activity	activity	NOUN
bjp-25731	140	60	and	and	CCONJ
bjp-25731	140	61	lower	low	ADJ
bjp-25731	140	62	toxicity	toxicity	NOUN
bjp-25731	140	63	than	than	ADP
bjp-25731	140	64	the	the	DET
bjp-25731	140	65	reference	reference	NOUN
bjp-25731	140	66	drugs	drug	NOUN
bjp-25731	140	67	(	(	PUNCT
bjp-25731	140	68	figure	figure	NOUN
bjp-25731	140	69	9	9	NUM
bjp-25731	140	70	)	)	PUNCT
bjp-25731	140	71	.	.	PUNCT
bjp-25731	141	1	antimalarial	antimalarial	ADJ
bjp-25731	141	2	activity	activity	NOUN
bjp-25731	141	3	malaria	malaria	NOUN
bjp-25731	141	4	is	be	AUX
bjp-25731	141	5	a	a	DET
bjp-25731	141	6	well	well	ADV
bjp-25731	141	7	-	-	PUNCT
bjp-25731	141	8	known	know	VERB
bjp-25731	141	9	parasitic	parasitic	ADJ
bjp-25731	141	10	disease	disease	NOUN
bjp-25731	141	11	in	in	ADP
bjp-25731	141	12	tropical	tropical	ADJ
bjp-25731	141	13	regions	region	NOUN
bjp-25731	141	14	of	of	ADP
bjp-25731	141	15	the	the	DET
bjp-25731	141	16	world	world	NOUN
bjp-25731	141	17	affecting	affect	VERB
bjp-25731	141	18	billons	billon	NOUN
bjp-25731	141	19	of	of	ADP
bjp-25731	141	20	global	global	ADJ
bjp-25731	141	21	population	population	NOUN
bjp-25731	141	22	today	today	NOUN
bjp-25731	141	23	(	(	PUNCT
bjp-25731	141	24	birhan	birhan	PROPN
bjp-25731	141	25	et	et	PROPN
bjp-25731	141	26	al	al	PROPN
bjp-25731	141	27	.	.	PROPN
bjp-25731	141	28	,	,	PUNCT
bjp-25731	141	29	2015	2015	NUM
bjp-25731	141	30	;	;	PUNCT
bjp-25731	141	31	franklin	franklin	PROPN
bjp-25731	141	32	et	et	PROPN
bjp-25731	141	33	al	al	PROPN
bjp-25731	141	34	.	.	PROPN
bjp-25731	141	35	,	,	PUNCT
bjp-25731	141	36	2011	2011	NUM
bjp-25731	141	37	)	)	PUNCT
bjp-25731	141	38	.	.	PUNCT
bjp-25731	142	1	taking	take	VERB
bjp-25731	142	2	drug	drug	NOUN
bjp-25731	142	3	resistant	resistant	ADJ
bjp-25731	142	4	challenge	challenge	NOUN
bjp-25731	142	5	into	into	ADP
bjp-25731	142	6	consideration	consideration	NOUN
bjp-25731	142	7	,	,	PUNCT
bjp-25731	142	8	an	an	DET
bjp-25731	142	9	impressive	impressive	ADJ
bjp-25731	142	10	and	and	CCONJ
bjp-25731	142	11	violent	violent	ADJ
bjp-25731	142	12	universal	universal	ADJ
bjp-25731	142	13	attempt	attempt	NOUN
bjp-25731	142	14	is	be	AUX
bjp-25731	142	15	continuously	continuously	ADV
bjp-25731	142	16	engaged	engage	VERB
bjp-25731	142	17	for	for	ADP
bjp-25731	142	18	efficient	efficient	ADJ
bjp-25731	142	19	development	development	NOUN
bjp-25731	142	20	new	new	ADJ
bjp-25731	142	21	antiplasmodial	antiplasmodial	ADJ
bjp-25731	142	22	drugs	drug	NOUN
bjp-25731	142	23	for	for	ADP
bjp-25731	142	24	treatment	treatment	NOUN
bjp-25731	142	25	of	of	ADP
bjp-25731	142	26	this	this	DET
bjp-25731	142	27	well	well	ADV
bjp-25731	142	28	-	-	PUNCT
bjp-25731	142	29	known	know	VERB
bjp-25731	142	30	illness	illness	NOUN
bjp-25731	142	31	(	(	PUNCT
bjp-25731	142	32	birhan	birhan	PROPN
bjp-25731	142	33	et	et	PROPN
bjp-25731	142	34	al	al	PROPN
bjp-25731	142	35	.	.	PROPN
bjp-25731	142	36	,	,	PUNCT
bjp-25731	142	37	2015	2015	NUM
bjp-25731	142	38	;	;	PUNCT
bjp-25731	142	39	olliaro	olliaro	NOUN
bjp-25731	142	40	and	and	CCONJ
bjp-25731	142	41	wells	well	NOUN
bjp-25731	142	42	,	,	PUNCT
bjp-25731	142	43	2009	2009	NUM
bjp-25731	142	44	)	)	PUNCT
bjp-25731	142	45	.	.	PUNCT
bjp-25731	143	1	although	although	SCONJ
bjp-25731	143	2	,	,	PUNCT
bjp-25731	143	3	the	the	DET
bjp-25731	143	4	volume	volume	NOUN
bjp-25731	143	5	of	of	ADP
bjp-25731	143	6	cases	case	NOUN
bjp-25731	143	7	and	and	CCONJ
bjp-25731	143	8	mortality	mortality	NOUN
bjp-25731	143	9	rate	rate	NOUN
bjp-25731	143	10	linked	link	VERB
bjp-25731	143	11	with	with	ADP
bjp-25731	143	12	his	his	PRON
bjp-25731	143	13	illness	illness	NOUN
bjp-25731	143	14	are	be	AUX
bjp-25731	143	15	reducing	reduce	VERB
bjp-25731	143	16	according	accord	VERB
bjp-25731	143	17	to	to	ADP
bjp-25731	143	18	recent	recent	ADJ
bjp-25731	143	19	update	update	NOUN
bjp-25731	143	20	,	,	PUNCT
bjp-25731	143	21	yet	yet	CCONJ
bjp-25731	143	22	it	it	PRON
bjp-25731	143	23	is	be	AUX
bjp-25731	143	24	the	the	DET
bjp-25731	143	25	deadliest	deadly	ADJ
bjp-25731	143	26	disease	disease	NOUN
bjp-25731	143	27	known	know	VERB
bjp-25731	143	28	globally	globally	ADV
bjp-25731	143	29	(	(	PUNCT
bjp-25731	143	30	birhan	birhan	NOUN
bjp-25731	143	31	et	et	PROPN
bjp-25731	143	32	al	al	PROPN
bjp-25731	143	33	.	.	PROPN
bjp-25731	143	34	,	,	PUNCT
bjp-25731	143	35	2015	2015	NUM
bjp-25731	143	36	)	)	PUNCT
bjp-25731	143	37	.	.	PUNCT
bjp-25731	144	1	the	the	DET
bjp-25731	144	2	in	in	ADP
bjp-25731	144	3	vivo	vivo	ADJ
bjp-25731	144	4	antimalarial	antimalarial	ADJ
bjp-25731	144	5	activities	activity	NOUN
bjp-25731	144	6	of	of	ADP
bjp-25731	144	7	the	the	DET
bjp-25731	144	8	series	series	NOUN
bjp-25731	144	9	of	of	ADP
bjp-25731	144	10	quinazolines	quinazoline	NOUN
bjp-25731	144	11	evaluated	evaluate	VERB
bjp-25731	144	12	with	with	ADP
bjp-25731	144	13	the	the	DET
bjp-25731	144	14	aid	aid	NOUN
bjp-25731	144	15	of	of	ADP
bjp-25731	144	16	4	4	NUM
bjp-25731	144	17	days	day	NOUN
bjp-25731	144	18	suppressive	suppressive	ADJ
bjp-25731	144	19	standard	standard	ADJ
bjp-25731	144	20	experiment	experiment	NOUN
bjp-25731	144	21	against	against	ADP
bjp-25731	144	22	mice	mouse	NOUN
bjp-25731	144	23	infected	infect	VERB
bjp-25731	144	24	with	with	ADP
bjp-25731	144	25	plasmodium	plasmodium	NOUN
bjp-25731	144	26	berghei	berghei	PROPN
bjp-25731	144	27	anka	anka	PROPN
bjp-25731	144	28	which	which	PRON
bjp-25731	144	29	were	be	AUX
bjp-25731	144	30	chloroquinesensitive	chloroquinesensitive	ADJ
bjp-25731	144	31	isolates	isolate	NOUN
bjp-25731	144	32	revealed	reveal	VERB
bjp-25731	144	33	that	that	SCONJ
bjp-25731	144	34	3	3	NUM
bjp-25731	144	35	-	-	PUNCT
bjp-25731	144	36	aryl-2(substitutedstyryl)-4(3h)-quinazolinones	aryl-2(substitutedstyryl)-4(3h)-quinazolinone	NOUN
bjp-25731	144	37	possessed	possess	VERB
bjp-25731	144	38	improved	improve	VERB
bjp-25731	144	39	and	and	CCONJ
bjp-25731	144	40	enhanced	enhance	VERB
bjp-25731	144	41	antimalarial	antimalarial	ADJ
bjp-25731	144	42	properties	property	NOUN
bjp-25731	144	43	activities	activity	NOUN
bjp-25731	144	44	having	having	AUX
bjp-25731	144	45	mean	mean	VERB
bjp-25731	144	46	suppression	suppression	NOUN
bjp-25731	144	47	of	of	ADP
bjp-25731	144	48	67.6	67.6	NUM
bjp-25731	144	49	%	%	NOUN
bjp-25731	144	50	(	(	PUNCT
bjp-25731	144	51	birhan	birhan	PROPN
bjp-25731	144	52	et	et	PROPN
bjp-25731	144	53	al	al	PROPN
bjp-25731	144	54	.	.	PROPN
bjp-25731	144	55	,	,	PUNCT
bjp-25731	144	56	2015	2015	NUM
bjp-25731	144	57	)	)	PUNCT
bjp-25731	144	58	.	.	PUNCT
bjp-25731	145	1	the	the	DET
bjp-25731	145	2	mean	mean	ADJ
bjp-25731	145	3	parasitemia	parasitemia	NOUN
bjp-25731	145	4	level	level	NOUN
bjp-25731	145	5	in	in	ADP
bjp-25731	145	6	mice	mouse	NOUN
bjp-25731	145	7	treated	treat	VERB
bjp-25731	145	8	with	with	ADP
bjp-25731	145	9	this	this	DET
bjp-25731	145	10	compound	compound	NOUN
bjp-25731	145	11	(	(	PUNCT
bjp-25731	145	12	17.7	17.7	NUM
bjp-25731	145	13	±	±	NUM
bjp-25731	145	14	0.4	0.4	NUM
bjp-25731	145	15	)	)	PUNCT
bjp-25731	145	16	was	be	AUX
bjp-25731	145	17	noticed	notice	VERB
bjp-25731	145	18	to	to	PART
bjp-25731	145	19	have	have	AUX
bjp-25731	145	20	been	be	AUX
bjp-25731	145	21	4	4	NUM
bjp-25731	145	22	times	time	NOUN
bjp-25731	145	23	lesser	less	ADJ
bjp-25731	145	24	than	than	ADP
bjp-25731	145	25	that	that	PRON
bjp-25731	145	26	of	of	ADP
bjp-25731	145	27	negative	negative	ADJ
bjp-25731	145	28	control	control	NOUN
bjp-25731	145	29	(	(	PUNCT
bjp-25731	145	30	65.2	65.2	NUM
bjp-25731	145	31	±	±	NUM
bjp-25731	145	32	0.7	0.7	NUM
bjp-25731	145	33	)	)	PUNCT
bjp-25731	145	34	(	(	PUNCT
bjp-25731	145	35	birhan	birhan	ADP
bjp-25731	145	36	et	et	PROPN
bjp-25731	145	37	al	al	PROPN
bjp-25731	145	38	.	.	PROPN
bjp-25731	145	39	,	,	PUNCT
bjp-25731	145	40	2015	2015	NUM
bjp-25731	145	41	)	)	PUNCT
bjp-25731	145	42	.	.	PUNCT
bjp-25731	146	1	this	this	DET
bjp-25731	146	2	shoed	shoed	NOUN
bjp-25731	146	3	that	that	SCONJ
bjp-25731	146	4	the	the	DET
bjp-25731	146	5	targeted	target	VERB
bjp-25731	146	6	compounds	compound	NOUN
bjp-25731	146	7	have	have	AUX
bjp-25731	146	8	significantly	significantly	ADV
bjp-25731	146	9	decreased	decrease	VERB
bjp-25731	146	10	parasite	parasite	ADJ
bjp-25731	146	11	load	load	NOUN
bjp-25731	146	12	(	(	PUNCT
bjp-25731	146	13	birhan	birhan	PROPN
bjp-25731	146	14	et	et	PROPN
bjp-25731	146	15	al	al	PROPN
bjp-25731	146	16	.	.	PROPN
bjp-25731	146	17	,	,	PUNCT
bjp-25731	146	18	2015	2015	NUM
bjp-25731	146	19	)	)	PUNCT
bjp-25731	146	20	.	.	PUNCT
bjp-25731	147	1	previous	previous	ADJ
bjp-25731	147	2	studies	study	NOUN
bjp-25731	147	3	showed	show	VERB
bjp-25731	147	4	that	that	SCONJ
bjp-25731	147	5	the	the	DET
bjp-25731	147	6	presence	presence	NOUN
bjp-25731	147	7	of	of	ADP
bjp-25731	147	8	amino	amino	ADJ
bjp-25731	147	9	substituents	substituent	NOUN
bjp-25731	147	10	on	on	ADP
bjp-25731	147	11	positions	position	NOUN
bjp-25731	147	12	2	2	NUM
bjp-25731	147	13	and	and	CCONJ
bjp-25731	147	14	4	4	NUM
bjp-25731	147	15	,	,	PUNCT
bjp-25731	147	16	enhanced	enhance	VERB
bjp-25731	147	17	the	the	DET
bjp-25731	147	18	antimalarial	antimalarial	ADJ
bjp-25731	147	19	potential	potential	NOUN
bjp-25731	147	20	of	of	ADP
bjp-25731	147	21	6	6	NUM
bjp-25731	147	22	-	-	PUNCT
bjp-25731	147	23	substituted	substitute	VERB
bjp-25731	147	24	quinazoline	quinazoline	NOUN
bjp-25731	147	25	(	(	PUNCT
bjp-25731	147	26	rojas	rojas	PROPN
bjp-25731	147	27	-	-	PUNCT
bjp-25731	147	28	aguirre	aguirre	PROPN
bjp-25731	147	29	et	et	PROPN
bjp-25731	147	30	al	al	PROPN
bjp-25731	147	31	.	.	PROPN
bjp-25731	147	32	,	,	PUNCT
bjp-25731	147	33	2012	2012	NUM
bjp-25731	147	34	;	;	PUNCT
bjp-25731	147	35	jäntschi	jäntschi	NOUN
bjp-25731	147	36	and	and	CCONJ
bjp-25731	147	37	bolboacă	bolboacă	NOUN
bjp-25731	147	38	,	,	PUNCT
bjp-25731	147	39	2006	2006	NUM
bjp-25731	147	40	)	)	PUNCT
bjp-25731	147	41	.	.	PUNCT
bjp-25731	148	1	hence	hence	ADV
bjp-25731	148	2	,	,	PUNCT
bjp-25731	148	3	this	this	PRON
bjp-25731	148	4	led	lead	VERB
bjp-25731	148	5	to	to	ADP
bjp-25731	148	6	the	the	DET
bjp-25731	148	7	strong	strong	ADJ
bjp-25731	148	8	effect	effect	NOUN
bjp-25731	148	9	of	of	ADP
bjp-25731	148	10	quinazoline	quinazoline	NOUN
bjp-25731	148	11	derivative	derivative	ADJ
bjp-25731	148	12	18	18	NUM
bjp-25731	148	13	as	as	ADP
bjp-25731	148	14	an	an	DET
bjp-25731	148	15	antimalarial	antimalarial	ADJ
bjp-25731	148	16	motif	motif	NOUN
bjp-25731	148	17	on	on	ADP
bjp-25731	148	18	human	human	ADJ
bjp-25731	148	19	erythrocytes	erythrocyte	NOUN
bjp-25731	148	20	and	and	CCONJ
bjp-25731	148	21	on	on	ADP
bjp-25731	148	22	cell	cell	NOUN
bjp-25731	148	23	membrane	membrane	NOUN
bjp-25731	148	24	molecular	molecular	ADJ
bjp-25731	148	25	model	model	NOUN
bjp-25731	148	26	(	(	PUNCT
bjp-25731	148	27	rojas	rojas	PROPN
bjp-25731	148	28	-	-	PUNCT
bjp-25731	148	29	aguirre	aguirre	PROPN
bjp-25731	148	30	et	et	PROPN
bjp-25731	148	31	al	al	PROPN
bjp-25731	148	32	.	.	PROPN
bjp-25731	148	33	,	,	PUNCT
bjp-25731	148	34	2012	2012	NUM
bjp-25731	148	35	)	)	PUNCT
bjp-25731	148	36	.	.	PUNCT
bjp-25731	149	1	likewise	likewise	ADV
bjp-25731	149	2	,	,	PUNCT
bjp-25731	149	3	antimalarial	antimalarial	ADJ
bjp-25731	149	4	activity	activity	NOUN
bjp-25731	149	5	of	of	ADP
bjp-25731	149	6	quinazoline	quinazoline	NOUN
bjp-25731	149	7	19	19	NUM
bjp-25731	149	8	was	be	AUX
bjp-25731	149	9	reported	report	VERB
bjp-25731	149	10	to	to	PART
bjp-25731	149	11	be	be	AUX
bjp-25731	149	12	by	by	ADP
bjp-25731	149	13	topological	topological	ADJ
bjp-25731	149	14	and	and	CCONJ
bjp-25731	149	15	geometrical	geometrical	ADJ
bjp-25731	149	16	nature	nature	NOUN
bjp-25731	149	17	and	and	CCONJ
bjp-25731	149	18	was	be	AUX
bjp-25731	149	19	strongly	strongly	ADV
bjp-25731	149	20	dependent	dependent	ADJ
bjp-25731	149	21	on	on	ADP
bjp-25731	149	22	partial	partial	ADJ
bjp-25731	149	23	changes	change	NOUN
bjp-25731	149	24	as	as	SCONJ
bjp-25731	149	25	predicted	predict	VERB
bjp-25731	149	26	by	by	ADP
bjp-25731	149	27	mdf	mdf	PROPN
bjp-25731	149	28	sar	sar	PROPN
bjp-25731	149	29	methodology	methodology	PROPN
bjp-25731	149	30	(	(	PUNCT
bjp-25731	149	31	jäntschi	jäntschi	NOUN
bjp-25731	149	32	and	and	CCONJ
bjp-25731	149	33	bolboacă	bolboacă	NOUN
bjp-25731	149	34	,	,	PUNCT
bjp-25731	149	35	2006	2006	NUM
bjp-25731	149	36	)	)	PUNCT
bjp-25731	149	37	.	.	PUNCT
bjp-25731	150	1	nonetheless	nonetheless	ADV
bjp-25731	150	2	,	,	PUNCT
bjp-25731	150	3	for	for	ADP
bjp-25731	150	4	the	the	DET
bjp-25731	150	5	pyrrolo[3,2	pyrrolo[3,2	PROPN
bjp-25731	150	6	-	-	PUNCT
bjp-25731	150	7	f	f	PROPN
bjp-25731	150	8	]	]	X
bjp-25731	150	9	quinazoline	quinazoline	NOUN
bjp-25731	150	10	20	20	NUM
bjp-25731	150	11	,	,	PUNCT
bjp-25731	150	12	acetamido	acetamido	NOUN
bjp-25731	150	13	moieties	moiety	NOUN
bjp-25731	150	14	on	on	ADP
bjp-25731	150	15	positions	position	NOUN
bjp-25731	150	16	2	2	NUM
bjp-25731	150	17	and	and	CCONJ
bjp-25731	150	18	4	4	NUM
bjp-25731	150	19	was	be	AUX
bjp-25731	150	20	an	an	DET
bjp-25731	150	21	essential	essential	ADJ
bjp-25731	150	22	pharmacophoric	pharmacophoric	ADJ
bjp-25731	150	23	framework	framework	NOUN
bjp-25731	150	24	for	for	ADP
bjp-25731	150	25	magical	magical	ADJ
bjp-25731	150	26	anti	anti	ADJ
bjp-25731	150	27	-	-	ADJ
bjp-25731	150	28	plasmodial	plasmodial	ADJ
bjp-25731	150	29	potential	potential	ADJ
bjp-25731	150	30	work	work	NOUN
bjp-25731	150	31	in	in	ADP
bjp-25731	150	32	another	another	DET
bjp-25731	150	33	study	study	NOUN
bjp-25731	150	34	(	(	PUNCT
bjp-25731	150	35	guan	guan	PROPN
bjp-25731	150	36	et	et	PROPN
bjp-25731	150	37	al	al	PROPN
bjp-25731	150	38	.	.	PROPN
bjp-25731	150	39	,	,	PUNCT
bjp-25731	150	40	2005	2005	NUM
bjp-25731	150	41	;	;	PUNCT
bjp-25731	150	42	figure	figure	NOUN
bjp-25731	150	43	10	10	NUM
bjp-25731	150	44	)	)	PUNCT
bjp-25731	150	45	.	.	PUNCT
bjp-25731	151	1	hdac	hdac	PROPN
bjp-25731	151	2	inhibitory	inhibitory	ADJ
bjp-25731	151	3	activity	activity	NOUN
bjp-25731	151	4	hdacs	hdac	NOUN
bjp-25731	151	5	and	and	CCONJ
bjp-25731	151	6	histone	histone	NOUN
bjp-25731	151	7	acetyltransferases	acetyltransferase	NOUN
bjp-25731	151	8	(	(	PUNCT
bjp-25731	151	9	hats	hat	NOUN
bjp-25731	151	10	)	)	PUNCT
bjp-25731	151	11	work	work	NOUN
bjp-25731	151	12	in	in	ADP
bjp-25731	151	13	contrary	contrary	ADV
bjp-25731	151	14	to	to	ADP
bjp-25731	151	15	altered	altered	ADJ
bjp-25731	151	16	chromatin	chromatin	NOUN
bjp-25731	151	17	and	and	CCONJ
bjp-25731	151	18	therefore	therefore	ADV
bjp-25731	151	19	provide	provide	VERB
bjp-25731	151	20	a	a	DET
bjp-25731	151	21	guidance	guidance	NOUN
bjp-25731	151	22	for	for	ADP
bjp-25731	151	23	gene	gene	NOUN
bjp-25731	151	24	expression	expression	NOUN
bjp-25731	151	25	(	(	PUNCT
bjp-25731	151	26	lin	lin	PROPN
bjp-25731	151	27	et	et	PROPN
bjp-25731	151	28	al	al	PROPN
bjp-25731	151	29	.	.	PROPN
bjp-25731	151	30	,	,	PUNCT
bjp-25731	151	31	2016	2016	NUM
bjp-25731	151	32	;	;	PUNCT
bjp-25731	151	33	pickup	pickup	NOUN
bjp-25731	151	34	et	et	PROPN
bjp-25731	151	35	al	al	PROPN
bjp-25731	151	36	.	.	PROPN
bjp-25731	151	37	,	,	PUNCT
bjp-25731	151	38	2013	2013	NUM
bjp-25731	151	39	)	)	PUNCT
bjp-25731	151	40	.	.	PUNCT
bjp-25731	152	1	hdacs	hdac	NOUN
bjp-25731	152	2	could	could	AUX
bjp-25731	152	3	forcefully	forcefully	ADV
bjp-25731	152	4	suppress	suppress	VERB
bjp-25731	152	5	the	the	DET
bjp-25731	152	6	transfer	transfer	NOUN
bjp-25731	152	7	of	of	ADP
bjp-25731	152	8	genetic	genetic	ADJ
bjp-25731	152	9	code	code	NOUN
bjp-25731	152	10	through	through	ADP
bjp-25731	152	11	existence	existence	NOUN
bjp-25731	152	12	of	of	ADP
bjp-25731	152	13	chromatin	chromatin	NOUN
bjp-25731	152	14	condensation	condensation	NOUN
bjp-25731	152	15	with	with	ADP
bjp-25731	152	16	regard	regard	NOUN
bjp-25731	152	17	to	to	ADP
bjp-25731	152	18	in	in	ADP
bjp-25731	152	19	response	response	NOUN
bjp-25731	152	20	to	to	ADP
bjp-25731	152	21	the	the	DET
bjp-25731	152	22	dismissal	dismissal	NOUN
bjp-25731	152	23	of	of	ADP
bjp-25731	152	24	acetyl	acetyl	NOUN
bjp-25731	152	25	functionality	functionality	NOUN
bjp-25731	152	26	from	from	ADP
bjp-25731	152	27	histone	histone	NOUN
bjp-25731	152	28	ends	end	NOUN
bjp-25731	152	29	(	(	PUNCT
bjp-25731	152	30	lin	lin	PROPN
bjp-25731	152	31	et	et	PROPN
bjp-25731	152	32	al	al	PROPN
bjp-25731	152	33	.	.	PROPN
bjp-25731	152	34	,	,	PUNCT
bjp-25731	152	35	2016	2016	NUM
bjp-25731	152	36	;	;	PUNCT
bjp-25731	152	37	bolden	bolden	PROPN
bjp-25731	152	38	et	et	PROPN
bjp-25731	152	39	al	al	PROPN
bjp-25731	152	40	.	.	PROPN
bjp-25731	152	41	,	,	PUNCT
bjp-25731	152	42	2006	2006	NUM
bjp-25731	152	43	)	)	PUNCT
bjp-25731	152	44	.	.	PUNCT
bjp-25731	153	1	a	a	DET
bjp-25731	153	2	quinazoline	quinazoline	NOUN
bjp-25731	153	3	-	-	PUNCT
bjp-25731	153	4	based	base	VERB
bjp-25731	153	5	hdac	hdac	NOUN
bjp-25731	153	6	inhibitor	inhibitor	NOUN
bjp-25731	153	7	was	be	AUX
bjp-25731	153	8	reported	report	VERB
bjp-25731	153	9	to	to	PART
bjp-25731	153	10	affect	affect	VERB
bjp-25731	153	11	genetically	genetically	ADV
bjp-25731	153	12	expressed	express	VERB
bjp-25731	153	13	routes	route	NOUN
bjp-25731	153	14	towards	towards	ADP
bjp-25731	153	15	cholesterol	cholesterol	NOUN
bjp-25731	153	16	biosynthesis	biosynthesis	NOUN
bjp-25731	153	17	via	via	ADP
bjp-25731	153	18	mevalonate	mevalonate	NOUN
bjp-25731	153	19	within	within	ADP
bjp-25731	153	20	prostate	prostate	NOUN
bjp-25731	153	21	cancer	cancer	NOUN
bjp-25731	153	22	cells	cell	NOUN
bjp-25731	153	23	(	(	PUNCT
bjp-25731	153	24	lin	lin	PROPN
bjp-25731	153	25	et	et	PROPN
bjp-25731	153	26	al	al	PROPN
bjp-25731	153	27	.	.	PROPN
bjp-25731	153	28	,	,	PUNCT
bjp-25731	153	29	figure	figure	VERB
bjp-25731	153	30	8	8	NUM
bjp-25731	153	31	:	:	PUNCT
bjp-25731	153	32	some	some	DET
bjp-25731	153	33	quinazoline	quinazoline	ADJ
bjp-25731	153	34	motifs	motif	NOUN
bjp-25731	153	35	with	with	ADP
bjp-25731	153	36	kinase	kinase	NOUN
bjp-25731	153	37	inhibitory	inhibitory	ADJ
bjp-25731	153	38	activity	activity	NOUN
bjp-25731	153	39	figure	figure	NOUN
bjp-25731	153	40	9	9	NUM
bjp-25731	153	41	:	:	PUNCT
bjp-25731	153	42	some	some	DET
bjp-25731	153	43	quinazoline	quinazoline	ADJ
bjp-25731	153	44	motifs	motif	NOUN
bjp-25731	153	45	with	with	ADP
bjp-25731	153	46	anticonvulsant	anticonvulsant	ADJ
bjp-25731	153	47	activity	activity	NOUN
bjp-25731	153	48	bangladesh	bangladesh	NOUN
bjp-25731	153	49	j	j	PROPN
bjp-25731	153	50	pharmacol	pharmacol	PROPN
bjp-25731	153	51	2016	2016	NUM
bjp-25731	153	52	;	;	PUNCT
bjp-25731	153	53	11	11	NUM
bjp-25731	153	54	:	:	PUNCT
bjp-25731	153	55	716	716	NUM
bjp-25731	153	56	-	-	SYM
bjp-25731	153	57	733	733	NUM
bjp-25731	153	58	723	723	NUM
bjp-25731	153	59	2016	2016	NUM
bjp-25731	153	60	)	)	PUNCT
bjp-25731	153	61	.	.	PUNCT
bjp-25731	154	1	histone	histone	NOUN
bjp-25731	154	2	deacetylases	deacetylase	NOUN
bjp-25731	154	3	(	(	PUNCT
bjp-25731	154	4	hdac	hdac	NOUN
bjp-25731	154	5	)	)	PUNCT
bjp-25731	154	6	play	play	VERB
bjp-25731	154	7	crucial	crucial	ADJ
bjp-25731	154	8	roles	role	NOUN
bjp-25731	154	9	in	in	ADP
bjp-25731	154	10	numerous	numerous	ADJ
bjp-25731	154	11	biological	biological	ADJ
bjp-25731	154	12	processes	process	NOUN
bjp-25731	154	13	;	;	PUNCT
bjp-25731	154	14	hence	hence	ADV
bjp-25731	154	15	,	,	PUNCT
bjp-25731	154	16	hdac	hdac	ADJ
bjp-25731	154	17	inhibitory	inhibitory	ADJ
bjp-25731	154	18	potential	potential	NOUN
bjp-25731	154	19	of	of	ADP
bjp-25731	154	20	two	two	NUM
bjp-25731	154	21	structurally	structurally	ADV
bjp-25731	154	22	related	relate	VERB
bjp-25731	154	23	quinazoline	quinazoline	NOUN
bjp-25731	154	24	21	21	NUM
bjp-25731	154	25	and	and	CCONJ
bjp-25731	154	26	22	22	NUM
bjp-25731	154	27	was	be	AUX
bjp-25731	154	28	compared	compare	VERB
bjp-25731	154	29	based	base	VERB
bjp-25731	154	30	on	on	ADP
bjp-25731	154	31	the	the	DET
bjp-25731	154	32	effect	effect	NOUN
bjp-25731	154	33	of	of	ADP
bjp-25731	154	34	the	the	DET
bjp-25731	154	35	substituents	substituent	NOUN
bjp-25731	154	36	on	on	ADP
bjp-25731	154	37	the	the	DET
bjp-25731	154	38	anilino	anilino	NOUN
bjp-25731	154	39	-	-	PUNCT
bjp-25731	154	40	phenyl	phenyl	NOUN
bjp-25731	154	41	at	at	ADP
bjp-25731	154	42	4position	4position	NUM
bjp-25731	154	43	of	of	ADP
bjp-25731	154	44	quinazoline	quinazoline	NOUN
bjp-25731	154	45	.	.	PUNCT
bjp-25731	155	1	the	the	DET
bjp-25731	155	2	encouraged	encouraged	ADJ
bjp-25731	155	3	activity	activity	NOUN
bjp-25731	155	4	of	of	ADP
bjp-25731	155	5	compound	compound	NOUN
bjp-25731	155	6	21	21	NUM
bjp-25731	155	7	against	against	ADP
bjp-25731	155	8	hdac	hdac	PROPN
bjp-25731	155	9	(	(	PUNCT
bjp-25731	155	10	zhang	zhang	PROPN
bjp-25731	155	11	et	et	PROPN
bjp-25731	155	12	al	al	PROPN
bjp-25731	155	13	.	.	PROPN
bjp-25731	155	14	,	,	PUNCT
bjp-25731	155	15	2013b	2013b	NUM
bjp-25731	155	16	)	)	PUNCT
bjp-25731	155	17	concurred	concur	VERB
bjp-25731	155	18	with	with	ADP
bjp-25731	155	19	established	establish	VERB
bjp-25731	155	20	fact	fact	NOUN
bjp-25731	155	21	that	that	SCONJ
bjp-25731	155	22	hydroxamic	hydroxamic	ADJ
bjp-25731	155	23	acid	acid	NOUN
bjp-25731	155	24	commonly	commonly	ADV
bjp-25731	155	25	exhibit	exhibit	VERB
bjp-25731	155	26	better	well	ADJ
bjp-25731	155	27	efficacy	efficacy	NOUN
bjp-25731	155	28	as	as	ADP
bjp-25731	155	29	hdac	hdac	PROPN
bjp-25731	155	30	inhibitor	inhibitor	NOUN
bjp-25731	155	31	than	than	ADP
bjp-25731	155	32	carboxyl	carboxyl	NOUN
bjp-25731	155	33	-	-	PUNCT
bjp-25731	155	34	based	base	VERB
bjp-25731	155	35	ones	one	NOUN
bjp-25731	155	36	(	(	PUNCT
bjp-25731	155	37	zhang	zhang	X
bjp-25731	155	38	et	et	PROPN
bjp-25731	155	39	al	al	PROPN
bjp-25731	155	40	.	.	PROPN
bjp-25731	155	41	,	,	PUNCT
bjp-25731	155	42	2013b	2013b	NUM
bjp-25731	155	43	;	;	PUNCT
bjp-25731	155	44	kramer	kramer	PROPN
bjp-25731	155	45	,	,	PUNCT
bjp-25731	155	46	2009	2009	NUM
bjp-25731	155	47	)	)	PUNCT
bjp-25731	155	48	while	while	SCONJ
bjp-25731	155	49	quinazoline	quinazoline	VERB
bjp-25731	155	50	22	22	NUM
bjp-25731	155	51	with	with	ADP
bjp-25731	155	52	meta	meta	ADJ
bjp-25731	155	53	-	-	PUNCT
bjp-25731	155	54	substitution	substitution	NOUN
bjp-25731	155	55	and	and	CCONJ
bjp-25731	155	56	unsaturation	unsaturation	NOUN
bjp-25731	155	57	near	near	ADP
bjp-25731	155	58	hydroxamic	hydroxamic	PROPN
bjp-25731	155	59	showed	show	VERB
bjp-25731	155	60	even	even	ADV
bjp-25731	155	61	more	more	ADJ
bjp-25731	155	62	potency	potency	NOUN
bjp-25731	155	63	with	with	ADP
bjp-25731	155	64	ic50	ic50	PROPN
bjp-25731	155	65	of	of	ADP
bjp-25731	155	66	0.2	0.2	NUM
bjp-25731	155	67	±	±	NUM
bjp-25731	155	68	0.02	0.02	NUM
bjp-25731	155	69	μm	μm	NOUN
bjp-25731	155	70	(	(	PUNCT
bjp-25731	155	71	zhang	zhang	X
bjp-25731	155	72	et	et	PROPN
bjp-25731	155	73	al	al	PROPN
bjp-25731	155	74	.	.	PROPN
bjp-25731	155	75	,	,	PUNCT
bjp-25731	155	76	2013b	2013b	NUM
bjp-25731	155	77	)	)	PUNCT
bjp-25731	155	78	(	(	PUNCT
bjp-25731	155	79	figure	figure	NOUN
bjp-25731	155	80	11	11	NUM
bjp-25731	155	81	)	)	PUNCT
bjp-25731	155	82	.	.	PUNCT
bjp-25731	156	1	anti	anti	ADJ
bjp-25731	156	2	-	-	ADJ
bjp-25731	156	3	hiv	hiv	ADJ
bjp-25731	156	4	activity	activity	NOUN
bjp-25731	156	5	hiv-1	hiv-1	PUNCT
bjp-25731	156	6	is	be	AUX
bjp-25731	156	7	an	an	DET
bjp-25731	156	8	etiological	etiological	ADJ
bjp-25731	156	9	agent	agent	NOUN
bjp-25731	156	10	of	of	ADP
bjp-25731	156	11	aids	aid	NOUN
bjp-25731	156	12	which	which	PRON
bjp-25731	156	13	is	be	AUX
bjp-25731	156	14	universal	universal	ADJ
bjp-25731	156	15	pandemic	pandemic	ADJ
bjp-25731	156	16	disease	disease	NOUN
bjp-25731	156	17	that	that	PRON
bjp-25731	156	18	has	have	AUX
bjp-25731	156	19	led	lead	VERB
bjp-25731	156	20	to	to	ADP
bjp-25731	156	21	the	the	DET
bjp-25731	156	22	death	death	NOUN
bjp-25731	156	23	of	of	ADP
bjp-25731	156	24	over	over	ADP
bjp-25731	156	25	34	34	NUM
bjp-25731	156	26	million	million	NUM
bjp-25731	156	27	of	of	ADP
bjp-25731	156	28	the	the	DET
bjp-25731	156	29	world	world	NOUN
bjp-25731	156	30	population	population	NOUN
bjp-25731	156	31	(	(	PUNCT
bjp-25731	156	32	famiglini	famiglini	NOUN
bjp-25731	156	33	and	and	CCONJ
bjp-25731	156	34	silvestri	silvestri	ADJ
bjp-25731	156	35	,	,	PUNCT
bjp-25731	156	36	2016	2016	NUM
bjp-25731	156	37	)	)	PUNCT
bjp-25731	156	38	.	.	PUNCT
bjp-25731	157	1	in	in	ADP
bjp-25731	157	2	2014	2014	NUM
bjp-25731	157	3	alone	alone	ADV
bjp-25731	157	4	,	,	PUNCT
bjp-25731	157	5	aids	aids	PROPN
bjp-25731	157	6	was	be	AUX
bjp-25731	157	7	responsible	responsible	ADJ
bjp-25731	157	8	for	for	ADP
bjp-25731	157	9	approximately	approximately	ADV
bjp-25731	157	10	1.2	1.2	NUM
bjp-25731	157	11	million	million	NUM
bjp-25731	157	12	mortality	mortality	NOUN
bjp-25731	157	13	cases	case	NOUN
bjp-25731	157	14	reported	report	VERB
bjp-25731	157	15	globally	globally	ADV
bjp-25731	157	16	in	in	ADP
bjp-25731	157	17	2014	2014	NUM
bjp-25731	157	18	(	(	PUNCT
bjp-25731	157	19	who	who	PRON
bjp-25731	157	20	,	,	PUNCT
bjp-25731	157	21	2015	2015	NUM
bjp-25731	157	22	)	)	PUNCT
bjp-25731	157	23	.	.	PUNCT
bjp-25731	158	1	review	review	NOUN
bjp-25731	158	2	by	by	ADP
bjp-25731	158	3	famiglini	famiglini	NOUN
bjp-25731	158	4	and	and	CCONJ
bjp-25731	158	5	silvestri	silvestri	ADJ
bjp-25731	158	6	,	,	PUNCT
bjp-25731	158	7	(	(	PUNCT
bjp-25731	158	8	2016	2016	NUM
bjp-25731	158	9	)	)	PUNCT
bjp-25731	158	10	exemplified	exemplify	VERB
bjp-25731	158	11	many	many	ADJ
bjp-25731	158	12	studies	study	NOUN
bjp-25731	158	13	carried	carry	VERB
bjp-25731	158	14	out	out	ADP
bjp-25731	158	15	on	on	ADP
bjp-25731	158	16	the	the	DET
bjp-25731	158	17	evaluation	evaluation	NOUN
bjp-25731	158	18	of	of	ADP
bjp-25731	158	19	influence	influence	NOUN
bjp-25731	158	20	of	of	ADP
bjp-25731	158	21	chirality	chirality	NOUN
bjp-25731	158	22	upon	upon	SCONJ
bjp-25731	158	23	antiretroviral	antiretroviral	ADJ
bjp-25731	158	24	properties	property	NOUN
bjp-25731	158	25	of	of	ADP
bjp-25731	158	26	highly	highly	ADV
bjp-25731	158	27	rated	rate	VERB
bjp-25731	158	28	hiv-1	hiv-1	PUNCT
bjp-25731	158	29	nnrti	nnrti	NOUN
bjp-25731	158	30	molecules	molecule	NOUN
bjp-25731	158	31	,	,	PUNCT
bjp-25731	158	32	which	which	PRON
bjp-25731	158	33	include	include	VERB
bjp-25731	158	34	alkenyl	alkenyl	NOUN
bjp-25731	158	35	substituted	substitute	VERB
bjp-25731	158	36	quinazolinone	quinazolinone	PROPN
bjp-25731	158	37	and	and	CCONJ
bjp-25731	158	38	nevirapine	nevirapine	ADJ
bjp-25731	158	39	(	(	PUNCT
bjp-25731	158	40	famiglini	famiglini	NOUN
bjp-25731	158	41	and	and	CCONJ
bjp-25731	158	42	silvestri	silvestri	ADJ
bjp-25731	158	43	,	,	PUNCT
bjp-25731	158	44	2016	2016	NUM
bjp-25731	158	45	)	)	PUNCT
bjp-25731	158	46	.	.	PUNCT
bjp-25731	159	1	the	the	DET
bjp-25731	159	2	chiral	chiral	ADJ
bjp-25731	159	3	segregation	segregation	NOUN
bjp-25731	159	4	,	,	PUNCT
bjp-25731	159	5	enantiospecific	enantiospecific	ADJ
bjp-25731	159	6	synthesis	synthesis	NOUN
bjp-25731	159	7	,	,	PUNCT
bjp-25731	159	8	in	in	ADP
bjp-25731	159	9	addition	addition	NOUN
bjp-25731	159	10	to	to	ADP
bjp-25731	159	11	biological	biological	ADJ
bjp-25731	159	12	activity	activity	NOUN
bjp-25731	159	13	of	of	ADP
bjp-25731	159	14	the	the	DET
bjp-25731	159	15	hiv-1	hiv-1	X
bjp-25731	159	16	nnrtis	nnrtis	NOUN
bjp-25731	159	17	were	be	AUX
bjp-25731	159	18	fully	fully	ADV
bjp-25731	159	19	expatiated	expatiate	VERB
bjp-25731	159	20	(	(	PUNCT
bjp-25731	159	21	famiglini	famiglini	NOUN
bjp-25731	159	22	and	and	CCONJ
bjp-25731	159	23	silvestri	silvestri	ADJ
bjp-25731	159	24	,	,	PUNCT
bjp-25731	159	25	2016	2016	NUM
bjp-25731	159	26	)	)	PUNCT
bjp-25731	159	27	.	.	PUNCT
bjp-25731	160	1	an	an	DET
bjp-25731	160	2	array	array	NOUN
bjp-25731	160	3	of	of	ADP
bjp-25731	160	4	new	new	ADJ
bjp-25731	160	5	quinazoline	quinazoline	NOUN
bjp-25731	160	6	-	-	PUNCT
bjp-25731	160	7	triazine	triazine	NOUN
bjp-25731	160	8	scaffolds	scaffold	NOUN
bjp-25731	160	9	were	be	AUX
bjp-25731	160	10	prepared	prepare	VERB
bjp-25731	160	11	from	from	ADP
bjp-25731	160	12	the	the	DET
bjp-25731	160	13	reaction	reaction	NOUN
bjp-25731	160	14	of	of	ADP
bjp-25731	160	15	cyanuric	cyanuric	ADJ
bjp-25731	160	16	halide	halide	NOUN
bjp-25731	160	17	and	and	CCONJ
bjp-25731	160	18	anthranilic	anthranilic	NOUN
bjp-25731	160	19	acid	acid	NOUN
bjp-25731	160	20	via	via	ADP
bjp-25731	160	21	a	a	DET
bjp-25731	160	22	sequential	sequential	ADJ
bjp-25731	160	23	pathway	pathway	NOUN
bjp-25731	160	24	(	(	PUNCT
bjp-25731	160	25	mendozamartínez	mendozamartínez	PROPN
bjp-25731	160	26	et	et	PROPN
bjp-25731	160	27	al	al	PROPN
bjp-25731	160	28	.	.	PROPN
bjp-25731	160	29	,	,	PUNCT
bjp-25731	160	30	2015	2015	NUM
bjp-25731	160	31	)	)	PUNCT
bjp-25731	160	32	and	and	CCONJ
bjp-25731	160	33	confirmed	confirm	VERB
bjp-25731	160	34	to	to	PART
bjp-25731	160	35	possess	possess	VERB
bjp-25731	160	36	encouraging	encourage	VERB
bjp-25731	160	37	anti	anti	ADJ
bjp-25731	160	38	-	-	ADJ
bjp-25731	160	39	hiv	hiv	ADJ
bjp-25731	160	40	activity	activity	NOUN
bjp-25731	160	41	(	(	PUNCT
bjp-25731	160	42	modh	modh	NOUN
bjp-25731	160	43	et	et	PROPN
bjp-25731	160	44	al	al	PROPN
bjp-25731	160	45	.	.	PROPN
bjp-25731	160	46	,	,	PUNCT
bjp-25731	160	47	2014	2014	NUM
bjp-25731	160	48	)	)	PUNCT
bjp-25731	160	49	.	.	PUNCT
bjp-25731	161	1	a	a	DET
bjp-25731	161	2	series	series	NOUN
bjp-25731	161	3	of	of	ADP
bjp-25731	161	4	dihydrobenzo[h]quinazol	dihydrobenzo[h]quinazol	PROPN
bjp-25731	161	5	ine	ine	PROPN
bjp-25731	161	6	derivatives	derivative	NOUN
bjp-25731	161	7	were	be	AUX
bjp-25731	161	8	synthesized	synthesize	VERB
bjp-25731	161	9	by	by	ADP
bjp-25731	161	10	mohamed	mohamed	PROPN
bjp-25731	161	11	et	et	PROPN
bjp-25731	161	12	al	al	PROPN
bjp-25731	161	13	.	.	PROPN
bjp-25731	162	1	(	(	PUNCT
bjp-25731	162	2	2012	2012	NUM
bjp-25731	162	3	)	)	PUNCT
bjp-25731	162	4	for	for	ADP
bjp-25731	162	5	the	the	DET
bjp-25731	162	6	purpose	purpose	NOUN
bjp-25731	162	7	of	of	ADP
bjp-25731	162	8	anti	anti	ADJ
bjp-25731	162	9	-	-	ADJ
bjp-25731	162	10	hiv	hiv	ADJ
bjp-25731	162	11	examination	examination	NOUN
bjp-25731	162	12	.	.	PUNCT
bjp-25731	163	1	they	they	PRON
bjp-25731	163	2	reported	report	VERB
bjp-25731	163	3	that	that	SCONJ
bjp-25731	163	4	4	4	NUM
bjp-25731	163	5	-	-	PUNCT
bjp-25731	163	6	thiophen	thiophen	NOUN
bjp-25731	163	7	-2	-2	NOUN
bjp-25731	163	8	-	-	PUNCT
bjp-25731	163	9	ylquinazoline	ylquinazoline	PROPN
bjp-25731	163	10	derivative	derivative	NOUN
bjp-25731	163	11	(	(	PUNCT
bjp-25731	163	12	ic50	ic50	PROPN
bjp-25731	163	13	=	=	PROPN
bjp-25731	163	14	2.1	2.1	NUM
bjp-25731	163	15	μm	μm	NUM
bjp-25731	163	16	)	)	PUNCT
bjp-25731	163	17	emerged	emerge	VERB
bjp-25731	163	18	as	as	ADP
bjp-25731	163	19	the	the	DET
bjp-25731	163	20	best	good	ADJ
bjp-25731	163	21	anti	anti	NOUN
bjp-25731	163	22	-	-	NOUN
bjp-25731	163	23	hiv	hiv	ADJ
bjp-25731	163	24	among	among	ADP
bjp-25731	163	25	the	the	DET
bjp-25731	163	26	series	series	NOUN
bjp-25731	163	27	with	with	ADP
bjp-25731	163	28	therapeutic	therapeutic	ADJ
bjp-25731	163	29	index	index	NOUN
bjp-25731	163	30	of	of	ADP
bjp-25731	163	31	1.9	1.9	NUM
bjp-25731	163	32	×	×	NOUN
bjp-25731	163	33	105	105	NUM
bjp-25731	163	34	.	.	PUNCT
bjp-25731	164	1	concerning	concern	VERB
bjp-25731	164	2	the	the	DET
bjp-25731	164	3	mechanism	mechanism	NOUN
bjp-25731	164	4	of	of	ADP
bjp-25731	164	5	action	action	NOUN
bjp-25731	164	6	as	as	ADP
bjp-25731	164	7	anti	anti	ADJ
bjp-25731	164	8	-	-	ADJ
bjp-25731	164	9	hiv	hiv	ADJ
bjp-25731	164	10	,	,	PUNCT
bjp-25731	164	11	these	these	DET
bjp-25731	164	12	compounds	compound	NOUN
bjp-25731	164	13	were	be	AUX
bjp-25731	164	14	reverse	reverse	ADJ
bjp-25731	164	15	transcriptase	transcriptase	NOUN
bjp-25731	164	16	inhibitors	inhibitor	NOUN
bjp-25731	164	17	.	.	PUNCT
bjp-25731	165	1	phosphodiesterase	phosphodiesterase	NOUN
bjp-25731	165	2	(	(	PUNCT
bjp-25731	165	3	pde	pde	NOUN
bjp-25731	165	4	)	)	PUNCT
bjp-25731	165	5	inhibitors	inhibitor	NOUN
bjp-25731	165	6	pde	pde	NOUN
bjp-25731	165	7	groups	group	NOUN
bjp-25731	165	8	possess	possess	VERB
bjp-25731	165	9	numerous	numerous	ADJ
bjp-25731	165	10	variants	variant	NOUN
bjp-25731	165	11	which	which	PRON
bjp-25731	165	12	are	be	AUX
bjp-25731	165	13	commonly	commonly	ADV
bjp-25731	165	14	special	special	ADJ
bjp-25731	165	15	tissue	tissue	NOUN
bjp-25731	165	16	-	-	PUNCT
bjp-25731	165	17	expression	expression	NOUN
bjp-25731	165	18	traits	trait	NOUN
bjp-25731	165	19	,	,	PUNCT
bjp-25731	165	20	gene	gene	NOUN
bjp-25731	165	21	controlling	controlling	NOUN
bjp-25731	165	22	,	,	PUNCT
bjp-25731	165	23	enzymatic	enzymatic	ADJ
bjp-25731	165	24	regulation	regulation	NOUN
bjp-25731	165	25	via	via	ADP
bjp-25731	165	26	phosphorylation	phosphorylation	NOUN
bjp-25731	165	27	and	and	CCONJ
bjp-25731	165	28	regulatory	regulatory	ADJ
bjp-25731	165	29	proteins	protein	NOUN
bjp-25731	165	30	,	,	PUNCT
bjp-25731	165	31	subcellular	subcellular	ADJ
bjp-25731	165	32	localization	localization	NOUN
bjp-25731	165	33	,	,	PUNCT
bjp-25731	165	34	as	as	ADV
bjp-25731	165	35	well	well	ADV
bjp-25731	165	36	as	as	ADP
bjp-25731	165	37	collaboration	collaboration	NOUN
bjp-25731	165	38	with	with	ADP
bjp-25731	165	39	association	association	NOUN
bjp-25731	165	40	proteins	protein	NOUN
bjp-25731	165	41	(	(	PUNCT
bjp-25731	165	42	omori	omori	NOUN
bjp-25731	165	43	and	and	CCONJ
bjp-25731	165	44	kotera	kotera	PROPN
bjp-25731	165	45	,	,	PUNCT
bjp-25731	165	46	2007	2007	NUM
bjp-25731	165	47	)	)	PUNCT
bjp-25731	165	48	.	.	PUNCT
bjp-25731	166	1	mono	mono	NOUN
bjp-25731	166	2	-	-	PUNCT
bjp-25731	166	3	substitution	substitution	NOUN
bjp-25731	166	4	on	on	ADP
bjp-25731	166	5	position	position	NOUN
bjp-25731	166	6	6	6	NUM
bjp-25731	166	7	of	of	ADP
bjp-25731	166	8	quinazoline	quinazoline	NOUN
bjp-25731	166	9	core	core	NOUN
bjp-25731	166	10	was	be	AUX
bjp-25731	166	11	crucial	crucial	ADJ
bjp-25731	166	12	for	for	ADP
bjp-25731	166	13	effective	effective	ADJ
bjp-25731	166	14	inhibition	inhibition	NOUN
bjp-25731	166	15	wherein	wherein	ADJ
bjp-25731	166	16	substituents	substituent	NOUN
bjp-25731	166	17	of	of	ADP
bjp-25731	166	18	priority	priority	NOUN
bjp-25731	166	19	which	which	PRON
bjp-25731	166	20	possessed	possess	VERB
bjp-25731	166	21	tight	tight	ADJ
bjp-25731	166	22	package	package	NOUN
bjp-25731	166	23	and	and	CCONJ
bjp-25731	166	24	hydrophobicity	hydrophobicity	NOUN
bjp-25731	166	25	are	be	AUX
bjp-25731	166	26	:	:	PUNCT
bjp-25731	166	27	methoxy	methoxy	ADJ
bjp-25731	166	28	(	(	PUNCT
bjp-25731	166	29	23b	23b	NOUN
bjp-25731	166	30	,	,	PUNCT
bjp-25731	166	31	ic50	ic50	PROPN
bjp-25731	166	32	=	=	PROPN
bjp-25731	166	33	0.23	0.23	NUM
bjp-25731	166	34	µm	µm	NOUN
bjp-25731	166	35	)	)	PUNCT
bjp-25731	166	36	,	,	PUNCT
bjp-25731	166	37	methyl	methyl	NOUN
bjp-25731	166	38	(	(	PUNCT
bjp-25731	166	39	23c	23c	NOUN
bjp-25731	166	40	,	,	PUNCT
bjp-25731	166	41	0.10	0.10	NUM
bjp-25731	166	42	µm	µm	NOUN
bjp-25731	166	43	)	)	PUNCT
bjp-25731	166	44	,	,	PUNCT
bjp-25731	166	45	chloro	chloro	X
bjp-25731	166	46	(	(	PUNCT
bjp-25731	166	47	23d	23d	NUM
bjp-25731	166	48	,	,	PUNCT
bjp-25731	166	49	0.019	0.019	NUM
bjp-25731	166	50	µm	µm	NOUN
bjp-25731	166	51	)	)	PUNCT
bjp-25731	166	52	,	,	PUNCT
bjp-25731	166	53	thiomethyl	thiomethyl	PROPN
bjp-25731	166	54	(	(	PUNCT
bjp-25731	166	55	23f	23f	NOUN
bjp-25731	166	56	,	,	PUNCT
bjp-25731	166	57	0.031	0.031	NUM
bjp-25731	166	58	µm	µm	NOUN
bjp-25731	166	59	)	)	PUNCT
bjp-25731	166	60	,	,	PUNCT
bjp-25731	166	61	and	and	CCONJ
bjp-25731	166	62	cyano	cyano	X
bjp-25731	166	63	(	(	PUNCT
bjp-25731	166	64	23p	23p	NUM
bjp-25731	166	65	,	,	PUNCT
bjp-25731	166	66	0.090	0.090	NUM
bjp-25731	166	67	µm	µm	NOUN
bjp-25731	166	68	)	)	PUNCT
bjp-25731	166	69	functionalities	functionality	NOUN
bjp-25731	166	70	(	(	PUNCT
bjp-25731	166	71	takase	takase	NOUN
bjp-25731	166	72	et	et	PROPN
bjp-25731	166	73	al	al	PROPN
bjp-25731	166	74	.	.	PROPN
bjp-25731	166	75	,	,	PUNCT
bjp-25731	166	76	1994	1994	NUM
bjp-25731	166	77	)	)	PUNCT
bjp-25731	166	78	as	as	SCONJ
bjp-25731	166	79	shown	show	VERB
bjp-25731	166	80	in	in	ADP
bjp-25731	166	81	figure	figure	NOUN
bjp-25731	166	82	12	12	NUM
bjp-25731	166	83	.	.	PUNCT
bjp-25731	167	1	administration	administration	NOUN
bjp-25731	167	2	of	of	ADP
bjp-25731	167	3	3	3	PROPN
bjp-25731	167	4	-	-	PUNCT
bjp-25731	167	5	substitutedquinazolin-2,4dithione	substitutedquinazolin-2,4dithione	NOUN
bjp-25731	167	6	as	as	SCONJ
bjp-25731	167	7	optimized	optimize	VERB
bjp-25731	167	8	pde7	pde7	NOUN
bjp-25731	167	9	inhibitor	inhibitor	NOUN
bjp-25731	167	10	improved	improve	VERB
bjp-25731	167	11	brain	brain	NOUN
bjp-25731	167	12	damage	damage	NOUN
bjp-25731	167	13	and	and	CCONJ
bjp-25731	167	14	enhanced	enhance	VERB
bjp-25731	167	15	behavioral	behavioral	ADJ
bjp-25731	167	16	aftermath	aftermath	NOUN
bjp-25731	167	17	in	in	ADP
bjp-25731	167	18	a	a	DET
bjp-25731	167	19	permanent	permanent	ADJ
bjp-25731	167	20	middle	middle	ADJ
bjp-25731	167	21	cerebral	cerebral	ADJ
bjp-25731	167	22	artery	artery	NOUN
bjp-25731	167	23	obstruction	obstruction	NOUN
bjp-25731	167	24	(	(	PUNCT
bjp-25731	167	25	pmcao	pmcao	NOUN
bjp-25731	167	26	)	)	PUNCT
bjp-25731	167	27	stroke	stroke	NOUN
bjp-25731	167	28	model	model	NOUN
bjp-25731	167	29	(	(	PUNCT
bjp-25731	167	30	redondo	redondo	PROPN
bjp-25731	167	31	et	et	PROPN
bjp-25731	167	32	al	al	PROPN
bjp-25731	167	33	.	.	PROPN
bjp-25731	167	34	,	,	PUNCT
bjp-25731	167	35	2012	2012	NUM
bjp-25731	167	36	;	;	PUNCT
bjp-25731	167	37	susín	susín	NOUN
bjp-25731	167	38	et	et	PROPN
bjp-25731	167	39	al	al	PROPN
bjp-25731	167	40	.	.	PROPN
bjp-25731	167	41	,	,	PUNCT
bjp-25731	167	42	2012	2012	NUM
bjp-25731	167	43	)	)	PUNCT
bjp-25731	167	44	.	.	PUNCT
bjp-25731	168	1	sánchez	sánchez	PROPN
bjp-25731	168	2	et	et	PROPN
bjp-25731	168	3	al	al	PROPN
bjp-25731	168	4	.	.	PROPN
bjp-25731	169	1	(	(	PUNCT
bjp-25731	169	2	2013	2013	NUM
bjp-25731	169	3	)	)	PUNCT
bjp-25731	169	4	reported	report	VERB
bjp-25731	169	5	the	the	DET
bjp-25731	169	6	inhibitory	inhibitory	ADJ
bjp-25731	169	7	potencies	potency	NOUN
bjp-25731	169	8	of	of	ADP
bjp-25731	169	9	quinazoline-4	quinazoline-4	PROPN
bjp-25731	169	10	-	-	PUNCT
bjp-25731	169	11	thione	thione	ADJ
bjp-25731	169	12	24	24	NUM
bjp-25731	169	13	at	at	ADP
bjp-25731	169	14	submicromolar	submicromolar	ADJ
bjp-25731	169	15	levels	level	NOUN
bjp-25731	169	16	against	against	ADP
bjp-25731	169	17	the	the	DET
bjp-25731	169	18	catalytic	catalytic	ADJ
bjp-25731	169	19	domain	domain	NOUN
bjp-25731	169	20	of	of	ADP
bjp-25731	169	21	pde7	pde7	PROPN
bjp-25731	169	22	.	.	PUNCT
bjp-25731	170	1	smallmolecule	smallmolecule	NOUN
bjp-25731	170	2	phosphodiesterase	phosphodiesterase	NOUN
bjp-25731	170	3	probe	probe	NOUN
bjp-25731	170	4	investigation	investigation	NOUN
bjp-25731	170	5	figure	figure	NOUN
bjp-25731	170	6	10	10	NUM
bjp-25731	170	7	:	:	PUNCT
bjp-25731	170	8	some	some	DET
bjp-25731	170	9	quinazoline	quinazoline	ADJ
bjp-25731	170	10	motifs	motif	NOUN
bjp-25731	170	11	with	with	ADP
bjp-25731	170	12	antimalarial	antimalarial	ADJ
bjp-25731	170	13	activity	activity	NOUN
bjp-25731	170	14	figure	figure	NOUN
bjp-25731	170	15	11	11	NUM
bjp-25731	170	16	:	:	PUNCT
bjp-25731	170	17	some	some	DET
bjp-25731	170	18	quinazoline	quinazoline	ADJ
bjp-25731	170	19	motifs	motif	NOUN
bjp-25731	170	20	which	which	PRON
bjp-25731	170	21	served	serve	VERB
bjp-25731	170	22	as	as	ADP
bjp-25731	170	23	hdac	hdac	NOUN
bjp-25731	170	24	inhibitors	inhibitor	NOUN
bjp-25731	170	25	724	724	NUM
bjp-25731	170	26	bangladesh	bangladesh	NOUN
bjp-25731	170	27	j	j	PROPN
bjp-25731	170	28	pharmacol	pharmacol	PROPN
bjp-25731	170	29	2016	2016	NUM
bjp-25731	170	30	;	;	PUNCT
bjp-25731	170	31	11	11	NUM
bjp-25731	170	32	:	:	PUNCT
bjp-25731	170	33	716	716	NUM
bjp-25731	170	34	-	-	SYM
bjp-25731	170	35	733	733	NUM
bjp-25731	170	36	established	establish	VERB
bjp-25731	170	37	4	4	NUM
bjp-25731	170	38	-	-	NOUN
bjp-25731	170	39	aminoquinazoline	aminoquinazoline	NOUN
bjp-25731	170	40	25	25	NUM
bjp-25731	170	41	as	as	ADP
bjp-25731	170	42	pde1	pde1	ADJ
bjp-25731	170	43	inhibitors	inhibitor	NOUN
bjp-25731	170	44	that	that	PRON
bjp-25731	170	45	readily	readily	ADV
bjp-25731	170	46	cross	cross	VERB
bjp-25731	170	47	the	the	DET
bjp-25731	170	48	blood	blood	NOUN
bjp-25731	170	49	brain	brain	NOUN
bjp-25731	170	50	barrier	barrier	NOUN
bjp-25731	170	51	(	(	PUNCT
bjp-25731	170	52	humphrey	humphrey	PROPN
bjp-25731	170	53	et	et	PROPN
bjp-25731	170	54	al	al	PROPN
bjp-25731	170	55	.	.	PROPN
bjp-25731	170	56	,	,	PUNCT
bjp-25731	170	57	2014	2014	NUM
bjp-25731	170	58	)	)	PUNCT
bjp-25731	170	59	.	.	PUNCT
bjp-25731	171	1	antihypertensive	antihypertensive	ADJ
bjp-25731	171	2	activity	activity	NOUN
bjp-25731	171	3	hypertension	hypertension	NOUN
bjp-25731	171	4	is	be	AUX
bjp-25731	171	5	well	well	ADV
bjp-25731	171	6	-	-	PUNCT
bjp-25731	171	7	known	know	VERB
bjp-25731	171	8	to	to	PART
bjp-25731	171	9	be	be	AUX
bjp-25731	171	10	major	major	ADJ
bjp-25731	171	11	community	community	NOUN
bjp-25731	171	12	health	health	NOUN
bjp-25731	171	13	challenge	challenge	NOUN
bjp-25731	171	14	among	among	ADP
bjp-25731	171	15	both	both	DET
bjp-25731	171	16	middle	middle	NOUN
bjp-25731	171	17	-	-	PUNCT
bjp-25731	171	18	aged	aged	ADJ
bjp-25731	171	19	and	and	CCONJ
bjp-25731	171	20	older	old	ADJ
bjp-25731	171	21	population	population	NOUN
bjp-25731	171	22	(	(	PUNCT
bjp-25731	171	23	deadwania	deadwania	NOUN
bjp-25731	171	24	,	,	PUNCT
bjp-25731	171	25	2011	2011	NUM
bjp-25731	171	26	)	)	PUNCT
bjp-25731	171	27	.	.	PUNCT
bjp-25731	172	1	the	the	DET
bjp-25731	172	2	administration	administration	NOUN
bjp-25731	172	3	of	of	ADP
bjp-25731	172	4	l2286	l2286	ADJ
bjp-25731	172	5	in	in	ADP
bjp-25731	172	6	hypertensive	hypertensive	ADJ
bjp-25731	172	7	animals	animal	NOUN
bjp-25731	172	8	has	have	AUX
bjp-25731	172	9	been	be	AUX
bjp-25731	172	10	hypothesized	hypothesize	VERB
bjp-25731	172	11	to	to	PART
bjp-25731	172	12	decrease	decrease	VERB
bjp-25731	172	13	oxidative	oxidative	ADJ
bjp-25731	172	14	stress	stress	NOUN
bjp-25731	172	15	,	,	PUNCT
bjp-25731	172	16	modulate	modulate	VERB
bjp-25731	172	17	signaling	signal	VERB
bjp-25731	172	18	pathways	pathway	NOUN
bjp-25731	172	19	(	(	PUNCT
bjp-25731	172	20	pi-3k	pi-3k	PROPN
bjp-25731	172	21	-	-	PUNCT
bjp-25731	172	22	akt	akt	PROPN
bjp-25731	172	23	,	,	PUNCT
bjp-25731	172	24	map	map	NOUN
bjp-25731	172	25	kinases	kinase	NOUN
bjp-25731	172	26	)	)	PUNCT
bjp-25731	172	27	and	and	CCONJ
bjp-25731	172	28	attenuate	attenuate	VERB
bjp-25731	172	29	nf	nf	ADJ
bjp-25731	172	30	-	-	PUNCT
bjp-25731	172	31	κb	κb	NOUN
bjp-25731	172	32	activation	activation	NOUN
bjp-25731	172	33	,	,	PUNCT
bjp-25731	172	34	thereby	thereby	ADV
bjp-25731	172	35	reduces	reduce	VERB
bjp-25731	172	36	the	the	DET
bjp-25731	172	37	hypertension	hypertension	NOUN
bjp-25731	172	38	-	-	PUNCT
bjp-25731	172	39	induced	induce	VERB
bjp-25731	172	40	adverse	adverse	ADJ
bjp-25731	172	41	vascular	vascular	ADJ
bjp-25731	172	42	changes	change	NOUN
bjp-25731	172	43	(	(	PUNCT
bjp-25731	172	44	magyar	magyar	PROPN
bjp-25731	172	45	et	et	PROPN
bjp-25731	172	46	al	al	PROPN
bjp-25731	172	47	.	.	PROPN
bjp-25731	172	48	,	,	PUNCT
bjp-25731	172	49	2014	2014	NUM
bjp-25731	172	50	)	)	PUNCT
bjp-25731	172	51	.	.	PUNCT
bjp-25731	173	1	it	it	PRON
bjp-25731	173	2	is	be	AUX
bjp-25731	173	3	well	well	ADV
bjp-25731	173	4	established	establish	VERB
bjp-25731	173	5	that	that	SCONJ
bjp-25731	173	6	parp	parp	ADJ
bjp-25731	173	7	inhibitors	inhibitor	NOUN
bjp-25731	173	8	can	can	AUX
bjp-25731	173	9	prevent	prevent	VERB
bjp-25731	173	10	oxidative	oxidative	ADJ
bjp-25731	173	11	stress	stress	NOUN
bjp-25731	173	12	induced	induce	VERB
bjp-25731	173	13	tissue	tissue	NOUN
bjp-25731	173	14	damage	damage	NOUN
bjp-25731	173	15	;	;	PUNCT
bjp-25731	173	16	they	they	PRON
bjp-25731	173	17	can	can	AUX
bjp-25731	173	18	favorably	favorably	ADV
bjp-25731	173	19	modulate	modulate	VERB
bjp-25731	173	20	pi-3	pi-3	NOUN
bjp-25731	173	21	-	-	PUNCT
bjp-25731	173	22	kinase	kinase	NOUN
bjp-25731	173	23	/	/	SYM
bjp-25731	173	24	akt-1	akt-1	PUNCT
bjp-25731	173	25	and	and	CCONJ
bjp-25731	173	26	map	map	VERB
bjp-25731	173	27	kinase	kinase	PROPN
bjp-25731	173	28	pathways	pathway	NOUN
bjp-25731	173	29	,	,	PUNCT
bjp-25731	173	30	and	and	CCONJ
bjp-25731	173	31	inhibit	inhibit	VERB
bjp-25731	173	32	nf	nf	ADJ
bjp-25731	173	33	-	-	PUNCT
bjp-25731	173	34	κb	κb	NOUN
bjp-25731	173	35	activation	activation	NOUN
bjp-25731	173	36	(	(	PUNCT
bjp-25731	173	37	radnai	radnai	NOUN
bjp-25731	173	38	et	et	NOUN
bjp-25731	173	39	al	al	PROPN
bjp-25731	173	40	.	.	PROPN
bjp-25731	173	41	,	,	PUNCT
bjp-25731	173	42	2012	2012	NUM
bjp-25731	173	43	)	)	PUNCT
bjp-25731	173	44	.	.	PUNCT
bjp-25731	174	1	although	although	SCONJ
bjp-25731	174	2	,	,	PUNCT
bjp-25731	174	3	parp	parp	ADJ
bjp-25731	174	4	inhibition	inhibition	NOUN
bjp-25731	174	5	did	do	AUX
bjp-25731	174	6	not	not	PART
bjp-25731	174	7	have	have	VERB
bjp-25731	174	8	any	any	DET
bjp-25731	174	9	antihypertensive	antihypertensive	ADJ
bjp-25731	174	10	effect	effect	NOUN
bjp-25731	174	11	,	,	PUNCT
bjp-25731	174	12	it	it	PRON
bjp-25731	174	13	enforces	enforce	VERB
bjp-25731	174	14	salient	salient	NOUN
bjp-25731	174	15	safeguarding	safeguard	VERB
bjp-25731	174	16	upon	upon	SCONJ
bjp-25731	174	17	process	process	NOUN
bjp-25731	174	18	of	of	ADP
bjp-25731	174	19	change	change	NOUN
bjp-25731	174	20	of	of	ADP
bjp-25731	174	21	hypertensive	hypertensive	ADJ
bjp-25731	174	22	heart	heart	NOUN
bjp-25731	174	23	disorder	disorder	NOUN
bjp-25731	174	24	to	to	ADP
bjp-25731	174	25	heart	heart	NOUN
bjp-25731	174	26	failure	failure	NOUN
bjp-25731	174	27	in	in	ADP
bjp-25731	174	28	shrs	shrs	PROPN
bjp-25731	174	29	(	(	PUNCT
bjp-25731	174	30	magyar	magyar	PROPN
bjp-25731	174	31	et	et	PROPN
bjp-25731	174	32	al	al	PROPN
bjp-25731	174	33	.	.	PROPN
bjp-25731	174	34	,	,	PUNCT
bjp-25731	174	35	2014	2014	NUM
bjp-25731	174	36	;	;	PUNCT
bjp-25731	174	37	bartha	bartha	PROPN
bjp-25731	174	38	et	et	PROPN
bjp-25731	174	39	al	al	PROPN
bjp-25731	174	40	.	.	PROPN
bjp-25731	174	41	,	,	PUNCT
bjp-25731	174	42	2009	2009	NUM
bjp-25731	174	43	)	)	PUNCT
bjp-25731	174	44	.	.	PUNCT
bjp-25731	175	1	a	a	DET
bjp-25731	175	2	series	series	NOUN
bjp-25731	175	3	of	of	ADP
bjp-25731	175	4	novel	novel	ADJ
bjp-25731	175	5	substituted	substitute	VERB
bjp-25731	175	6	quinazolin-4(3h	quinazolin-4(3h	NOUN
bjp-25731	175	7	)	)	PUNCT
bjp-25731	175	8	-one	-one	NUM
bjp-25731	175	9	derivatives	derivative	NOUN
bjp-25731	175	10	,	,	PUNCT
bjp-25731	175	11	with	with	ADP
bjp-25731	175	12	acute	acute	ADJ
bjp-25731	175	13	ld50>1000	ld50>1000	VERB
bjp-25731	175	14	mg	mg	PROPN
bjp-25731	175	15	/	/	SYM
bjp-25731	175	16	kg	kg	PROPN
bjp-25731	175	17	,	,	PUNCT
bjp-25731	175	18	showed	show	VERB
bjp-25731	175	19	enhanced	enhanced	ADJ
bjp-25731	175	20	bioactivity	bioactivity	NOUN
bjp-25731	175	21	than	than	ADP
bjp-25731	175	22	standard	standard	ADJ
bjp-25731	175	23	drug	drug	NOUN
bjp-25731	175	24	prazosin	prazosin	NOUN
bjp-25731	175	25	,	,	PUNCT
bjp-25731	175	26	which	which	PRON
bjp-25731	175	27	plays	play	VERB
bjp-25731	175	28	unique	unique	ADJ
bjp-25731	175	29	role	role	NOUN
bjp-25731	175	30	as	as	ADP
bjp-25731	175	31	anti	anti	ADJ
bjp-25731	175	32	-	-	ADJ
bjp-25731	175	33	hypertensive	hypertensive	ADJ
bjp-25731	175	34	agent	agent	NOUN
bjp-25731	175	35	through	through	ADP
bjp-25731	175	36	1	1	NUM
bjp-25731	175	37	blocking	blocking	NOUN
bjp-25731	175	38	procedure	procedure	NOUN
bjp-25731	175	39	(	(	PUNCT
bjp-25731	175	40	pathak	pathak	PROPN
bjp-25731	175	41	et	et	PROPN
bjp-25731	175	42	al	al	PROPN
bjp-25731	175	43	.	.	PROPN
bjp-25731	175	44	,	,	PUNCT
bjp-25731	175	45	2014	2014	NUM
bjp-25731	175	46	)	)	PUNCT
bjp-25731	175	47	.	.	PUNCT
bjp-25731	176	1	the	the	DET
bjp-25731	176	2	effect	effect	NOUN
bjp-25731	176	3	of	of	ADP
bjp-25731	176	4	l-2286	l-2286	PROPN
bjp-25731	176	5	on	on	ADP
bjp-25731	176	6	systolic	systolic	ADJ
bjp-25731	176	7	blood	blood	NOUN
bjp-25731	176	8	pressure	pressure	NOUN
bjp-25731	176	9	(	(	PUNCT
bjp-25731	176	10	sbp	sbp	NOUN
bjp-25731	176	11	)	)	PUNCT
bjp-25731	176	12	was	be	AUX
bjp-25731	176	13	investigated	investigate	VERB
bjp-25731	176	14	by	by	ADP
bjp-25731	176	15	magyar	magyar	PROPN
bjp-25731	176	16	et	et	PROPN
bjp-25731	176	17	al	al	PROPN
bjp-25731	176	18	.	.	PROPN
bjp-25731	177	1	(	(	PUNCT
bjp-25731	177	2	2014	2014	NUM
bjp-25731	177	3	)	)	PUNCT
bjp-25731	177	4	.	.	PUNCT
bjp-25731	178	1	it	it	PRON
bjp-25731	178	2	was	be	AUX
bjp-25731	178	3	discovered	discover	VERB
bjp-25731	178	4	that	that	SCONJ
bjp-25731	178	5	within	within	ADP
bjp-25731	178	6	32	32	NUM
bjp-25731	178	7	week	week	NOUN
bjp-25731	178	8	of	of	ADP
bjp-25731	178	9	experimental	experimental	ADJ
bjp-25731	178	10	duration	duration	NOUN
bjp-25731	178	11	,	,	PUNCT
bjp-25731	178	12	sbp	sbp	NOUN
bjp-25731	178	13	of	of	ADP
bjp-25731	178	14	hypertensive	hypertensive	ADJ
bjp-25731	178	15	(	(	PUNCT
bjp-25731	178	16	shr	shr	PROPN
bjp-25731	178	17	-	-	PUNCT
bjp-25731	178	18	c	c	PROPN
bjp-25731	178	19	,	,	PUNCT
bjp-25731	178	20	shr	shr	PROPN
bjp-25731	178	21	-	-	PUNCT
bjp-25731	178	22	l	l	NOUN
bjp-25731	178	23	)	)	PUNCT
bjp-25731	178	24	rats	rat	NOUN
bjp-25731	178	25	was	be	AUX
bjp-25731	178	26	remarkably	remarkably	ADV
bjp-25731	178	27	greater	great	ADJ
bjp-25731	178	28	as	as	SCONJ
bjp-25731	178	29	compared	compare	VERB
bjp-25731	178	30	with	with	ADP
bjp-25731	178	31	normotensive	normotensive	ADJ
bjp-25731	178	32	(	(	PUNCT
bjp-25731	178	33	wky	wky	ADJ
bjp-25731	178	34	)	)	PUNCT
bjp-25731	178	35	rats	rat	NOUN
bjp-25731	178	36	(	(	PUNCT
bjp-25731	178	37	magyar	magyar	PROPN
bjp-25731	178	38	et	et	PROPN
bjp-25731	178	39	al	al	PROPN
bjp-25731	178	40	.	.	PROPN
bjp-25731	178	41	,	,	PUNCT
bjp-25731	178	42	2014	2014	NUM
bjp-25731	178	43	)	)	PUNCT
bjp-25731	178	44	and	and	CCONJ
bjp-25731	178	45	the	the	DET
bjp-25731	178	46	detail	detail	NOUN
bjp-25731	178	47	of	of	ADP
bjp-25731	178	48	the	the	DET
bjp-25731	178	49	finding	finding	NOUN
bjp-25731	178	50	is	be	AUX
bjp-25731	178	51	shown	show	VERB
bjp-25731	178	52	in	in	ADP
bjp-25731	178	53	figure	figure	NOUN
bjp-25731	178	54	13	13	NUM
bjp-25731	178	55	.	.	PUNCT
bjp-25731	179	1	administering	administer	VERB
bjp-25731	179	2	l-2286	l-2286	PROPN
bjp-25731	179	3	was	be	AUX
bjp-25731	179	4	noticed	notice	VERB
bjp-25731	179	5	to	to	PART
bjp-25731	179	6	contribute	contribute	VERB
bjp-25731	179	7	no	no	DET
bjp-25731	179	8	significant	significant	ADJ
bjp-25731	179	9	change	change	NOUN
bjp-25731	179	10	to	to	ADP
bjp-25731	179	11	sbp	sbp	PROPN
bjp-25731	179	12	of	of	ADP
bjp-25731	179	13	shr	shr	PROPN
bjp-25731	179	14	rats	rat	NOUN
bjp-25731	179	15	during	during	ADP
bjp-25731	179	16	the	the	DET
bjp-25731	179	17	32	32	NUM
bjp-25731	179	18	week	week	NOUN
bjp-25731	179	19	treatment	treatment	NOUN
bjp-25731	179	20	period	period	NOUN
bjp-25731	179	21	(	(	PUNCT
bjp-25731	179	22	magyar	magyar	PROPN
bjp-25731	179	23	et	et	PROPN
bjp-25731	179	24	al	al	PROPN
bjp-25731	179	25	.	.	PROPN
bjp-25731	179	26	,	,	PUNCT
bjp-25731	179	27	2014	2014	NUM
bjp-25731	179	28	)	)	PUNCT
bjp-25731	179	29	.	.	PUNCT
bjp-25731	180	1	melanin	melanin	NOUN
bjp-25731	180	2	-	-	PUNCT
bjp-25731	180	3	concentrating	concentrate	VERB
bjp-25731	180	4	hormone	hormone	NOUN
bjp-25731	180	5	receptor	receptor	NOUN
bjp-25731	180	6	1	1	NUM
bjp-25731	180	7	antagonists	antagonist	NOUN
bjp-25731	180	8	obesity	obesity	NOUN
bjp-25731	180	9	is	be	AUX
bjp-25731	180	10	a	a	DET
bjp-25731	180	11	chronic	chronic	ADJ
bjp-25731	180	12	universal	universal	ADJ
bjp-25731	180	13	epidemic	epidemic	NOUN
bjp-25731	180	14	disease	disease	NOUN
bjp-25731	180	15	(	(	PUNCT
bjp-25731	180	16	pokin	pokin	NOUN
bjp-25731	180	17	et	et	PROPN
bjp-25731	180	18	al	al	PROPN
bjp-25731	180	19	.	.	PROPN
bjp-25731	180	20	,	,	PUNCT
bjp-25731	180	21	2012	2012	NUM
bjp-25731	180	22	)	)	PUNCT
bjp-25731	180	23	which	which	PRON
bjp-25731	180	24	affects	affect	VERB
bjp-25731	180	25	a	a	DET
bjp-25731	180	26	large	large	ADJ
bjp-25731	180	27	number	number	NOUN
bjp-25731	180	28	of	of	ADP
bjp-25731	180	29	people	people	NOUN
bjp-25731	180	30	globally	globally	ADV
bjp-25731	180	31	.	.	PUNCT
bjp-25731	181	1	over	over	ADP
bjp-25731	181	2	the	the	DET
bjp-25731	181	3	past	past	ADJ
bjp-25731	181	4	30	30	NUM
bjp-25731	181	5	years	year	NOUN
bjp-25731	181	6	in	in	ADP
bjp-25731	181	7	united	united	PROPN
bjp-25731	181	8	states	states	PROPN
bjp-25731	181	9	;	;	PUNCT
bjp-25731	181	10	60	60	NUM
bjp-25731	181	11	%	%	NOUN
bjp-25731	181	12	of	of	ADP
bjp-25731	181	13	adults	adult	NOUN
bjp-25731	181	14	are	be	AUX
bjp-25731	181	15	currently	currently	ADV
bjp-25731	181	16	either	either	CCONJ
bjp-25731	181	17	obese	obese	ADJ
bjp-25731	181	18	or	or	CCONJ
bjp-25731	181	19	overweight	overweight	ADJ
bjp-25731	181	20	(	(	PUNCT
bjp-25731	181	21	hurt	hurt	VERB
bjp-25731	181	22	et	et	PROPN
bjp-25731	181	23	al	al	PROPN
bjp-25731	181	24	.	.	PROPN
bjp-25731	181	25	,	,	PUNCT
bjp-25731	181	26	2010	2010	NUM
bjp-25731	181	27	)	)	PUNCT
bjp-25731	181	28	.	.	PUNCT
bjp-25731	182	1	based	base	VERB
bjp-25731	182	2	on	on	ADP
bjp-25731	182	3	recent	recent	ADJ
bjp-25731	182	4	national	national	ADJ
bjp-25731	182	5	health	health	NOUN
bjp-25731	182	6	and	and	CCONJ
bjp-25731	182	7	nutrition	nutrition	NOUN
bjp-25731	182	8	examination	examination	NOUN
bjp-25731	182	9	survey	survey	NOUN
bjp-25731	182	10	,	,	PUNCT
bjp-25731	182	11	it	it	PRON
bjp-25731	182	12	was	be	AUX
bjp-25731	182	13	established	establish	VERB
bjp-25731	182	14	that	that	ADV
bjp-25731	182	15	great	great	ADJ
bjp-25731	182	16	than	than	ADP
bjp-25731	182	17	one	one	NUM
bjp-25731	182	18	-	-	PUNCT
bjp-25731	182	19	third	third	NOUN
bjp-25731	182	20	of	of	ADP
bjp-25731	182	21	the	the	DET
bjp-25731	182	22	adults	adult	NOUN
bjp-25731	182	23	(	(	PUNCT
bjp-25731	182	24	36	36	NUM
bjp-25731	182	25	%	%	NOUN
bjp-25731	182	26	)	)	PUNCT
bjp-25731	182	27	population	population	NOUN
bjp-25731	182	28	in	in	ADP
bjp-25731	182	29	us	we	PRON
bjp-25731	182	30	are	be	AUX
bjp-25731	182	31	obese	obese	ADJ
bjp-25731	182	32	due	due	ADJ
bjp-25731	182	33	to	to	ADP
bjp-25731	182	34	body	body	NOUN
bjp-25731	182	35	mass	mass	NOUN
bjp-25731	182	36	index	index	NOUN
bjp-25731	182	37	(	(	PUNCT
bjp-25731	182	38	bmi	bmi	PROPN
bjp-25731	182	39	)	)	PUNCT
bjp-25731	182	40	above	above	ADP
bjp-25731	182	41	30	30	NUM
bjp-25731	182	42	kg	kg	NOUN
bjp-25731	182	43	/	/	SYM
bjp-25731	182	44	m2	m2	PROPN
bjp-25731	182	45	(	(	PUNCT
bjp-25731	182	46	högberg	högberg	PROPN
bjp-25731	182	47	et	et	PROPN
bjp-25731	182	48	al	al	PROPN
bjp-25731	182	49	.	.	PROPN
bjp-25731	182	50	,	,	PUNCT
bjp-25731	182	51	2012	2012	NUM
bjp-25731	182	52	)	)	PUNCT
bjp-25731	182	53	.	.	PUNCT
bjp-25731	183	1	melanin	melanin	NOUN
bjp-25731	183	2	-	-	PUNCT
bjp-25731	183	3	concentrating	concentrate	VERB
bjp-25731	183	4	hormone	hormone	NOUN
bjp-25731	183	5	(	(	PUNCT
bjp-25731	183	6	mch	mch	PROPN
bjp-25731	183	7	)	)	PUNCT
bjp-25731	183	8	is	be	AUX
bjp-25731	183	9	a	a	DET
bjp-25731	183	10	crucial	crucial	ADJ
bjp-25731	183	11	mediator	mediator	NOUN
bjp-25731	183	12	of	of	ADP
bjp-25731	183	13	energy	energy	NOUN
bjp-25731	183	14	figure	figure	NOUN
bjp-25731	183	15	12	12	NUM
bjp-25731	183	16	:	:	PUNCT
bjp-25731	183	17	selected	select	VERB
bjp-25731	183	18	quinazoline	quinazoline	ADJ
bjp-25731	183	19	motifs	motif	NOUN
bjp-25731	183	20	with	with	ADP
bjp-25731	183	21	notable	notable	ADJ
bjp-25731	183	22	pde	pde	NOUN
bjp-25731	183	23	inhibitory	inhibitory	ADJ
bjp-25731	183	24	efficiency	efficiency	NOUN
bjp-25731	183	25	figure	figure	NOUN
bjp-25731	183	26	13	13	NUM
bjp-25731	183	27	:	:	PUNCT
bjp-25731	183	28	sbp	sbp	NOUN
bjp-25731	183	29	values	value	NOUN
bjp-25731	183	30	of	of	ADP
bjp-25731	183	31	normotensive	normotensive	NOUN
bjp-25731	183	32	(	(	PUNCT
bjp-25731	183	33	wky	wky	VERB
bjp-25731	183	34	-	-	PUNCT
bjp-25731	183	35	c	c	NOUN
bjp-25731	183	36	,	,	PUNCT
bjp-25731	183	37	wky	wky	ADJ
bjp-25731	183	38	-	-	PUNCT
bjp-25731	183	39	l	l	NOUN
bjp-25731	183	40	)	)	PUNCT
bjp-25731	183	41	and	and	CCONJ
bjp-25731	183	42	hypertensive	hypertensive	ADJ
bjp-25731	183	43	(	(	PUNCT
bjp-25731	183	44	shr	shr	PROPN
bjp-25731	183	45	-	-	PUNCT
bjp-25731	183	46	c	c	PROPN
bjp-25731	183	47	,	,	PUNCT
bjp-25731	183	48	shr	shr	PROPN
bjp-25731	183	49	-	-	PUNCT
bjp-25731	183	50	l	l	NOUN
bjp-25731	183	51	)	)	PUNCT
bjp-25731	183	52	rats	rat	NOUN
bjp-25731	183	53	.	.	PUNCT
bjp-25731	184	1	values	value	NOUN
bjp-25731	184	2	are	be	AUX
bjp-25731	184	3	means	mean	VERB
bjp-25731	184	4	±	±	NUM
bjp-25731	184	5	sem	sem	NOUN
bjp-25731	184	6	.	.	PUNCT
bjp-25731	185	1	*	*	PUNCT
bjp-25731	185	2	p<0.05	p<0.05	PROPN
bjp-25731	185	3	(	(	PUNCT
bjp-25731	185	4	magyar	magyar	PROPN
bjp-25731	185	5	et	et	PROPN
bjp-25731	185	6	al	al	PROPN
bjp-25731	185	7	.	.	PROPN
bjp-25731	185	8	,	,	PUNCT
bjp-25731	185	9	2014	2014	NUM
bjp-25731	185	10	)	)	PUNCT
bjp-25731	185	11	shr	shr	PROPN
bjp-25731	185	12	shr	shr	PROPN
bjp-25731	185	13	-	-	PUNCT
bjp-25731	185	14	l	l	NOUN
bjp-25731	185	15	wky	wky	ADJ
bjp-25731	185	16	wky	wky	ADJ
bjp-25731	185	17	-	-	PUNCT
bjp-25731	185	18	l	l	NOUN
bjp-25731	185	19	s	s	NOUN
bjp-25731	185	20	ys	ys	NOUN
bjp-25731	185	21	to	to	ADP
bjp-25731	185	22	lic	lic	PROPN
bjp-25731	185	23	b	b	PROPN
bjp-25731	186	1	lo	lo	PROPN
bjp-25731	187	1	od	od	PROPN
bjp-25731	187	2	p	p	PROPN
bjp-25731	187	3	re	re	VERB
bjp-25731	187	4	ss	ss	INTJ
bjp-25731	187	5	ur	ur	INTJ
bjp-25731	187	6	e	e	PROPN
bjp-25731	187	7	(	(	PUNCT
bjp-25731	187	8	h	h	NOUN
bjp-25731	187	9	gm	gm	PROPN
bjp-25731	187	10	m	m	NOUN
bjp-25731	187	11	)	)	PUNCT
bjp-25731	187	12	260	260	NUM
bjp-25731	187	13	240	240	NUM
bjp-25731	187	14	220	220	NUM
bjp-25731	187	15	200	200	NUM
bjp-25731	187	16	180	180	NUM
bjp-25731	187	17	160	160	NUM
bjp-25731	187	18	140	140	NUM
bjp-25731	187	19	120	120	NUM
bjp-25731	187	20	100	100	NUM
bjp-25731	187	21	5	5	NUM
bjp-25731	187	22	10	10	NUM
bjp-25731	187	23	15	15	NUM
bjp-25731	187	24	20	20	NUM
bjp-25731	187	25	25	25	NUM
bjp-25731	187	26	30	30	NUM
bjp-25731	187	27	35	35	NUM
bjp-25731	187	28	40	40	NUM
bjp-25731	187	29	45	45	NUM
bjp-25731	187	30	age	age	NOUN
bjp-25731	187	31	(	(	PUNCT
bjp-25731	187	32	weeks	week	NOUN
bjp-25731	187	33	)	)	PUNCT
bjp-25731	187	34	bangladesh	bangladesh	NOUN
bjp-25731	187	35	j	j	PROPN
bjp-25731	187	36	pharmacol	pharmacol	PROPN
bjp-25731	187	37	2016	2016	NUM
bjp-25731	187	38	;	;	PUNCT
bjp-25731	187	39	11	11	NUM
bjp-25731	187	40	:	:	PUNCT
bjp-25731	187	41	716	716	NUM
bjp-25731	187	42	-	-	SYM
bjp-25731	187	43	733	733	NUM
bjp-25731	187	44	725	725	NUM
bjp-25731	187	45	homeostasis	homeostasis	NOUN
bjp-25731	187	46	(	(	PUNCT
bjp-25731	187	47	jeon	jeon	NOUN
bjp-25731	187	48	and	and	CCONJ
bjp-25731	187	49	cheon	cheon	PROPN
bjp-25731	187	50	,	,	PUNCT
bjp-25731	187	51	2009	2009	NUM
bjp-25731	187	52	)	)	PUNCT
bjp-25731	187	53	which	which	PRON
bjp-25731	187	54	stimulates	stimulate	VERB
bjp-25731	187	55	ingested	ingest	VERB
bjp-25731	187	56	food	food	NOUN
bjp-25731	187	57	in	in	ADP
bjp-25731	187	58	mice	mouse	NOUN
bjp-25731	187	59	upon	upon	SCONJ
bjp-25731	187	60	intra	intra	ADJ
bjp-25731	187	61	cerebro	cerebro	PROPN
bjp-25731	187	62	-	-	PUNCT
bjp-25731	187	63	ventricular	ventricular	NOUN
bjp-25731	187	64	(	(	PUNCT
bjp-25731	187	65	icv	icv	PROPN
bjp-25731	187	66	)	)	PUNCT
bjp-25731	187	67	injection	injection	NOUN
bjp-25731	187	68	.	.	PUNCT
bjp-25731	188	1	hence	hence	ADV
bjp-25731	188	2	,	,	PUNCT
bjp-25731	188	3	melanin	melanin	NOUN
bjp-25731	188	4	-	-	PUNCT
bjp-25731	188	5	concentrating	concentrate	VERB
bjp-25731	188	6	hormone	hormone	NOUN
bjp-25731	188	7	receptor	receptor	NOUN
bjp-25731	188	8	1	1	NUM
bjp-25731	188	9	(	(	PUNCT
bjp-25731	188	10	mchr1	mchr1	NOUN
bjp-25731	188	11	)	)	PUNCT
bjp-25731	188	12	antagonist	antagonist	NOUN
bjp-25731	188	13	was	be	AUX
bjp-25731	188	14	reported	report	VERB
bjp-25731	188	15	to	to	PART
bjp-25731	188	16	be	be	AUX
bjp-25731	188	17	a	a	DET
bjp-25731	188	18	viable	viable	ADJ
bjp-25731	188	19	option	option	NOUN
bjp-25731	188	20	for	for	ADP
bjp-25731	188	21	the	the	DET
bjp-25731	188	22	treatment	treatment	NOUN
bjp-25731	188	23	of	of	ADP
bjp-25731	188	24	obesity	obesity	NOUN
bjp-25731	188	25	(	(	PUNCT
bjp-25731	188	26	högberg	högberg	PROPN
bjp-25731	188	27	et	et	PROPN
bjp-25731	188	28	al	al	PROPN
bjp-25731	188	29	.	.	PROPN
bjp-25731	188	30	,	,	PUNCT
bjp-25731	188	31	2012	2012	NUM
bjp-25731	188	32	)	)	PUNCT
bjp-25731	188	33	.	.	PUNCT
bjp-25731	189	1	melanin	melanin	NOUN
bjp-25731	189	2	-	-	PUNCT
bjp-25731	189	3	concentrating	concentrate	VERB
bjp-25731	189	4	hormone	hormone	NOUN
bjp-25731	189	5	receptor	receptor	NOUN
bjp-25731	189	6	1	1	NUM
bjp-25731	189	7	(	(	PUNCT
bjp-25731	189	8	mchr1	mchr1	NOUN
bjp-25731	189	9	)	)	PUNCT
bjp-25731	189	10	antagonising	antagonise	VERB
bjp-25731	189	11	quinazoline	quinazoline	ADJ
bjp-25731	189	12	derivatives	derivative	NOUN
bjp-25731	189	13	were	be	AUX
bjp-25731	189	14	authenticated	authenticate	VERB
bjp-25731	189	15	to	to	PART
bjp-25731	189	16	exhibit	exhibit	VERB
bjp-25731	189	17	remarkable	remarkable	ADJ
bjp-25731	189	18	and	and	CCONJ
bjp-25731	189	19	significant	significant	ADJ
bjp-25731	189	20	antiobesity	antiobesity	NOUN
bjp-25731	189	21	properties	property	NOUN
bjp-25731	189	22	(	(	PUNCT
bjp-25731	189	23	sasmal	sasmal	NOUN
bjp-25731	189	24	et	et	NOUN
bjp-25731	189	25	al	al	PROPN
bjp-25731	189	26	.	.	PROPN
bjp-25731	189	27	,	,	PUNCT
bjp-25731	189	28	2012	2012	NUM
bjp-25731	189	29	)	)	PUNCT
bjp-25731	189	30	.	.	PUNCT
bjp-25731	190	1	pharmacokinetic	pharmacokinetic	ADJ
bjp-25731	190	2	profile	profile	NOUN
bjp-25731	190	3	showed	show	VERB
bjp-25731	190	4	that	that	DET
bjp-25731	190	5	oral	oral	ADJ
bjp-25731	190	6	administration	administration	NOUN
bjp-25731	190	7	of	of	ADP
bjp-25731	190	8	30	30	NUM
bjp-25731	190	9	mg	mg	PROPN
bjp-25731	190	10	/	/	SYM
bjp-25731	190	11	kg	kg	NOUN
bjp-25731	190	12	b.i.d	b.i.d	PROPN
bjp-25731	190	13	.	.	PUNCT
bjp-25731	191	1	of	of	ADP
bjp-25731	191	2	4	4	NUM
bjp-25731	191	3	-	-	PUNCT
bjp-25731	191	4	morpholinyl	morpholinyl	NOUN
bjp-25731	191	5	quinazoline	quinazoline	NOUN
bjp-25731	191	6	led	lead	VERB
bjp-25731	191	7	to	to	ADP
bjp-25731	191	8	12	12	NUM
bjp-25731	191	9	%	%	NOUN
bjp-25731	191	10	weight	weight	NOUN
bjp-25731	191	11	reduction	reduction	NOUN
bjp-25731	191	12	within	within	ADP
bjp-25731	191	13	fourteen	fourteen	NUM
bjp-25731	191	14	days	day	NOUN
bjp-25731	191	15	in	in	ADP
bjp-25731	191	16	dioc57bl/6	dioc57bl/6	PROPN
bjp-25731	191	17	j	j	PROPN
bjp-25731	191	18	mice	mouse	NOUN
bjp-25731	191	19	.	.	PUNCT
bjp-25731	192	1	4	4	NUM
bjp-25731	192	2	-	-	PUNCT
bjp-25731	192	3	amino-2	amino-2	NUM
bjp-25731	192	4	-	-	PUNCT
bjp-25731	192	5	cyclohexyl	cyclohexyl	NOUN
bjp-25731	192	6	aminoquinazoline	aminoquinazoline	NOUN
bjp-25731	192	7	and	and	CCONJ
bjp-25731	192	8	4dimethylaminoquinazoline	4dimethylaminoquinazoline	NUM
bjp-25731	192	9	were	be	AUX
bjp-25731	192	10	reported	report	VERB
bjp-25731	192	11	to	to	PART
bjp-25731	192	12	exhibit	exhibit	VERB
bjp-25731	192	13	highly	highly	ADV
bjp-25731	192	14	promising	promising	ADJ
bjp-25731	192	15	anti	anti	ADJ
bjp-25731	192	16	-	-	NOUN
bjp-25731	192	17	obesity	obesity	NOUN
bjp-25731	192	18	for	for	ADP
bjp-25731	192	19	suitable	suitable	ADJ
bjp-25731	192	20	weight	weight	NOUN
bjp-25731	192	21	loss	loss	NOUN
bjp-25731	192	22	programme	programme	NOUN
bjp-25731	192	23	due	due	ADP
bjp-25731	192	24	to	to	ADP
bjp-25731	192	25	their	their	PRON
bjp-25731	192	26	good	good	ADJ
bjp-25731	192	27	affinity	affinity	NOUN
bjp-25731	192	28	for	for	ADP
bjp-25731	192	29	human	human	ADJ
bjp-25731	192	30	mchr1	mchr1	NOUN
bjp-25731	193	1	(	(	PUNCT
bjp-25731	193	2	kanuma	kanuma	ADV
bjp-25731	193	3	et	et	PROPN
bjp-25731	193	4	al	al	PROPN
bjp-25731	193	5	.	.	PROPN
bjp-25731	193	6	,	,	PUNCT
bjp-25731	193	7	2005	2005	NUM
bjp-25731	193	8	)	)	PUNCT
bjp-25731	193	9	.	.	PUNCT
bjp-25731	194	1	cathepsin	cathepsin	VERB
bjp-25731	194	2	inhibitory	inhibitory	ADJ
bjp-25731	194	3	activity	activity	NOUN
bjp-25731	194	4	bischalcones	bischalcone	NOUN
bjp-25731	194	5	containing	contain	VERB
bjp-25731	194	6	2(1h)-quinazolinones	2(1h)-quinazolinones	NUM
bjp-25731	194	7	and	and	CCONJ
bjp-25731	194	8	2	2	NUM
bjp-25731	194	9	(	(	PUNCT
bjp-25731	194	10	1h)-quinazolinethiones	1h)-quinazolinethiones	NUM
bjp-25731	194	11	analogs	analog	NOUN
bjp-25731	194	12	were	be	AUX
bjp-25731	194	13	designed	design	VERB
bjp-25731	194	14	and	and	CCONJ
bjp-25731	194	15	evaluated	evaluate	VERB
bjp-25731	194	16	for	for	ADP
bjp-25731	194	17	inhibitory	inhibitory	ADJ
bjp-25731	194	18	potential	potential	NOUN
bjp-25731	194	19	(	(	PUNCT
bjp-25731	194	20	khan	khan	PROPN
bjp-25731	194	21	et	et	PROPN
bjp-25731	194	22	al	al	PROPN
bjp-25731	194	23	.	.	PROPN
bjp-25731	194	24	,	,	PUNCT
bjp-25731	194	25	2015	2015	NUM
bjp-25731	194	26	)	)	PUNCT
bjp-25731	194	27	against	against	ADP
bjp-25731	194	28	cathepsin	cathepsin	NOUN
bjp-25731	194	29	b	b	PROPN
bjp-25731	194	30	and	and	CCONJ
bjp-25731	194	31	cathepsin	cathepsin	PROPN
bjp-25731	194	32	h	h	NOUN
bjp-25731	194	33	(	(	PUNCT
bjp-25731	194	34	raghav	raghav	PROPN
bjp-25731	194	35	and	and	CCONJ
bjp-25731	194	36	singh	singh	PROPN
bjp-25731	194	37	,	,	PUNCT
bjp-25731	194	38	2014	2014	NUM
bjp-25731	194	39	)	)	PUNCT
bjp-25731	194	40	.	.	PUNCT
bjp-25731	195	1	it	it	PRON
bjp-25731	195	2	was	be	AUX
bjp-25731	195	3	found	find	VERB
bjp-25731	195	4	that	that	SCONJ
bjp-25731	195	5	26a	26a	NOUN
bjp-25731	195	6	(	(	PUNCT
bjp-25731	195	7	x	x	SYM
bjp-25731	195	8	=	=	SYM
bjp-25731	195	9	o	o	NOUN
bjp-25731	195	10	)	)	PUNCT
bjp-25731	195	11	showed	show	VERB
bjp-25731	195	12	maximum	maximum	ADJ
bjp-25731	195	13	inhibition	inhibition	NOUN
bjp-25731	195	14	at	at	ADP
bjp-25731	195	15	0.1	0.1	NUM
bjp-25731	195	16	nm	nm	NOUN
bjp-25731	195	17	while	while	SCONJ
bjp-25731	195	18	the	the	DET
bjp-25731	195	19	thione	thione	ADJ
bjp-25731	195	20	analog	analog	NOUN
bjp-25731	195	21	26b	26b	NOUN
bjp-25731	195	22	(	(	PUNCT
bjp-25731	195	23	x	x	SYM
bjp-25731	195	24	=	=	SYM
bjp-25731	195	25	s	s	X
bjp-25731	195	26	)	)	PUNCT
bjp-25731	195	27	showed	show	VERB
bjp-25731	195	28	maximum	maximum	ADJ
bjp-25731	195	29	inhibition	inhibition	NOUN
bjp-25731	195	30	at	at	ADP
bjp-25731	195	31	0.05	0.05	NUM
bjp-25731	195	32	nm	nm	NOUN
bjp-25731	195	33	which	which	PRON
bjp-25731	195	34	was	be	AUX
bjp-25731	195	35	2	2	NUM
bjp-25731	195	36	-	-	NOUN
bjp-25731	195	37	fold	fold	VERB
bjp-25731	195	38	more	more	ADV
bjp-25731	195	39	active	active	ADJ
bjp-25731	195	40	than	than	ADP
bjp-25731	195	41	79	79	NUM
bjp-25731	195	42	(	(	PUNCT
bjp-25731	195	43	raghav	raghav	PROPN
bjp-25731	195	44	and	and	CCONJ
bjp-25731	195	45	singh	singh	PROPN
bjp-25731	195	46	,	,	PUNCT
bjp-25731	195	47	2014	2014	NUM
bjp-25731	195	48	)	)	PUNCT
bjp-25731	195	49	.	.	PUNCT
bjp-25731	196	1	among	among	ADP
bjp-25731	196	2	quinazoline	quinazoline	NOUN
bjp-25731	196	3	derivatives	derivative	NOUN
bjp-25731	196	4	,	,	PUNCT
bjp-25731	196	5	2,6	2,6	NUM
bjp-25731	196	6	-	-	NOUN
bjp-25731	196	7	bis(4’(dimethylamino)benzylidene)cyclohexanone	bis(4’(dimethylamino)benzylidene)cyclohexanone	NOUN
bjp-25731	196	8	27a	27a	NOUN
bjp-25731	196	9	(	(	PUNCT
bjp-25731	196	10	x	x	SYM
bjp-25731	196	11	=	=	SYM
bjp-25731	196	12	o	o	NOUN
bjp-25731	196	13	)	)	PUNCT
bjp-25731	196	14	was	be	AUX
bjp-25731	196	15	found	find	VERB
bjp-25731	196	16	to	to	PART
bjp-25731	196	17	exhibit	exhibit	VERB
bjp-25731	196	18	100	100	NUM
bjp-25731	196	19	%	%	NOUN
bjp-25731	196	20	inhibition	inhibition	NOUN
bjp-25731	196	21	at	at	ADP
bjp-25731	196	22	0.1	0.1	NUM
bjp-25731	196	23	nm	nm	NOUN
bjp-25731	196	24	which	which	PRON
bjp-25731	196	25	was	be	AUX
bjp-25731	196	26	four	four	NUM
bjp-25731	196	27	times	time	NOUN
bjp-25731	196	28	more	more	ADV
bjp-25731	196	29	active	active	ADJ
bjp-25731	196	30	than	than	ADP
bjp-25731	196	31	the	the	DET
bjp-25731	196	32	thione	thione	ADJ
bjp-25731	196	33	counterpart	counterpart	NOUN
bjp-25731	196	34	27b	27b	NOUN
bjp-25731	196	35	(	(	PUNCT
bjp-25731	196	36	x	x	SYM
bjp-25731	196	37	=	=	SYM
bjp-25731	196	38	s	s	X
bjp-25731	196	39	)	)	PUNCT
bjp-25731	196	40	with	with	ADP
bjp-25731	196	41	maximum	maximum	ADJ
bjp-25731	196	42	inhibition	inhibition	NOUN
bjp-25731	196	43	of	of	ADP
bjp-25731	196	44	0.025	0.025	NUM
bjp-25731	196	45	nm	nm	NOUN
bjp-25731	196	46	(	(	PUNCT
bjp-25731	196	47	figure	figure	NOUN
bjp-25731	196	48	14	14	NUM
bjp-25731	196	49	)	)	PUNCT
bjp-25731	196	50	.	.	PUNCT
bjp-25731	197	1	antibacterial	antibacterial	ADJ
bjp-25731	197	2	activity	activity	NOUN
bjp-25731	197	3	bacterial	bacterial	ADJ
bjp-25731	197	4	resistance	resistance	NOUN
bjp-25731	197	5	to	to	ADP
bjp-25731	197	6	existing	exist	VERB
bjp-25731	197	7	drugs	drug	NOUN
bjp-25731	197	8	is	be	AUX
bjp-25731	197	9	a	a	DET
bjp-25731	197	10	growing	grow	VERB
bjp-25731	197	11	problem	problem	NOUN
bjp-25731	197	12	in	in	ADP
bjp-25731	197	13	the	the	DET
bjp-25731	197	14	world	world	NOUN
bjp-25731	197	15	.	.	PUNCT
bjp-25731	198	1	considerable	considerable	ADJ
bjp-25731	198	2	researches	research	NOUN
bjp-25731	198	3	have	have	AUX
bjp-25731	198	4	been	be	AUX
bjp-25731	198	5	performed	perform	VERB
bjp-25731	198	6	on	on	ADP
bjp-25731	198	7	the	the	DET
bjp-25731	198	8	synthesis	synthesis	NOUN
bjp-25731	198	9	of	of	ADP
bjp-25731	198	10	new	new	ADJ
bjp-25731	198	11	quinazolinone	quinazolinone	NOUN
bjp-25731	198	12	derivatives	derivative	NOUN
bjp-25731	198	13	with	with	ADP
bjp-25731	198	14	potent	potent	ADJ
bjp-25731	198	15	antibacterial	antibacterial	ADJ
bjp-25731	198	16	activity	activity	NOUN
bjp-25731	198	17	against	against	ADP
bjp-25731	198	18	the	the	DET
bjp-25731	198	19	gram	gram	NOUN
bjp-25731	198	20	+	+	PROPN
bjp-25731	198	21	ve	ve	NOUN
bjp-25731	198	22	bacteria	bacteria	NOUN
bjp-25731	198	23	via	via	ADP
bjp-25731	198	24	the	the	DET
bjp-25731	198	25	way	way	NOUN
bjp-25731	198	26	they	they	PRON
bjp-25731	198	27	interact	interact	VERB
bjp-25731	198	28	within	within	ADP
bjp-25731	198	29	the	the	DET
bjp-25731	198	30	cell	cell	NOUN
bjp-25731	198	31	wall	wall	NOUN
bjp-25731	198	32	and	and	CCONJ
bjp-25731	198	33	dna	dna	PROPN
bjp-25731	198	34	cores	core	NOUN
bjp-25731	198	35	(	(	PUNCT
bjp-25731	198	36	mohamed	mohamed	PROPN
bjp-25731	198	37	et	et	PROPN
bjp-25731	198	38	al	al	PROPN
bjp-25731	198	39	.	.	PROPN
bjp-25731	198	40	,	,	PUNCT
bjp-25731	198	41	2013	2013	NUM
bjp-25731	198	42	)	)	PUNCT
bjp-25731	198	43	.	.	PUNCT
bjp-25731	199	1	from	from	ADP
bjp-25731	199	2	valuable	valuable	ADJ
bjp-25731	199	3	information	information	NOUN
bjp-25731	199	4	gathered	gather	VERB
bjp-25731	199	5	by	by	ADP
bjp-25731	199	6	a	a	DET
bjp-25731	199	7	previous	previous	ADJ
bjp-25731	199	8	review	review	NOUN
bjp-25731	199	9	,	,	PUNCT
bjp-25731	199	10	structure	structure	NOUN
bjp-25731	199	11	activity	activity	NOUN
bjp-25731	199	12	relationship	relationship	NOUN
bjp-25731	199	13	studies	study	NOUN
bjp-25731	199	14	of	of	ADP
bjp-25731	199	15	quinazolinone	quinazolinone	NOUN
bjp-25731	199	16	derivatives	derivative	NOUN
bjp-25731	199	17	in	in	ADP
bjp-25731	199	18	various	various	ADJ
bjp-25731	199	19	literatures	literature	NOUN
bjp-25731	199	20	have	have	AUX
bjp-25731	199	21	revealed	reveal	VERB
bjp-25731	199	22	that	that	SCONJ
bjp-25731	199	23	substitution	substitution	NOUN
bjp-25731	199	24	at	at	ADP
bjp-25731	199	25	positions	position	NOUN
bjp-25731	199	26	2	2	NUM
bjp-25731	199	27	and	and	CCONJ
bjp-25731	199	28	3	3	NUM
bjp-25731	199	29	,	,	PUNCT
bjp-25731	199	30	existence	existence	NOUN
bjp-25731	199	31	of	of	ADP
bjp-25731	199	32	halogen	halogen	NOUN
bjp-25731	199	33	atom	atom	NOUN
bjp-25731	199	34	at	at	ADP
bjp-25731	199	35	6	6	NUM
bjp-25731	199	36	and	and	CCONJ
bjp-25731	199	37	8	8	NUM
bjp-25731	199	38	positions	position	NOUN
bjp-25731	199	39	and	and	CCONJ
bjp-25731	199	40	substitution	substitution	NOUN
bjp-25731	199	41	(	(	PUNCT
bjp-25731	199	42	mainly	mainly	ADV
bjp-25731	199	43	amine	amine	ADJ
bjp-25731	199	44	or	or	CCONJ
bjp-25731	199	45	substituted	substitute	VERB
bjp-25731	199	46	amine	amine	NOUN
bjp-25731	199	47	)	)	PUNCT
bjp-25731	199	48	at	at	ADP
bjp-25731	199	49	4th	4th	ADJ
bjp-25731	199	50	position	position	NOUN
bjp-25731	199	51	of	of	ADP
bjp-25731	199	52	the	the	DET
bjp-25731	199	53	quinazolinone	quinazolinone	NOUN
bjp-25731	199	54	ring	ring	NOUN
bjp-25731	199	55	can	can	AUX
bjp-25731	199	56	improve	improve	VERB
bjp-25731	199	57	their	their	PRON
bjp-25731	199	58	antimicrobial	antimicrobial	ADJ
bjp-25731	199	59	activities	activity	NOUN
bjp-25731	199	60	(	(	PUNCT
bjp-25731	199	61	jafari	jafari	PROPN
bjp-25731	199	62	et	et	PROPN
bjp-25731	199	63	al	al	PROPN
bjp-25731	199	64	.	.	PROPN
bjp-25731	199	65	,	,	PUNCT
bjp-25731	199	66	2016	2016	NUM
bjp-25731	199	67	)	)	PUNCT
bjp-25731	199	68	.	.	PUNCT
bjp-25731	200	1	for	for	ADP
bjp-25731	200	2	instance	instance	NOUN
bjp-25731	200	3	,	,	PUNCT
bjp-25731	200	4	the	the	DET
bjp-25731	200	5	primary	primary	NOUN
bjp-25731	200	6	in	in	ADP
bjp-25731	200	7	vitro	vitro	X
bjp-25731	200	8	bioassay	bioassay	NOUN
bjp-25731	200	9	at	at	ADP
bjp-25731	200	10	100	100	NUM
bjp-25731	200	11	mg	mg	NOUN
bjp-25731	200	12	/	/	SYM
bjp-25731	200	13	ml	ml	X
bjp-25731	200	14	against	against	ADP
bjp-25731	200	15	tobacco	tobacco	NOUN
bjp-25731	200	16	and	and	CCONJ
bjp-25731	200	17	tomato	tomato	NOUN
bjp-25731	200	18	bacterial	bacterial	ADJ
bjp-25731	200	19	wilt	wilt	NOUN
bjp-25731	200	20	revealed	reveal	VERB
bjp-25731	200	21	2,3	2,3	NUM
bjp-25731	200	22	-	-	PUNCT
bjp-25731	200	23	disubstituted	disubstitute	VERB
bjp-25731	200	24	quinazolin-4	quinazolin-4	NOUN
bjp-25731	200	25	-	-	NOUN
bjp-25731	200	26	one	one	NUM
bjp-25731	200	27	28	28	NUM
bjp-25731	201	1	(	(	PUNCT
bjp-25731	201	2	wang	wang	PROPN
bjp-25731	201	3	et	et	PROPN
bjp-25731	201	4	al	al	PROPN
bjp-25731	201	5	.	.	PROPN
bjp-25731	201	6	,	,	PUNCT
bjp-25731	201	7	2014	2014	NUM
bjp-25731	201	8	)	)	PUNCT
bjp-25731	201	9	as	as	ADP
bjp-25731	201	10	strong	strong	ADJ
bjp-25731	201	11	antibacterial	antibacterial	ADJ
bjp-25731	201	12	agents	agent	NOUN
bjp-25731	201	13	using	use	VERB
bjp-25731	201	14	turbidimeter	turbidimeter	ADJ
bjp-25731	201	15	test	test	NOUN
bjp-25731	201	16	(	(	PUNCT
bjp-25731	201	17	wang	wang	PROPN
bjp-25731	201	18	et	et	PROPN
bjp-25731	201	19	al	al	PROPN
bjp-25731	201	20	.	.	PROPN
bjp-25731	201	21	,	,	PUNCT
bjp-25731	201	22	2013	2013	NUM
bjp-25731	201	23	)	)	PUNCT
bjp-25731	201	24	according	accord	VERB
bjp-25731	201	25	to	to	ADP
bjp-25731	201	26	the	the	DET
bjp-25731	201	27	findings	finding	NOUN
bjp-25731	201	28	of	of	ADP
bjp-25731	201	29	liu	liu	PROPN
bjp-25731	201	30	et	et	PROPN
bjp-25731	201	31	al	al	PROPN
bjp-25731	201	32	.	.	PROPN
bjp-25731	202	1	(	(	PUNCT
bjp-25731	202	2	2014	2014	NUM
bjp-25731	202	3	)	)	PUNCT
bjp-25731	202	4	,	,	PUNCT
bjp-25731	202	5	4,6disubstituted	4,6disubstitute	VERB
bjp-25731	202	6	quinazoline	quinazoline	NOUN
bjp-25731	202	7	metabolite	metabolite	NOUN
bjp-25731	202	8	,	,	PUNCT
bjp-25731	202	9	lapatin	lapatin	PROPN
bjp-25731	202	10	b	b	PROPN
bjp-25731	202	11	29	29	NUM
bjp-25731	202	12	showed	show	VERB
bjp-25731	202	13	moderate	moderate	ADJ
bjp-25731	202	14	inhibitory	inhibitory	ADJ
bjp-25731	202	15	activity	activity	NOUN
bjp-25731	202	16	against	against	ADP
bjp-25731	202	17	aquapathogenic	aquapathogenic	ADJ
bjp-25731	202	18	bacteria	bacteria	NOUN
bjp-25731	202	19	vibrio	vibrio	ADJ
bjp-25731	202	20	harveyi	harveyi	NOUN
bjp-25731	202	21	(	(	PUNCT
bjp-25731	202	22	figure	figure	NOUN
bjp-25731	202	23	15	15	NUM
bjp-25731	202	24	)	)	PUNCT
bjp-25731	202	25	.	.	PUNCT
bjp-25731	203	1	antifungal	antifungal	ADJ
bjp-25731	203	2	activity	activity	NOUN
bjp-25731	203	3	three	three	NUM
bjp-25731	203	4	-	-	PUNCT
bjp-25731	203	5	component	component	NOUN
bjp-25731	203	6	design	design	NOUN
bjp-25731	203	7	of	of	ADP
bjp-25731	203	8	quinazolinone	quinazolinone	NOUN
bjp-25731	203	9	scaffolds	scaffold	NOUN
bjp-25731	203	10	bearing	bear	VERB
bjp-25731	203	11	3	3	NUM
bjp-25731	203	12	-	-	PUNCT
bjp-25731	203	13	acrylamino	acrylamino	ADJ
bjp-25731	203	14	side	side	NOUN
bjp-25731	203	15	chain	chain	NOUN
bjp-25731	203	16	was	be	AUX
bjp-25731	203	17	evaluated	evaluate	VERB
bjp-25731	203	18	with	with	ADP
bjp-25731	203	19	the	the	DET
bjp-25731	203	20	aid	aid	NOUN
bjp-25731	203	21	of	of	ADP
bjp-25731	203	22	catalytic	catalytic	ADJ
bjp-25731	203	23	amount	amount	NOUN
bjp-25731	203	24	of	of	ADP
bjp-25731	203	25	ceo2	ceo2	NOUN
bjp-25731	203	26	nanoparticles	nanoparticle	NOUN
bjp-25731	203	27	followed	follow	VERB
bjp-25731	203	28	by	by	ADP
bjp-25731	203	29	in	in	ADP
bjp-25731	203	30	vitro	vitro	X
bjp-25731	203	31	screening	screening	NOUN
bjp-25731	203	32	of	of	ADP
bjp-25731	203	33	the	the	DET
bjp-25731	203	34	targeted	target	VERB
bjp-25731	203	35	quinazolinone	quinazolinone	NOUN
bjp-25731	203	36	for	for	ADP
bjp-25731	203	37	antifungal	antifungal	ADJ
bjp-25731	203	38	potential	potential	NOUN
bjp-25731	203	39	upon	upon	SCONJ
bjp-25731	203	40	selected	select	VERB
bjp-25731	203	41	phytopathogenic	phytopathogenic	ADJ
bjp-25731	203	42	fungi	fungus	NOUN
bjp-25731	203	43	(	(	PUNCT
bjp-25731	203	44	zhang	zhang	X
bjp-25731	203	45	et	et	PROPN
bjp-25731	203	46	al	al	PROPN
bjp-25731	203	47	.	.	PROPN
bjp-25731	203	48	,	,	PUNCT
bjp-25731	203	49	2016	2016	NUM
bjp-25731	203	50	)	)	PUNCT
bjp-25731	203	51	.	.	PUNCT
bjp-25731	204	1	the	the	DET
bjp-25731	204	2	importance	importance	NOUN
bjp-25731	204	3	of	of	ADP
bjp-25731	204	4	amide	amide	NOUN
bjp-25731	204	5	was	be	AUX
bjp-25731	204	6	verified	verify	VERB
bjp-25731	204	7	and	and	CCONJ
bjp-25731	204	8	docking	docking	NOUN
bjp-25731	204	9	study	study	NOUN
bjp-25731	204	10	revealed	reveal	VERB
bjp-25731	204	11	the	the	DET
bjp-25731	204	12	potential	potential	ADJ
bjp-25731	204	13	antifungal	antifungal	ADJ
bjp-25731	204	14	mechanism	mechanism	NOUN
bjp-25731	204	15	of	of	ADP
bjp-25731	204	16	action	action	NOUN
bjp-25731	204	17	of	of	ADP
bjp-25731	204	18	the	the	DET
bjp-25731	204	19	quinazolinone	quinazolinone	NOUN
bjp-25731	204	20	was	be	AUX
bjp-25731	204	21	via	via	ADP
bjp-25731	204	22	chitinase	chitinase	NOUN
bjp-25731	204	23	inhibition	inhibition	NOUN
bjp-25731	204	24	(	(	PUNCT
bjp-25731	204	25	zhang	zhang	PROPN
bjp-25731	204	26	et	et	PROPN
bjp-25731	204	27	al	al	PROPN
bjp-25731	204	28	.	.	PROPN
bjp-25731	204	29	,	,	PUNCT
bjp-25731	204	30	2016	2016	NUM
bjp-25731	204	31	)	)	PUNCT
bjp-25731	204	32	.	.	PUNCT
bjp-25731	205	1	among	among	ADP
bjp-25731	205	2	quinazoline	quinazoline	NOUN
bjp-25731	205	3	examined	examine	VERB
bjp-25731	205	4	upon	upon	SCONJ
bjp-25731	205	5	candida	candida	PROPN
bjp-25731	205	6	,	,	PUNCT
bjp-25731	205	7	aspergillus	aspergillus	NOUN
bjp-25731	205	8	species	specie	NOUN
bjp-25731	205	9	and	and	CCONJ
bjp-25731	205	10	cryptococcus	cryptococcus	PROPN
bjp-25731	205	11	neoformans	neoforman	NOUN
bjp-25731	205	12	,	,	PUNCT
bjp-25731	205	13	most	most	ADJ
bjp-25731	205	14	of	of	ADP
bjp-25731	205	15	5	5	NUM
bjp-25731	205	16	-	-	PUNCT
bjp-25731	205	17	hydroxy	hydroxy	NOUN
bjp-25731	205	18	-	-	PUNCT
bjp-25731	205	19	furo[2,3	furo[2,3	ADJ
bjp-25731	205	20	-f]quinazolines	-f]quinazoline	NOUN
bjp-25731	205	21	showed	show	VERB
bjp-25731	205	22	good	good	ADJ
bjp-25731	205	23	antifungal	antifungal	ADJ
bjp-25731	205	24	activity	activity	NOUN
bjp-25731	205	25	by	by	ADP
bjp-25731	205	26	complete	complete	ADJ
bjp-25731	205	27	inhibition	inhibition	NOUN
bjp-25731	205	28	of	of	ADP
bjp-25731	205	29	the	the	DET
bjp-25731	205	30	growth	growth	NOUN
bjp-25731	205	31	of	of	ADP
bjp-25731	205	32	candida	candida	PROPN
bjp-25731	205	33	figure	figure	NOUN
bjp-25731	205	34	14	14	NUM
bjp-25731	205	35	:	:	PUNCT
bjp-25731	205	36	selected	select	VERB
bjp-25731	205	37	bischalcones	bischalcone	NOUN
bjp-25731	205	38	with	with	ADP
bjp-25731	205	39	cathepsin	cathepsin	NOUN
bjp-25731	205	40	inhibitory	inhibitory	ADJ
bjp-25731	205	41	activity	activity	NOUN
bjp-25731	205	42	figure	figure	NOUN
bjp-25731	205	43	15	15	NUM
bjp-25731	205	44	:	:	PUNCT
bjp-25731	205	45	selected	select	VERB
bjp-25731	205	46	quinazoline	quinazoline	ADJ
bjp-25731	205	47	motifs	motif	NOUN
bjp-25731	205	48	with	with	ADP
bjp-25731	205	49	antibacterial	antibacterial	ADJ
bjp-25731	205	50	activity	activity	NOUN
bjp-25731	205	51	726	726	NUM
bjp-25731	205	52	bangladesh	bangladesh	NOUN
bjp-25731	205	53	j	j	PROPN
bjp-25731	205	54	pharmacol	pharmacol	PROPN
bjp-25731	205	55	2016	2016	NUM
bjp-25731	205	56	;	;	PUNCT
bjp-25731	205	57	11	11	NUM
bjp-25731	205	58	:	:	PUNCT
bjp-25731	205	59	716	716	NUM
bjp-25731	205	60	-	-	SYM
bjp-25731	205	61	733	733	NUM
bjp-25731	205	62	and	and	CCONJ
bjp-25731	205	63	aspergillus	aspergillus	NOUN
bjp-25731	205	64	species	specie	NOUN
bjp-25731	205	65	when	when	SCONJ
bjp-25731	205	66	examined	examine	VERB
bjp-25731	205	67	at	at	ADP
bjp-25731	205	68	the	the	DET
bjp-25731	205	69	mic	mic	ADJ
bjp-25731	205	70	value	value	NOUN
bjp-25731	205	71	12.5	12.5	NUM
bjp-25731	205	72	μg	μg	NOUN
bjp-25731	205	73	/	/	SYM
bjp-25731	205	74	ml	ml	PROPN
bjp-25731	205	75	(	(	PUNCT
bjp-25731	205	76	ryu	ryu	PROPN
bjp-25731	205	77	et	et	PROPN
bjp-25731	205	78	al	al	PROPN
bjp-25731	205	79	.	.	PROPN
bjp-25731	205	80	,	,	PUNCT
bjp-25731	205	81	2012	2012	NUM
bjp-25731	205	82	)	)	PUNCT
bjp-25731	205	83	.	.	PUNCT
bjp-25731	206	1	in	in	ADP
bjp-25731	206	2	another	another	DET
bjp-25731	206	3	study	study	NOUN
bjp-25731	206	4	,	,	PUNCT
bjp-25731	206	5	a	a	DET
bjp-25731	206	6	series	series	NOUN
bjp-25731	206	7	of	of	ADP
bjp-25731	206	8	benzo[h]thiazolo[2,3	benzo[h]thiazolo[2,3	PROPN
bjp-25731	206	9	-	-	PUNCT
bjp-25731	206	10	b]quinazolinone	b]quinazolinone	NOUN
bjp-25731	206	11	designed	design	VERB
bjp-25731	206	12	and	and	CCONJ
bjp-25731	206	13	successfully	successfully	ADV
bjp-25731	206	14	evaluated	evaluate	VERB
bjp-25731	206	15	for	for	ADP
bjp-25731	206	16	their	their	PRON
bjp-25731	206	17	antifungal	antifungal	ADJ
bjp-25731	206	18	activity	activity	NOUN
bjp-25731	206	19	(	(	PUNCT
bjp-25731	206	20	gali	gali	PROPN
bjp-25731	206	21	et	et	PROPN
bjp-25731	206	22	al	al	PROPN
bjp-25731	206	23	.	.	PROPN
bjp-25731	206	24	,	,	PUNCT
bjp-25731	206	25	2014	2014	NUM
bjp-25731	206	26	)	)	PUNCT
bjp-25731	207	1	while	while	SCONJ
bjp-25731	207	2	sar	sar	VERB
bjp-25731	207	3	analysis	analysis	NOUN
bjp-25731	207	4	of	of	ADP
bjp-25731	207	5	some	some	DET
bjp-25731	207	6	tetrazolo	tetrazolo	ADJ
bjp-25731	207	7	[	[	X
bjp-25731	207	8	1,5	1,5	NUM
bjp-25731	207	9	-	-	PUNCT
bjp-25731	207	10	c]quinazoline-5	c]quinazoline-5	NOUN
bjp-25731	207	11	-	-	PUNCT
bjp-25731	207	12	thione	thione	ADJ
bjp-25731	207	13	derivatives	derivative	NOUN
bjp-25731	207	14	for	for	ADP
bjp-25731	207	15	their	their	PRON
bjp-25731	207	16	inhibitory	inhibitory	ADJ
bjp-25731	207	17	activity	activity	NOUN
bjp-25731	207	18	against	against	ADP
bjp-25731	207	19	candida	candida	NOUN
bjp-25731	207	20	albicans	albican	NOUN
bjp-25731	207	21	,	,	PUNCT
bjp-25731	207	22	show	show	VERB
bjp-25731	207	23	them	they	PRON
bjp-25731	207	24	to	to	PART
bjp-25731	207	25	be	be	AUX
bjp-25731	207	26	very	very	ADV
bjp-25731	207	27	potent	potent	ADJ
bjp-25731	207	28	at	at	ADP
bjp-25731	207	29	concentration	concentration	NOUN
bjp-25731	207	30	of	of	ADP
bjp-25731	207	31	100	100	NUM
bjp-25731	207	32	μg	μg	NOUN
bjp-25731	207	33	(	(	PUNCT
bjp-25731	207	34	antypenko	antypenko	PROPN
bjp-25731	207	35	et	et	PROPN
bjp-25731	207	36	al	al	PROPN
bjp-25731	207	37	.	.	PROPN
bjp-25731	207	38	,	,	PUNCT
bjp-25731	207	39	2013	2013	NUM
bjp-25731	207	40	)	)	PUNCT
bjp-25731	207	41	.	.	PUNCT
bjp-25731	208	1	antiviral	antiviral	ADJ
bjp-25731	208	2	activity	activity	NOUN
bjp-25731	208	3	viral	viral	ADJ
bjp-25731	208	4	diseases	disease	NOUN
bjp-25731	208	5	threaten	threaten	VERB
bjp-25731	208	6	latest	late	ADJ
bjp-25731	208	7	therapeutic	therapeutic	ADJ
bjp-25731	208	8	breakthrough	breakthrough	NOUN
bjp-25731	208	9	because	because	SCONJ
bjp-25731	208	10	of	of	ADP
bjp-25731	208	11	high	high	ADJ
bjp-25731	208	12	mutation	mutation	NOUN
bjp-25731	208	13	rates	rate	NOUN
bjp-25731	208	14	found	find	VERB
bjp-25731	208	15	among	among	ADP
bjp-25731	208	16	viruses	virus	NOUN
bjp-25731	208	17	,	,	PUNCT
bjp-25731	208	18	which	which	PRON
bjp-25731	208	19	empower	empower	VERB
bjp-25731	208	20	them	they	PRON
bjp-25731	208	21	to	to	PART
bjp-25731	208	22	escape	escape	VERB
bjp-25731	208	23	immune	immune	ADJ
bjp-25731	208	24	systems	system	NOUN
bjp-25731	208	25	and	and	CCONJ
bjp-25731	208	26	develop	develop	VERB
bjp-25731	208	27	resistance	resistance	NOUN
bjp-25731	208	28	to	to	ADP
bjp-25731	208	29	old	old	ADJ
bjp-25731	208	30	existing	exist	VERB
bjp-25731	208	31	commercially	commercially	ADV
bjp-25731	208	32	available	available	ADJ
bjp-25731	208	33	drugs	drug	NOUN
bjp-25731	208	34	(	(	PUNCT
bjp-25731	208	35	al	al	PROPN
bjp-25731	208	36	-	-	PUNCT
bjp-25731	208	37	salahi	salahi	PROPN
bjp-25731	208	38	et	et	PROPN
bjp-25731	208	39	al	al	PROPN
bjp-25731	208	40	.	.	PROPN
bjp-25731	208	41	,	,	PUNCT
bjp-25731	208	42	2016	2016	NUM
bjp-25731	208	43	;	;	PUNCT
bjp-25731	208	44	jaime	jaime	NOUN
bjp-25731	208	45	et	et	PROPN
bjp-25731	208	46	al	al	PROPN
bjp-25731	208	47	.	.	PROPN
bjp-25731	208	48	,	,	PUNCT
bjp-25731	208	49	2013	2013	NUM
bjp-25731	208	50	)	)	PUNCT
bjp-25731	208	51	.	.	PUNCT
bjp-25731	209	1	benzoquinazoline	benzoquinazoline	NOUN
bjp-25731	209	2	compounds	compound	NOUN
bjp-25731	209	3	have	have	AUX
bjp-25731	209	4	been	be	AUX
bjp-25731	209	5	reported	report	VERB
bjp-25731	209	6	to	to	PART
bjp-25731	209	7	exhibit	exhibit	VERB
bjp-25731	209	8	an	an	DET
bjp-25731	209	9	interesting	interesting	ADJ
bjp-25731	209	10	antiviral	antiviral	ADJ
bjp-25731	209	11	activity	activity	NOUN
bjp-25731	209	12	which	which	PRON
bjp-25731	209	13	was	be	AUX
bjp-25731	209	14	why	why	SCONJ
bjp-25731	209	15	evaluation	evaluation	NOUN
bjp-25731	209	16	of	of	ADP
bjp-25731	209	17	recently	recently	ADV
bjp-25731	209	18	prepared	prepare	VERB
bjp-25731	209	19	2	2	NUM
bjp-25731	209	20	-	-	PUNCT
bjp-25731	209	21	thioxo	thioxo	NOUN
bjp-25731	209	22	-	-	PUNCT
bjp-25731	209	23	based	base	VERB
bjp-25731	209	24	benzo[g	benzo[g	VERB
bjp-25731	209	25	]	]	PUNCT
bjp-25731	209	26	quinazolin-4(3h)-ones	quinazolin-4(3h)-one	NOUN
bjp-25731	209	27	was	be	AUX
bjp-25731	209	28	reported	report	VERB
bjp-25731	209	29	against	against	ADP
bjp-25731	209	30	herpes	herpe	NOUN
bjp-25731	209	31	simplex	simplex	NOUN
bjp-25731	209	32	and	and	CCONJ
bjp-25731	209	33	coxsackie	coxsackie	NOUN
bjp-25731	209	34	virus	virus	NOUN
bjp-25731	209	35	(	(	PUNCT
bjp-25731	209	36	al	al	PROPN
bjp-25731	209	37	-	-	PUNCT
bjp-25731	209	38	salahi	salahi	PROPN
bjp-25731	209	39	et	et	PROPN
bjp-25731	209	40	al	al	PROPN
bjp-25731	209	41	.	.	PROPN
bjp-25731	209	42	,	,	PUNCT
bjp-25731	209	43	2016	2016	NUM
bjp-25731	209	44	)	)	PUNCT
bjp-25731	209	45	.	.	PUNCT
bjp-25731	210	1	systematic	systematic	ADJ
bjp-25731	210	2	evaluation	evaluation	NOUN
bjp-25731	210	3	of	of	ADP
bjp-25731	210	4	a	a	DET
bjp-25731	210	5	series	series	NOUN
bjp-25731	210	6	of	of	ADP
bjp-25731	210	7	thioquinazoline	thioquinazoline	NOUN
bjp-25731	210	8	against	against	ADP
bjp-25731	210	9	tobacco	tobacco	NOUN
bjp-25731	210	10	mosaic	mosaic	PROPN
bjp-25731	210	11	virus	virus	NOUN
bjp-25731	210	12	(	(	PUNCT
bjp-25731	210	13	tmv	tmv	NOUN
bjp-25731	210	14	)	)	PUNCT
bjp-25731	210	15	led	lead	VERB
bjp-25731	210	16	to	to	ADP
bjp-25731	210	17	the	the	DET
bjp-25731	210	18	discovery	discovery	NOUN
bjp-25731	210	19	of	of	ADP
bjp-25731	210	20	quinazolin-4	quinazolin-4	NOUN
bjp-25731	210	21	-	-	NOUN
bjp-25731	210	22	yl	yl	NOUN
bjp-25731	210	23	based	base	VERB
bjp-25731	210	24	prop-2	prop-2	PROPN
bjp-25731	210	25	-	-	PUNCT
bjp-25731	210	26	en-1	en-1	NOUN
bjp-25731	210	27	-	-	PUNCT
bjp-25731	210	28	one	one	NOUN
bjp-25731	210	29	that	that	PRON
bjp-25731	210	30	exhibited	exhibit	VERB
bjp-25731	210	31	encouraging	encourage	VERB
bjp-25731	210	32	protection	protection	NOUN
bjp-25731	210	33	properties	property	NOUN
bjp-25731	210	34	(	(	PUNCT
bjp-25731	210	35	ec50	ec50	PROPN
bjp-25731	210	36	=	=	PROPN
bjp-25731	210	37	138.1	138.1	NUM
bjp-25731	210	38	μg	μg	PROPN
bjp-25731	210	39	/	/	SYM
bjp-25731	210	40	ml	ml	NOUN
bjp-25731	210	41	)	)	PUNCT
bjp-25731	210	42	upon	upon	SCONJ
bjp-25731	210	43	tmv	tmv	NOUN
bjp-25731	210	44	in	in	ADP
bjp-25731	210	45	vivo	vivo	NOUN
bjp-25731	210	46	,	,	PUNCT
bjp-25731	210	47	which	which	PRON
bjp-25731	210	48	was	be	AUX
bjp-25731	210	49	over	over	ADP
bjp-25731	210	50	three	three	NUM
bjp-25731	210	51	times	time	NOUN
bjp-25731	210	52	more	more	ADV
bjp-25731	210	53	active	active	ADJ
bjp-25731	210	54	than	than	ADP
bjp-25731	210	55	ribavirin	ribavirin	NOUN
bjp-25731	210	56	(	(	PUNCT
bjp-25731	210	57	ec50	ec50	PROPN
bjp-25731	210	58	=	=	PROPN
bjp-25731	210	59	436.0	436.0	NUM
bjp-25731	210	60	μg	μg	NOUN
bjp-25731	210	61	/	/	SYM
bjp-25731	210	62	ml	ml	NOUN
bjp-25731	210	63	)	)	PUNCT
bjp-25731	210	64	standard	standard	NOUN
bjp-25731	210	65	(	(	PUNCT
bjp-25731	210	66	wan	wan	PROPN
bjp-25731	210	67	et	et	PROPN
bjp-25731	210	68	al	al	PROPN
bjp-25731	210	69	.	.	PROPN
bjp-25731	210	70	,	,	PUNCT
bjp-25731	210	71	2015	2015	NUM
bjp-25731	210	72	)	)	PUNCT
bjp-25731	210	73	.	.	PUNCT
bjp-25731	211	1	a	a	DET
bjp-25731	211	2	series	series	NOUN
bjp-25731	211	3	of	of	ADP
bjp-25731	211	4	quinazoline	quinazoline	NOUN
bjp-25731	211	5	prepared	prepare	VERB
bjp-25731	211	6	via	via	ADP
bjp-25731	211	7	schiff	schiff	NOUN
bjp-25731	211	8	bases	basis	NOUN
bjp-25731	211	9	formation	formation	NOUN
bjp-25731	211	10	were	be	AUX
bjp-25731	211	11	screened	screen	VERB
bjp-25731	211	12	against	against	ADP
bjp-25731	211	13	herpes	herpe	NOUN
bjp-25731	211	14	simplex	simplex	NOUN
bjp-25731	211	15	virus-1	virus-1	ADP
bjp-25731	211	16	(	(	PUNCT
bjp-25731	211	17	kos	kos	PROPN
bjp-25731	211	18	)	)	PUNCT
bjp-25731	211	19	,	,	PUNCT
bjp-25731	211	20	virus-2	virus-2	NUM
bjp-25731	211	21	(	(	PUNCT
bjp-25731	211	22	g	g	NOUN
bjp-25731	211	23	)	)	PUNCT
bjp-25731	211	24	and	and	CCONJ
bjp-25731	211	25	vaccinia	vaccinia	NOUN
bjp-25731	211	26	virus	virus	NOUN
bjp-25731	211	27	(	(	PUNCT
bjp-25731	211	28	ali	ali	PROPN
bjp-25731	211	29	et	et	PROPN
bjp-25731	211	30	al	al	PROPN
bjp-25731	211	31	.	.	PROPN
bjp-25731	211	32	,	,	PUNCT
bjp-25731	211	33	2007	2007	NUM
bjp-25731	211	34	)	)	PUNCT
bjp-25731	211	35	,	,	PUNCT
bjp-25731	211	36	wherein	wherein	SCONJ
bjp-25731	211	37	(	(	PUNCT
bjp-25731	211	38	e)-3-((2hydroxybenzylidene	e)-3-((2hydroxybenzylidene	NOUN
bjp-25731	211	39	)	)	PUNCT
bjp-25731	211	40	amino)-2	amino)-2	PROPN
bjp-25731	211	41	-	-	PUNCT
bjp-25731	211	42	phenyl	phenyl	NOUN
bjp-25731	211	43	quinazolin-4	quinazolin-4	PROPN
bjp-25731	211	44	(	(	PUNCT
bjp-25731	211	45	3h)-one	3h)-one	NOUN
bjp-25731	211	46	emerged	emerge	VERB
bjp-25731	211	47	as	as	ADP
bjp-25731	211	48	the	the	DET
bjp-25731	211	49	most	most	ADV
bjp-25731	211	50	promising	promising	ADJ
bjp-25731	211	51	antiviral	antiviral	ADJ
bjp-25731	211	52	motif	motif	NOUN
bjp-25731	211	53	against	against	ADP
bjp-25731	211	54	the	the	DET
bjp-25731	211	55	entire	entire	ADJ
bjp-25731	211	56	tested	test	VERB
bjp-25731	211	57	virus	virus	NOUN
bjp-25731	211	58	(	(	PUNCT
bjp-25731	211	59	kumar	kumar	PROPN
bjp-25731	211	60	et	et	PROPN
bjp-25731	211	61	al	al	PROPN
bjp-25731	211	62	.	.	PROPN
bjp-25731	211	63	,	,	PUNCT
bjp-25731	211	64	2010	2010	NUM
bjp-25731	211	65	)	)	PUNCT
bjp-25731	211	66	.	.	PUNCT
bjp-25731	212	1	it	it	PRON
bjp-25731	212	2	has	have	AUX
bjp-25731	212	3	also	also	ADV
bjp-25731	212	4	been	be	AUX
bjp-25731	212	5	reported	report	VERB
bjp-25731	212	6	that	that	SCONJ
bjp-25731	212	7	high	high	ADJ
bjp-25731	212	8	indicator	indicator	NOUN
bjp-25731	212	9	of	of	ADP
bjp-25731	212	10	the	the	DET
bjp-25731	212	11	antiviral	antiviral	ADJ
bjp-25731	212	12	activity	activity	NOUN
bjp-25731	212	13	of	of	ADP
bjp-25731	212	14	n	n	CCONJ
bjp-25731	212	15	-	-	PUNCT
bjp-25731	212	16	methyl-2-((2	methyl-2-((2	ADV
bjp-25731	212	17	-	-	PUNCT
bjp-25731	212	18	oxo-3	oxo-3	ADP
bjp-25731	212	19	-	-	PUNCT
bjp-25731	212	20	phenyl-2h-[1,2,4]triazino[2,3	phenyl-2h-[1,2,4]triazino[2,3	NUM
bjp-25731	212	21	-	-	PUNCT
bjp-25731	212	22	c]quinazolin-6	c]quinazolin-6	NOUN
bjp-25731	212	23	-	-	PUNCT
bjp-25731	212	24	yl)thio)acetamide	yl)thio)acetamide	NOUN
bjp-25731	213	1	(	(	PUNCT
bjp-25731	213	2	kolavenko	kolavenko	NOUN
bjp-25731	213	3	et	et	PROPN
bjp-25731	213	4	al	al	PROPN
bjp-25731	213	5	.	.	PROPN
bjp-25731	213	6	,	,	PUNCT
bjp-25731	213	7	2013	2013	NUM
bjp-25731	213	8	)	)	PUNCT
bjp-25731	213	9	bearing	bearing	NOUN
bjp-25731	213	10	-	-	PUNCT
bjp-25731	213	11	adamantane	adamantane	NOUN
bjp-25731	213	12	against	against	ADP
bjp-25731	213	13	influenza	influenza	NOUN
bjp-25731	213	14	type	type	NOUN
bjp-25731	214	1	a	a	DET
bjp-25731	214	2	h3n2	h3n2	NOUN
bjp-25731	214	3	was	be	AUX
bjp-25731	214	4	due	due	ADJ
bjp-25731	214	5	to	to	ADP
bjp-25731	214	6	insertion	insertion	NOUN
bjp-25731	214	7	of	of	ADP
bjp-25731	214	8	carcass	carcass	PROPN
bjp-25731	214	9	amine	amine	PROPN
bjp-25731	214	10	.	.	PUNCT
bjp-25731	215	1	anti	anti	ADJ
bjp-25731	215	2	-	-	ADJ
bjp-25731	215	3	oxidant	oxidant	ADJ
bjp-25731	215	4	activity	activity	NOUN
bjp-25731	215	5	reactive	reactive	ADJ
bjp-25731	215	6	oxygen	oxygen	NOUN
bjp-25731	215	7	species	specie	NOUN
bjp-25731	215	8	(	(	PUNCT
bjp-25731	215	9	ros	ros	PROPN
bjp-25731	215	10	)	)	PUNCT
bjp-25731	215	11	which	which	PRON
bjp-25731	215	12	include	include	VERB
bjp-25731	215	13	1o2	1o2	NUM
bjp-25731	215	14	,	,	PUNCT
bjp-25731	215	15	o2	o2	PROPN
bjp-25731	215	16	and	and	CCONJ
bjp-25731	215	17	.oh	.oh	PUNCT
bjp-25731	215	18	free	free	ADJ
bjp-25731	215	19	radicals	radical	NOUN
bjp-25731	215	20	and	and	CCONJ
bjp-25731	215	21	hydrogen	hydrogen	NOUN
bjp-25731	215	22	h2o2	h2o2	NOUN
bjp-25731	215	23	were	be	AUX
bjp-25731	215	24	commonly	commonly	ADV
bjp-25731	215	25	produced	produce	VERB
bjp-25731	215	26	as	as	ADP
bjp-25731	215	27	side	side	NOUN
bjp-25731	215	28	products	product	NOUN
bjp-25731	215	29	from	from	ADP
bjp-25731	215	30	either	either	CCONJ
bjp-25731	215	31	biochemical	biochemical	ADJ
bjp-25731	215	32	interaction	interaction	NOUN
bjp-25731	215	33	or	or	CCONJ
bjp-25731	215	34	through	through	ADP
bjp-25731	215	35	exogenous	exogenous	ADJ
bjp-25731	215	36	factors	factor	NOUN
bjp-25731	215	37	(	(	PUNCT
bjp-25731	215	38	sergey	sergey	PROPN
bjp-25731	215	39	et	et	PROPN
bjp-25731	215	40	al	al	PROPN
bjp-25731	215	41	.	.	PROPN
bjp-25731	215	42	,	,	PUNCT
bjp-25731	215	43	2010	2010	NUM
bjp-25731	215	44	)	)	PUNCT
bjp-25731	215	45	.	.	PUNCT
bjp-25731	216	1	ros	ros	PROPN
bjp-25731	216	2	play	play	VERB
bjp-25731	216	3	a	a	DET
bjp-25731	216	4	vital	vital	ADJ
bjp-25731	216	5	role	role	NOUN
bjp-25731	216	6	as	as	ADV
bjp-25731	216	7	far	far	ADV
bjp-25731	216	8	as	as	SCONJ
bjp-25731	216	9	aging	age	VERB
bjp-25731	216	10	and	and	CCONJ
bjp-25731	216	11	pathogenetic	pathogenetic	ADJ
bjp-25731	216	12	traits	trait	NOUN
bjp-25731	216	13	of	of	ADP
bjp-25731	216	14	age	age	NOUN
bjp-25731	216	15	responsive	responsive	ADJ
bjp-25731	216	16	diseases	disease	NOUN
bjp-25731	216	17	are	be	AUX
bjp-25731	216	18	concerned	concerned	ADJ
bjp-25731	216	19	(	(	PUNCT
bjp-25731	216	20	vagdevi	vagdevi	PROPN
bjp-25731	216	21	et	et	PROPN
bjp-25731	216	22	al	al	PROPN
bjp-25731	216	23	.	.	PROPN
bjp-25731	216	24	,	,	PUNCT
bjp-25731	216	25	2012	2012	NUM
bjp-25731	216	26	;	;	PUNCT
bjp-25731	216	27	manasa	manasa	PROPN
bjp-25731	216	28	et	et	PROPN
bjp-25731	216	29	al	al	PROPN
bjp-25731	216	30	.	.	PROPN
bjp-25731	216	31	,	,	PUNCT
bjp-25731	216	32	2011	2011	NUM
bjp-25731	216	33	)	)	PUNCT
bjp-25731	216	34	.	.	PUNCT
bjp-25731	217	1	an	an	DET
bjp-25731	217	2	array	array	NOUN
bjp-25731	217	3	of	of	ADP
bjp-25731	217	4	quinazoline-2,4	quinazoline-2,4	NOUN
bjp-25731	217	5	-	-	PUNCT
bjp-25731	217	6	dione	dione	ADJ
bjp-25731	217	7	schiff	schiff	NOUN
bjp-25731	217	8	bases	basis	NOUN
bjp-25731	217	9	were	be	AUX
bjp-25731	217	10	reported	report	VERB
bjp-25731	217	11	to	to	PART
bjp-25731	217	12	possess	possess	VERB
bjp-25731	217	13	over	over	ADP
bjp-25731	217	14	50	50	NUM
bjp-25731	217	15	%	%	NOUN
bjp-25731	217	16	inhibitory	inhibitory	ADJ
bjp-25731	217	17	efficiency	efficiency	NOUN
bjp-25731	217	18	upon	upon	SCONJ
bjp-25731	217	19	dpph	dpph	PROPN
bjp-25731	217	20	(	(	PUNCT
bjp-25731	217	21	ic50	ic50	PROPN
bjp-25731	217	22	=	=	SYM
bjp-25731	217	23	25	25	NUM
bjp-25731	217	24	-	-	SYM
bjp-25731	217	25	50	50	NUM
bjp-25731	217	26	μg	μg	NOUN
bjp-25731	217	27	/	/	SYM
bjp-25731	217	28	ml	ml	NOUN
bjp-25731	217	29	)	)	PUNCT
bjp-25731	217	30	and	and	CCONJ
bjp-25731	217	31	most	most	ADJ
bjp-25731	217	32	of	of	ADP
bjp-25731	217	33	the	the	DET
bjp-25731	217	34	compounds	compound	NOUN
bjp-25731	217	35	showed	show	VERB
bjp-25731	217	36	a	a	DET
bjp-25731	217	37	dose	dose	ADJ
bjp-25731	217	38	dependent	dependent	ADJ
bjp-25731	217	39	behavior	behavior	NOUN
bjp-25731	217	40	in	in	ADP
bjp-25731	217	41	frap	frap	NOUN
bjp-25731	217	42	assay	assay	PROPN
bjp-25731	217	43	(	(	PUNCT
bjp-25731	217	44	vagdevi	vagdevi	PROPN
bjp-25731	217	45	et	et	PROPN
bjp-25731	217	46	al	al	PROPN
bjp-25731	217	47	.	.	PROPN
bjp-25731	217	48	,	,	PUNCT
bjp-25731	217	49	2012	2012	NUM
bjp-25731	217	50	)	)	PUNCT
bjp-25731	217	51	.	.	PUNCT
bjp-25731	218	1	2	2	NUM
bjp-25731	218	2	-	-	PUNCT
bjp-25731	218	3	methyl-3-(pyrrolidin-2ylidene	methyl-3-(pyrrolidin-2ylidene	NOUN
bjp-25731	218	4	amino)quinazolin-4(3h)-one	amino)quinazolin-4(3h)-one	NOUN
bjp-25731	218	5	was	be	AUX
bjp-25731	218	6	reported	report	VERB
bjp-25731	218	7	to	to	PART
bjp-25731	218	8	be	be	AUX
bjp-25731	218	9	much	much	ADV
bjp-25731	218	10	higher	high	ADJ
bjp-25731	218	11	in	in	ADP
bjp-25731	218	12	activity	activity	NOUN
bjp-25731	218	13	compared	compare	VERB
bjp-25731	218	14	with	with	ADP
bjp-25731	218	15	ascorbic	ascorbic	NOUN
bjp-25731	218	16	acid	acid	NOUN
bjp-25731	218	17	standard	standard	NOUN
bjp-25731	218	18	(	(	PUNCT
bjp-25731	218	19	al	al	PROPN
bjp-25731	218	20	-	-	PUNCT
bjp-25731	218	21	azawi	azawi	ADJ
bjp-25731	218	22	,	,	PUNCT
bjp-25731	218	23	2016	2016	NUM
bjp-25731	218	24	)	)	PUNCT
bjp-25731	218	25	.	.	PUNCT
bjp-25731	219	1	it	it	PRON
bjp-25731	219	2	also	also	ADV
bjp-25731	219	3	served	serve	VERB
bjp-25731	219	4	as	as	ADP
bjp-25731	219	5	a	a	DET
bjp-25731	219	6	powerful	powerful	ADJ
bjp-25731	219	7	and	and	CCONJ
bjp-25731	219	8	highly	highly	ADV
bjp-25731	219	9	resourceful	resourceful	ADJ
bjp-25731	219	10	scavenger	scavenger	NOUN
bjp-25731	219	11	against	against	ADP
bjp-25731	219	12	dpph	dpph	NOUN
bjp-25731	219	13	and	and	CCONJ
bjp-25731	219	14	nitric	nitric	ADJ
bjp-25731	219	15	oxide	oxide	NOUN
bjp-25731	219	16	(	(	PUNCT
bjp-25731	219	17	al	al	PROPN
bjp-25731	219	18	-	-	PUNCT
bjp-25731	219	19	azawi	azawi	ADJ
bjp-25731	219	20	,	,	PUNCT
bjp-25731	219	21	2016	2016	NUM
bjp-25731	219	22	)	)	PUNCT
bjp-25731	219	23	.	.	PUNCT
bjp-25731	220	1	antidiabetic	antidiabetic	ADJ
bjp-25731	220	2	activity	activity	NOUN
bjp-25731	220	3	due	due	ADP
bjp-25731	220	4	to	to	ADP
bjp-25731	220	5	widespread	widespread	ADJ
bjp-25731	220	6	nature	nature	NOUN
bjp-25731	220	7	of	of	ADP
bjp-25731	220	8	diabetes	diabetes	NOUN
bjp-25731	220	9	mellitus	mellitus	NOUN
bjp-25731	220	10	globally	globally	ADV
bjp-25731	220	11	,	,	PUNCT
bjp-25731	220	12	a	a	DET
bjp-25731	220	13	great	great	ADJ
bjp-25731	220	14	deal	deal	NOUN
bjp-25731	220	15	of	of	ADP
bjp-25731	220	16	effort	effort	NOUN
bjp-25731	220	17	in	in	ADP
bjp-25731	220	18	applied	applied	ADJ
bjp-25731	220	19	research	research	NOUN
bjp-25731	220	20	is	be	AUX
bjp-25731	220	21	on	on	ADV
bjp-25731	220	22	-	-	PUNCT
bjp-25731	220	23	going	go	VERB
bjp-25731	220	24	for	for	ADP
bjp-25731	220	25	the	the	DET
bjp-25731	220	26	discovery	discovery	NOUN
bjp-25731	220	27	of	of	ADP
bjp-25731	220	28	new	new	ADJ
bjp-25731	220	29	heterocyclic	heterocyclic	ADJ
bjp-25731	220	30	molecules	molecule	NOUN
bjp-25731	220	31	as	as	ADP
bjp-25731	220	32	antidiabetic	antidiabetic	ADJ
bjp-25731	220	33	agents	agent	NOUN
bjp-25731	220	34	with	with	ADP
bjp-25731	220	35	a	a	DET
bjp-25731	220	36	well	well	ADV
bjp-25731	220	37	detailed	detailed	ADJ
bjp-25731	220	38	information	information	NOUN
bjp-25731	220	39	on	on	ADP
bjp-25731	220	40	its	its	PRON
bjp-25731	220	41	mode	mode	NOUN
bjp-25731	220	42	of	of	ADP
bjp-25731	220	43	action	action	NOUN
bjp-25731	220	44	(	(	PUNCT
bjp-25731	220	45	islam	islam	PROPN
bjp-25731	220	46	and	and	CCONJ
bjp-25731	220	47	loot	loot	PROPN
bjp-25731	220	48	,	,	PUNCT
bjp-25731	220	49	2009	2009	NUM
bjp-25731	220	50	;	;	PUNCT
bjp-25731	220	51	cheng	cheng	PROPN
bjp-25731	220	52	,	,	PUNCT
bjp-25731	220	53	2005	2005	NUM
bjp-25731	220	54	)	)	PUNCT
bjp-25731	220	55	.	.	PUNCT
bjp-25731	221	1	sublethal	sublethal	NOUN
bjp-25731	221	2	dosage	dosage	NOUN
bjp-25731	221	3	testing	testing	NOUN
bjp-25731	221	4	for	for	ADP
bjp-25731	221	5	1	1	NUM
bjp-25731	221	6	-	-	PUNCT
bjp-25731	221	7	thioxo-1,2,7,8,9,10	thioxo-1,2,7,8,9,10	NOUN
bjp-25731	221	8	-	-	PUNCT
bjp-25731	221	9	hexahydro-3h	hexahydro-3h	NOUN
bjp-25731	221	10	-	-	PUNCT
bjp-25731	221	11	pyrimido[1,6	pyrimido[1,6	NOUN
bjp-25731	221	12	-	-	PUNCT
bjp-25731	221	13	a]quinazolin-3	a]quinazolin-3	NOUN
bjp-25731	221	14	-	-	PUNCT
bjp-25731	221	15	one	one	NOUN
bjp-25731	221	16	showed	show	VERB
bjp-25731	221	17	that	that	SCONJ
bjp-25731	221	18	it	it	PRON
bjp-25731	221	19	has	have	VERB
bjp-25731	221	20	remarkable	remarkable	ADJ
bjp-25731	221	21	potential	potential	NOUN
bjp-25731	221	22	in	in	ADP
bjp-25731	221	23	(	(	PUNCT
bjp-25731	221	24	n	n	CCONJ
bjp-25731	221	25	-	-	PUNCT
bjp-25731	221	26	stz	stz	NOUN
bjp-25731	221	27	)	)	PUNCT
bjp-25731	221	28	diabetic	diabetic	ADJ
bjp-25731	221	29	male	male	NOUN
bjp-25731	221	30	as	as	ADP
bjp-25731	221	31	antihyperglycemic	antihyperglycemic	ADJ
bjp-25731	221	32	agent	agent	NOUN
bjp-25731	221	33	(	(	PUNCT
bjp-25731	221	34	ahmed	ahmed	PROPN
bjp-25731	221	35	et	et	PROPN
bjp-25731	221	36	al	al	PROPN
bjp-25731	221	37	.	.	PROPN
bjp-25731	221	38	,	,	PUNCT
bjp-25731	221	39	2012	2012	NUM
bjp-25731	221	40	)	)	PUNCT
bjp-25731	221	41	.	.	PUNCT
bjp-25731	222	1	the	the	DET
bjp-25731	222	2	(	(	PUNCT
bjp-25731	222	3	nstz	nstz	NOUN
bjp-25731	222	4	)	)	PUNCT
bjp-25731	222	5	diabetic	diabetic	ADJ
bjp-25731	222	6	male	male	NOUN
bjp-25731	222	7	model	model	NOUN
bjp-25731	222	8	used	use	VERB
bjp-25731	222	9	in	in	ADP
bjp-25731	222	10	the	the	DET
bjp-25731	222	11	study	study	NOUN
bjp-25731	222	12	acquired	acquire	VERB
bjp-25731	222	13	biological	biological	ADJ
bjp-25731	222	14	and	and	CCONJ
bjp-25731	222	15	pathological	pathological	ADJ
bjp-25731	222	16	diagnostic	diagnostic	ADJ
bjp-25731	222	17	sign	sign	NOUN
bjp-25731	222	18	related	relate	VERB
bjp-25731	222	19	to	to	ADP
bjp-25731	222	20	the	the	DET
bjp-25731	222	21	type	type	NOUN
bjp-25731	222	22	2	2	NUM
bjp-25731	222	23	diabetes	diabetes	NOUN
bjp-25731	222	24	in	in	ADP
bjp-25731	222	25	mankind	mankind	NOUN
bjp-25731	222	26	(	(	PUNCT
bjp-25731	222	27	islam	islam	PROPN
bjp-25731	222	28	and	and	CCONJ
bjp-25731	222	29	loot	loot	PROPN
bjp-25731	222	30	,	,	PUNCT
bjp-25731	222	31	2009	2009	NUM
bjp-25731	222	32	)	)	PUNCT
bjp-25731	222	33	.	.	PUNCT
bjp-25731	223	1	the	the	DET
bjp-25731	223	2	one	one	NUM
bjp-25731	223	3	-	-	PUNCT
bjp-25731	223	4	pot	pot	NOUN
bjp-25731	223	5	synthesis	synthesis	NOUN
bjp-25731	223	6	of	of	ADP
bjp-25731	223	7	a	a	DET
bjp-25731	223	8	series	series	NOUN
bjp-25731	223	9	of	of	ADP
bjp-25731	223	10	quinazolin-4	quinazolin-4	NOUN
bjp-25731	223	11	-	-	NOUN
bjp-25731	223	12	one	one	NUM
bjp-25731	223	13	in	in	ADP
bjp-25731	223	14	the	the	DET
bjp-25731	223	15	presence	presence	NOUN
bjp-25731	223	16	of	of	ADP
bjp-25731	223	17	[	[	X
bjp-25731	223	18	bmim+][bf4-	bmim+][bf4-	X
bjp-25731	223	19	]	]	X
bjp-25731	223	20	as	as	SCONJ
bjp-25731	223	21	green	green	ADJ
bjp-25731	223	22	and	and	CCONJ
bjp-25731	223	23	reusable	reusable	ADJ
bjp-25731	223	24	catalyst	catalyst	NOUN
bjp-25731	223	25	was	be	AUX
bjp-25731	223	26	reported	report	VERB
bjp-25731	223	27	and	and	CCONJ
bjp-25731	223	28	the	the	DET
bjp-25731	223	29	attempted	attempt	VERB
bjp-25731	223	30	investigation	investigation	NOUN
bjp-25731	223	31	of	of	ADP
bjp-25731	223	32	antidiabetic	antidiabetic	ADJ
bjp-25731	223	33	activity	activity	NOUN
bjp-25731	223	34	showed	show	VERB
bjp-25731	223	35	3-(5	3-(5	NOUN
bjp-25731	223	36	-	-	PUNCT
bjp-25731	223	37	bromopyridin-2	bromopyridin-2	NUM
bjp-25731	223	38	-	-	PUNCT
bjp-25731	223	39	yl	yl	NOUN
bjp-25731	223	40	)	)	PUNCT
bjp-25731	223	41	quinazolin-4(3h)-one	quinazolin-4(3h)-one	NOUN
bjp-25731	223	42	to	to	PART
bjp-25731	223	43	be	be	AUX
bjp-25731	223	44	the	the	DET
bjp-25731	223	45	most	most	ADV
bjp-25731	223	46	active	active	ADJ
bjp-25731	223	47	in	in	ADP
bjp-25731	223	48	this	this	DET
bjp-25731	223	49	series	series	NOUN
bjp-25731	223	50	(	(	PUNCT
bjp-25731	223	51	dongamanti	dongamanti	PROPN
bjp-25731	223	52	et	et	PROPN
bjp-25731	223	53	al	al	PROPN
bjp-25731	223	54	.	.	PROPN
bjp-25731	223	55	,	,	PUNCT
bjp-25731	223	56	2012	2012	NUM
bjp-25731	223	57	)	)	PUNCT
bjp-25731	223	58	.	.	PUNCT
bjp-25731	224	1	antithrombosis	antithrombosis	NOUN
bjp-25731	224	2	activity	activity	NOUN
bjp-25731	224	3	activated	activate	VERB
bjp-25731	224	4	factor	factor	NOUN
bjp-25731	224	5	x	x	SYM
bjp-25731	224	6	(	(	PUNCT
bjp-25731	224	7	fxa	fxa	NOUN
bjp-25731	224	8	)	)	PUNCT
bjp-25731	224	9	is	be	AUX
bjp-25731	224	10	a	a	DET
bjp-25731	224	11	formidable	formidable	ADJ
bjp-25731	224	12	player	player	NOUN
bjp-25731	224	13	in	in	ADP
bjp-25731	224	14	thrombin	thrombin	NOUN
bjp-25731	224	15	generation	generation	NOUN
bjp-25731	224	16	through	through	ADP
bjp-25731	224	17	coagulation	coagulation	NOUN
bjp-25731	224	18	cascade	cascade	NOUN
bjp-25731	224	19	responsibility	responsibility	NOUN
bjp-25731	224	20	during	during	ADP
bjp-25731	224	21	the	the	DET
bjp-25731	224	22	process	process	NOUN
bjp-25731	224	23	of	of	ADP
bjp-25731	224	24	atrial	atrial	ADJ
bjp-25731	224	25	fibrillation	fibrillation	NOUN
bjp-25731	224	26	(	(	PUNCT
bjp-25731	224	27	bukowska	bukowska	VERB
bjp-25731	224	28	et	et	NOUN
bjp-25731	224	29	al	al	PROPN
bjp-25731	224	30	.	.	PROPN
bjp-25731	224	31	,	,	PUNCT
bjp-25731	224	32	2013	2013	NUM
bjp-25731	224	33	)	)	PUNCT
bjp-25731	224	34	.	.	PUNCT
bjp-25731	225	1	activated	activate	VERB
bjp-25731	225	2	factor	factor	NOUN
bjp-25731	225	3	x	x	NOUN
bjp-25731	225	4	fxa	fxa	NOUN
bjp-25731	225	5	and	and	CCONJ
bjp-25731	225	6	tachyarrhythmia	tachyarrhythmia	PROPN
bjp-25731	225	7	act	act	VERB
bjp-25731	225	8	synergistically	synergistically	ADV
bjp-25731	225	9	to	to	PART
bjp-25731	225	10	increase	increase	VERB
bjp-25731	225	11	expression	expression	NOUN
bjp-25731	225	12	of	of	ADP
bjp-25731	225	13	protease	protease	NOUN
bjp-25731	225	14	-	-	PUNCT
bjp-25731	225	15	activated	activate	VERB
bjp-25731	225	16	receptors	receptor	NOUN
bjp-25731	225	17	and	and	CCONJ
bjp-25731	225	18	inflammatory	inflammatory	ADJ
bjp-25731	225	19	mediators	mediator	NOUN
bjp-25731	225	20	(	(	PUNCT
bjp-25731	225	21	bukowska	bukowska	VERB
bjp-25731	225	22	et	et	NOUN
bjp-25731	225	23	al	al	PROPN
bjp-25731	225	24	.	.	PROPN
bjp-25731	225	25	,	,	PUNCT
bjp-25731	225	26	2013	2013	NUM
bjp-25731	225	27	)	)	PUNCT
bjp-25731	225	28	.	.	PUNCT
bjp-25731	226	1	some	some	DET
bjp-25731	226	2	quinazoline	quinazoline	NOUN
bjp-25731	226	3	derivative	derivative	ADJ
bjp-25731	226	4	exerted	exert	VERB
bjp-25731	226	5	inhibition	inhibition	NOUN
bjp-25731	226	6	of	of	ADP
bjp-25731	226	7	inflammation	inflammation	NOUN
bjp-25731	226	8	via	via	ADP
bjp-25731	226	9	this	this	DET
bjp-25731	226	10	route	route	NOUN
bjp-25731	226	11	.	.	PUNCT
bjp-25731	227	1	elinogrel	elinogrel	PROPN
bjp-25731	227	2	30	30	NUM
bjp-25731	227	3	,	,	PUNCT
bjp-25731	227	4	the	the	DET
bjp-25731	227	5	structure	structure	NOUN
bjp-25731	227	6	shown	show	VERB
bjp-25731	227	7	in	in	ADP
bjp-25731	227	8	figure	figure	NOUN
bjp-25731	227	9	16	16	NUM
bjp-25731	227	10	is	be	AUX
bjp-25731	227	11	a	a	DET
bjp-25731	227	12	marketed	market	VERB
bjp-25731	227	13	available	available	ADJ
bjp-25731	227	14	antithrombosis	antithrombosis	NOUN
bjp-25731	227	15	drug	drug	NOUN
bjp-25731	227	16	containing	contain	VERB
bjp-25731	227	17	quinazolinone	quinazolinone	PROPN
bjp-25731	227	18	moiety	moiety	NOUN
bjp-25731	227	19	(	(	PUNCT
bjp-25731	227	20	nayyar	nayyar	PROPN
bjp-25731	227	21	and	and	CCONJ
bjp-25731	227	22	arpanarana	arpanarana	PROPN
bjp-25731	227	23	,	,	PUNCT
bjp-25731	227	24	2011	2011	NUM
bjp-25731	227	25	)	)	PUNCT
bjp-25731	227	26	.	.	PUNCT
bjp-25731	228	1	structure	structure	NOUN
bjp-25731	228	2	-	-	PUNCT
bjp-25731	228	3	activity	activity	NOUN
bjp-25731	228	4	relationship	relationship	NOUN
bjp-25731	228	5	study	study	NOUN
bjp-25731	228	6	(	(	PUNCT
bjp-25731	228	7	sar	sar	PROPN
bjp-25731	228	8	)	)	PUNCT
bjp-25731	228	9	the	the	DET
bjp-25731	228	10	sar	sar	PROPN
bjp-25731	228	11	study	study	NOUN
bjp-25731	228	12	carried	carry	VERB
bjp-25731	228	13	out	out	ADP
bjp-25731	228	14	on	on	ADP
bjp-25731	228	15	the	the	DET
bjp-25731	228	16	selected	select	VERB
bjp-25731	228	17	molecules	molecule	NOUN
bjp-25731	228	18	showed	show	VERB
bjp-25731	228	19	that	that	SCONJ
bjp-25731	228	20	electron	electron	NOUN
bjp-25731	228	21	-	-	PUNCT
bjp-25731	228	22	withdrawing	withdrawing	NOUN
bjp-25731	228	23	and	and	CCONJ
bjp-25731	228	24	electron	electron	NOUN
bjp-25731	228	25	-	-	PUNCT
bjp-25731	228	26	donating	donating	NOUN
bjp-25731	228	27	could	could	AUX
bjp-25731	228	28	inform	inform	VERB
bjp-25731	228	29	a	a	DET
bjp-25731	228	30	synthetic	synthetic	ADJ
bjp-25731	228	31	chemist	chemist	NOUN
bjp-25731	228	32	about	about	ADP
bjp-25731	228	33	the	the	DET
bjp-25731	228	34	choice	choice	NOUN
bjp-25731	228	35	of	of	ADP
bjp-25731	228	36	a	a	DET
bjp-25731	228	37	suitable	suitable	ADJ
bjp-25731	228	38	substitution	substitution	NOUN
bjp-25731	228	39	pattern	pattern	NOUN
bjp-25731	228	40	.	.	PUNCT
bjp-25731	229	1	some	some	DET
bjp-25731	229	2	heterocyclic	heterocyclic	ADJ
bjp-25731	229	3	moieties	moiety	NOUN
bjp-25731	229	4	attachments	attachment	NOUN
bjp-25731	229	5	are	be	AUX
bjp-25731	229	6	the	the	DET
bjp-25731	229	7	basic	basic	ADJ
bjp-25731	229	8	templates	template	NOUN
bjp-25731	229	9	responsible	responsible	ADJ
bjp-25731	229	10	for	for	ADP
bjp-25731	229	11	the	the	DET
bjp-25731	229	12	regulation	regulation	NOUN
bjp-25731	229	13	of	of	ADP
bjp-25731	229	14	biological	biological	ADJ
bjp-25731	229	15	activity	activity	NOUN
bjp-25731	229	16	of	of	ADP
bjp-25731	229	17	targeted	target	VERB
bjp-25731	229	18	quinazoline	quinazoline	NOUN
bjp-25731	229	19	derivative	derivative	NOUN
bjp-25731	229	20	synthesized	synthesize	VERB
bjp-25731	229	21	.	.	PUNCT
bjp-25731	230	1	from	from	ADP
bjp-25731	230	2	the	the	DET
bjp-25731	230	3	painstaking	painstaking	ADJ
bjp-25731	230	4	examination	examination	NOUN
bjp-25731	230	5	of	of	ADP
bjp-25731	230	6	the	the	DET
bjp-25731	230	7	sar	sar	NOUN
bjp-25731	230	8	,	,	PUNCT
bjp-25731	230	9	it	it	PRON
bjp-25731	230	10	was	be	AUX
bjp-25731	230	11	collectively	collectively	ADV
bjp-25731	230	12	noted	note	VERB
bjp-25731	230	13	that	that	SCONJ
bjp-25731	230	14	the	the	DET
bjp-25731	230	15	positions	position	NOUN
bjp-25731	230	16	2	2	NUM
bjp-25731	230	17	,	,	PUNCT
bjp-25731	230	18	4	4	NUM
bjp-25731	230	19	and	and	CCONJ
bjp-25731	230	20	6	6	NUM
bjp-25731	230	21	are	be	AUX
bjp-25731	230	22	major	major	ADJ
bjp-25731	230	23	points	point	NOUN
bjp-25731	230	24	of	of	ADP
bjp-25731	230	25	biological	biological	ADJ
bjp-25731	230	26	relevance	relevance	NOUN
bjp-25731	230	27	for	for	ADP
bjp-25731	230	28	improved	improved	ADJ
bjp-25731	230	29	activities	activity	NOUN
bjp-25731	230	30	for	for	ADP
bjp-25731	230	31	possible	possible	ADJ
bjp-25731	230	32	drug	drug	NOUN
bjp-25731	230	33	design	design	NOUN
bjp-25731	230	34	(	(	PUNCT
bjp-25731	230	35	wang	wang	PROPN
bjp-25731	230	36	and	and	CCONJ
bjp-25731	230	37	gao	gao	PROPN
bjp-25731	230	38	,	,	PUNCT
bjp-25731	230	39	2013	2013	NUM
bjp-25731	230	40	)	)	PUNCT
bjp-25731	230	41	.	.	PUNCT
bjp-25731	231	1	various	various	ADJ
bjp-25731	231	2	2,4,6trisubstituted	2,4,6trisubstituted	NUM
bjp-25731	231	3	positions	position	NOUN
bjp-25731	231	4	of	of	ADP
bjp-25731	231	5	quinazoline	quinazoline	NOUN
bjp-25731	231	6	derivatives	derivative	NOUN
bjp-25731	231	7	have	have	AUX
bjp-25731	231	8	been	be	AUX
bjp-25731	231	9	evaluated	evaluate	VERB
bjp-25731	231	10	as	as	ADP
bjp-25731	231	11	essential	essential	ADJ
bjp-25731	231	12	pharmacophoric	pharmacophoric	ADJ
bjp-25731	231	13	placement	placement	NOUN
bjp-25731	231	14	for	for	ADP
bjp-25731	231	15	the	the	DET
bjp-25731	231	16	enhancement	enhancement	NOUN
bjp-25731	231	17	of	of	ADP
bjp-25731	231	18	bioactivity	bioactivity	NOUN
bjp-25731	231	19	(	(	PUNCT
bjp-25731	231	20	chandrika	chandrika	NOUN
bjp-25731	231	21	et	et	PROPN
bjp-25731	231	22	al	al	PROPN
bjp-25731	231	23	.	.	PROPN
bjp-25731	231	24	,	,	PUNCT
bjp-25731	231	25	2009	2009	NUM
bjp-25731	231	26	)	)	PUNCT
bjp-25731	231	27	.	.	PUNCT
bjp-25731	232	1	in	in	ADP
bjp-25731	232	2	addition	addition	NOUN
bjp-25731	232	3	,	,	PUNCT
bjp-25731	232	4	the	the	DET
bjp-25731	232	5	substitution	substitution	NOUN
bjp-25731	232	6	on	on	ADP
bjp-25731	232	7	the	the	DET
bjp-25731	232	8	pyrimidine	pyrimidine	NOUN
bjp-25731	232	9	ring	ring	NOUN
bjp-25731	232	10	shows	show	VERB
bjp-25731	232	11	more	more	ADJ
bjp-25731	232	12	of	of	ADP
bjp-25731	232	13	an	an	DET
bjp-25731	232	14	antimalarial	antimalarial	ADJ
bjp-25731	232	15	activity	activity	NOUN
bjp-25731	232	16	variation	variation	NOUN
bjp-25731	232	17	of	of	ADP
bjp-25731	232	18	a	a	DET
bjp-25731	232	19	quinazoline	quinazoline	NOUN
bjp-25731	232	20	derivative	derivative	NOUN
bjp-25731	232	21	(	(	PUNCT
bjp-25731	232	22	khan	khan	PROPN
bjp-25731	232	23	et	et	PROPN
bjp-25731	232	24	al	al	PROPN
bjp-25731	232	25	.	.	PROPN
bjp-25731	232	26	,	,	PUNCT
bjp-25731	232	27	2014	2014	NUM
bjp-25731	232	28	)	)	PUNCT
bjp-25731	232	29	.	.	PUNCT
bjp-25731	233	1	triazolofused	triazolofuse	VERB
bjp-25731	233	2	quinazoline	quinazoline	NOUN
bjp-25731	233	3	31	31	NUM
bjp-25731	233	4	with	with	ADP
bjp-25731	233	5	morpholinyl	morpholinyl	NOUN
bjp-25731	233	6	in	in	ADP
bjp-25731	233	7	2	2	NUM
bjp-25731	233	8	-	-	PUNCT
bjp-25731	233	9	position	position	NOUN
bjp-25731	233	10	and	and	CCONJ
bjp-25731	233	11	chloro	chloro	NOUN
bjp-25731	233	12	on	on	ADP
bjp-25731	233	13	6	6	NUM
bjp-25731	233	14	-	-	PUNCT
bjp-25731	233	15	position	position	NOUN
bjp-25731	233	16	was	be	AUX
bjp-25731	233	17	the	the	DET
bjp-25731	233	18	most	most	ADV
bjp-25731	233	19	potent	potent	ADJ
bjp-25731	233	20	antimicrobial	antimicrobial	ADJ
bjp-25731	233	21	scaffold	scaffold	NOUN
bjp-25731	233	22	among	among	ADP
bjp-25731	233	23	the	the	DET
bjp-25731	233	24	series	series	NOUN
bjp-25731	233	25	synthesized	synthesize	VERB
bjp-25731	233	26	by	by	ADP
bjp-25731	233	27	jantova	jantova	PROPN
bjp-25731	233	28	et	et	PROPN
bjp-25731	233	29	al	al	PROPN
bjp-25731	233	30	,	,	PUNCT
bjp-25731	233	31	(	(	PUNCT
bjp-25731	233	32	2005	2005	NUM
bjp-25731	233	33	)	)	PUNCT
bjp-25731	233	34	.	.	PUNCT
bjp-25731	234	1	presence	presence	NOUN
bjp-25731	234	2	of	of	ADP
bjp-25731	234	3	electron	electron	NOUN
bjp-25731	234	4	donating	donate	VERB
bjp-25731	234	5	bangladesh	bangladesh	PROPN
bjp-25731	234	6	j	j	PROPN
bjp-25731	234	7	pharmacol	pharmacol	PROPN
bjp-25731	234	8	2016	2016	NUM
bjp-25731	234	9	;	;	PUNCT
bjp-25731	234	10	11	11	NUM
bjp-25731	234	11	:	:	PUNCT
bjp-25731	234	12	716	716	NUM
bjp-25731	234	13	-	-	SYM
bjp-25731	234	14	733	733	NUM
bjp-25731	234	15	727	727	NUM
bjp-25731	234	16	diamine	diamine	NOUN
bjp-25731	234	17	at	at	ADP
bjp-25731	234	18	4	4	NUM
bjp-25731	234	19	-	-	PUNCT
bjp-25731	234	20	position	position	NOUN
bjp-25731	234	21	increased	increase	VERB
bjp-25731	234	22	the	the	DET
bjp-25731	234	23	anti	anti	ADJ
bjp-25731	234	24	-	-	ADJ
bjp-25731	234	25	inflammatory	inflammatory	ADJ
bjp-25731	234	26	efficacy	efficacy	NOUN
bjp-25731	234	27	of	of	ADP
bjp-25731	234	28	32	32	NUM
bjp-25731	234	29	(	(	PUNCT
bjp-25731	234	30	lin	lin	PROPN
bjp-25731	234	31	et	et	PROPN
bjp-25731	234	32	al	al	PROPN
bjp-25731	234	33	.	.	PROPN
bjp-25731	234	34	,	,	PUNCT
bjp-25731	234	35	2010	2010	NUM
bjp-25731	234	36	)	)	PUNCT
bjp-25731	234	37	.	.	PUNCT
bjp-25731	235	1	polar	polar	ADJ
bjp-25731	235	2	functionality	functionality	NOUN
bjp-25731	235	3	like	like	ADP
bjp-25731	235	4	hydroxamate	hydroxamate	NOUN
bjp-25731	235	5	when	when	SCONJ
bjp-25731	235	6	inserted	insert	VERB
bjp-25731	235	7	at	at	ADP
bjp-25731	235	8	position-4	position-4	NUM
bjp-25731	235	9	of	of	ADP
bjp-25731	235	10	quinazoline	quinazoline	NOUN
bjp-25731	235	11	templates	template	NOUN
bjp-25731	235	12	,	,	PUNCT
bjp-25731	235	13	core	core	NOUN
bjp-25731	235	14	was	be	AUX
bjp-25731	235	15	reported	report	VERB
bjp-25731	235	16	to	to	PART
bjp-25731	235	17	probably	probably	ADV
bjp-25731	235	18	provide	provide	VERB
bjp-25731	235	19	a	a	DET
bjp-25731	235	20	very	very	ADV
bjp-25731	235	21	active	active	ADJ
bjp-25731	235	22	hdaci	hdaci	NOUN
bjp-25731	235	23	/	/	SYM
bjp-25731	235	24	her2i	her2i	X
bjp-25731	235	25	hybrid	hybrid	NOUN
bjp-25731	235	26	as	as	SCONJ
bjp-25731	235	27	seen	see	VERB
bjp-25731	235	28	in	in	ADP
bjp-25731	235	29	33	33	NUM
bjp-25731	235	30	which	which	PRON
bjp-25731	235	31	was	be	AUX
bjp-25731	235	32	the	the	DET
bjp-25731	235	33	most	most	ADV
bjp-25731	235	34	potent	potent	ADJ
bjp-25731	235	35	hdac	hdac	NOUN
bjp-25731	235	36	inhibitor	inhibitor	NOUN
bjp-25731	235	37	among	among	ADP
bjp-25731	235	38	the	the	DET
bjp-25731	235	39	quinazolines	quinazoline	NOUN
bjp-25731	235	40	designed	design	VERB
bjp-25731	235	41	and	and	CCONJ
bjp-25731	235	42	synthesized	synthesize	VERB
bjp-25731	235	43	by	by	ADP
bjp-25731	235	44	zhang	zhang	PROPN
bjp-25731	235	45	et	et	PROPN
bjp-25731	235	46	al	al	PROPN
bjp-25731	235	47	.	.	PROPN
bjp-25731	236	1	(	(	PUNCT
bjp-25731	236	2	2013b	2013b	NUM
bjp-25731	236	3	)	)	PUNCT
bjp-25731	236	4	.	.	PUNCT
bjp-25731	237	1	some	some	DET
bjp-25731	237	2	structural	structural	ADJ
bjp-25731	237	3	representations	representation	NOUN
bjp-25731	237	4	of	of	ADP
bjp-25731	237	5	quinazoline	quinazoline	NOUN
bjp-25731	237	6	templates	template	NOUN
bjp-25731	237	7	for	for	ADP
bjp-25731	237	8	sar	sar	PROPN
bjp-25731	237	9	study	study	PROPN
bjp-25731	237	10	are	be	AUX
bjp-25731	237	11	as	as	SCONJ
bjp-25731	237	12	shown	show	VERB
bjp-25731	237	13	in	in	ADP
bjp-25731	237	14	figure	figure	NOUN
bjp-25731	237	15	17	17	NUM
bjp-25731	237	16	.	.	PUNCT
bjp-25731	238	1	conclusion	conclusion	NOUN
bjp-25731	238	2	it	it	PRON
bjp-25731	238	3	is	be	AUX
bjp-25731	238	4	reported	report	VERB
bjp-25731	238	5	that	that	SCONJ
bjp-25731	238	6	in	in	ADP
bjp-25731	238	7	recent	recent	ADJ
bjp-25731	238	8	times	time	NOUN
bjp-25731	238	9	lots	lot	NOUN
bjp-25731	238	10	of	of	ADP
bjp-25731	238	11	pathogens	pathogen	NOUN
bjp-25731	238	12	and	and	CCONJ
bjp-25731	238	13	causative	causative	ADJ
bjp-25731	238	14	agent	agent	NOUN
bjp-25731	238	15	of	of	ADP
bjp-25731	238	16	diseases	disease	NOUN
bjp-25731	238	17	have	have	AUX
bjp-25731	238	18	grown	grow	VERB
bjp-25731	238	19	resistant	resistant	ADJ
bjp-25731	238	20	abilities	ability	NOUN
bjp-25731	238	21	to	to	ADP
bjp-25731	238	22	the	the	DET
bjp-25731	238	23	old	old	ADJ
bjp-25731	238	24	existing	exist	VERB
bjp-25731	238	25	and	and	CCONJ
bjp-25731	238	26	commercially	commercially	ADV
bjp-25731	238	27	available	available	ADJ
bjp-25731	238	28	drugs	drug	NOUN
bjp-25731	238	29	,	,	PUNCT
bjp-25731	238	30	which	which	PRON
bjp-25731	238	31	have	have	AUX
bjp-25731	238	32	made	make	VERB
bjp-25731	238	33	the	the	DET
bjp-25731	238	34	cure	cure	NOUN
bjp-25731	238	35	of	of	ADP
bjp-25731	238	36	these	these	DET
bjp-25731	238	37	diseases	disease	NOUN
bjp-25731	238	38	harder	hard	ADV
bjp-25731	238	39	and	and	CCONJ
bjp-25731	238	40	almost	almost	ADV
bjp-25731	238	41	impossible	impossible	ADJ
bjp-25731	238	42	.	.	PUNCT
bjp-25731	239	1	quinazoline	quinazoline	NOUN
bjp-25731	239	2	derivatives	derivative	NOUN
bjp-25731	239	3	are	be	AUX
bjp-25731	239	4	considered	consider	VERB
bjp-25731	239	5	as	as	ADP
bjp-25731	239	6	important	important	ADJ
bjp-25731	239	7	precursors	precursor	NOUN
bjp-25731	239	8	for	for	ADP
bjp-25731	239	9	the	the	DET
bjp-25731	239	10	synthesis	synthesis	NOUN
bjp-25731	239	11	of	of	ADP
bjp-25731	239	12	various	various	ADJ
bjp-25731	239	13	physiologically	physiologically	ADV
bjp-25731	239	14	significant	significant	ADJ
bjp-25731	239	15	and	and	CCONJ
bjp-25731	239	16	pharmacologically	pharmacologically	ADV
bjp-25731	239	17	utilized	utilize	VERB
bjp-25731	239	18	molecules	molecule	NOUN
bjp-25731	239	19	.	.	PUNCT
bjp-25731	240	1	this	this	DET
bjp-25731	240	2	present	present	ADJ
bjp-25731	240	3	article	article	NOUN
bjp-25731	240	4	provides	provide	VERB
bjp-25731	240	5	the	the	DET
bjp-25731	240	6	researchers	researcher	NOUN
bjp-25731	240	7	with	with	ADP
bjp-25731	240	8	a	a	DET
bjp-25731	240	9	pool	pool	NOUN
bjp-25731	240	10	of	of	ADP
bjp-25731	240	11	diagnostic	diagnostic	ADJ
bjp-25731	240	12	information	information	NOUN
bjp-25731	240	13	in	in	ADP
bjp-25731	240	14	quinazoline	quinazoline	NOUN
bjp-25731	240	15	templates	template	NOUN
bjp-25731	240	16	and	and	CCONJ
bjp-25731	240	17	thorough	thorough	ADJ
bjp-25731	240	18	understanding	understanding	NOUN
bjp-25731	240	19	of	of	ADP
bjp-25731	240	20	their	their	PRON
bjp-25731	240	21	structure	structure	NOUN
bjp-25731	240	22	activity	activity	NOUN
bjp-25731	240	23	relationship	relationship	NOUN
bjp-25731	240	24	study	study	NOUN
bjp-25731	240	25	in	in	ADP
bjp-25731	240	26	order	order	NOUN
bjp-25731	240	27	to	to	PART
bjp-25731	240	28	help	help	VERB
bjp-25731	240	29	mankind	mankind	NOUN
bjp-25731	240	30	against	against	ADP
bjp-25731	240	31	the	the	DET
bjp-25731	240	32	adverse	adverse	ADJ
bjp-25731	240	33	effect	effect	NOUN
bjp-25731	240	34	of	of	ADP
bjp-25731	240	35	drug	drug	NOUN
bjp-25731	240	36	-	-	PUNCT
bjp-25731	240	37	resistance	resistance	NOUN
bjp-25731	240	38	pathogens	pathogen	NOUN
bjp-25731	240	39	and	and	CCONJ
bjp-25731	240	40	newly	newly	ADV
bjp-25731	240	41	occurring	occur	VERB
bjp-25731	240	42	infectious	infectious	ADJ
bjp-25731	240	43	diseases	disease	NOUN
bjp-25731	240	44	.	.	PUNCT
bjp-25731	241	1	this	this	PRON
bjp-25731	241	2	further	far	ADV
bjp-25731	241	3	helps	help	VERB
bjp-25731	241	4	in	in	ADP
bjp-25731	241	5	designing	design	VERB
bjp-25731	241	6	large	large	ADJ
bjp-25731	241	7	number	number	NOUN
bjp-25731	241	8	of	of	ADP
bjp-25731	241	9	quinazoline	quinazoline	NOUN
bjp-25731	241	10	and	and	CCONJ
bjp-25731	241	11	quinazolinone	quinazolinone	NOUN
bjp-25731	241	12	compounds	compound	NOUN
bjp-25731	241	13	with	with	ADP
bjp-25731	241	14	a	a	DET
bjp-25731	241	15	strong	strong	ADJ
bjp-25731	241	16	impact	impact	NOUN
bjp-25731	241	17	in	in	ADP
bjp-25731	241	18	curing	cure	VERB
bjp-25731	241	19	many	many	ADJ
bjp-25731	241	20	fatal	fatal	ADJ
bjp-25731	241	21	disorders	disorder	NOUN
bjp-25731	241	22	and	and	CCONJ
bjp-25731	241	23	infectious	infectious	ADJ
bjp-25731	241	24	diseases	disease	NOUN
bjp-25731	241	25	.	.	PUNCT
bjp-25731	242	1	quinazoline	quinazoline	NOUN
bjp-25731	242	2	derivatives	derivative	NOUN
bjp-25731	242	3	are	be	AUX
bjp-25731	242	4	therefore	therefore	ADV
bjp-25731	242	5	projected	project	VERB
bjp-25731	242	6	as	as	ADP
bjp-25731	242	7	valuable	valuable	ADJ
bjp-25731	242	8	tools	tool	NOUN
bjp-25731	242	9	for	for	ADP
bjp-25731	242	10	the	the	DET
bjp-25731	242	11	development	development	NOUN
bjp-25731	242	12	of	of	ADP
bjp-25731	242	13	novel	novel	ADJ
bjp-25731	242	14	pharmacological	pharmacological	ADJ
bjp-25731	242	15	entities	entity	NOUN
bjp-25731	242	16	treatment	treatment	NOUN
bjp-25731	242	17	of	of	ADP
bjp-25731	242	18	diverse	diverse	ADJ
bjp-25731	242	19	infectious	infectious	ADJ
bjp-25731	242	20	diseases	disease	NOUN
bjp-25731	242	21	and	and	CCONJ
bjp-25731	242	22	disorder	disorder	NOUN
bjp-25731	242	23	in	in	ADP
bjp-25731	242	24	the	the	DET
bjp-25731	242	25	therapeutic	therapeutic	ADJ
bjp-25731	242	26	medicine	medicine	NOUN
bjp-25731	242	27	.	.	PUNCT
bjp-25731	243	1	conflict	conflict	NOUN
bjp-25731	243	2	of	of	ADP
bjp-25731	243	3	interest	interest	NOUN
bjp-25731	243	4	authors	author	NOUN
bjp-25731	243	5	hereby	hereby	ADV
bjp-25731	243	6	declare	declare	VERB
bjp-25731	243	7	that	that	SCONJ
bjp-25731	243	8	there	there	PRON
bjp-25731	243	9	are	be	VERB
bjp-25731	243	10	no	no	DET
bjp-25731	243	11	conflict	conflict	NOUN
bjp-25731	243	12	of	of	ADP
bjp-25731	243	13	interest	interest	NOUN
bjp-25731	243	14	as	as	ADP
bjp-25731	243	15	regard	regard	NOUN
bjp-25731	243	16	to	to	ADP
bjp-25731	243	17	this	this	DET
bjp-25731	243	18	work	work	NOUN
bjp-25731	243	19	.	.	PUNCT
bjp-25731	244	1	references	reference	NOUN
bjp-25731	244	2	ahmed	ahme	VERB
bjp-25731	244	3	om	om	PROPN
bjp-25731	244	4	,	,	PUNCT
bjp-25731	244	5	hussein	hussein	PROPN
bjp-25731	244	6	am	be	AUX
bjp-25731	244	7	,	,	PUNCT
bjp-25731	244	8	ahmed	ahmed	PROPN
bjp-25731	244	9	rr	rr	PROPN
bjp-25731	244	10	.	.	PROPN
bjp-25731	244	11	antidiabetic	antidiabetic	ADJ
bjp-25731	244	12	and	and	CCONJ
bjp-25731	244	13	antioxidant	antioxidant	ADJ
bjp-25731	244	14	effects	effect	NOUN
bjp-25731	244	15	of	of	ADP
bjp-25731	244	16	newly	newly	ADV
bjp-25731	244	17	synthesized	synthesize	VERB
bjp-25731	244	18	pyrimido[1,6	pyrimido[1,6	PROPN
bjp-25731	244	19	-	-	PUNCT
bjp-25731	244	20	a]pyrimidine	a]pyrimidine	NOUN
bjp-25731	244	21	derivatives	derivative	NOUN
bjp-25731	244	22	in	in	ADP
bjp-25731	244	23	neonatal	neonatal	ADJ
bjp-25731	244	24	streptozotocin	streptozotocin	NOUN
bjp-25731	244	25	-	-	PUNCT
bjp-25731	244	26	induced	induce	VERB
bjp-25731	244	27	diabetic	diabetic	ADJ
bjp-25731	244	28	rats	rat	NOUN
bjp-25731	244	29	.	.	PUNCT
bjp-25731	245	1	med	med	ADJ
bjp-25731	245	2	chem	chem	NOUN
bjp-25731	245	3	.	.	PUNCT
bjp-25731	246	1	2012	2012	NUM
bjp-25731	246	2	;	;	PUNCT
bjp-25731	246	3	2	2	NUM
bjp-25731	246	4	:	:	SYM
bjp-25731	246	5	20	20	NUM
bjp-25731	246	6	-	-	SYM
bjp-25731	246	7	28	28	NUM
bjp-25731	246	8	.	.	PUNCT
bjp-25731	247	1	ajani	ajani	PROPN
bjp-25731	247	2	oo	oo	VERB
bjp-25731	247	3	.	.	PUNCT
bjp-25731	248	1	present	present	ADJ
bjp-25731	248	2	status	status	NOUN
bjp-25731	248	3	of	of	ADP
bjp-25731	248	4	quinoxaline	quinoxaline	ADJ
bjp-25731	248	5	motifs	motif	NOUN
bjp-25731	248	6	:	:	PUNCT
bjp-25731	248	7	excellent	excellent	ADJ
bjp-25731	248	8	pathfinders	pathfinder	NOUN
bjp-25731	248	9	in	in	ADP
bjp-25731	248	10	therapeutic	therapeutic	ADJ
bjp-25731	248	11	medicine	medicine	NOUN
bjp-25731	248	12	.	.	PUNCT
bjp-25731	249	1	eur	eur	PROPN
bjp-25731	249	2	j	j	PROPN
bjp-25731	249	3	med	med	PROPN
bjp-25731	249	4	chem	chem	NOUN
bjp-25731	249	5	.	.	PUNCT
bjp-25731	250	1	2014	2014	NUM
bjp-25731	250	2	;	;	PUNCT
bjp-25731	250	3	85	85	NUM
bjp-25731	250	4	:	:	PUNCT
bjp-25731	250	5	688	688	NUM
bjp-25731	250	6	-	-	SYM
bjp-25731	250	7	715	715	NUM
bjp-25731	250	8	.	.	PUNCT
bjp-25731	251	1	ajani	ajani	PROPN
bjp-25731	251	2	oo	oo	PROPN
bjp-25731	251	3	,	,	PUNCT
bjp-25731	251	4	nwinyi	nwinyi	NOUN
bjp-25731	251	5	oc	oc	PROPN
bjp-25731	251	6	.	.	PUNCT
bjp-25731	251	7	synthesis	synthesis	NOUN
bjp-25731	251	8	and	and	CCONJ
bjp-25731	251	9	evaluation	evaluation	NOUN
bjp-25731	251	10	of	of	ADP
bjp-25731	251	11	antimicrobial	antimicrobial	ADJ
bjp-25731	251	12	activity	activity	NOUN
bjp-25731	251	13	of	of	ADP
bjp-25731	251	14	phenyl	phenyl	NOUN
bjp-25731	251	15	and	and	CCONJ
bjp-25731	251	16	furan-2	furan-2	PROPN
bjp-25731	251	17	-	-	PUNCT
bjp-25731	251	18	yl[1,2,4]triazolo[4,3	yl[1,2,4]triazolo[4,3	NOUN
bjp-25731	251	19	-	-	PUNCT
bjp-25731	251	20	a	a	NOUN
bjp-25731	251	21	]	]	X
bjp-25731	251	22	quinoxalin-4(5h)-one	quinoxalin-4(5h)-one	NOUN
bjp-25731	251	23	and	and	CCONJ
bjp-25731	251	24	their	their	PRON
bjp-25731	251	25	hydrazone	hydrazone	NOUN
bjp-25731	251	26	precursors	precursor	NOUN
bjp-25731	251	27	.	.	PUNCT
bjp-25731	252	1	canadian	canadian	PROPN
bjp-25731	252	2	j	j	PROPN
bjp-25731	252	3	pure	pure	PROPN
bjp-25731	252	4	appl	appl	PROPN
bjp-25731	252	5	sci	sci	PROPN
bjp-25731	252	6	.	.	PROPN
bjp-25731	252	7	2009	2009	NUM
bjp-25731	252	8	;	;	PUNCT
bjp-25731	252	9	3	3	NUM
bjp-25731	252	10	:	:	PUNCT
bjp-25731	252	11	983	983	NUM
bjp-25731	252	12	-	-	SYM
bjp-25731	252	13	92	92	NUM
bjp-25731	252	14	.	.	PUNCT
bjp-25731	253	1	alafeefy	alafeefy	PROPN
bjp-25731	253	2	am	am	PROPN
bjp-25731	253	3	,	,	PUNCT
bjp-25731	253	4	ceruso	ceruso	PROPN
bjp-25731	253	5	m	m	PROPN
bjp-25731	253	6	,	,	PUNCT
bjp-25731	253	7	al	al	PROPN
bjp-25731	253	8	-	-	PUNCT
bjp-25731	253	9	tamimi	tamimi	PROPN
bjp-25731	253	10	ams	am	NOUN
bjp-25731	253	11	,	,	PUNCT
bjp-25731	253	12	prete	prete	NOUN
bjp-25731	253	13	sd	sd	NOUN
bjp-25731	253	14	,	,	PUNCT
bjp-25731	253	15	capasso	capasso	ADJ
bjp-25731	253	16	c	c	NOUN
bjp-25731	253	17	,	,	PUNCT
bjp-25731	253	18	supuran	supuran	NOUN
bjp-25731	253	19	,	,	PUNCT
bjp-25731	253	20	ct	ct	PROPN
bjp-25731	253	21	.	.	PUNCT
bjp-25731	253	22	quinazoline	quinazoline	NOUN
bjp-25731	253	23	–	–	PUNCT
bjp-25731	253	24	sulfonamides	sulfonamide	NOUN
bjp-25731	253	25	with	with	ADP
bjp-25731	253	26	potent	potent	ADJ
bjp-25731	253	27	inhibitory	inhibitory	ADJ
bjp-25731	253	28	activity	activity	NOUN
bjp-25731	253	29	against	against	ADP
bjp-25731	253	30	the	the	DET
bjp-25731	253	31	-carbonic	-carbonic	ADJ
bjp-25731	253	32	anhydrase	anhydrase	NOUN
bjp-25731	253	33	from	from	ADP
bjp-25731	253	34	vibrio	vibrio	ADJ
bjp-25731	253	35	cholera	cholera	NOUN
bjp-25731	253	36	.	.	PUNCT
bjp-25731	254	1	bioorg	bioorg	PROPN
bjp-25731	254	2	med	med	PROPN
bjp-25731	254	3	chem	chem	NOUN
bjp-25731	254	4	.	.	PUNCT
bjp-25731	255	1	2014	2014	NUM
bjp-25731	255	2	;	;	PUNCT
bjp-25731	255	3	22	22	NUM
bjp-25731	255	4	:	:	SYM
bjp-25731	255	5	5133	5133	NUM
bjp-25731	255	6	-	-	SYM
bjp-25731	255	7	40	40	NUM
bjp-25731	255	8	.	.	PUNCT
bjp-25731	256	1	al	al	PROPN
bjp-25731	256	2	-	-	PUNCT
bjp-25731	256	3	azawi	azawi	PROPN
bjp-25731	256	4	k.	k.	PROPN
bjp-25731	256	5	synthesis	synthesis	PROPN
bjp-25731	256	6	,	,	PUNCT
bjp-25731	256	7	characterization	characterization	NOUN
bjp-25731	256	8	and	and	CCONJ
bjp-25731	256	9	anti	anti	ADJ
bjp-25731	256	10	-	-	ADJ
bjp-25731	256	11	oxidant	oxidant	ADJ
bjp-25731	256	12	studies	study	NOUN
bjp-25731	256	13	of	of	ADP
bjp-25731	256	14	quinazolin	quinazolin	NOUN
bjp-25731	256	15	derivatives	derivative	NOUN
bjp-25731	256	16	.	.	PUNCT
bjp-25731	257	1	orient	orient	PROPN
bjp-25731	257	2	j	j	PROPN
bjp-25731	257	3	chem	chem	NOUN
bjp-25731	257	4	.	.	PUNCT
bjp-25731	258	1	2016	2016	NUM
bjp-25731	258	2	;	;	PUNCT
bjp-25731	258	3	32	32	NUM
bjp-25731	258	4	:	:	PUNCT
bjp-25731	258	5	585	585	NUM
bjp-25731	258	6	-	-	SYM
bjp-25731	258	7	90	90	NUM
bjp-25731	258	8	.	.	PUNCT
bjp-25731	259	1	ali	ali	PROPN
bjp-25731	259	2	ma	ma	PROPN
bjp-25731	259	3	,	,	PUNCT
bjp-25731	259	4	shaharyar	shaharyar	PROPN
bjp-25731	259	5	m	m	PROPN
bjp-25731	259	6	,	,	PUNCT
bjp-25731	259	7	de	de	PROPN
bjp-25731	259	8	clercq	clercq	PROPN
bjp-25731	259	9	e.	e.	PROPN
bjp-25731	259	10	synthesis	synthesis	NOUN
bjp-25731	259	11	of	of	ADP
bjp-25731	259	12	5-(4	5-(4	NOUN
bjp-25731	259	13	-	-	PUNCT
bjp-25731	259	14	hydroxy3	hydroxy3	NOUN
bjp-25731	259	15	-	-	PUNCT
bjp-25731	259	16	methylphenyl)-5-(substitutedphenyl)-4	methylphenyl)-5-(substitutedphenyl)-4	VERB
bjp-25731	259	17	,	,	PUNCT
bjp-25731	259	18	5	5	NUM
bjp-25731	259	19	-	-	PUNCT
bjp-25731	259	20	dihydro-1h-1pyrazolyl-4	dihydro-1h-1pyrazolyl-4	NOUN
bjp-25731	259	21	-	-	PUNCT
bjp-25731	259	22	pyridylmethanone	pyridylmethanone	NOUN
bjp-25731	259	23	derivatives	derivative	NOUN
bjp-25731	259	24	with	with	ADP
bjp-25731	259	25	antiviral	antiviral	ADJ
bjp-25731	259	26	activity	activity	NOUN
bjp-25731	259	27	.	.	PUNCT
bjp-25731	260	1	j	j	PROPN
bjp-25731	260	2	enzym	enzym	NOUN
bjp-25731	260	3	inhib	inhib	VERB
bjp-25731	260	4	med	med	ADJ
bjp-25731	260	5	chem	chem	NOUN
bjp-25731	260	6	.	.	PUNCT
bjp-25731	261	1	2007	2007	NUM
bjp-25731	261	2	;	;	PUNCT
bjp-25731	261	3	22	22	NUM
bjp-25731	261	4	:	:	PUNCT
bjp-25731	261	5	702	702	NUM
bjp-25731	261	6	-	-	SYM
bjp-25731	261	7	08	08	NUM
bjp-25731	261	8	.	.	PUNCT
bjp-25731	262	1	al	al	PROPN
bjp-25731	262	2	-	-	PUNCT
bjp-25731	262	3	omary	omary	PROPN
bjp-25731	262	4	fa	fa	PROPN
bjp-25731	262	5	,	,	PUNCT
bjp-25731	262	6	hassan	hassan	PROPN
bjp-25731	262	7	gs	gs	PROPN
bjp-25731	262	8	,	,	PUNCT
bjp-25731	262	9	el	el	PROPN
bjp-25731	262	10	-	-	PROPN
bjp-25731	262	11	messery	messery	PROPN
bjp-25731	263	1	sm	sm	PROPN
bjp-25731	263	2	,	,	PUNCT
bjp-25731	263	3	el	el	PROPN
bjp-25731	263	4	-	-	PROPN
bjp-25731	263	5	subbagh	subbagh	PROPN
bjp-25731	263	6	hi	hi	PROPN
bjp-25731	263	7	.	.	PROPN
bjp-25731	263	8	substituted	substitute	VERB
bjp-25731	263	9	thiazoles	thiazole	NOUN
bjp-25731	263	10	v.	v.	ADP
bjp-25731	263	11	synthesis	synthesis	NOUN
bjp-25731	263	12	and	and	CCONJ
bjp-25731	263	13	antitumor	antitumor	NOUN
bjp-25731	263	14	activity	activity	NOUN
bjp-25731	263	15	of	of	ADP
bjp-25731	263	16	novel	novel	NOUN
bjp-25731	263	17	thiazolo[2,3	thiazolo[2,3	PROPN
bjp-25731	263	18	-	-	PUNCT
bjp-25731	263	19	b]quinazoline	b]quinazoline	PROPN
bjp-25731	263	20	and	and	CCONJ
bjp-25731	263	21	pyrido[4,3	pyrido[4,3	PROPN
bjp-25731	263	22	-	-	PUNCT
bjp-25731	263	23	d]thiazolo	d]thiazolo	PROPN
bjp-25731	263	24	[	[	PUNCT
bjp-25731	263	25	3,2	3,2	NUM
bjp-25731	263	26	-	-	PUNCT
bjp-25731	263	27	a]pyrimidine	a]pyrimidine	VERB
bjp-25731	263	28	analogues	analogue	NOUN
bjp-25731	263	29	.	.	PUNCT
bjp-25731	264	1	eur	eur	PROPN
bjp-25731	264	2	j	j	PROPN
bjp-25731	264	3	med	med	PROPN
bjp-25731	264	4	chem	chem	NOUN
bjp-25731	264	5	.	.	PUNCT
bjp-25731	265	1	2012	2012	NUM
bjp-25731	265	2	;	;	PUNCT
bjp-25731	265	3	47	47	NUM
bjp-25731	265	4	:	:	SYM
bjp-25731	265	5	6572	6572	NUM
bjp-25731	265	6	.	.	PUNCT
bjp-25731	266	1	al	al	PROPN
bjp-25731	266	2	-	-	PUNCT
bjp-25731	266	3	salahi	salahi	PROPN
bjp-25731	266	4	r	r	NOUN
bjp-25731	266	5	,	,	PUNCT
bjp-25731	266	6	abuelizz	abuelizz	NOUN
bjp-25731	266	7	ha	ha	INTJ
bjp-25731	266	8	,	,	PUNCT
bjp-25731	266	9	ghabbour	ghabbour	NOUN
bjp-25731	266	10	ha	ha	INTJ
bjp-25731	266	11	,	,	PUNCT
bjp-25731	266	12	el	el	PROPN
bjp-25731	266	13	-	-	PROPN
bjp-25731	266	14	dib	dib	PROPN
bjp-25731	266	15	r	r	NOUN
bjp-25731	266	16	,	,	PUNCT
bjp-25731	266	17	marzouk	marzouk	CCONJ
bjp-25731	266	18	m.	m.	NOUN
bjp-25731	266	19	molecular	molecular	ADJ
bjp-25731	266	20	docking	docking	NOUN
bjp-25731	266	21	study	study	NOUN
bjp-25731	266	22	and	and	CCONJ
bjp-25731	266	23	antiviral	antiviral	ADJ
bjp-25731	266	24	evaluation	evaluation	NOUN
bjp-25731	266	25	of	of	ADP
bjp-25731	266	26	2thioxo	2thioxo	PROPN
bjp-25731	266	27	-	-	PUNCT
bjp-25731	266	28	benzo[g]quinazolin-4(3h)-one	benzo[g]quinazolin-4(3h)-one	NOUN
bjp-25731	266	29	derivatives	derivative	NOUN
bjp-25731	266	30	.	.	PUNCT
bjp-25731	267	1	chem	chem	NOUN
bjp-25731	267	2	cent	cent	NOUN
bjp-25731	267	3	j.	j.	PROPN
bjp-25731	267	4	2016	2016	NUM
bjp-25731	267	5	;	;	PUNCT
bjp-25731	267	6	10	10	NUM
bjp-25731	267	7	:	:	SYM
bjp-25731	267	8	21	21	NUM
bjp-25731	267	9	.	.	X
bjp-25731	268	1	aly	aly	PROPN
bjp-25731	268	2	mm	mm	PROPN
bjp-25731	268	3	,	,	PUNCT
bjp-25731	268	4	mohamed	mohamed	PROPN
bjp-25731	268	5	ya	ya	PROPN
bjp-25731	268	6	,	,	PUNCT
bjp-25731	268	7	el	el	PROPN
bjp-25731	268	8	-	-	PUNCT
bjp-25731	268	9	bayouki	bayouki	VERB
bjp-25731	268	10	km	km	PROPN
bjp-25731	268	11	,	,	PUNCT
bjp-25731	268	12	basyouni	basyouni	PROPN
bjp-25731	268	13	wm	wm	PROPN
bjp-25731	268	14	,	,	PUNCT
bjp-25731	268	15	abbas	abbas	PROPN
bjp-25731	268	16	s.y	s.y	PROPN
bjp-25731	268	17	.	.	PROPN
bjp-25731	268	18	synthesis	synthesis	NOUN
bjp-25731	268	19	of	of	ADP
bjp-25731	268	20	some	some	DET
bjp-25731	268	21	new4(3h)-quinazolinone-2carboxaldehyde	new4(3h)-quinazolinone-2carboxaldehyde	NOUN
bjp-25731	268	22	thiosemicarbazones	thiosemicarbazone	NOUN
bjp-25731	268	23	and	and	CCONJ
bjp-25731	268	24	their	their	PRON
bjp-25731	268	25	metal	metal	NOUN
bjp-25731	268	26	complexes	complex	NOUN
bjp-25731	268	27	and	and	CCONJ
bjp-25731	268	28	a	a	DET
bjp-25731	268	29	study	study	NOUN
bjp-25731	268	30	on	on	ADP
bjp-25731	268	31	their	their	PRON
bjp-25731	268	32	anticonvulsant	anticonvulsant	ADJ
bjp-25731	268	33	,	,	PUNCT
bjp-25731	268	34	analgesic	analgesic	ADJ
bjp-25731	268	35	,	,	PUNCT
bjp-25731	268	36	cytotoxic	cytotoxic	ADJ
bjp-25731	268	37	and	and	CCONJ
bjp-25731	268	38	antimicrobial	antimicrobial	ADJ
bjp-25731	268	39	activities	activity	NOUN
bjp-25731	268	40	.	.	PUNCT
bjp-25731	269	1	eur	eur	PROPN
bjp-25731	269	2	j	j	PROPN
bjp-25731	269	3	med	med	PROPN
bjp-25731	269	4	chem	chem	NOUN
bjp-25731	269	5	.	.	PUNCT
bjp-25731	270	1	2010	2010	NUM
bjp-25731	270	2	;	;	PUNCT
bjp-25731	270	3	45	45	NUM
bjp-25731	270	4	:	:	SYM
bjp-25731	270	5	3365	3365	NUM
bjp-25731	270	6	-	-	SYM
bjp-25731	270	7	73	73	NUM
bjp-25731	270	8	.	.	PUNCT
bjp-25731	271	1	figure	figure	NOUN
bjp-25731	271	2	16	16	NUM
bjp-25731	271	3	:	:	PUNCT
bjp-25731	271	4	elinogrel	elinogrel	NOUN
bjp-25731	271	5	as	as	ADP
bjp-25731	271	6	selected	select	VERB
bjp-25731	271	7	quinazoline	quinazoline	NOUN
bjp-25731	271	8	-	-	PUNCT
bjp-25731	271	9	based	base	VERB
bjp-25731	271	10	antithrombotic	antithrombotic	ADJ
bjp-25731	271	11	marketed	market	VERB
bjp-25731	271	12	drug	drug	NOUN
bjp-25731	271	13	figure	figure	NOUN
bjp-25731	271	14	17	17	NUM
bjp-25731	271	15	:	:	PUNCT
bjp-25731	271	16	representative	representative	ADJ
bjp-25731	271	17	quinazoline	quinazoline	NOUN
bjp-25731	271	18	motifs	motif	NOUN
bjp-25731	271	19	for	for	ADP
bjp-25731	271	20	sar	sar	PROPN
bjp-25731	271	21	study	study	PROPN
bjp-25731	271	22	728	728	NUM
bjp-25731	271	23	bangladesh	bangladesh	PROPN
bjp-25731	271	24	j	j	PROPN
bjp-25731	271	25	pharmacol	pharmacol	PROPN
bjp-25731	271	26	2016	2016	NUM
bjp-25731	271	27	;	;	PUNCT
bjp-25731	271	28	11	11	NUM
bjp-25731	271	29	:	:	PUNCT
bjp-25731	271	30	716	716	NUM
bjp-25731	271	31	-	-	SYM
bjp-25731	271	32	733	733	NUM
bjp-25731	271	33	anand	anand	PROPN
bjp-25731	271	34	t	t	PROPN
bjp-25731	271	35	,	,	PUNCT
bjp-25731	271	36	sivaraman	sivaraman	NOUN
bjp-25731	271	37	g	g	PROPN
bjp-25731	271	38	,	,	PUNCT
bjp-25731	271	39	chellappa	chellappa	PROPN
bjp-25731	271	40	d.	d.	PROPN
bjp-25731	271	41	quinazoline	quinazoline	PROPN
bjp-25731	271	42	copper(ii	copper(ii	PROPN
bjp-25731	271	43	)	)	PUNCT
bjp-25731	271	44	ensemble	ensemble	ADJ
bjp-25731	271	45	as	as	ADP
bjp-25731	271	46	turn	turn	NOUN
bjp-25731	271	47	-	-	PUNCT
bjp-25731	271	48	on	on	ADP
bjp-25731	271	49	fluorescence	fluorescence	NOUN
bjp-25731	271	50	sensor	sensor	NOUN
bjp-25731	271	51	for	for	ADP
bjp-25731	271	52	cysteine	cysteine	NOUN
bjp-25731	271	53	and	and	CCONJ
bjp-25731	271	54	chemodosimeter	chemodosimeter	VERB
bjp-25731	271	55	for	for	ADP
bjp-25731	271	56	no	no	NOUN
bjp-25731	271	57	.	.	PUNCT
bjp-25731	272	1	j	j	PROPN
bjp-25731	272	2	photochem	photochem	PROPN
bjp-25731	272	3	photobiol	photobiol	PROPN
bjp-25731	272	4	a	a	DET
bjp-25731	272	5	:	:	PUNCT
bjp-25731	272	6	chem	chem	NOUN
bjp-25731	272	7	.	.	PUNCT
bjp-25731	272	8	2014	2014	NUM
bjp-25731	272	9	;	;	PUNCT
bjp-25731	272	10	281	281	NUM
bjp-25731	272	11	:	:	PUNCT
bjp-25731	272	12	47	47	NUM
bjp-25731	272	13	-	-	SYM
bjp-25731	272	14	52	52	NUM
bjp-25731	272	15	.	.	PUNCT
bjp-25731	273	1	ankita	ankita	PROPN
bjp-25731	273	2	w	w	PROPN
bjp-25731	273	3	,	,	PUNCT
bjp-25731	273	4	pranay	pranay	PROPN
bjp-25731	273	5	w	w	PROPN
bjp-25731	273	6	,	,	PUNCT
bjp-25731	273	7	nishi	nishi	NOUN
bjp-25731	273	8	g	g	PROPN
bjp-25731	273	9	,	,	PUNCT
bjp-25731	273	10	rai	rai	PROPN
bjp-25731	273	11	ak	ak	PROPN
bjp-25731	273	12	,	,	PUNCT
bjp-25731	273	13	srivastav	srivastav	ADJ
bjp-25731	273	14	rs	rs	NOUN
bjp-25731	273	15	.	.	PUNCT
bjp-25731	274	1	novel	novel	ADJ
bjp-25731	274	2	class	class	NOUN
bjp-25731	274	3	of	of	ADP
bjp-25731	274	4	semi	semi	ADJ
bjp-25731	274	5	synthetic	synthetic	ADJ
bjp-25731	274	6	natural	natural	ADJ
bjp-25731	274	7	products	product	NOUN
bjp-25731	274	8	derived	derive	VERB
bjp-25731	274	9	from	from	ADP
bjp-25731	274	10	lupeol	lupeol	NOUN
bjp-25731	274	11	as	as	ADP
bjp-25731	274	12	antitubercular	antitubercular	ADJ
bjp-25731	274	13	agents	agent	NOUN
bjp-25731	274	14	.	.	PUNCT
bjp-25731	275	1	stand	stand	VERB
bjp-25731	275	2	res	re	NOUN
bjp-25731	275	3	j	j	PROPN
bjp-25731	275	4	pharm	pharm	PROPN
bjp-25731	275	5	pharmacol	pharmacol	PROPN
bjp-25731	275	6	.	.	PUNCT
bjp-25731	275	7	2014	2014	NUM
bjp-25731	275	8	;	;	PUNCT
bjp-25731	275	9	2	2	NUM
bjp-25731	275	10	:	:	SYM
bjp-25731	275	11	40	40	NUM
bjp-25731	275	12	-	-	SYM
bjp-25731	275	13	45	45	NUM
bjp-25731	275	14	.	.	PUNCT
bjp-25731	276	1	antonello	antonello	PROPN
bjp-25731	276	2	a	a	PRON
bjp-25731	276	3	,	,	PUNCT
bjp-25731	276	4	tarozzi	tarozzi	NOUN
bjp-25731	276	5	a	a	PRON
bjp-25731	276	6	,	,	PUNCT
bjp-25731	276	7	morroni	morroni	NOUN
bjp-25731	276	8	f	f	PROPN
bjp-25731	276	9	,	,	PUNCT
bjp-25731	276	10	cavalli	cavalli	PROPN
bjp-25731	276	11	a	a	X
bjp-25731	276	12	,	,	PUNCT
bjp-25731	276	13	rosini	rosini	PROPN
bjp-25731	276	14	m	m	PROPN
bjp-25731	276	15	,	,	PUNCT
bjp-25731	276	16	hrelia	hrelia	PROPN
bjp-25731	276	17	p	p	X
bjp-25731	276	18	,	,	PUNCT
bjp-25731	276	19	bolognesi	bolognesi	NOUN
bjp-25731	276	20	ml	ml	PROPN
bjp-25731	276	21	,	,	PUNCT
bjp-25731	276	22	melchiorre	melchiorre	PROPN
bjp-25731	276	23	c.	c.	PROPN
bjp-25731	276	24	multitarget	multitarget	PROPN
bjp-25731	276	25	-	-	PUNCT
bjp-25731	276	26	directed	direct	VERB
bjp-25731	276	27	drug	drug	NOUN
bjp-25731	276	28	design	design	NOUN
bjp-25731	276	29	strategy	strategy	NOUN
bjp-25731	276	30	:	:	PUNCT
bjp-25731	276	31	a	a	DET
bjp-25731	276	32	novel	novel	ADJ
bjp-25731	276	33	molecule	molecule	NOUN
bjp-25731	276	34	designed	design	VERB
bjp-25731	276	35	to	to	PART
bjp-25731	276	36	block	block	VERB
bjp-25731	276	37	epidermal	epidermal	ADJ
bjp-25731	276	38	growth	growth	NOUN
bjp-25731	276	39	factor	factor	NOUN
bjp-25731	276	40	receptor	receptor	NOUN
bjp-25731	276	41	(	(	PUNCT
bjp-25731	276	42	egfr	egfr	X
bjp-25731	276	43	)	)	PUNCT
bjp-25731	276	44	and	and	CCONJ
bjp-25731	276	45	to	to	PART
bjp-25731	276	46	exert	exert	VERB
bjp-25731	276	47	proapoptotic	proapoptotic	ADJ
bjp-25731	276	48	effects	effect	NOUN
bjp-25731	276	49	.	.	PUNCT
bjp-25731	277	1	j	j	PROPN
bjp-25731	277	2	med	med	PROPN
bjp-25731	277	3	chem	chem	NOUN
bjp-25731	277	4	.	.	PUNCT
bjp-25731	278	1	2006	2006	NUM
bjp-25731	278	2	;	;	PUNCT
bjp-25731	278	3	49	49	NUM
bjp-25731	278	4	:	:	PUNCT
bjp-25731	278	5	6642	6642	NUM
bjp-25731	278	6	-	-	SYM
bjp-25731	278	7	45	45	NUM
bjp-25731	278	8	.	.	PUNCT
bjp-25731	279	1	antypenko	antypenko	PROPN
bjp-25731	279	2	lm	lm	PROPN
bjp-25731	279	3	,	,	PUNCT
bjp-25731	279	4	kovalenko	kovalenko	ADJ
bjp-25731	279	5	si	si	NOUN
bjp-25731	279	6	,	,	PUNCT
bjp-25731	279	7	antypenko	antypenko	PROPN
bjp-25731	279	8	om	om	PROPN
bjp-25731	279	9	,	,	PUNCT
bjp-25731	279	10	katsev	katsev	PROPN
bjp-25731	279	11	am	am	PROPN
bjp-25731	279	12	,	,	PUNCT
bjp-25731	279	13	achkasova	achkasova	PROPN
bjp-25731	279	14	am	be	AUX
bjp-25731	279	15	.	.	PUNCT
bjp-25731	280	1	design	design	NOUN
bjp-25731	280	2	and	and	CCONJ
bjp-25731	280	3	evaluation	evaluation	NOUN
bjp-25731	280	4	of	of	ADP
bjp-25731	280	5	novel	novel	ADJ
bjp-25731	280	6	antimicrobial	antimicrobial	ADJ
bjp-25731	280	7	and	and	CCONJ
bjp-25731	280	8	anti	anti	ADJ
bjp-25731	280	9	-	-	ADJ
bjp-25731	280	10	cancer	cancer	ADJ
bjp-25731	280	11	agents	agent	NOUN
bjp-25731	280	12	among	among	ADP
bjp-25731	280	13	tetrazolo[1,5	tetrazolo[1,5	PROPN
bjp-25731	280	14	-	-	PUNCT
bjp-25731	280	15	c]quinazo	c]quinazo	NOUN
bjp-25731	280	16	line-5	line-5	NUM
bjp-25731	280	17	-	-	PUNCT
bjp-25731	280	18	thiones	thione	NOUN
bjp-25731	280	19	derivatives	derivative	NOUN
bjp-25731	280	20	.	.	PUNCT
bjp-25731	281	1	sci	sci	PROPN
bjp-25731	281	2	pharm	pharm	PROPN
bjp-25731	281	3	.	.	PUNCT
bjp-25731	282	1	2013	2013	NUM
bjp-25731	282	2	;	;	PUNCT
bjp-25731	282	3	81	81	NUM
bjp-25731	282	4	:	:	SYM
bjp-25731	282	5	15	15	NUM
bjp-25731	282	6	-	-	SYM
bjp-25731	282	7	52	52	NUM
bjp-25731	282	8	.	.	PUNCT
bjp-25731	283	1	armarego	armarego	PROPN
bjp-25731	283	2	wlf	wlf	PROPN
bjp-25731	283	3	.	.	PUNCT
bjp-25731	284	1	the	the	DET
bjp-25731	284	2	chemistry	chemistry	NOUN
bjp-25731	284	3	of	of	ADP
bjp-25731	284	4	heterocyclic	heterocyclic	ADJ
bjp-25731	284	5	compounds	compound	NOUN
bjp-25731	284	6	:	:	PUNCT
bjp-25731	284	7	fused	fuse	VERB
bjp-25731	284	8	pyrimidines	pyrimidine	NOUN
bjp-25731	284	9	,	,	PUNCT
bjp-25731	284	10	part	part	NOUN
bjp-25731	284	11	1	1	NUM
bjp-25731	284	12	,	,	PUNCT
bjp-25731	284	13	quinazolines	quinazoline	NOUN
bjp-25731	284	14	.	.	PUNCT
bjp-25731	285	1	new	new	PROPN
bjp-25731	285	2	jersey	jersey	PROPN
bjp-25731	285	3	,	,	PUNCT
bjp-25731	285	4	john	john	PROPN
bjp-25731	285	5	wiley	wiley	PROPN
bjp-25731	285	6	and	and	CCONJ
bjp-25731	285	7	sons	sons	PROPN
bjp-25731	285	8	inc	inc	PROPN
bjp-25731	285	9	.	.	PROPN
bjp-25731	285	10	,	,	PUNCT
bjp-25731	285	11	1967	1967	NUM
bjp-25731	285	12	,	,	PUNCT
bjp-25731	285	13	24	24	NUM
bjp-25731	285	14	,	,	PUNCT
bjp-25731	285	15	p	p	NOUN
bjp-25731	285	16	11	11	NUM
bjp-25731	285	17	,	,	PUNCT
bjp-25731	285	18	12	12	NUM
bjp-25731	285	19	,	,	PUNCT
bjp-25731	285	20	270	270	NUM
bjp-25731	285	21	,	,	PUNCT
bjp-25731	285	22	391	391	NUM
bjp-25731	285	23	.	.	PUNCT
bjp-25731	286	1	arya	arya	PROPN
bjp-25731	286	2	k	k	PROPN
bjp-25731	286	3	,	,	PUNCT
bjp-25731	286	4	tomar	tomar	ADJ
bjp-25731	286	5	r	r	PROPN
bjp-25731	286	6	,	,	PUNCT
bjp-25731	286	7	rawat	rawat	PROPN
bjp-25731	286	8	ds	ds	PROPN
bjp-25731	286	9	.	.	PROPN
bjp-25731	286	10	greener	green	ADJ
bjp-25731	286	11	synthesis	synthesis	NOUN
bjp-25731	286	12	and	and	CCONJ
bjp-25731	286	13	photo	photo	NOUN
bjp-25731	286	14	-	-	PUNCT
bjp-25731	286	15	anti	anti	ADJ
bjp-25731	286	16	-proliferative	-proliferative	ADJ
bjp-25731	286	17	activity	activity	NOUN
bjp-25731	286	18	of	of	ADP
bjp-25731	286	19	novel	novel	NOUN
bjp-25731	286	20	fluorinated	fluorinate	VERB
bjp-25731	286	21	benzothiazolo[2,3b]quinazoline	benzothiazolo[2,3b]quinazoline	NOUN
bjp-25731	286	22	.	.	PUNCT
bjp-25731	287	1	med	med	ADJ
bjp-25731	287	2	chem	chem	NOUN
bjp-25731	287	3	res	re	NOUN
bjp-25731	287	4	.	.	PUNCT
bjp-25731	287	5	2014	2014	NUM
bjp-25731	287	6	;	;	PUNCT
bjp-25731	287	7	23	23	NUM
bjp-25731	287	8	:	:	SYM
bjp-25731	287	9	896	896	NUM
bjp-25731	287	10	-	-	SYM
bjp-25731	287	11	904	904	NUM
bjp-25731	287	12	.	.	PUNCT
bjp-25731	288	1	asif	asif	PROPN
bjp-25731	288	2	m.	m.	PROPN
bjp-25731	288	3	chemical	chemical	PROPN
bjp-25731	288	4	characteristics	characteristic	NOUN
bjp-25731	288	5	,	,	PUNCT
bjp-25731	288	6	synthetic	synthetic	ADJ
bjp-25731	288	7	methods	method	NOUN
bjp-25731	288	8	,	,	PUNCT
bjp-25731	288	9	and	and	CCONJ
bjp-25731	288	10	biological	biological	ADJ
bjp-25731	288	11	potential	potential	NOUN
bjp-25731	288	12	of	of	ADP
bjp-25731	288	13	quinazoline	quinazoline	NOUN
bjp-25731	288	14	and	and	CCONJ
bjp-25731	288	15	quinazolinone	quinazolinone	NOUN
bjp-25731	288	16	derivatives	derivative	NOUN
bjp-25731	288	17	.	.	PUNCT
bjp-25731	289	1	int	int	PROPN
bjp-25731	289	2	j	j	PROPN
bjp-25731	289	3	med	med	PROPN
bjp-25731	289	4	chem	chem	NOUN
bjp-25731	289	5	.	.	PUNCT
bjp-25731	290	1	2014	2014	NUM
bjp-25731	290	2	;	;	PUNCT
bjp-25731	290	3	2014	2014	NUM
bjp-25731	290	4	:	:	PUNCT
bjp-25731	291	1	p	p	X
bjp-25731	291	2	27	27	NUM
bjp-25731	291	3	.	.	PUNCT
bjp-25731	292	1	barbosa	barbosa	PROPN
bjp-25731	292	2	mlc	mlc	PROPN
bjp-25731	292	3	,	,	PUNCT
bjp-25731	292	4	lima	lima	PROPN
bjp-25731	292	5	lm	lm	PROPN
bjp-25731	292	6	,	,	PUNCT
bjp-25731	292	7	tesch	tesch	PROPN
bjp-25731	292	8	r	r	PROPN
bjp-25731	292	9	,	,	PUNCT
bjp-25731	292	10	sant’anna	sant’anna	NOUN
bjp-25731	292	11	cmr	cmr	PROPN
bjp-25731	292	12	,	,	PUNCT
bjp-25731	292	13	totzke	totzke	PROPN
bjp-25731	292	14	f	f	PROPN
bjp-25731	292	15	,	,	PUNCT
bjp-25731	292	16	kubbutat	kubbutat	PROPN
bjp-25731	292	17	mhg	mhg	PROPN
bjp-25731	292	18	,	,	PUNCT
bjp-25731	292	19	schächtele	schächtele	PROPN
bjp-25731	292	20	c	c	PROPN
bjp-25731	292	21	,	,	PUNCT
bjp-25731	292	22	laufer	laufer	PROPN
bjp-25731	292	23	sa	sa	PROPN
bjp-25731	292	24	,	,	PUNCT
bjp-25731	292	25	barreiro	barreiro	PROPN
bjp-25731	292	26	ej	ej	PROPN
bjp-25731	292	27	.	.	PROPN
bjp-25731	292	28	novel	novel	PROPN
bjp-25731	292	29	2	2	NUM
bjp-25731	292	30	-	-	PUNCT
bjp-25731	292	31	chloro-4	chloro-4	NUM
bjp-25731	292	32	-	-	PUNCT
bjp-25731	292	33	anilino	anilino	NOUN
bjp-25731	292	34	-	-	PUNCT
bjp-25731	292	35	quinazoline	quinazoline	NOUN
bjp-25731	292	36	derivatives	derivative	NOUN
bjp-25731	292	37	as	as	ADP
bjp-25731	292	38	egfr	egfr	NOUN
bjp-25731	292	39	and	and	CCONJ
bjp-25731	292	40	vegfr-2	vegfr-2	NUM
bjp-25731	292	41	dual	dual	ADJ
bjp-25731	292	42	inhibitors	inhibitor	NOUN
bjp-25731	292	43	.	.	PUNCT
bjp-25731	293	1	eur	eur	PROPN
bjp-25731	293	2	j	j	PROPN
bjp-25731	293	3	med	med	PROPN
bjp-25731	293	4	chem	chem	NOUN
bjp-25731	293	5	.	.	PUNCT
bjp-25731	294	1	2014	2014	NUM
bjp-25731	294	2	;	;	PUNCT
bjp-25731	294	3	71	71	NUM
bjp-25731	294	4	:	:	SYM
bjp-25731	294	5	1	1	NUM
bjp-25731	294	6	-	-	SYM
bjp-25731	294	7	14	14	NUM
bjp-25731	294	8	.	.	PUNCT
bjp-25731	295	1	bartha	bartha	PROPN
bjp-25731	295	2	e	e	PROPN
bjp-25731	295	3	,	,	PUNCT
bjp-25731	295	4	solti	solti	PROPN
bjp-25731	295	5	i	i	PROPN
bjp-25731	295	6	,	,	PUNCT
bjp-25731	295	7	kereskai	kereskai	PROPN
bjp-25731	295	8	l	l	NOUN
bjp-25731	295	9	,	,	PUNCT
bjp-25731	295	10	lantos	lantos	PROPN
bjp-25731	295	11	j	j	PROPN
bjp-25731	295	12	,	,	PUNCT
bjp-25731	295	13	plozer	plozer	NOUN
bjp-25731	295	14	,	,	PUNCT
bjp-25731	295	15	e	e	NOUN
bjp-25731	295	16	,	,	PUNCT
bjp-25731	295	17	magyar	magyar	PROPN
bjp-25731	295	18	k	k	PROPN
bjp-25731	295	19	,	,	PUNCT
bjp-25731	295	20	szabados	szabado	NOUN
bjp-25731	295	21	e	e	PROPN
bjp-25731	295	22	,	,	PUNCT
bjp-25731	295	23	kalai	kalai	PROPN
bjp-25731	295	24	t	t	PROPN
bjp-25731	295	25	,	,	PUNCT
bjp-25731	295	26	hideg	hideg	PROPN
bjp-25731	295	27	k	k	PROPN
bjp-25731	295	28	,	,	PUNCT
bjp-25731	295	29	halmosi	halmosi	NOUN
bjp-25731	295	30	r	r	NOUN
bjp-25731	295	31	,	,	PUNCT
bjp-25731	295	32	sumegi	sumegi	PROPN
bjp-25731	295	33	b	b	PROPN
bjp-25731	295	34	,	,	PUNCT
bjp-25731	295	35	kalman	kalman	PROPN
bjp-25731	295	36	t.	t.	PROPN
bjp-25731	295	37	parp	parp	PROPN
bjp-25731	295	38	inhibition	inhibition	NOUN
bjp-25731	295	39	delays	delay	NOUN
bjp-25731	295	40	transition	transition	NOUN
bjp-25731	295	41	of	of	ADP
bjp-25731	295	42	hypertensive	hypertensive	NOUN
bjp-25731	295	43	cardiopathy	cardiopathy	ADJ
bjp-25731	295	44	to	to	ADP
bjp-25731	295	45	heart	heart	NOUN
bjp-25731	295	46	failure	failure	NOUN
bjp-25731	295	47	in	in	ADP
bjp-25731	295	48	spontaneously	spontaneously	ADV
bjp-25731	295	49	hypertensive	hypertensive	ADJ
bjp-25731	295	50	rats	rat	NOUN
bjp-25731	295	51	.	.	PUNCT
bjp-25731	296	1	cardiovasc	cardiovasc	PROPN
bjp-25731	296	2	res	res	PROPN
bjp-25731	296	3	.	.	PUNCT
bjp-25731	296	4	2009	2009	NUM
bjp-25731	296	5	;	;	PUNCT
bjp-25731	296	6	83	83	NUM
bjp-25731	296	7	:	:	SYM
bjp-25731	296	8	501	501	NUM
bjp-25731	296	9	-	-	SYM
bjp-25731	296	10	10	10	NUM
bjp-25731	296	11	.	.	PUNCT
bjp-25731	297	1	birhan	birhan	PROPN
bjp-25731	297	2	ys	ys	PROPN
bjp-25731	297	3	,	,	PUNCT
bjp-25731	297	4	bekhit	bekhit	PROPN
bjp-25731	297	5	aa	aa	NOUN
bjp-25731	297	6	,	,	PUNCT
bjp-25731	297	7	hymete	hymete	ADJ
bjp-25731	297	8	a.	a.	NOUN
bjp-25731	297	9	in	in	ADP
bjp-25731	297	10	vivo	vivo	ADJ
bjp-25731	297	11	antimalarial	antimalarial	ADJ
bjp-25731	297	12	evaluation	evaluation	NOUN
bjp-25731	297	13	of	of	ADP
bjp-25731	297	14	some	some	DET
bjp-25731	297	15	2,3	2,3	NUM
bjp-25731	297	16	-	-	ADJ
bjp-25731	297	17	disubstituted-4(3h)-quinazolinone	disubstituted-4(3h)-quinazolinone	ADJ
bjp-25731	297	18	derivatives	derivative	NOUN
bjp-25731	297	19	.	.	PUNCT
bjp-25731	298	1	bmc	bmc	ADJ
bjp-25731	298	2	res	re	NOUN
bjp-25731	298	3	notes	note	NOUN
bjp-25731	298	4	2015	2015	NUM
bjp-25731	298	5	;	;	PUNCT
bjp-25731	298	6	8	8	NUM
bjp-25731	298	7	:	:	SYM
bjp-25731	298	8	589	589	NUM
bjp-25731	298	9	-	-	SYM
bjp-25731	298	10	94	94	NUM
bjp-25731	298	11	.	.	PUNCT
bjp-25731	299	1	bolden	bolden	PROPN
bjp-25731	299	2	je	je	PROPN
bjp-25731	299	3	,	,	PUNCT
bjp-25731	299	4	peart	peart	PROPN
bjp-25731	299	5	mj	mj	PROPN
bjp-25731	299	6	,	,	PUNCT
bjp-25731	299	7	johnstone	johnstone	PROPN
bjp-25731	299	8	rw	rw	PROPN
bjp-25731	299	9	.	.	PUNCT
bjp-25731	299	10	anti	anti	ADJ
bjp-25731	299	11	-	-	ADJ
bjp-25731	299	12	cancer	cancer	ADJ
bjp-25731	299	13	activities	activity	NOUN
bjp-25731	299	14	of	of	ADP
bjp-25731	299	15	histone	histone	NOUN
bjp-25731	299	16	deacetylase	deacetylase	NOUN
bjp-25731	299	17	inhibitors	inhibitor	NOUN
bjp-25731	299	18	.	.	PUNCT
bjp-25731	300	1	nat	nat	PROPN
bjp-25731	300	2	rev	rev	VERB
bjp-25731	300	3	drug	drug	NOUN
bjp-25731	300	4	discovery	discovery	NOUN
bjp-25731	300	5	.	.	PUNCT
bjp-25731	301	1	2006	2006	NUM
bjp-25731	301	2	;	;	PUNCT
bjp-25731	301	3	5	5	NUM
bjp-25731	301	4	:	:	SYM
bjp-25731	301	5	769	769	NUM
bjp-25731	301	6	-	-	SYM
bjp-25731	301	7	84	84	NUM
bjp-25731	301	8	.	.	PUNCT
bjp-25731	302	1	bukowska	bukowska	VERB
bjp-25731	302	2	a	a	PRON
bjp-25731	302	3	,	,	PUNCT
bjp-25731	302	4	zacharias	zacharias	PROPN
bjp-25731	302	5	i	i	PROPN
bjp-25731	302	6	,	,	PUNCT
bjp-25731	302	7	weinert	weinert	PROPN
bjp-25731	302	8	s	s	PROPN
bjp-25731	302	9	,	,	PUNCT
bjp-25731	302	10	skopp	skopp	PROPN
bjp-25731	302	11	k	k	PROPN
bjp-25731	302	12	,	,	PUNCT
bjp-25731	302	13	hartmann	hartmann	PROPN
bjp-25731	302	14	c	c	PROPN
bjp-25731	302	15	,	,	PUNCT
bjp-25731	302	16	huth	huth	PROPN
bjp-25731	302	17	c	c	AUX
bjp-25731	302	18	,	,	PUNCT
bjp-25731	302	19	goette	goette	NOUN
bjp-25731	302	20	a.	a.	NOUN
bjp-25731	302	21	coagulation	coagulation	NOUN
bjp-25731	302	22	factor	factor	NOUN
bjp-25731	302	23	xa	xa	PROPN
bjp-25731	302	24	induces	induce	VERB
bjp-25731	302	25	an	an	DET
bjp-25731	302	26	inflammatory	inflammatory	ADJ
bjp-25731	302	27	signaling	signal	VERB
bjp-25731	302	28	by	by	ADP
bjp-25731	302	29	activation	activation	NOUN
bjp-25731	302	30	of	of	ADP
bjp-25731	302	31	protease	protease	NOUN
bjp-25731	302	32	-	-	PUNCT
bjp-25731	302	33	activated	activate	VERB
bjp-25731	302	34	receptors	receptor	NOUN
bjp-25731	302	35	in	in	ADP
bjp-25731	302	36	human	human	ADJ
bjp-25731	302	37	atrial	atrial	ADJ
bjp-25731	302	38	tissue	tissue	NOUN
bjp-25731	302	39	.	.	PUNCT
bjp-25731	303	1	eur	eur	PROPN
bjp-25731	303	2	j	j	PROPN
bjp-25731	303	3	pharmacol	pharmacol	PROPN
bjp-25731	303	4	.	.	PUNCT
bjp-25731	304	1	2013	2013	NUM
bjp-25731	305	1	;	;	PUNCT
bjp-25731	305	2	718	718	NUM
bjp-25731	305	3	:	:	PUNCT
bjp-25731	305	4	114	114	NUM
bjp-25731	305	5	-	-	SYM
bjp-25731	305	6	23	23	NUM
bjp-25731	305	7	.	.	PUNCT
bjp-25731	306	1	bursavich	bursavich	PROPN
bjp-25731	306	2	mg	mg	PROPN
bjp-25731	306	3	,	,	PUNCT
bjp-25731	306	4	dastrup	dastrup	NOUN
bjp-25731	306	5	d	d	PROPN
bjp-25731	306	6	,	,	PUNCT
bjp-25731	306	7	shenderovich	shenderovich	PROPN
bjp-25731	306	8	m	m	PROPN
bjp-25731	306	9	,	,	PUNCT
bjp-25731	306	10	yager	yager	PROPN
bjp-25731	306	11	km	km	PROPN
bjp-25731	306	12	,	,	PUNCT
bjp-25731	306	13	cimbora	cimbora	PROPN
bjp-25731	306	14	dm	dm	PROPN
bjp-25731	306	15	,	,	PUNCT
bjp-25731	306	16	williams	williams	PROPN
bjp-25731	306	17	b.	b.	PROPN
bjp-25731	306	18	,	,	PUNCT
bjp-25731	306	19	kumar	kumar	PROPN
bjp-25731	306	20	dv	dv	PROPN
bjp-25731	306	21	.	.	PROPN
bjp-25731	306	22	novel	novel	PROPN
bjp-25731	306	23	mps1	mps1	PROPN
bjp-25731	306	24	kinase	kinase	PROPN
bjp-25731	306	25	inhibitors	inhibitor	NOUN
bjp-25731	306	26	:	:	PUNCT
bjp-25731	306	27	from	from	ADP
bjp-25731	306	28	purine	purine	NOUN
bjp-25731	306	29	to	to	PART
bjp-25731	306	30	pyrrolopyrimidine	pyrrolopyrimidine	VERB
bjp-25731	306	31	and	and	CCONJ
bjp-25731	306	32	quinazoline	quinazoline	NOUN
bjp-25731	306	33	leads	lead	NOUN
bjp-25731	306	34	.	.	PUNCT
bjp-25731	307	1	bioorg	bioorg	PROPN
bjp-25731	307	2	med	med	PROPN
bjp-25731	307	3	chem	chem	NOUN
bjp-25731	307	4	lett	lett	PROPN
bjp-25731	307	5	.	.	PUNCT
bjp-25731	308	1	2013	2013	NUM
bjp-25731	308	2	;	;	PUNCT
bjp-25731	308	3	23	23	NUM
bjp-25731	308	4	:	:	SYM
bjp-25731	308	5	6829	6829	NUM
bjp-25731	308	6	-	-	SYM
bjp-25731	308	7	33	33	NUM
bjp-25731	308	8	.	.	PUNCT
bjp-25731	309	1	cai	cai	PROPN
bjp-25731	309	2	j	j	PROPN
bjp-25731	309	3	,	,	PUNCT
bjp-25731	309	4	sun	sun	PROPN
bjp-25731	309	5	m	m	PROPN
bjp-25731	309	6	,	,	PUNCT
bjp-25731	309	7	wu	wu	PROPN
bjp-25731	309	8	x	x	PROPN
bjp-25731	309	9	,	,	PUNCT
bjp-25731	309	10	chen	chen	PROPN
bjp-25731	309	11	j	j	PROPN
bjp-25731	309	12	,	,	PUNCT
bjp-25731	309	13	wang	wang	PROPN
bjp-25731	309	14	p	p	PROPN
bjp-25731	309	15	,	,	PUNCT
bjp-25731	309	16	zong	zong	PROPN
bjp-25731	309	17	x	x	PROPN
bjp-25731	309	18	,	,	PUNCT
bjp-25731	309	19	ji	ji	PROPN
bjp-25731	309	20	m.	m.	NOUN
bjp-25731	309	21	design	design	NOUN
bjp-25731	309	22	and	and	CCONJ
bjp-25731	309	23	synthesis	synthesis	NOUN
bjp-25731	309	24	of	of	ADP
bjp-25731	309	25	novel	novel	ADJ
bjp-25731	309	26	4	4	NUM
bjp-25731	309	27	-	-	PUNCT
bjp-25731	309	28	benzothiazole	benzothiazole	ADJ
bjp-25731	309	29	amino	amino	NOUN
bjp-25731	309	30	quinazolines	quinazoline	NOUN
bjp-25731	309	31	dasatinib	dasatinib	VERB
bjp-25731	309	32	derivatives	derivative	NOUN
bjp-25731	309	33	as	as	ADP
bjp-25731	309	34	potential	potential	ADJ
bjp-25731	309	35	antitumor	antitumor	PROPN
bjp-25731	309	36	agents	agent	NOUN
bjp-25731	309	37	.	.	PUNCT
bjp-25731	310	1	eur	eur	PROPN
bjp-25731	310	2	j	j	PROPN
bjp-25731	310	3	med	med	PROPN
bjp-25731	310	4	chem	chem	NOUN
bjp-25731	310	5	.	.	PUNCT
bjp-25731	311	1	2013	2013	NUM
bjp-25731	311	2	;	;	PUNCT
bjp-25731	311	3	63	63	NUM
bjp-25731	311	4	:	:	SYM
bjp-25731	311	5	702	702	NUM
bjp-25731	311	6	-	-	SYM
bjp-25731	311	7	12	12	NUM
bjp-25731	311	8	.	.	PUNCT
bjp-25731	311	9	chandrika	chandrika	PROPN
bjp-25731	311	10	pm	pm	VERB
bjp-25731	311	11	,	,	PUNCT
bjp-25731	311	12	yakaiah	yakaiah	PROPN
bjp-25731	311	13	t	t	PROPN
bjp-25731	311	14	,	,	PUNCT
bjp-25731	311	15	narsaiah	narsaiah	PROPN
bjp-25731	311	16	b	b	PROPN
bjp-25731	311	17	,	,	PUNCT
bjp-25731	311	18	sridhar	sridhar	NOUN
bjp-25731	311	19	v	v	NOUN
bjp-25731	311	20	,	,	PUNCT
bjp-25731	311	21	venugopal	venugopal	NOUN
bjp-25731	311	22	g	g	PROPN
bjp-25731	311	23	,	,	PUNCT
bjp-25731	311	24	rao	rao	NOUN
bjp-25731	311	25	jv	jv	NOUN
bjp-25731	311	26	,	,	PUNCT
bjp-25731	311	27	kumar	kumar	PROPN
bjp-25731	311	28	kp	kp	PROPN
bjp-25731	311	29	,	,	PUNCT
bjp-25731	311	30	murthy	murthy	PROPN
bjp-25731	311	31	usn	usn	PROPN
bjp-25731	311	32	,	,	PUNCT
bjp-25731	311	33	rao	rao	PROPN
bjp-25731	311	34	arr	arr	PROPN
bjp-25731	312	1	.	.	PROPN
bjp-25731	312	2	synthesis	synthesis	NOUN
bjp-25731	312	3	leading	lead	VERB
bjp-25731	312	4	to	to	ADP
bjp-25731	312	5	novel	novel	VERB
bjp-25731	312	6	2,4,6	2,4,6	NUM
bjp-25731	312	7	-	-	PUNCT
bjp-25731	312	8	trisubstituted	trisubstitute	VERB
bjp-25731	312	9	quinazoline	quinazoline	NOUN
bjp-25731	312	10	derivatives	derivative	NOUN
bjp-25731	312	11	,	,	PUNCT
bjp-25731	312	12	their	their	PRON
bjp-25731	312	13	antibacterial	antibacterial	ADJ
bjp-25731	312	14	and	and	CCONJ
bjp-25731	312	15	cytotoxic	cytotoxic	ADJ
bjp-25731	312	16	activity	activity	NOUN
bjp-25731	312	17	against	against	ADP
bjp-25731	312	18	thp-1	thp-1	ADP
bjp-25731	312	19	,	,	PUNCT
bjp-25731	312	20	hl60	hl60	PROPN
bjp-25731	312	21	and	and	CCONJ
bjp-25731	312	22	a375	a375	PROPN
bjp-25731	312	23	cell	cell	NOUN
bjp-25731	312	24	lines	line	NOUN
bjp-25731	312	25	.	.	PUNCT
bjp-25731	313	1	indian	indian	PROPN
bjp-25731	313	2	j	j	PROPN
bjp-25731	313	3	chem	chem	PROPN
bjp-25731	313	4	.	.	PUNCT
bjp-25731	313	5	2009	2009	NUM
bjp-25731	313	6	;	;	PUNCT
bjp-25731	313	7	48b	48b	NOUN
bjp-25731	313	8	:	:	PUNCT
bjp-25731	313	9	840	840	NUM
bjp-25731	313	10	-	-	SYM
bjp-25731	313	11	47	47	NUM
bjp-25731	313	12	.	.	PUNCT
bjp-25731	314	1	chandrika	chandrika	PROPN
bjp-25731	314	2	pm	pm	VERB
bjp-25731	314	3	,	,	PUNCT
bjp-25731	314	4	yakaiah	yakaiah	PROPN
bjp-25731	314	5	t	t	PROPN
bjp-25731	314	6	,	,	PUNCT
bjp-25731	314	7	rao	rao	PROPN
bjp-25731	314	8	arr	arr	PROPN
bjp-25731	314	9	,	,	PUNCT
bjp-25731	314	10	narsaiah	narsaiah	PROPN
bjp-25731	314	11	b	b	PROPN
bjp-25731	314	12	,	,	PUNCT
bjp-25731	314	13	reddy	reddy	PROPN
bjp-25731	314	14	nc	nc	PROPN
bjp-25731	314	15	,	,	PUNCT
bjp-25731	314	16	sridhar	sridhar	VERB
bjp-25731	314	17	v	v	NOUN
bjp-25731	314	18	,	,	PUNCT
bjp-25731	315	1	rao	rao	NOUN
bjp-25731	315	2	jv	jv	NOUN
bjp-25731	315	3	.	.	PUNCT
bjp-25731	315	4	synthesis	synthesis	NOUN
bjp-25731	315	5	of	of	ADP
bjp-25731	315	6	novel	novel	ADJ
bjp-25731	315	7	4,6	4,6	NUM
bjp-25731	315	8	-	-	PUNCT
bjp-25731	315	9	disubstituted	disubstitute	VERB
bjp-25731	315	10	quinazoline	quinazoline	NOUN
bjp-25731	315	11	derivatives	derivative	NOUN
bjp-25731	315	12	,	,	PUNCT
bjp-25731	315	13	their	their	PRON
bjp-25731	315	14	anti	anti	ADJ
bjp-25731	315	15	-	-	ADJ
bjp-25731	315	16	inflammatory	inflammatory	ADJ
bjp-25731	315	17	and	and	CCONJ
bjp-25731	315	18	anticancer	anticancer	NOUN
bjp-25731	315	19	activity	activity	NOUN
bjp-25731	315	20	(	(	PUNCT
bjp-25731	315	21	cytotoxic	cytotoxic	ADJ
bjp-25731	315	22	)	)	PUNCT
bjp-25731	315	23	against	against	ADP
bjp-25731	315	24	u937	u937	PROPN
bjp-25731	315	25	leukemia	leukemia	NOUN
bjp-25731	315	26	cell	cell	NOUN
bjp-25731	315	27	lines	line	NOUN
bjp-25731	315	28	.	.	PUNCT
bjp-25731	316	1	eur	eur	PROPN
bjp-25731	316	2	j	j	PROPN
bjp-25731	316	3	med	med	PROPN
bjp-25731	316	4	chem	chem	NOUN
bjp-25731	316	5	.	.	PUNCT
bjp-25731	317	1	2008	2008	NUM
bjp-25731	317	2	;	;	PUNCT
bjp-25731	317	3	43	43	NUM
bjp-25731	317	4	:	:	SYM
bjp-25731	317	5	846	846	NUM
bjp-25731	317	6	-	-	SYM
bjp-25731	317	7	52	52	NUM
bjp-25731	317	8	.	.	PUNCT
bjp-25731	318	1	chang	chang	PROPN
bjp-25731	318	2	fr	fr	PROPN
bjp-25731	318	3	,	,	PUNCT
bjp-25731	318	4	lee	lee	PROPN
bjp-25731	318	5	yh	yh	PROPN
bjp-25731	318	6	,	,	PUNCT
bjp-25731	318	7	yang	yang	PROPN
bjp-25731	318	8	yl	yl	PROPN
bjp-25731	318	9	,	,	PUNCT
bjp-25731	318	10	hsieh	hsieh	PROPN
bjp-25731	318	11	pw	pw	PROPN
bjp-25731	318	12	,	,	PUNCT
bjp-25731	318	13	khalil	khalil	PROPN
bjp-25731	318	14	at	at	ADP
bjp-25731	318	15	,	,	PUNCT
bjp-25731	318	16	chen	chen	PROPN
bjp-25731	318	17	cy	cy	PROPN
bjp-25731	318	18	,	,	PUNCT
bjp-25731	318	19	wu	wu	PROPN
bjp-25731	319	1	yc	yc	PROPN
bjp-25731	319	2	.	.	PUNCT
bjp-25731	320	1	secoiridoid	secoiridoid	PROPN
bjp-25731	320	2	glycoside	glycoside	PROPN
bjp-25731	320	3	and	and	CCONJ
bjp-25731	320	4	alkaloid	alkaloid	PROPN
bjp-25731	320	5	constituents	constituent	NOUN
bjp-25731	320	6	of	of	ADP
bjp-25731	320	7	hydrangea	hydrangea	NOUN
bjp-25731	320	8	chinensis	chinensis	NOUN
bjp-25731	320	9	.	.	PUNCT
bjp-25731	321	1	j	j	PROPN
bjp-25731	321	2	nat	nat	PROPN
bjp-25731	321	3	prod	prod	NOUN
bjp-25731	321	4	.	.	PUNCT
bjp-25731	321	5	2003	2003	NUM
bjp-25731	321	6	;	;	PUNCT
bjp-25731	321	7	66	66	NUM
bjp-25731	321	8	:	:	SYM
bjp-25731	321	9	1245	1245	NUM
bjp-25731	321	10	-	-	SYM
bjp-25731	321	11	48	48	NUM
bjp-25731	321	12	.	.	PUNCT
bjp-25731	322	1	chen	chen	PROPN
bjp-25731	322	2	l	l	PROPN
bjp-25731	322	3	,	,	PUNCT
bjp-25731	322	4	sun	sun	PROPN
bjp-25731	322	5	yx	yx	PROPN
bjp-25731	322	6	,	,	PUNCT
bjp-25731	322	7	chai	chai	NOUN
bjp-25731	322	8	yk	yk	PROPN
bjp-25731	322	9	,	,	PUNCT
bjp-25731	322	10	lee	lee	PROPN
bjp-25731	322	11	js	js	PROPN
bjp-25731	322	12	,	,	PUNCT
bjp-25731	322	13	song	song	PROPN
bjp-25731	322	14	ms	ms	PROPN
bjp-25731	322	15	,	,	PUNCT
bjp-25731	322	16	quan	quan	PROPN
bjp-25731	322	17	zs	zs	PROPN
bjp-25731	322	18	.	.	PUNCT
bjp-25731	322	19	synthesis	synthesis	NOUN
bjp-25731	322	20	and	and	CCONJ
bjp-25731	322	21	anticonvulsant	anticonvulsant	ADJ
bjp-25731	322	22	evaluation	evaluation	NOUN
bjp-25731	322	23	of	of	ADP
bjp-25731	322	24	4-(4	4-(4	PROPN
bjp-25731	322	25	-	-	PUNCT
bjp-25731	322	26	alkoxylphenyl)-3	alkoxylphenyl)-3	PROPN
bjp-25731	322	27	-	-	PUNCT
bjp-25731	322	28	ethyl	ethyl	PROPN
bjp-25731	322	29	-4h-1,2,4	-4h-1,2,4	PROPN
bjp-25731	322	30	-	-	PUNCT
bjp-25731	322	31	triazoles	triazole	NOUN
bjp-25731	322	32	as	as	ADP
bjp-25731	322	33	open	open	ADJ
bjp-25731	322	34	-	-	PUNCT
bjp-25731	322	35	chain	chain	NOUN
bjp-25731	322	36	analogues	analogue	NOUN
bjp-25731	322	37	of	of	ADP
bjp-25731	322	38	7	7	NUM
bjp-25731	322	39	-	-	PUNCT
bjp-25731	322	40	alkoxyl-4,5dihydro-1,2,4	alkoxyl-4,5dihydro-1,2,4	PROPN
bjp-25731	322	41	-	-	PUNCT
bjp-25731	322	42	triazolo[4,3	triazolo[4,3	NOUN
bjp-25731	322	43	-	-	PUNCT
bjp-25731	322	44	a]quinolines	a]quinoline	NOUN
bjp-25731	322	45	.	.	PUNCT
bjp-25731	322	46	bioorg	bioorg	PROPN
bjp-25731	322	47	med	med	PROPN
bjp-25731	322	48	chem	chem	NOUN
bjp-25731	322	49	.	.	PUNCT
bjp-25731	323	1	2007	2007	NUM
bjp-25731	323	2	;	;	PUNCT
bjp-25731	323	3	15	15	NUM
bjp-25731	323	4	:	:	SYM
bjp-25731	323	5	6775	6775	NUM
bjp-25731	323	6	-	-	SYM
bjp-25731	323	7	81	81	NUM
bjp-25731	323	8	.	.	PUNCT
bjp-25731	324	1	cheng	cheng	PROPN
bjp-25731	324	2	d.	d.	PROPN
bjp-25731	324	3	prevalence	prevalence	PROPN
bjp-25731	324	4	,	,	PUNCT
bjp-25731	324	5	predisposition	predisposition	NOUN
bjp-25731	324	6	and	and	CCONJ
bjp-25731	324	7	prevention	prevention	NOUN
bjp-25731	324	8	of	of	ADP
bjp-25731	324	9	type	type	NOUN
bjp-25731	324	10	ii	ii	NOUN
bjp-25731	324	11	diabetes	diabetes	NOUN
bjp-25731	324	12	.	.	PUNCT
bjp-25731	325	1	nutr	nutr	PROPN
bjp-25731	325	2	metab	metab	PROPN
bjp-25731	325	3	.	.	PUNCT
bjp-25731	326	1	2005	2005	NUM
bjp-25731	326	2	;	;	PUNCT
bjp-25731	326	3	2	2	NUM
bjp-25731	326	4	:	:	SYM
bjp-25731	326	5	29	29	NUM
bjp-25731	326	6	-	-	SYM
bjp-25731	326	7	39	39	NUM
bjp-25731	326	8	.	.	PUNCT
bjp-25731	327	1	connolly	connolly	PROPN
bjp-25731	327	2	dj	dj	PROPN
bjp-25731	327	3	,	,	PUNCT
bjp-25731	327	4	cusack	cusack	PROPN
bjp-25731	327	5	d	d	PROPN
bjp-25731	327	6	,	,	PUNCT
bjp-25731	327	7	sullivan	sullivan	PROPN
bjp-25731	327	8	tpo	tpo	PROPN
bjp-25731	327	9	,	,	PUNCT
bjp-25731	327	10	guiry	guiry	PROPN
bjp-25731	327	11	pj	pj	PROPN
bjp-25731	327	12	.	.	PUNCT
bjp-25731	327	13	synthesis	synthesis	NOUN
bjp-25731	327	14	of	of	ADP
bjp-25731	327	15	quinazolinones	quinazolinone	NOUN
bjp-25731	327	16	and	and	CCONJ
bjp-25731	327	17	quinazolines	quinazoline	NOUN
bjp-25731	327	18	.	.	PUNCT
bjp-25731	328	1	tetrahedron	tetrahedron	NOUN
bjp-25731	328	2	.	.	PUNCT
bjp-25731	329	1	2005	2005	NUM
bjp-25731	329	2	;	;	PUNCT
bjp-25731	329	3	61	61	NUM
bjp-25731	329	4	:	:	SYM
bjp-25731	329	5	10153	10153	NUM
bjp-25731	329	6	-	-	SYM
bjp-25731	329	7	202	202	NUM
bjp-25731	329	8	.	.	PUNCT
bjp-25731	330	1	corbett	corbett	PROPN
bjp-25731	330	2	el	el	PROPN
bjp-25731	330	3	,	,	PUNCT
bjp-25731	330	4	watt	watt	PROPN
bjp-25731	330	5	cj	cj	PROPN
bjp-25731	330	6	,	,	PUNCT
bjp-25731	330	7	walker	walker	PROPN
bjp-25731	330	8	n	n	PROPN
bjp-25731	330	9	,	,	PUNCT
bjp-25731	330	10	maher	maher	PROPN
bjp-25731	330	11	d	d	PROPN
bjp-25731	330	12	,	,	PUNCT
bjp-25731	330	13	williams	williams	PROPN
bjp-25731	330	14	bg	bg	PROPN
bjp-25731	330	15	,	,	PUNCT
bjp-25731	330	16	raviglione	raviglione	PROPN
bjp-25731	330	17	mc	mc	PROPN
bjp-25731	330	18	,	,	PUNCT
bjp-25731	330	19	dye	dye	PROPN
bjp-25731	330	20	c.	c.	PROPN
bjp-25731	330	21	the	the	DET
bjp-25731	330	22	growing	grow	VERB
bjp-25731	330	23	burden	burden	NOUN
bjp-25731	330	24	of	of	ADP
bjp-25731	330	25	tuberculosis	tuberculosis	NOUN
bjp-25731	330	26	:	:	PUNCT
bjp-25731	330	27	global	global	ADJ
bjp-25731	330	28	trends	trend	NOUN
bjp-25731	330	29	and	and	CCONJ
bjp-25731	330	30	interactions	interaction	NOUN
bjp-25731	330	31	with	with	ADP
bjp-25731	330	32	the	the	DET
bjp-25731	330	33	hiv	hiv	PROPN
bjp-25731	330	34	epidemic	epidemic	NOUN
bjp-25731	330	35	.	.	PUNCT
bjp-25731	331	1	arch	arch	PROPN
bjp-25731	331	2	intern	intern	PROPN
bjp-25731	331	3	med	med	PROPN
bjp-25731	331	4	.	.	PUNCT
bjp-25731	331	5	2003	2003	NUM
bjp-25731	331	6	;	;	PUNCT
bjp-25731	331	7	163	163	NUM
bjp-25731	331	8	:	:	SYM
bjp-25731	331	9	1009	1009	NUM
bjp-25731	331	10	-	-	SYM
bjp-25731	331	11	21	21	NUM
bjp-25731	331	12	.	.	PUNCT
bjp-25731	332	1	deepakumari	deepakumari	ADJ
bjp-25731	332	2	hn	hn	NOUN
bjp-25731	332	3	,	,	PUNCT
bjp-25731	332	4	jayanna	jayanna	PROPN
bjp-25731	332	5	bk	bk	PROPN
bjp-25731	332	6	,	,	PUNCT
bjp-25731	332	7	prashanth	prashanth	PROPN
bjp-25731	332	8	mk	mk	PROPN
bjp-25731	332	9	,	,	PUNCT
bjp-25731	332	10	revanasiddappa	revanasiddappa	PROPN
bjp-25731	332	11	hd	hd	PROPN
bjp-25731	332	12	,	,	PUNCT
bjp-25731	332	13	veeresh	veeresh	PROPN
bjp-25731	332	14	b.	b.	PROPN
bjp-25731	332	15	synthesis	synthesis	NOUN
bjp-25731	332	16	and	and	CCONJ
bjp-25731	332	17	anticonvulsant	anticonvulsant	ADJ
bjp-25731	332	18	activity	activity	NOUN
bjp-25731	332	19	of	of	ADP
bjp-25731	332	20	n-(substituted)-1	n-(substituted)-1	NOUN
bjp-25731	332	21	-	-	PUNCT
bjp-25731	332	22	methyl-2,4	methyl-2,4	NOUN
bjp-25731	332	23	-	-	PUNCT
bjp-25731	332	24	dioxo-1,2	dioxo-1,2	ADJ
bjp-25731	332	25	-	-	PUNCT
bjp-25731	332	26	dihydroquin	dihydroquin	ADJ
bjp-25731	332	27	azoline	azoline	NOUN
bjp-25731	332	28	-3(4h)-carboxamides	-3(4h)-carboxamides	PUNCT
bjp-25731	332	29	.	.	PUNCT
bjp-25731	332	30	arch	arch	ADJ
bjp-25731	332	31	pharm	pharm	PROPN
bjp-25731	332	32	.	.	PUNCT
bjp-25731	333	1	2016	2016	NUM
bjp-25731	333	2	.	.	PUNCT
bjp-25731	334	1	deedwania	deedwania	PROPN
bjp-25731	334	2	pc	pc	PROPN
bjp-25731	334	3	,	,	PUNCT
bjp-25731	334	4	blood	blood	NOUN
bjp-25731	334	5	pressure	pressure	NOUN
bjp-25731	334	6	control	control	NOUN
bjp-25731	334	7	in	in	ADP
bjp-25731	334	8	diabetes	diabetes	NOUN
bjp-25731	334	9	mellitus	mellitus	NOUN
bjp-25731	334	10	:	:	PUNCT
bjp-25731	334	11	is	be	AUX
bjp-25731	334	12	lower	low	ADJ
bjp-25731	334	13	always	always	ADV
bjp-25731	334	14	better	well	ADJ
bjp-25731	334	15	,	,	PUNCT
bjp-25731	334	16	and	and	CCONJ
bjp-25731	334	17	how	how	SCONJ
bjp-25731	334	18	low	low	ADJ
bjp-25731	334	19	should	should	AUX
bjp-25731	334	20	it	it	PRON
bjp-25731	334	21	go	go	VERB
bjp-25731	334	22	?	?	PUNCT
bjp-25731	335	1	circulation	circulation	NOUN
bjp-25731	335	2	2011	2011	NUM
bjp-25731	335	3	;	;	PUNCT
bjp-25731	335	4	123	123	NUM
bjp-25731	335	5	:	:	PUNCT
bjp-25731	335	6	2776	2776	NUM
bjp-25731	335	7	-	-	SYM
bjp-25731	335	8	78	78	NUM
bjp-25731	335	9	.	.	PUNCT
bjp-25731	336	1	ding	ding	PROPN
bjp-25731	336	2	mw	mw	PROPN
bjp-25731	336	3	,	,	PUNCT
bjp-25731	336	4	yang	yang	PROPN
bjp-25731	336	5	sj	sj	PROPN
bjp-25731	336	6	,	,	PUNCT
bjp-25731	336	7	chen	chen	PROPN
bjp-25731	336	8	yf	yf	PROPN
bjp-25731	336	9	.	.	PUNCT
bjp-25731	336	10	synthesis	synthesis	NOUN
bjp-25731	336	11	and	and	CCONJ
bjp-25731	336	12	fungicidal	fungicidal	ADJ
bjp-25731	336	13	activities	activity	NOUN
bjp-25731	336	14	of	of	ADP
bjp-25731	336	15	2	2	NUM
bjp-25731	336	16	-	-	PUNCT
bjp-25731	336	17	alkoxy-3h	alkoxy-3h	NOUN
bjp-25731	336	18	-	-	PUNCT
bjp-25731	336	19	quinazolin-4	quinazolin-4	NOUN
bjp-25731	336	20	-	-	PUNCT
bjp-25731	336	21	ones	one	NOUN
bjp-25731	336	22	.	.	PUNCT
bjp-25731	337	1	chinese	chinese	ADJ
bjp-25731	337	2	j	j	PROPN
bjp-25731	337	3	org	org	PROPN
bjp-25731	337	4	chem	chem	NOUN
bjp-25731	337	5	.	.	PUNCT
bjp-25731	338	1	2004	2004	NUM
bjp-25731	338	2	;	;	PUNCT
bjp-25731	338	3	24	24	NUM
bjp-25731	338	4	:	:	PUNCT
bjp-25731	338	5	923	923	NUM
bjp-25731	338	6	-	-	SYM
bjp-25731	338	7	1026	1026	NUM
bjp-25731	338	8	.	.	PUNCT
bjp-25731	339	1	dongamanti	dongamanti	PROPN
bjp-25731	339	2	a	a	DET
bjp-25731	339	3	,	,	PUNCT
bjp-25731	339	4	gadiparthi	gadiparthi	ADJ
bjp-25731	339	5	r	r	NOUN
bjp-25731	339	6	,	,	PUNCT
bjp-25731	339	7	redamala	redamala	NOUN
bjp-25731	339	8	r	r	NOUN
bjp-25731	339	9	,	,	PUNCT
bjp-25731	339	10	anireddy	anireddy	PROPN
bjp-25731	339	11	j	j	PROPN
bjp-25731	339	12	,	,	PUNCT
bjp-25731	339	13	burri	burri	NOUN
bjp-25731	339	14	n	n	CCONJ
bjp-25731	339	15	,	,	PUNCT
bjp-25731	339	16	vantikommu	vantikommu	PROPN
bjp-25731	339	17	j.	j.	PROPN
bjp-25731	339	18	synthesis	synthesis	PROPN
bjp-25731	339	19	,	,	PUNCT
bjp-25731	339	20	antibacterial	antibacterial	ADJ
bjp-25731	339	21	,	,	PUNCT
bjp-25731	339	22	anti	anti	ADJ
bjp-25731	339	23	-	-	ADJ
bjp-25731	339	24	asthmatic	asthmatic	ADJ
bjp-25731	339	25	and	and	CCONJ
bjp-25731	339	26	anti	anti	ADJ
bjp-25731	339	27	-	-	ADJ
bjp-25731	339	28	diabetic	diabetic	ADJ
bjp-25731	339	29	activities	activity	NOUN
bjp-25731	339	30	of	of	ADP
bjp-25731	339	31	novel	novel	ADJ
bjp-25731	339	32	3	3	NUM
bjp-25731	339	33	-	-	PUNCT
bjp-25731	339	34	substituted	substitute	VERB
bjp-25731	339	35	quinazolin4	quinazolin4	NOUN
bjp-25731	339	36	-	-	PUNCT
bjp-25731	339	37	ones	one	NOUN
bjp-25731	339	38	using	use	VERB
bjp-25731	339	39	1	1	NUM
bjp-25731	339	40	-	-	PUNCT
bjp-25731	339	41	butyl-3	butyl-3	NUM
bjp-25731	339	42	-	-	PUNCT
bjp-25731	339	43	methyl	methyl	NOUN
bjp-25731	339	44	-	-	PUNCT
bjp-25731	339	45	imidazoliumtetrafluoro	imidazoliumtetrafluoro	NOUN
bjp-25731	339	46	borate	borate	NOUN
bjp-25731	339	47	[	[	X
bjp-25731	339	48	bmim+][bf4-	bmim+][bf4-	X
bjp-25731	339	49	]	]	X
bjp-25731	339	50	as	as	ADP
bjp-25731	339	51	a	a	DET
bjp-25731	339	52	green	green	ADJ
bjp-25731	339	53	,	,	PUNCT
bjp-25731	339	54	efficient	efficient	ADJ
bjp-25731	339	55	and	and	CCONJ
bjp-25731	339	56	reusable	reusable	ADJ
bjp-25731	339	57	catalyst	catalyst	NOUN
bjp-25731	339	58	under	under	ADP
bjp-25731	339	59	solvent	solvent	ADJ
bjp-25731	339	60	free	free	ADJ
bjp-25731	339	61	conditions	condition	NOUN
bjp-25731	339	62	.	.	PUNCT
bjp-25731	340	1	j	j	PROPN
bjp-25731	340	2	chem	chem	NOUN
bjp-25731	340	3	pharm	pharm	NOUN
bjp-25731	340	4	res	re	NOUN
bjp-25731	340	5	.	.	PUNCT
bjp-25731	340	6	2012	2012	NUM
bjp-25731	340	7	;	;	PUNCT
bjp-25731	340	8	4	4	NUM
bjp-25731	340	9	:	:	SYM
bjp-25731	340	10	3991	3991	NUM
bjp-25731	340	11	-	-	SYM
bjp-25731	340	12	4000	4000	NUM
bjp-25731	340	13	.	.	PUNCT
bjp-25731	341	1	du	du	PROPN
bjp-25731	341	2	j	j	PROPN
bjp-25731	341	3	,	,	PUNCT
bjp-25731	341	4	kang	kang	PROPN
bjp-25731	341	5	y	y	PROPN
bjp-25731	341	6	,	,	PUNCT
bjp-25731	341	7	zhao	zhao	PROPN
bjp-25731	341	8	y	y	PROPN
bjp-25731	341	9	,	,	PUNCT
bjp-25731	341	10	zheng	zheng	PROPN
bjp-25731	341	11	w	w	PROPN
bjp-25731	341	12	,	,	PUNCT
bjp-25731	341	13	zhang	zhang	PROPN
bjp-25731	341	14	y	y	PROPN
bjp-25731	341	15	,	,	PUNCT
bjp-25731	341	16	lin	lin	PROPN
bjp-25731	341	17	y	y	PROPN
bjp-25731	341	18	,	,	PUNCT
bjp-25731	341	19	wang	wang	PROPN
bjp-25731	341	20	z	z	PROPN
bjp-25731	341	21	,	,	PUNCT
bjp-25731	341	22	wang	wang	PROPN
bjp-25731	341	23	y	y	PROPN
bjp-25731	341	24	,	,	PUNCT
bjp-25731	341	25	luo	luo	PROPN
bjp-25731	341	26	q	q	PROPN
bjp-25731	341	27	,	,	PUNCT
bjp-25731	341	28	wu	wu	PROPN
bjp-25731	341	29	k	k	PROPN
bjp-25731	341	30	,	,	PUNCT
bjp-25731	341	31	wang	wang	PROPN
bjp-25731	341	32	f.	f.	PROPN
bjp-25731	341	33	synthesis	synthesis	PROPN
bjp-25731	341	34	,	,	PUNCT
bjp-25731	341	35	characterization	characterization	NOUN
bjp-25731	341	36	,	,	PUNCT
bjp-25731	341	37	and	and	CCONJ
bjp-25731	341	38	in	in	ADP
bjp-25731	341	39	vitro	vitro	X
bjp-25731	341	40	antitumor	antitumor	NOUN
bjp-25731	341	41	activity	activity	NOUN
bjp-25731	341	42	of	of	ADP
bjp-25731	341	43	ruthenium(ii	ruthenium(ii	NOUN
bjp-25731	341	44	)	)	PUNCT
bjp-25731	341	45	polypyridyl	polypyridyl	ADJ
bjp-25731	341	46	complexes	complexe	VERB
bjp-25731	341	47	tethering	tether	VERB
bjp-25731	341	48	egfr	egfr	ADV
bjp-25731	341	49	-	-	PUNCT
bjp-25731	341	50	inhibiting	inhibit	VERB
bjp-25731	341	51	4	4	NUM
bjp-25731	341	52	-	-	NOUN
bjp-25731	341	53	anilinoquinazolines	anilinoquinazoline	NOUN
bjp-25731	341	54	.	.	PUNCT
bjp-25731	342	1	inorg	inorg	PROPN
bjp-25731	342	2	chem	chem	NOUN
bjp-25731	342	3	.	.	PUNCT
bjp-25731	343	1	2016	2016	NUM
bjp-25731	343	2	;	;	PUNCT
bjp-25731	343	3	55	55	NUM
bjp-25731	343	4	:	:	SYM
bjp-25731	343	5	4595	4595	NUM
bjp-25731	343	6	-	-	SYM
bjp-25731	343	7	605	605	NUM
bjp-25731	343	8	.	.	PUNCT
bjp-25731	344	1	eicher	eicher	PROPN
bjp-25731	344	2	t	t	PROPN
bjp-25731	344	3	,	,	PUNCT
bjp-25731	344	4	hauptmann	hauptmann	PROPN
bjp-25731	344	5	s.	s.	PROPN
bjp-25731	344	6	the	the	DET
bjp-25731	344	7	chemistry	chemistry	NOUN
bjp-25731	344	8	of	of	ADP
bjp-25731	344	9	heterocycles	heterocycle	NOUN
bjp-25731	344	10	:	:	PUNCT
bjp-25731	345	1	structure	structure	NOUN
bjp-25731	345	2	,	,	PUNCT
bjp-25731	345	3	reactions	reaction	NOUN
bjp-25731	345	4	,	,	PUNCT
bjp-25731	345	5	syntheses	synthesis	NOUN
bjp-25731	345	6	,	,	PUNCT
bjp-25731	345	7	and	and	CCONJ
bjp-25731	345	8	applications	application	NOUN
bjp-25731	345	9	.	.	PUNCT
bjp-25731	346	1	2nd	2nd	ADJ
bjp-25731	346	2	edn	edn	PROPN
bjp-25731	346	3	.	.	PUNCT
bjp-25731	347	1	2003	2003	NUM
bjp-25731	347	2	.	.	PUNCT
bjp-25731	348	1	el	el	NOUN
bjp-25731	348	2	-	-	PUNCT
bjp-25731	348	3	azab	azab	ADV
bjp-25731	348	4	as	as	ADP
bjp-25731	348	5	,	,	PUNCT
bjp-25731	348	6	abdel	abdel	PROPN
bjp-25731	348	7	-	-	PUNCT
bjp-25731	348	8	hamide	hamide	PROPN
bjp-25731	348	9	sg	sg	PROPN
bjp-25731	348	10	,	,	PUNCT
bjp-25731	348	11	sayed	say	VERB
bjp-25731	348	12	-	-	PUNCT
bjp-25731	348	13	ahmed	ahmed	PROPN
bjp-25731	348	14	mm	mm	PROPN
bjp-25731	348	15	,	,	PUNCT
bjp-25731	348	16	hassan	hassan	PROPN
bjp-25731	348	17	gs	gs	PROPN
bjp-25731	348	18	,	,	PUNCT
bjp-25731	348	19	el	el	PROPN
bjp-25731	348	20	-	-	PUNCT
bjp-25731	348	21	hadiyah	hadiyah	PROPN
bjp-25731	348	22	tm	tm	PROPN
bjp-25731	348	23	,	,	PUNCT
bjp-25731	348	24	al	al	PROPN
bjp-25731	348	25	-	-	PROPN
bjp-25731	348	26	shabanah	shabanah	PROPN
bjp-25731	348	27	oa	oa	PROPN
bjp-25731	348	28	,	,	PUNCT
bjp-25731	348	29	al	al	PROPN
bjp-25731	348	30	-	-	PUNCT
bjp-25731	348	31	deeb	deeb	PROPN
bjp-25731	348	32	oa	oa	PROPN
bjp-25731	348	33	,	,	PUNCT
bjp-25731	348	34	elsubbagh	elsubbagh	PROPN
bjp-25731	348	35	hi	hi	INTJ
bjp-25731	348	36	novel	novel	NOUN
bjp-25731	348	37	4(3h)-quinazolinone	4(3h)-quinazolinone	NUM
bjp-25731	348	38	analogs	analog	NOUN
bjp-25731	348	39	:	:	PUNCT
bjp-25731	349	1	synthesis	synthesis	NOUN
bjp-25731	349	2	and	and	CCONJ
bjp-25731	349	3	anticonvulsant	anticonvulsant	ADJ
bjp-25731	349	4	activity	activity	NOUN
bjp-25731	349	5	.	.	PUNCT
bjp-25731	350	1	med	med	ADJ
bjp-25731	350	2	chem	chem	NOUN
bjp-25731	350	3	res	re	NOUN
bjp-25731	350	4	.	.	PUNCT
bjp-25731	350	5	2013	2013	NUM
bjp-25731	350	6	;	;	PUNCT
bjp-25731	350	7	22	22	NUM
bjp-25731	350	8	:	:	SYM
bjp-25731	350	9	281527	281527	NUM
bjp-25731	350	10	.	.	PUNCT
bjp-25731	351	1	el	el	NOUN
bjp-25731	351	2	-	-	PUNCT
bjp-25731	351	3	azab	azab	ADV
bjp-25731	351	4	as	as	ADP
bjp-25731	351	5	,	,	PUNCT
bjp-25731	351	6	eltahir	eltahir	PROPN
bjp-25731	351	7	keh	keh	PROPN
bjp-25731	351	8	.	.	PUNCT
bjp-25731	352	1	design	design	NOUN
bjp-25731	352	2	,	,	PUNCT
bjp-25731	352	3	synthesis	synthesis	NOUN
bjp-25731	352	4	and	and	CCONJ
bjp-25731	352	5	anticonvulsant	anticonvulsant	ADJ
bjp-25731	352	6	evaluation	evaluation	NOUN
bjp-25731	352	7	of	of	ADP
bjp-25731	352	8	novel	novel	ADJ
bjp-25731	352	9	8	8	NUM
bjp-25731	352	10	-	-	PUNCT
bjp-25731	352	11	substituted-4(3h)-quinazolines	substituted-4(3h)-quinazoline	NOUN
bjp-25731	352	12	.	.	PUNCT
bjp-25731	353	1	bangladesh	bangladesh	PROPN
bjp-25731	353	2	j	j	PROPN
bjp-25731	353	3	pharmacol	pharmacol	PROPN
bjp-25731	353	4	2016	2016	NUM
bjp-25731	353	5	;	;	PUNCT
bjp-25731	353	6	11	11	NUM
bjp-25731	353	7	:	:	PUNCT
bjp-25731	353	8	716	716	NUM
bjp-25731	353	9	-	-	SYM
bjp-25731	353	10	733	733	NUM
bjp-25731	353	11	729	729	NUM
bjp-25731	353	12	med	med	ADJ
bjp-25731	353	13	chem	chem	NOUN
bjp-25731	353	14	res	re	NOUN
bjp-25731	353	15	.	.	PUNCT
bjp-25731	353	16	2012	2012	NUM
bjp-25731	353	17	;	;	PUNCT
bjp-25731	353	18	21	21	NUM
bjp-25731	353	19	:	:	PUNCT
bjp-25731	353	20	3785	3785	NUM
bjp-25731	353	21	-	-	SYM
bjp-25731	353	22	96	96	NUM
bjp-25731	353	23	.	.	PUNCT
bjp-25731	354	1	elkamhawy	elkamhawy	PROPN
bjp-25731	354	2	a	a	PROPN
bjp-25731	354	3	,	,	PUNCT
bjp-25731	354	4	lee	lee	PROPN
bjp-25731	354	5	j	j	PROPN
bjp-25731	354	6	,	,	PUNCT
bjp-25731	354	7	park	park	PROPN
bjp-25731	354	8	bg	bg	PROPN
bjp-25731	354	9	,	,	PUNCT
bjp-25731	354	10	park	park	NOUN
bjp-25731	354	11	i	i	PROPN
bjp-25731	354	12	,	,	PUNCT
bjp-25731	354	13	pae	pae	X
bjp-25731	354	14	an	an	PROPN
bjp-25731	354	15	,	,	PUNCT
bjp-25731	354	16	roh	roh	PROPN
bjp-25731	354	17	ej	ej	PROPN
bjp-25731	354	18	.	.	PROPN
bjp-25731	354	19	novel	novel	PROPN
bjp-25731	354	20	quinazoline	quinazoline	NOUN
bjp-25731	354	21	-	-	PUNCT
bjp-25731	354	22	urea	urea	NOUN
bjp-25731	354	23	analogues	analogue	NOUN
bjp-25731	354	24	as	as	ADP
bjp-25731	354	25	modulators	modulator	NOUN
bjp-25731	354	26	for	for	ADP
bjp-25731	354	27	a	a	DET
bjp-25731	354	28	-induced	-induce	VERB
bjp-25731	354	29	mitochondrial	mitochondrial	ADJ
bjp-25731	354	30	dysfunction	dysfunction	NOUN
bjp-25731	354	31	:	:	PUNCT
bjp-25731	354	32	design	design	NOUN
bjp-25731	354	33	,	,	PUNCT
bjp-25731	354	34	synthesis	synthesis	NOUN
bjp-25731	354	35	,	,	PUNCT
bjp-25731	354	36	and	and	CCONJ
bjp-25731	354	37	molecular	molecular	ADJ
bjp-25731	354	38	docking	docking	NOUN
bjp-25731	354	39	study	study	NOUN
bjp-25731	354	40	.	.	PUNCT
bjp-25731	355	1	eur	eur	PROPN
bjp-25731	355	2	j	j	PROPN
bjp-25731	355	3	med	med	PROPN
bjp-25731	355	4	chem	chem	NOUN
bjp-25731	355	5	.	.	PUNCT
bjp-25731	356	1	2014	2014	NUM
bjp-25731	356	2	;	;	PUNCT
bjp-25731	356	3	84	84	NUM
bjp-25731	356	4	:	:	PUNCT
bjp-25731	356	5	466	466	NUM
bjp-25731	356	6	-	-	SYM
bjp-25731	356	7	75	75	NUM
bjp-25731	356	8	.	.	PUNCT
bjp-25731	357	1	famiglini	famiglini	PROPN
bjp-25731	357	2	v	v	PROPN
bjp-25731	357	3	,	,	PUNCT
bjp-25731	357	4	silvestri	silvestri	PROPN
bjp-25731	357	5	r.	r.	PROPN
bjp-25731	357	6	focus	focus	NOUN
bjp-25731	357	7	on	on	ADP
bjp-25731	357	8	chirality	chirality	NOUN
bjp-25731	357	9	of	of	ADP
bjp-25731	357	10	hiv-1	hiv-1	PUNCT
bjp-25731	357	11	nonnucleoside	nonnucleoside	ADV
bjp-25731	357	12	reverse	reverse	ADJ
bjp-25731	357	13	transcriptase	transcriptase	NOUN
bjp-25731	357	14	inhibitors	inhibitor	NOUN
bjp-25731	357	15	.	.	PUNCT
bjp-25731	358	1	molecules	molecule	NOUN
bjp-25731	358	2	2016	2016	NUM
bjp-25731	358	3	;	;	PUNCT
bjp-25731	358	4	21	21	NUM
bjp-25731	358	5	:	:	PUNCT
bjp-25731	358	6	221	221	NUM
bjp-25731	358	7	-	-	SYM
bjp-25731	358	8	39	39	NUM
bjp-25731	358	9	.	.	PUNCT
bjp-25731	359	1	farag	farag	PROPN
bjp-25731	359	2	aa	aa	PROPN
bjp-25731	359	3	,	,	PUNCT
bjp-25731	359	4	khalifa	khalifa	PROPN
bjp-25731	359	5	em	em	PRON
bjp-25731	359	6	,	,	PUNCT
bjp-25731	359	7	sadik	sadik	PROPN
bjp-25731	359	8	na	na	PROPN
bjp-25731	359	9	,	,	PUNCT
bjp-25731	359	10	abbas	abbas	PROPN
bjp-25731	359	11	sy	sy	PROPN
bjp-25731	359	12	,	,	PUNCT
bjp-25731	359	13	al	al	PROPN
bjp-25731	359	14	-	-	PUNCT
bjp-25731	359	15	sehemi	sehemi	PROPN
bjp-25731	359	16	ag	ag	PROPN
bjp-25731	359	17	,	,	PUNCT
bjp-25731	359	18	ammar	ammar	PROPN
bjp-25731	359	19	ya	ya	PROPN
bjp-25731	359	20	.	.	PUNCT
bjp-25731	359	21	synthesis	synthesis	NOUN
bjp-25731	359	22	,	,	PUNCT
bjp-25731	359	23	characterization	characterization	NOUN
bjp-25731	359	24	,	,	PUNCT
bjp-25731	359	25	and	and	CCONJ
bjp-25731	359	26	evaluation	evaluation	NOUN
bjp-25731	359	27	of	of	ADP
bjp-25731	359	28	some	some	DET
bjp-25731	359	29	novel	novel	ADJ
bjp-25731	359	30	4(3h)-quinazolinone	4(3h)-quinazolinone	NUM
bjp-25731	359	31	derivatives	derivative	NOUN
bjp-25731	359	32	as	as	ADP
bjp-25731	359	33	antiinflammatory	antiinflammatory	NOUN
bjp-25731	359	34	and	and	CCONJ
bjp-25731	359	35	analgesic	analgesic	ADJ
bjp-25731	359	36	agents	agent	NOUN
bjp-25731	359	37	.	.	PUNCT
bjp-25731	360	1	med	med	ADJ
bjp-25731	360	2	chem	chem	NOUN
bjp-25731	360	3	res	re	NOUN
bjp-25731	360	4	.	.	PUNCT
bjp-25731	360	5	2013	2013	NUM
bjp-25731	360	6	;	;	PUNCT
bjp-25731	360	7	22	22	NUM
bjp-25731	360	8	:	:	SYM
bjp-25731	360	9	440	440	NUM
bjp-25731	360	10	-	-	SYM
bjp-25731	360	11	52	52	NUM
bjp-25731	360	12	.	.	PUNCT
bjp-25731	361	1	fares	fare	NOUN
bjp-25731	361	2	m	m	PROPN
bjp-25731	361	3	,	,	PUNCT
bjp-25731	361	4	eldehna	eldehna	PROPN
bjp-25731	361	5	wm	wm	PROPN
bjp-25731	361	6	,	,	PUNCT
bjp-25731	361	7	abou	abou	PROPN
bjp-25731	361	8	-	-	PUNCT
bjp-25731	361	9	seri	seri	PROPN
bjp-25731	361	10	sm	sm	PROPN
bjp-25731	361	11	,	,	PUNCT
bjp-25731	361	12	abdel	abdel	PROPN
bjp-25731	361	13	-	-	PUNCT
bjp-25731	361	14	aziz	aziz	PROPN
bjp-25731	361	15	ha	ha	PROPN
bjp-25731	361	16	,	,	PUNCT
bjp-25731	361	17	aly	aly	PROPN
bjp-25731	361	18	mh	mh	PROPN
bjp-25731	361	19	,	,	PUNCT
bjp-25731	361	20	tolba	tolba	PROPN
bjp-25731	361	21	mf	mf	X
bjp-25731	361	22	.	.	PROPN
bjp-25731	361	23	design	design	NOUN
bjp-25731	361	24	,	,	PUNCT
bjp-25731	361	25	synthesis	synthesis	NOUN
bjp-25731	361	26	and	and	CCONJ
bjp-25731	361	27	in	in	ADP
bjp-25731	361	28	vitro	vitro	X
bjp-25731	361	29	antiproliferative	antiproliferative	ADJ
bjp-25731	361	30	activity	activity	NOUN
bjp-25731	361	31	of	of	ADP
bjp-25731	361	32	novel	novel	ADJ
bjp-25731	361	33	isatin	isatin	ADJ
bjp-25731	361	34	-	-	PUNCT
bjp-25731	361	35	quinazoline	quinazoline	ADJ
bjp-25731	361	36	hybrids	hybrid	NOUN
bjp-25731	361	37	.	.	PUNCT
bjp-25731	362	1	arch	arch	ADJ
bjp-25731	362	2	pharm	pharm	NOUN
bjp-25731	362	3	(	(	PUNCT
bjp-25731	362	4	weinheim	weinheim	PROPN
bjp-25731	362	5	)	)	PUNCT
bjp-25731	362	6	.	.	PUNCT
bjp-25731	363	1	2015	2015	NUM
bjp-25731	363	2	;	;	PUNCT
bjp-25731	363	3	348	348	NUM
bjp-25731	363	4	:	:	PUNCT
bjp-25731	363	5	144	144	NUM
bjp-25731	363	6	-	-	SYM
bjp-25731	363	7	54	54	NUM
bjp-25731	363	8	.	.	PUNCT
bjp-25731	364	1	franklin	franklin	PROPN
bjp-25731	364	2	bs	bs	PROPN
bjp-25731	364	3	,	,	PUNCT
bjp-25731	364	4	ishizaka	ishizaka	PROPN
bjp-25731	364	5	st	st	PROPN
bjp-25731	364	6	,	,	PUNCT
bjp-25731	364	7	lamphier	lamphier	NOUN
bjp-25731	364	8	m	m	PROPN
bjp-25731	364	9	,	,	PUNCT
bjp-25731	364	10	gusovsky	gusovsky	ADJ
bjp-25731	364	11	f	f	NOUN
bjp-25731	364	12	,	,	PUNCT
bjp-25731	364	13	hansen	hansen	PROPN
bjp-25731	364	14	h	h	PROPN
bjp-25731	364	15	,	,	PUNCT
bjp-25731	364	16	rose	rise	VERB
bjp-25731	364	17	j	j	PROPN
bjp-25731	364	18	,	,	PUNCT
bjp-25731	364	19	zheng	zheng	PROPN
bjp-25731	364	20	w	w	PROPN
bjp-25731	364	21	,	,	PUNCT
bjp-25731	364	22	ataíde	ataíde	PROPN
bjp-25731	364	23	ma	ma	PROPN
bjp-25731	364	24	,	,	PUNCT
bjp-25731	364	25	de	de	PROPN
bjp-25731	364	26	oliveira	oliveira	PROPN
bjp-25731	364	27	rb	rb	PROPN
bjp-25731	364	28	,	,	PUNCT
bjp-25731	364	29	golenbock	golenbock	NOUN
bjp-25731	364	30	dt	dt	NOUN
bjp-25731	364	31	,	,	PUNCT
bjp-25731	364	32	gazzinelli	gazzinelli	PROPN
bjp-25731	364	33	rt	rt	PROPN
bjp-25731	364	34	.	.	PUNCT
bjp-25731	365	1	therapeutical	therapeutical	ADJ
bjp-25731	365	2	targeting	target	VERB
bjp-25731	365	3	of	of	ADP
bjp-25731	365	4	nucleic	nucleic	ADJ
bjp-25731	365	5	acidsensing	acidsense	VERB
bjp-25731	365	6	toll	toll	NOUN
bjp-25731	365	7	-	-	PUNCT
bjp-25731	365	8	like	like	ADJ
bjp-25731	365	9	receptors	receptor	NOUN
bjp-25731	365	10	prevents	prevent	VERB
bjp-25731	365	11	experimental	experimental	ADJ
bjp-25731	365	12	cerebral	cerebral	ADJ
bjp-25731	365	13	malaria	malaria	NOUN
bjp-25731	365	14	.	.	PUNCT
bjp-25731	366	1	proc	proc	PROPN
bjp-25731	366	2	natl	natl	PROPN
bjp-25731	366	3	acad	acad	PROPN
bjp-25731	366	4	sci	sci	PROPN
bjp-25731	366	5	usa	usa	PROPN
bjp-25731	366	6	.	.	PROPN
bjp-25731	366	7	2011	2011	NUM
bjp-25731	366	8	;	;	PUNCT
bjp-25731	366	9	108	108	NUM
bjp-25731	366	10	:	:	SYM
bjp-25731	366	11	3689	3689	NUM
bjp-25731	366	12	-	-	SYM
bjp-25731	366	13	94	94	NUM
bjp-25731	366	14	.	.	PUNCT
bjp-25731	367	1	fung	fung	PROPN
bjp-25731	367	2	c	c	PROPN
bjp-25731	367	3	,	,	PUNCT
bjp-25731	367	4	grandis	grandis	PROPN
bjp-25731	367	5	jr	jr	PROPN
bjp-25731	367	6	.	.	PUNCT
bjp-25731	367	7	emerging	emerge	VERB
bjp-25731	367	8	drugs	drug	NOUN
bjp-25731	367	9	to	to	PART
bjp-25731	367	10	treat	treat	VERB
bjp-25731	367	11	squamous	squamous	ADJ
bjp-25731	367	12	cell	cell	NOUN
bjp-25731	367	13	carcinomas	carcinoma	NOUN
bjp-25731	367	14	of	of	ADP
bjp-25731	367	15	the	the	DET
bjp-25731	367	16	head	head	NOUN
bjp-25731	367	17	and	and	CCONJ
bjp-25731	367	18	neck	neck	NOUN
bjp-25731	367	19	.	.	PUNCT
bjp-25731	368	1	expert	expert	NOUN
bjp-25731	368	2	opin	opin	NOUN
bjp-25731	368	3	emerg	emerg	NOUN
bjp-25731	368	4	drugs	drug	NOUN
bjp-25731	368	5	.	.	PUNCT
bjp-25731	369	1	2010	2010	NUM
bjp-25731	369	2	;	;	PUNCT
bjp-25731	369	3	15	15	NUM
bjp-25731	369	4	:	:	SYM
bjp-25731	369	5	355	355	NUM
bjp-25731	369	6	-	-	SYM
bjp-25731	369	7	73	73	NUM
bjp-25731	369	8	.	.	PUNCT
bjp-25731	370	1	gali	gali	PROPN
bjp-25731	370	2	r	r	PROPN
bjp-25731	370	3	,	,	PUNCT
bjp-25731	370	4	banothu	banothu	PROPN
bjp-25731	370	5	j	j	PROPN
bjp-25731	370	6	,	,	PUNCT
bjp-25731	370	7	porika	porika	PROPN
bjp-25731	370	8	m	m	PROPN
bjp-25731	370	9	,	,	PUNCT
bjp-25731	370	10	velpula	velpula	NOUN
bjp-25731	370	11	r	r	NOUN
bjp-25731	370	12	,	,	PUNCT
bjp-25731	370	13	hnamte	hnamte	NOUN
bjp-25731	370	14	s	s	PART
bjp-25731	370	15	,	,	PUNCT
bjp-25731	370	16	bavantula	bavantula	ADJ
bjp-25731	370	17	r	r	NOUN
bjp-25731	370	18	,	,	PUNCT
bjp-25731	370	19	abbagani	abbagani	PROPN
bjp-25731	370	20	s	s	PROPN
bjp-25731	370	21	,	,	PUNCT
bjp-25731	370	22	busi	busi	PROPN
bjp-25731	370	23	s.	s.	PROPN
bjp-25731	370	24	indolyl	indolyl	PROPN
bjp-25731	370	25	methylenebenzo[h]thiazolo	methylenebenzo[h]thiazolo	PROPN
bjp-25731	371	1	[	[	PUNCT
bjp-25731	371	2	2,3	2,3	NUM
bjp-25731	371	3	-	-	NUM
bjp-25731	371	4	b]quinazolinones	b]quinazolinone	NOUN
bjp-25731	371	5	:	:	PUNCT
bjp-25731	371	6	synthesis	synthesis	NOUN
bjp-25731	371	7	,	,	PUNCT
bjp-25731	371	8	characterization	characterization	NOUN
bjp-25731	371	9	and	and	CCONJ
bjp-25731	371	10	evaluation	evaluation	NOUN
bjp-25731	371	11	of	of	ADP
bjp-25731	371	12	anti	anti	ADJ
bjp-25731	371	13	-	-	ADJ
bjp-25731	371	14	cancer	cancer	ADJ
bjp-25731	371	15	and	and	CCONJ
bjp-25731	371	16	antimicrobial	antimicrobial	ADJ
bjp-25731	371	17	activities	activity	NOUN
bjp-25731	371	18	.	.	PUNCT
bjp-25731	372	1	bioorg	bioorg	PROPN
bjp-25731	372	2	med	med	PROPN
bjp-25731	372	3	chem	chem	NOUN
bjp-25731	372	4	lett	lett	PROPN
bjp-25731	372	5	.	.	PUNCT
bjp-25731	373	1	2014	2014	NUM
bjp-25731	373	2	;	;	PUNCT
bjp-25731	373	3	24	24	NUM
bjp-25731	373	4	:	:	PUNCT
bjp-25731	373	5	4239	4239	NUM
bjp-25731	373	6	-	-	SYM
bjp-25731	373	7	42	42	NUM
bjp-25731	373	8	.	.	PUNCT
bjp-25731	374	1	garofalo	garofalo	PROPN
bjp-25731	374	2	a	a	PROPN
bjp-25731	374	3	,	,	PUNCT
bjp-25731	374	4	goossens	goossens	PROPN
bjp-25731	374	5	l	l	PROPN
bjp-25731	374	6	,	,	PUNCT
bjp-25731	374	7	lemoine	lemoine	PROPN
bjp-25731	374	8	a	a	X
bjp-25731	374	9	,	,	PUNCT
bjp-25731	374	10	ravez	ravez	NOUN
bjp-25731	374	11	s	s	PROPN
bjp-25731	374	12	,	,	PUNCT
bjp-25731	374	13	six	six	NUM
bjp-25731	374	14	p	p	NOUN
bjp-25731	374	15	,	,	PUNCT
bjp-25731	374	16	howsam	howsam	PROPN
bjp-25731	374	17	,	,	PUNCT
bjp-25731	374	18	m	m	PRON
bjp-25731	374	19	,	,	PUNCT
bjp-25731	374	20	farce	farce	NOUN
bjp-25731	374	21	a	a	PRON
bjp-25731	374	22	,	,	PUNCT
bjp-25731	374	23	depreux	depreux	ADJ
bjp-25731	374	24	p.	p.	NOUN
bjp-25731	375	1	[	[	X
bjp-25731	375	2	4-(6,7	4-(6,7	ADV
bjp-25731	375	3	-	-	PUNCT
bjp-25731	375	4	disubstituted	disubstitute	VERB
bjp-25731	375	5	quinazolin-4ylamino)phenyl	quinazolin-4ylamino)phenyl	NOUN
bjp-25731	375	6	]	]	PUNCT
bjp-25731	375	7	carbamic	carbamic	ADJ
bjp-25731	375	8	acid	acid	NOUN
bjp-25731	375	9	esters	ester	NOUN
bjp-25731	375	10	:	:	PUNCT
bjp-25731	375	11	a	a	DET
bjp-25731	375	12	novel	novel	ADJ
bjp-25731	375	13	series	series	NOUN
bjp-25731	375	14	of	of	ADP
bjp-25731	375	15	dual	dual	ADJ
bjp-25731	375	16	egfr	egfr	NOUN
bjp-25731	375	17	/	/	SYM
bjp-25731	375	18	vegfr-2	vegfr-2	NUM
bjp-25731	375	19	tyrosine	tyrosine	NOUN
bjp-25731	375	20	kinase	kinase	PROPN
bjp-25731	375	21	inhibitors	inhibitor	NOUN
bjp-25731	375	22	.	.	PUNCT
bjp-25731	376	1	med	med	ADJ
bjp-25731	376	2	chem	chem	NOUN
bjp-25731	376	3	commun	commun	PROPN
bjp-25731	376	4	.	.	PUNCT
bjp-25731	377	1	2011	2011	NUM
bjp-25731	377	2	;	;	PUNCT
bjp-25731	377	3	2	2	NUM
bjp-25731	377	4	:	:	SYM
bjp-25731	377	5	65	65	NUM
bjp-25731	377	6	-	-	SYM
bjp-25731	377	7	72	72	NUM
bjp-25731	377	8	.	.	PUNCT
bjp-25731	378	1	ghorab	ghorab	PROPN
bjp-25731	378	2	mm	mm	PROPN
bjp-25731	378	3	,	,	PUNCT
bjp-25731	378	4	alsaid	alsaid	PROPN
bjp-25731	378	5	ms	ms	PROPN
bjp-25731	378	6	,	,	PUNCT
bjp-25731	378	7	al	al	PROPN
bjp-25731	378	8	-	-	PROPN
bjp-25731	378	9	dosari	dosari	PROPN
bjp-25731	378	10	ms	ms	PROPN
bjp-25731	378	11	,	,	PUNCT
bjp-25731	378	12	el	el	PROPN
bjp-25731	378	13	-	-	PUNCT
bjp-25731	378	14	gazzar	gazzar	NOUN
bjp-25731	378	15	mg	mg	PROPN
bjp-25731	378	16	,	,	PUNCT
bjp-25731	378	17	parvez	parvez	PROPN
bjp-25731	378	18	mk	mk	PROPN
bjp-25731	378	19	.	.	PUNCT
bjp-25731	378	20	design	design	NOUN
bjp-25731	378	21	,	,	PUNCT
bjp-25731	378	22	synthesis	synthesis	NOUN
bjp-25731	378	23	and	and	CCONJ
bjp-25731	378	24	anti	anti	ADJ
bjp-25731	378	25	-	-	ADJ
bjp-25731	378	26	cancer	cancer	ADJ
bjp-25731	378	27	evaluation	evaluation	NOUN
bjp-25731	378	28	of	of	ADP
bjp-25731	378	29	novel	novel	ADJ
bjp-25731	378	30	quinazoline	quinazoline	NOUN
bjp-25731	378	31	-	-	PUNCT
bjp-25731	378	32	sulfonamide	sulfonamide	NOUN
bjp-25731	378	33	hybrids	hybrid	NOUN
bjp-25731	378	34	.	.	PUNCT
bjp-25731	379	1	molecules	molecule	NOUN
bjp-25731	379	2	2016	2016	NUM
bjp-25731	379	3	;	;	PUNCT
bjp-25731	379	4	21	21	NUM
bjp-25731	379	5	:	:	SYM
bjp-25731	379	6	189200	189200	NUM
bjp-25731	379	7	.	.	PUNCT
bjp-25731	380	1	guan	guan	PROPN
bjp-25731	380	2	j	j	PROPN
bjp-25731	380	3	,	,	PUNCT
bjp-25731	380	4	zhang	zhang	PROPN
bjp-25731	380	5	q	q	PROPN
bjp-25731	380	6	,	,	PUNCT
bjp-25731	380	7	o’neil	o’neil	PROPN
bjp-25731	380	8	m	m	PROPN
bjp-25731	380	9	,	,	PUNCT
bjp-25731	380	10	obaldia	obaldia	PROPN
bjp-25731	380	11	iii	iii	PROPN
bjp-25731	380	12	n	n	CCONJ
bjp-25731	380	13	,	,	PUNCT
bjp-25731	380	14	ager	ager	PROPN
bjp-25731	380	15	a	a	PRON
bjp-25731	380	16	,	,	PUNCT
bjp-25731	380	17	gerena	gerena	PROPN
bjp-25731	380	18	l	l	PROPN
bjp-25731	380	19	,	,	PUNCT
bjp-25731	380	20	lin	lin	PROPN
bjp-25731	380	21	aj	aj	PROPN
bjp-25731	380	22	.	.	PROPN
bjp-25731	380	23	antimalarial	antimalarial	ADJ
bjp-25731	380	24	activities	activity	NOUN
bjp-25731	380	25	of	of	ADP
bjp-25731	380	26	new	new	ADJ
bjp-25731	380	27	pyrrolo[3,2	pyrrolo[3,2	ADJ
bjp-25731	380	28	-	-	ADJ
bjp-25731	380	29	f]quinazoline-1,3	f]quinazoline-1,3	ADJ
bjp-25731	380	30	-	-	PUNCT
bjp-25731	380	31	diamine	diamine	ADJ
bjp-25731	380	32	derivatives	derivative	NOUN
bjp-25731	380	33	.	.	PUNCT
bjp-25731	381	1	antimicrob	antimicrob	PROPN
bjp-25731	381	2	agent	agent	PROPN
bjp-25731	381	3	chemother	chemother	PROPN
bjp-25731	381	4	.	.	PUNCT
bjp-25731	382	1	2005	2005	NUM
bjp-25731	382	2	;	;	PUNCT
bjp-25731	382	3	49	49	NUM
bjp-25731	382	4	:	:	SYM
bjp-25731	382	5	4928	4928	NUM
bjp-25731	382	6	-	-	SYM
bjp-25731	382	7	33	33	NUM
bjp-25731	382	8	.	.	PUNCT
bjp-25731	383	1	hassan	hassan	PROPN
bjp-25731	383	2	gs	gs	PROPN
bjp-25731	383	3	,	,	PUNCT
bjp-25731	383	4	georgey	georgey	PROPN
bjp-25731	383	5	hh	hh	PROPN
bjp-25731	383	6	,	,	PUNCT
bjp-25731	383	7	ibrahim	ibrahim	PROPN
bjp-25731	383	8	na	na	PROPN
bjp-25731	383	9	,	,	PUNCT
bjp-25731	383	10	zaki	zaki	PROPN
bjp-25731	383	11	ss	ss	PROPN
bjp-25731	383	12	.	.	PUNCT
bjp-25731	384	1	synthesis	synthesis	NOUN
bjp-25731	384	2	of	of	ADP
bjp-25731	384	3	novel	novel	ADJ
bjp-25731	384	4	substituted	substitute	VERB
bjp-25731	384	5	quinazoline	quinazoline	NOUN
bjp-25731	384	6	and	and	CCONJ
bjp-25731	384	7	quinazolin-4(3h)-one	quinazolin-4(3h)-one	NOUN
bjp-25731	384	8	derivatives	derivative	NOUN
bjp-25731	384	9	of	of	ADP
bjp-25731	384	10	expected	expect	VERB
bjp-25731	384	11	antitumor	antitumor	PROPN
bjp-25731	384	12	activity	activity	NOUN
bjp-25731	384	13	.	.	PUNCT
bjp-25731	385	1	der	der	ADJ
bjp-25731	385	2	pharm	pharm	NOUN
bjp-25731	385	3	chem	chem	PROPN
bjp-25731	385	4	.	.	PUNCT
bjp-25731	386	1	2015	2015	NUM
bjp-25731	386	2	;	;	PUNCT
bjp-25731	386	3	7	7	NUM
bjp-25731	386	4	:	:	SYM
bjp-25731	386	5	106	106	NUM
bjp-25731	386	6	-	-	SYM
bjp-25731	386	7	19	19	NUM
bjp-25731	386	8	.	.	PUNCT
bjp-25731	387	1	högberg	högberg	PROPN
bjp-25731	387	2	t	t	PROPN
bjp-25731	387	3	,	,	PUNCT
bjp-25731	387	4	frimurer	frimurer	ADP
bjp-25731	387	5	tm	tm	PROPN
bjp-25731	387	6	,	,	PUNCT
bjp-25731	387	7	sasmal	sasmal	ADJ
bjp-25731	387	8	pk	pk	NOUN
bjp-25731	387	9	.	.	PUNCT
bjp-25731	387	10	melanin	melanin	NOUN
bjp-25731	387	11	-	-	PUNCT
bjp-25731	387	12	concentrating	concentrate	VERB
bjp-25731	387	13	hormone	hormone	NOUN
bjp-25731	387	14	receptor	receptor	NOUN
bjp-25731	387	15	1	1	NUM
bjp-25731	387	16	(	(	PUNCT
bjp-25731	387	17	mchr1	mchr1	NOUN
bjp-25731	387	18	)	)	PUNCT
bjp-25731	387	19	antagonists	antagonist	NOUN
bjp-25731	387	20	–	–	PUNCT
bjp-25731	387	21	still	still	ADV
bjp-25731	387	22	a	a	DET
bjp-25731	387	23	viable	viable	ADJ
bjp-25731	387	24	approach	approach	NOUN
bjp-25731	387	25	for	for	ADP
bjp-25731	387	26	obesity	obesity	NOUN
bjp-25731	387	27	treatment	treatment	NOUN
bjp-25731	387	28	.	.	PUNCT
bjp-25731	388	1	bioorg	bioorg	PROPN
bjp-25731	388	2	med	med	PROPN
bjp-25731	388	3	chem	chem	NOUN
bjp-25731	388	4	lett	lett	PROPN
bjp-25731	388	5	.	.	PUNCT
bjp-25731	389	1	2012	2012	NUM
bjp-25731	389	2	;	;	PUNCT
bjp-25731	389	3	22	22	NUM
bjp-25731	389	4	:	:	SYM
bjp-25731	389	5	6039	6039	NUM
bjp-25731	389	6	-	-	SYM
bjp-25731	389	7	47	47	NUM
bjp-25731	389	8	humphrey	humphrey	PROPN
bjp-25731	389	9	jm	jm	PROPN
bjp-25731	389	10	,	,	PUNCT
bjp-25731	389	11	yang	yang	PROPN
bjp-25731	389	12	e	e	PROPN
bjp-25731	389	13	,	,	PUNCT
bjp-25731	389	14	am	be	AUX
bjp-25731	389	15	ende	ende	ADJ
bjp-25731	389	16	cw	cw	NOUN
bjp-25731	389	17	,	,	PUNCT
bjp-25731	389	18	arnold	arnold	PROPN
bjp-25731	389	19	ep	ep	PROPN
bjp-25731	389	20	,	,	PUNCT
bjp-25731	389	21	head	head	NOUN
bjp-25731	389	22	jl	jl	PROPN
bjp-25731	389	23	,	,	PUNCT
bjp-25731	389	24	jenkinson	jenkinson	PROPN
bjp-25731	389	25	s	s	PROPN
bjp-25731	389	26	,	,	PUNCT
bjp-25731	389	27	lebel	lebel	PROPN
bjp-25731	389	28	la	la	PROPN
bjp-25731	389	29	,	,	PUNCT
bjp-25731	389	30	liras	liras	PROPN
bjp-25731	389	31	s	s	PROPN
bjp-25731	389	32	,	,	PUNCT
bjp-25731	389	33	pandit	pandit	PROPN
bjp-25731	389	34	j	j	PROPN
bjp-25731	389	35	,	,	PUNCT
bjp-25731	389	36	samas	samas	PROPN
bjp-25731	389	37	b	b	PROPN
bjp-25731	389	38	,	,	PUNCT
bjp-25731	389	39	vajdos	vajdo	VERB
bjp-25731	389	40	f	f	PROPN
bjp-25731	389	41	,	,	PUNCT
bjp-25731	389	42	simons	simons	PROPN
bjp-25731	389	43	sp	sp	PROPN
bjp-25731	389	44	,	,	PUNCT
bjp-25731	389	45	evdokimov	evdokimov	NOUN
bjp-25731	389	46	a	a	X
bjp-25731	389	47	,	,	PUNCT
bjp-25731	389	48	mansour	mansour	PROPN
bjp-25731	389	49	m	m	PROPN
bjp-25731	389	50	,	,	PUNCT
bjp-25731	389	51	menniti	menniti	PROPN
bjp-25731	389	52	fs	fs	PROPN
bjp-25731	389	53	.	.	PROPN
bjp-25731	390	1	smallmolecule	smallmolecule	NOUN
bjp-25731	390	2	phosphodiesterase	phosphodiesterase	NOUN
bjp-25731	390	3	probes	probe	NOUN
bjp-25731	390	4	:	:	PUNCT
bjp-25731	390	5	discovery	discovery	NOUN
bjp-25731	390	6	of	of	ADP
bjp-25731	390	7	potent	potent	ADJ
bjp-25731	390	8	and	and	CCONJ
bjp-25731	390	9	selective	selective	ADJ
bjp-25731	390	10	cns	cns	NOUN
bjp-25731	390	11	-	-	PUNCT
bjp-25731	390	12	penetrable	penetrable	ADJ
bjp-25731	390	13	quinazoline	quinazoline	NOUN
bjp-25731	390	14	inhibitors	inhibitor	NOUN
bjp-25731	390	15	of	of	ADP
bjp-25731	390	16	pde1	pde1	PROPN
bjp-25731	390	17	.	.	PUNCT
bjp-25731	391	1	med	med	PROPN
bjp-25731	391	2	chem	chem	NOUN
bjp-25731	391	3	commun	commun	PROPN
bjp-25731	391	4	.	.	PUNCT
bjp-25731	391	5	2014	2014	NUM
bjp-25731	391	6	;	;	PUNCT
bjp-25731	391	7	5	5	NUM
bjp-25731	391	8	:	:	SYM
bjp-25731	391	9	1290	1290	NUM
bjp-25731	391	10	-	-	SYM
bjp-25731	391	11	96	96	NUM
bjp-25731	391	12	.	.	PUNCT
bjp-25731	392	1	hurt	hurt	PROPN
bjp-25731	392	2	rt	rt	PROPN
bjp-25731	392	3	,	,	PUNCT
bjp-25731	392	4	kulisek	kulisek	PROPN
bjp-25731	392	5	c	c	NOUN
bjp-25731	392	6	,	,	PUNCT
bjp-25731	392	7	buchanan	buchanan	PROPN
bjp-25731	392	8	la	la	PROPN
bjp-25731	392	9	,	,	PUNCT
bjp-25731	392	10	mcclave	mcclave	PROPN
bjp-25731	392	11	sa	sa	PROPN
bjp-25731	392	12	.	.	PUNCT
bjp-25731	393	1	the	the	DET
bjp-25731	393	2	obesity	obesity	NOUN
bjp-25731	393	3	epidemic	epidemic	NOUN
bjp-25731	393	4	:	:	PUNCT
bjp-25731	393	5	challenges	challenge	NOUN
bjp-25731	393	6	,	,	PUNCT
bjp-25731	393	7	health	health	NOUN
bjp-25731	393	8	initiatives	initiative	NOUN
bjp-25731	393	9	,	,	PUNCT
bjp-25731	393	10	and	and	CCONJ
bjp-25731	393	11	implications	implication	NOUN
bjp-25731	393	12	for	for	ADP
bjp-25731	393	13	gastroenterologists	gastroenterologist	NOUN
bjp-25731	393	14	.	.	PUNCT
bjp-25731	394	1	gastroenterol	gastroenterol	NOUN
bjp-25731	394	2	hepatol	hepatol	ADJ
bjp-25731	394	3	(	(	PUNCT
bjp-25731	394	4	n	n	NOUN
bjp-25731	394	5	y	y	NOUN
bjp-25731	394	6	)	)	PUNCT
bjp-25731	394	7	.	.	PUNCT
bjp-25731	395	1	2010	2010	NUM
bjp-25731	395	2	;	;	PUNCT
bjp-25731	395	3	6	6	NUM
bjp-25731	395	4	:	:	SYM
bjp-25731	395	5	780	780	NUM
bjp-25731	395	6	-92	-92	PROPN
bjp-25731	395	7	.	.	PUNCT
bjp-25731	395	8	hynes	hynes	PROPN
bjp-25731	395	9	ne	ne	PROPN
bjp-25731	395	10	,	,	PUNCT
bjp-25731	395	11	lane	lane	PROPN
bjp-25731	395	12	ha	ha	INTJ
bjp-25731	395	13	.	.	PROPN
bjp-25731	395	14	erbb	erbb	PROPN
bjp-25731	395	15	receptors	receptor	NOUN
bjp-25731	395	16	and	and	CCONJ
bjp-25731	395	17	cancer	cancer	NOUN
bjp-25731	395	18	:	:	PUNCT
bjp-25731	395	19	the	the	DET
bjp-25731	395	20	complexity	complexity	NOUN
bjp-25731	395	21	of	of	ADP
bjp-25731	395	22	targeted	target	VERB
bjp-25731	395	23	inhibitors	inhibitor	NOUN
bjp-25731	395	24	.	.	PUNCT
bjp-25731	396	1	nat	nat	PROPN
bjp-25731	396	2	rev	rev	PROPN
bjp-25731	396	3	cancer	cancer	NOUN
bjp-25731	396	4	.	.	PUNCT
bjp-25731	397	1	2005	2005	NUM
bjp-25731	397	2	;	;	PUNCT
bjp-25731	397	3	5	5	NUM
bjp-25731	397	4	:	:	PUNCT
bjp-25731	397	5	341	341	NUM
bjp-25731	397	6	-	-	SYM
bjp-25731	397	7	54	54	NUM
bjp-25731	397	8	.	.	PUNCT
bjp-25731	398	1	islam	islam	PROPN
bjp-25731	398	2	ms	ms	PROPN
bjp-25731	398	3	,	,	PUNCT
bjp-25731	398	4	loots	loot	NOUN
bjp-25731	398	5	dt	dt	PROPN
bjp-25731	398	6	.	.	PUNCT
bjp-25731	399	1	experimental	experimental	ADJ
bjp-25731	399	2	rodent	rodent	NOUN
bjp-25731	399	3	models	model	NOUN
bjp-25731	399	4	of	of	ADP
bjp-25731	399	5	type	type	NOUN
bjp-25731	399	6	2	2	NUM
bjp-25731	399	7	diabetes	diabetes	NOUN
bjp-25731	399	8	:	:	PUNCT
bjp-25731	399	9	a	a	DET
bjp-25731	399	10	review	review	NOUN
bjp-25731	399	11	.	.	PUNCT
bjp-25731	400	1	methods	method	NOUN
bjp-25731	400	2	find	find	VERB
bjp-25731	400	3	exp	exp	NOUN
bjp-25731	400	4	pharmacol	pharmacol	NOUN
bjp-25731	400	5	.	.	PUNCT
bjp-25731	400	6	2009	2009	NUM
bjp-25731	400	7	;	;	PUNCT
bjp-25731	400	8	31	31	NUM
bjp-25731	400	9	:	:	PUNCT
bjp-25731	400	10	249	249	NUM
bjp-25731	400	11	-	-	SYM
bjp-25731	400	12	61	61	NUM
bjp-25731	400	13	.	.	PUNCT
bjp-25731	401	1	jabir	jabir	PROPN
bjp-25731	401	2	nr	nr	PROPN
bjp-25731	401	3	,	,	PUNCT
bjp-25731	401	4	tabrez	tabrez	NOUN
bjp-25731	401	5	s	s	PROPN
bjp-25731	401	6	,	,	PUNCT
bjp-25731	401	7	ashraf	ashraf	PROPN
bjp-25731	401	8	gmd	gmd	PROPN
bjp-25731	401	9	,	,	PUNCT
bjp-25731	401	10	shakil	shakil	PROPN
bjp-25731	401	11	s	s	PROPN
bjp-25731	401	12	,	,	PUNCT
bjp-25731	401	13	damanhouri	damanhouri	PROPN
bjp-25731	401	14	ga	ga	PROPN
bjp-25731	401	15	,	,	PUNCT
bjp-25731	401	16	kamal	kamal	PROPN
bjp-25731	401	17	ma	ma	PROPN
bjp-25731	401	18	.	.	PROPN
bjp-25731	401	19	nanotechnology	nanotechnology	PROPN
bjp-25731	401	20	-	-	PUNCT
bjp-25731	401	21	based	base	VERB
bjp-25731	401	22	approaches	approach	NOUN
bjp-25731	401	23	in	in	ADP
bjp-25731	401	24	anticancer	anticancer	NOUN
bjp-25731	401	25	research	research	NOUN
bjp-25731	401	26	.	.	PUNCT
bjp-25731	402	1	int	int	PROPN
bjp-25731	402	2	j	j	PROPN
bjp-25731	402	3	nanomed	nanome	VERB
bjp-25731	402	4	.	.	PUNCT
bjp-25731	403	1	2012	2012	NUM
bjp-25731	403	2	;	;	PUNCT
bjp-25731	403	3	7	7	NUM
bjp-25731	403	4	:	:	SYM
bjp-25731	403	5	4391	4391	NUM
bjp-25731	403	6	-	-	SYM
bjp-25731	403	7	408	408	NUM
bjp-25731	403	8	.	.	PUNCT
bjp-25731	404	1	jafari	jafari	PROPN
bjp-25731	404	2	e	e	PROPN
bjp-25731	404	3	,	,	PUNCT
bjp-25731	404	4	khajouei	khajouei	PROPN
bjp-25731	404	5	mr	mr	PROPN
bjp-25731	404	6	,	,	PUNCT
bjp-25731	404	7	hassanzadeh	hassanzadeh	NOUN
bjp-25731	404	8	f	f	PROPN
bjp-25731	404	9	,	,	PUNCT
bjp-25731	404	10	hakimelahi	hakimelahi	PROPN
bjp-25731	404	11	gh	gh	PROPN
bjp-25731	404	12	,	,	PUNCT
bjp-25731	404	13	khodarahmi	khodarahmi	PROPN
bjp-25731	404	14	ga	ga	PROPN
bjp-25731	404	15	.	.	PROPN
bjp-25731	404	16	quinazolinone	quinazolinone	PROPN
bjp-25731	405	1	and	and	CCONJ
bjp-25731	405	2	quinazoline	quinazoline	ADJ
bjp-25731	405	3	derivatives	derivative	NOUN
bjp-25731	405	4	:	:	PUNCT
bjp-25731	405	5	recent	recent	ADJ
bjp-25731	405	6	structures	structure	NOUN
bjp-25731	405	7	with	with	ADP
bjp-25731	405	8	potent	potent	ADJ
bjp-25731	405	9	antimicrobial	antimicrobial	ADJ
bjp-25731	405	10	and	and	CCONJ
bjp-25731	405	11	cytotoxic	cytotoxic	ADJ
bjp-25731	405	12	activities	activity	NOUN
bjp-25731	405	13	.	.	PUNCT
bjp-25731	406	1	res	res	PROPN
bjp-25731	406	2	pharm	pharm	PROPN
bjp-25731	406	3	sci	sci	PROPN
bjp-25731	406	4	.	.	PROPN
bjp-25731	406	5	2016	2016	NUM
bjp-25731	406	6	;	;	PUNCT
bjp-25731	406	7	11	11	NUM
bjp-25731	406	8	:	:	SYM
bjp-25731	406	9	1	1	NUM
bjp-25731	406	10	-	-	SYM
bjp-25731	406	11	14	14	NUM
bjp-25731	406	12	.	.	PUNCT
bjp-25731	407	1	jaime	jaime	NOUN
bjp-25731	407	2	mfv	mfv	PROPN
bjp-25731	407	3	,	,	PUNCT
bjp-25731	407	4	redko	redko	NOUN
bjp-25731	407	5	f	f	PROPN
bjp-25731	407	6	,	,	PUNCT
bjp-25731	407	7	muschietti	muschietti	PROPN
bjp-25731	407	8	lv	lv	PROPN
bjp-25731	407	9	,	,	PUNCT
bjp-25731	407	10	campos	campos	PROPN
bjp-25731	407	11	rh	rh	PROPN
bjp-25731	407	12	,	,	PUNCT
bjp-25731	407	13	martino	martino	PROPN
bjp-25731	407	14	vs	vs	ADP
bjp-25731	407	15	,	,	PUNCT
bjp-25731	407	16	cavallaro	cavallaro	NOUN
bjp-25731	407	17	lv	lv	PROPN
bjp-25731	407	18	.	.	PUNCT
bjp-25731	408	1	in	in	ADP
bjp-25731	408	2	vitro	vitro	X
bjp-25731	408	3	antiviral	antiviral	ADJ
bjp-25731	408	4	activity	activity	NOUN
bjp-25731	408	5	of	of	ADP
bjp-25731	408	6	plant	plant	NOUN
bjp-25731	408	7	extracts	extract	NOUN
bjp-25731	408	8	from	from	ADP
bjp-25731	408	9	asteraceae	asteraceae	PROPN
bjp-25731	408	10	medicinal	medicinal	ADJ
bjp-25731	408	11	plants	plant	NOUN
bjp-25731	408	12	.	.	PUNCT
bjp-25731	409	1	virol	virol	PROPN
bjp-25731	409	2	j.	j.	PROPN
bjp-25731	409	3	2013	2013	NUM
bjp-25731	409	4	;	;	PUNCT
bjp-25731	409	5	10	10	NUM
bjp-25731	409	6	:	:	SYM
bjp-25731	409	7	245	245	NUM
bjp-25731	409	8	.	.	NUM
bjp-25731	410	1	jantova	jantova	PROPN
bjp-25731	410	2	s	s	X
bjp-25731	410	3	,	,	PUNCT
bjp-25731	410	4	ovadekova	ovadekova	X
bjp-25731	410	5	r	r	NOUN
bjp-25731	410	6	,	,	PUNCT
bjp-25731	410	7	letasiova	letasiova	PROPN
bjp-25731	410	8	s	s	AUX
bjp-25731	410	9	,	,	PUNCT
bjp-25731	410	10	spirkova	spirkova	X
bjp-25731	410	11	k	k	X
bjp-25731	410	12	,	,	PUNCT
bjp-25731	410	13	stankovsky	stankovsky	PROPN
bjp-25731	410	14	s.	s.	PROPN
bjp-25731	410	15	antimicrobial	antimicrobial	ADJ
bjp-25731	410	16	activity	activity	NOUN
bjp-25731	410	17	of	of	ADP
bjp-25731	410	18	some	some	DET
bjp-25731	410	19	substituted	substitute	VERB
bjp-25731	410	20	triazoloquinazolines	triazoloquinazoline	NOUN
bjp-25731	410	21	.	.	PUNCT
bjp-25731	411	1	folia	folia	PROPN
bjp-25731	411	2	microbiol	microbiol	PROPN
bjp-25731	411	3	.	.	PUNCT
bjp-25731	412	1	2005	2005	NUM
bjp-25731	412	2	;	;	PUNCT
bjp-25731	412	3	50	50	NUM
bjp-25731	412	4	:	:	SYM
bjp-25731	412	5	90	90	NUM
bjp-25731	412	6	-	-	SYM
bjp-25731	412	7	94	94	NUM
bjp-25731	412	8	.	.	PUNCT
bjp-25731	413	1	jäntschi	jäntschi	PROPN
bjp-25731	413	2	l	l	PROPN
bjp-25731	413	3	,	,	PUNCT
bjp-25731	413	4	bolboacă	bolboacă	VERB
bjp-25731	413	5	s.	s.	PROPN
bjp-25731	413	6	molecular	molecular	PROPN
bjp-25731	413	7	descriptors	descriptor	VERB
bjp-25731	413	8	family	family	NOUN
bjp-25731	413	9	on	on	ADP
bjp-25731	413	10	structure	structure	NOUN
bjp-25731	413	11	activity	activity	NOUN
bjp-25731	413	12	relationships	relationship	NOUN
bjp-25731	413	13	5	5	NUM
bjp-25731	413	14	.	.	PUNCT
bjp-25731	413	15	antimalarial	antimalarial	ADJ
bjp-25731	413	16	activity	activity	NOUN
bjp-25731	413	17	of	of	ADP
bjp-25731	413	18	2,4diamino-6	2,4diamino-6	NUM
bjp-25731	413	19	-	-	ADJ
bjp-25731	413	20	quinazoline	quinazoline	ADJ
bjp-25731	413	21	sulfonamide	sulfonamide	NOUN
bjp-25731	413	22	derivates	derivate	NOUN
bjp-25731	413	23	.	.	PUNCT
bjp-25731	414	1	leonardo	leonardo	PROPN
bjp-25731	414	2	j	j	PROPN
bjp-25731	414	3	sci	sci	PROPN
bjp-25731	414	4	.	.	PROPN
bjp-25731	414	5	2006	2006	NUM
bjp-25731	414	6	;	;	PUNCT
bjp-25731	414	7	8	8	NUM
bjp-25731	414	8	:	:	SYM
bjp-25731	414	9	77	77	NUM
bjp-25731	414	10	-	-	SYM
bjp-25731	414	11	88	88	NUM
bjp-25731	414	12	.	.	PUNCT
bjp-25731	415	1	jeon	jeon	PROPN
bjp-25731	415	2	mk	mk	PROPN
bjp-25731	415	3	,	,	PUNCT
bjp-25731	415	4	cheon	cheon	PROPN
bjp-25731	415	5	hg	hg	PROPN
bjp-25731	415	6	.	.	PUNCT
bjp-25731	416	1	promising	promise	VERB
bjp-25731	416	2	strategies	strategy	NOUN
bjp-25731	416	3	for	for	ADP
bjp-25731	416	4	obesity	obesity	NOUN
bjp-25731	416	5	pharmacotherapy	pharmacotherapy	NOUN
bjp-25731	416	6	:	:	PUNCT
bjp-25731	416	7	melanocortin-4	melanocortin-4	NUM
bjp-25731	416	8	(	(	PUNCT
bjp-25731	416	9	mc-4)receptor	mc-4)receptor	NOUN
bjp-25731	416	10	agonists	agonist	NOUN
bjp-25731	416	11	and	and	CCONJ
bjp-25731	416	12	melanin	melanin	NOUN
bjp-25731	416	13	concentrating	concentrate	VERB
bjp-25731	416	14	hormone	hormone	NOUN
bjp-25731	416	15	(	(	PUNCT
bjp-25731	416	16	mch	mch	PROPN
bjp-25731	416	17	)	)	PUNCT
bjp-25731	416	18	receptor-1	receptor-1	NUM
bjp-25731	416	19	antagonists	antagonist	NOUN
bjp-25731	416	20	.	.	PUNCT
bjp-25731	417	1	curr	curr	PROPN
bjp-25731	417	2	top	top	ADJ
bjp-25731	417	3	med	med	ADJ
bjp-25731	417	4	chem	chem	NOUN
bjp-25731	417	5	.	.	PUNCT
bjp-25731	418	1	2009	2009	NUM
bjp-25731	418	2	;	;	PUNCT
bjp-25731	418	3	9	9	NUM
bjp-25731	418	4	:	:	SYM
bjp-25731	418	5	504	504	NUM
bjp-25731	418	6	-	-	SYM
bjp-25731	418	7	38	38	NUM
bjp-25731	418	8	.	.	PUNCT
bjp-25731	419	1	jindal	jindal	PROPN
bjp-25731	419	2	dp	dp	PROPN
bjp-25731	419	3	,	,	PUNCT
bjp-25731	419	4	bhatti	bhatti	ADJ
bjp-25731	419	5	rs	rs	NOUN
bjp-25731	419	6	,	,	PUNCT
bjp-25731	419	7	ahlawat	ahlawat	VERB
bjp-25731	419	8	s	s	PROPN
bjp-25731	419	9	,	,	PUNCT
bjp-25731	419	10	gupta	gupta	PROPN
bjp-25731	419	11	r.	r.	NOUN
bjp-25731	419	12	synthesis	synthesis	NOUN
bjp-25731	419	13	and	and	CCONJ
bjp-25731	419	14	bronchodilatory	bronchodilatory	ADJ
bjp-25731	419	15	activity	activity	NOUN
bjp-25731	419	16	of	of	ADP
bjp-25731	419	17	some	some	DET
bjp-25731	419	18	nitrogen	nitrogen	NOUN
bjp-25731	419	19	bridgehead	bridgehead	NOUN
bjp-25731	419	20	compounds	compound	NOUN
bjp-25731	419	21	.	.	PUNCT
bjp-25731	420	1	eur	eur	PROPN
bjp-25731	420	2	j	j	PROPN
bjp-25731	420	3	med	med	PROPN
bjp-25731	420	4	chem	chem	NOUN
bjp-25731	420	5	.	.	PUNCT
bjp-25731	421	1	2002	2002	NUM
bjp-25731	421	2	;	;	PUNCT
bjp-25731	421	3	37	37	NUM
bjp-25731	421	4	:	:	PUNCT
bjp-25731	421	5	419	419	NUM
bjp-25731	421	6	-	-	SYM
bjp-25731	421	7	25	25	NUM
bjp-25731	421	8	.	.	PUNCT
bjp-25731	422	1	joule	joule	PROPN
bjp-25731	422	2	ja	ja	PROPN
bjp-25731	422	3	,	,	PUNCT
bjp-25731	422	4	mills	mills	PROPN
bjp-25731	422	5	k.	k.	PROPN
bjp-25731	422	6	heterocyclic	heterocyclic	PROPN
bjp-25731	422	7	chemistry	chemistry	NOUN
bjp-25731	422	8	.	.	PUNCT
bjp-25731	423	1	4th	4th	ADJ
bjp-25731	423	2	edn	edn	NOUN
bjp-25731	423	3	.	.	PUNCT
bjp-25731	424	1	oxford	oxford	PROPN
bjp-25731	424	2	,	,	PUNCT
bjp-25731	424	3	wiley	wiley	NOUN
bjp-25731	424	4	-	-	PUNCT
bjp-25731	424	5	blackwell	blackwell	NOUN
bjp-25731	424	6	publishers	publisher	NOUN
bjp-25731	424	7	,	,	PUNCT
bjp-25731	424	8	2000	2000	NUM
bjp-25731	424	9	,	,	PUNCT
bjp-25731	424	10	pp	pp	ADV
bjp-25731	424	11	12	12	NUM
bjp-25731	424	12	-	-	SYM
bjp-25731	424	13	18	18	NUM
bjp-25731	424	14	.	.	PUNCT
bjp-25731	425	1	kanuma	kanuma	PROPN
bjp-25731	426	1	k	k	NOUN
bjp-25731	426	2	,	,	PUNCT
bjp-25731	426	3	omodera	omodera	PROPN
bjp-25731	426	4	k	k	PROPN
bjp-25731	426	5	,	,	PUNCT
bjp-25731	426	6	nishiguchi	nishiguchi	PROPN
bjp-25731	426	7	m	m	PROPN
bjp-25731	426	8	,	,	PUNCT
bjp-25731	426	9	funakoshi	funakoshi	PROPN
bjp-25731	426	10	t	t	PROPN
bjp-25731	426	11	,	,	PUNCT
bjp-25731	426	12	chaki	chaki	PROPN
bjp-25731	426	13	s	s	PROPN
bjp-25731	426	14	,	,	PUNCT
bjp-25731	426	15	semple	semple	PROPN
bjp-25731	426	16	g	g	PROPN
bjp-25731	426	17	,	,	PUNCT
bjp-25731	426	18	tran	tran	PROPN
bjp-25731	426	19	ta	ta	PROPN
bjp-25731	426	20	,	,	PUNCT
bjp-25731	426	21	kramer	kramer	PROPN
bjp-25731	426	22	b	b	PROPN
bjp-25731	426	23	,	,	PUNCT
bjp-25731	426	24	hsu	hsu	PROPN
bjp-25731	426	25	d	d	PROPN
bjp-25731	426	26	,	,	PUNCT
bjp-25731	426	27	casper	casper	PROPN
bjp-25731	426	28	m	m	PROPN
bjp-25731	426	29	,	,	PUNCT
bjp-25731	426	30	thomsen	thomsen	PROPN
bjp-25731	426	31	b	b	PROPN
bjp-25731	426	32	,	,	PUNCT
bjp-25731	426	33	sekiguchi	sekiguchi	PROPN
bjp-25731	426	34	y.	y.	PROPN
bjp-25731	426	35	lead	lead	VERB
bjp-25731	426	36	optimization	optimization	NOUN
bjp-25731	426	37	of	of	ADP
bjp-25731	426	38	4-(dimethyl	4-(dimethyl	NUM
bjp-25731	426	39	amino	amino	NOUN
bjp-25731	426	40	)	)	PUNCT
bjp-25731	426	41	quinazolines	quinazoline	NOUN
bjp-25731	426	42	,	,	PUNCT
bjp-25731	426	43	potent	potent	ADJ
bjp-25731	426	44	and	and	CCONJ
bjp-25731	426	45	selective	selective	ADJ
bjp-25731	426	46	antagonists	antagonist	NOUN
bjp-25731	426	47	for	for	ADP
bjp-25731	426	48	the	the	DET
bjp-25731	426	49	melanin	melanin	NOUN
bjp-25731	426	50	-	-	PUNCT
bjp-25731	426	51	concentrating	concentrate	VERB
bjp-25731	426	52	hormone	hormone	NOUN
bjp-25731	426	53	receptor	receptor	NOUN
bjp-25731	426	54	1	1	NUM
bjp-25731	426	55	.	.	PUNCT
bjp-25731	426	56	bioorg	bioorg	PROPN
bjp-25731	426	57	med	med	PROPN
bjp-25731	426	58	chem	chem	NOUN
bjp-25731	426	59	lett	lett	PROPN
bjp-25731	426	60	.	.	PUNCT
bjp-25731	427	1	2005	2005	NUM
bjp-25731	427	2	;	;	PUNCT
bjp-25731	427	3	15	15	NUM
bjp-25731	427	4	:	:	SYM
bjp-25731	427	5	3853	3853	NUM
bjp-25731	427	6	-	-	SYM
bjp-25731	427	7	56	56	NUM
bjp-25731	427	8	.	.	PUNCT
bjp-25731	427	9	kashaw	kashaw	PROPN
bjp-25731	427	10	sk	sk	PROPN
bjp-25731	427	11	,	,	PUNCT
bjp-25731	427	12	kashaw	kashaw	PROPN
bjp-25731	427	13	v	v	PROPN
bjp-25731	427	14	,	,	PUNCT
bjp-25731	427	15	mishra	mishra	PROPN
bjp-25731	427	16	p	p	PROPN
bjp-25731	427	17	,	,	PUNCT
bjp-25731	427	18	jain	jain	PROPN
bjp-25731	427	19	nk	nk	PROPN
bjp-25731	427	20	,	,	PUNCT
bjp-25731	427	21	stables	stable	NOUN
bjp-25731	427	22	jp	jp	NOUN
bjp-25731	427	23	.	.	PUNCT
bjp-25731	428	1	synthesis	synthesis	NOUN
bjp-25731	428	2	,	,	PUNCT
bjp-25731	428	3	anticonvulsant	anticonvulsant	NOUN
bjp-25731	428	4	and	and	CCONJ
bjp-25731	428	5	cns	cns	NOUN
bjp-25731	428	6	depressant	depressant	ADJ
bjp-25731	428	7	activity	activity	NOUN
bjp-25731	428	8	of	of	ADP
bjp-25731	428	9	some	some	DET
bjp-25731	428	10	new	new	ADJ
bjp-25731	428	11	bioactive	bioactive	NOUN
bjp-25731	428	12	1-(4	1-(4	NUM
bjp-25731	428	13	-	-	PUNCT
bjp-25731	428	14	substituted	substitute	VERB
bjp-25731	428	15	-	-	PUNCT
bjp-25731	428	16	phenyl)-3-(4	phenyl)-3-(4	NOUN
bjp-25731	428	17	-	-	PUNCT
bjp-25731	428	18	oxo-2phenyl	oxo-2phenyl	NOUN
bjp-25731	428	19	/ethyl	/ethyl	PUNCT
bjp-25731	428	20	-4h	-4h	PROPN
bjp-25731	428	21	-	-	PUNCT
bjp-25731	428	22	quinazolin-3	quinazolin-3	NOUN
bjp-25731	428	23	-	-	PUNCT
bjp-25731	428	24	yl)-urea	yl)-urea	NOUN
bjp-25731	428	25	.	.	PUNCT
bjp-25731	429	1	eur	eur	PROPN
bjp-25731	429	2	j	j	PROPN
bjp-25731	429	3	med	med	PROPN
bjp-25731	429	4	chem	chem	NOUN
bjp-25731	429	5	.	.	PUNCT
bjp-25731	430	1	2009	2009	NUM
bjp-25731	430	2	;	;	PUNCT
bjp-25731	430	3	44	44	NUM
bjp-25731	430	4	:	:	SYM
bjp-25731	430	5	4335	4335	NUM
bjp-25731	430	6	-	-	SYM
bjp-25731	430	7	43	43	NUM
bjp-25731	430	8	.	.	PUNCT
bjp-25731	431	1	khan	khan	PROPN
bjp-25731	431	2	i	i	PROPN
bjp-25731	431	3	,	,	PUNCT
bjp-25731	431	4	ibrar	ibrar	NOUN
bjp-25731	431	5	a	a	NOUN
bjp-25731	431	6	,	,	PUNCT
bjp-25731	431	7	abbas	abbas	PROPN
bjp-25731	431	8	n	n	PART
bjp-25731	431	9	,	,	PUNCT
bjp-25731	431	10	saeed	saeed	PROPN
bjp-25731	431	11	a.	a.	PROPN
bjp-25731	431	12	recent	recent	PROPN
bjp-25731	431	13	advances	advance	NOUN
bjp-25731	431	14	in	in	ADP
bjp-25731	431	15	the	the	DET
bjp-25731	431	16	structural	structural	ADJ
bjp-25731	431	17	library	library	NOUN
bjp-25731	431	18	of	of	ADP
bjp-25731	431	19	functionalized	functionalized	ADJ
bjp-25731	431	20	quinazoline	quinazoline	NOUN
bjp-25731	431	21	and	and	CCONJ
bjp-25731	431	22	quinazolinone	quinazolinone	NOUN
bjp-25731	431	23	scaffolds	scaffold	NOUN
bjp-25731	431	24	:	:	PUNCT
bjp-25731	431	25	synthetic	synthetic	ADJ
bjp-25731	431	26	approaches	approach	NOUN
bjp-25731	431	27	and	and	CCONJ
bjp-25731	431	28	multifarious	multifarious	ADJ
bjp-25731	431	29	applications	application	NOUN
bjp-25731	431	30	.	.	PUNCT
bjp-25731	432	1	eur	eur	PROPN
bjp-25731	432	2	j	j	PROPN
bjp-25731	432	3	med	med	PROPN
bjp-25731	432	4	chem	chem	NOUN
bjp-25731	432	5	.	.	PUNCT
bjp-25731	433	1	2014	2014	NUM
bjp-25731	433	2	;	;	PUNCT
bjp-25731	433	3	76	76	NUM
bjp-25731	433	4	:	:	SYM
bjp-25731	433	5	193	193	NUM
bjp-25731	433	6	-	-	SYM
bjp-25731	433	7	244	244	NUM
bjp-25731	433	8	.	.	PUNCT
bjp-25731	434	1	khan	khan	PROPN
bjp-25731	434	2	i	i	PROPN
bjp-25731	434	3	,	,	PUNCT
bjp-25731	434	4	ibrar	ibrar	NOUN
bjp-25731	434	5	a	a	NOUN
bjp-25731	434	6	,	,	PUNCT
bjp-25731	434	7	ahmed	ahmed	PROPN
bjp-25731	434	8	w	w	PROPN
bjp-25731	434	9	,	,	PUNCT
bjp-25731	434	10	saeed	saeed	PROPN
bjp-25731	434	11	a.	a.	NOUN
bjp-25731	434	12	synthetic	synthetic	PROPN
bjp-25731	434	13	approaches	approach	NOUN
bjp-25731	434	14	,	,	PUNCT
bjp-25731	434	15	functionalization	functionalization	NOUN
bjp-25731	434	16	and	and	CCONJ
bjp-25731	434	17	therapeutic	therapeutic	ADJ
bjp-25731	434	18	potential	potential	NOUN
bjp-25731	434	19	of	of	ADP
bjp-25731	434	20	quinazolineand	quinazolineand	PROPN
bjp-25731	434	21	quinazolinone	quinazolinone	PROPN
bjp-25731	434	22	skeletons	skeleton	NOUN
bjp-25731	434	23	:	:	PUNCT
bjp-25731	434	24	advance	advance	NOUN
bjp-25731	434	25	continue	continue	VERB
bjp-25731	434	26	.	.	PUNCT
bjp-25731	435	1	eur	eur	PROPN
bjp-25731	435	2	j	j	PROPN
bjp-25731	435	3	730	730	NUM
bjp-25731	435	4	bangladesh	bangladesh	PROPN
bjp-25731	435	5	j	j	PROPN
bjp-25731	435	6	pharmacol	pharmacol	PROPN
bjp-25731	435	7	2016	2016	NUM
bjp-25731	435	8	;	;	PUNCT
bjp-25731	435	9	11	11	NUM
bjp-25731	435	10	:	:	PUNCT
bjp-25731	435	11	716	716	NUM
bjp-25731	435	12	-	-	SYM
bjp-25731	435	13	733	733	NUM
bjp-25731	435	14	http://www.ncbi.nlm.nih.gov/pubmed/25664631	http://www.ncbi.nlm.nih.gov/pubmed/25664631	NUM
bjp-25731	435	15	med	med	ADJ
bjp-25731	435	16	chem	chem	NOUN
bjp-25731	435	17	.	.	PUNCT
bjp-25731	436	1	2015	2015	NUM
bjp-25731	436	2	;	;	PUNCT
bjp-25731	436	3	90	90	NUM
bjp-25731	436	4	:	:	SYM
bjp-25731	436	5	124	124	NUM
bjp-25731	436	6	-	-	SYM
bjp-25731	436	7	69	69	NUM
bjp-25731	436	8	.	.	PUNCT
bjp-25731	437	1	king	king	PROPN
bjp-25731	437	2	am	be	AUX
bjp-25731	437	3	,	,	PUNCT
bjp-25731	437	4	marc	marc	PROPN
bjp-25731	437	5	dr	dr	PROPN
bjp-25731	437	6	,	,	PUNCT
bjp-25731	437	7	rafal	rafal	PROPN
bjp-25731	437	8	k	k	PROPN
bjp-25731	437	9	,	,	PUNCT
bjp-25731	437	10	anne	anne	PROPN
bjp-25731	437	11	v	v	PROPN
bjp-25731	437	12	,	,	PUNCT
bjp-25731	437	13	james	james	PROPN
bjp-25731	437	14	ps	ps	PROPN
bjp-25731	437	15	,	,	PUNCT
bjp-25731	437	16	harold	harold	PROPN
bjp-25731	437	17	k.	k.	PROPN
bjp-25731	437	18	defining	define	VERB
bjp-25731	437	19	the	the	DET
bjp-25731	437	20	structural	structural	ADJ
bjp-25731	437	21	parameters	parameter	NOUN
bjp-25731	437	22	that	that	PRON
bjp-25731	437	23	confer	confer	VERB
bjp-25731	437	24	anticonvulsant	anticonvulsant	ADJ
bjp-25731	437	25	activity	activity	NOUN
bjp-25731	437	26	by	by	ADP
bjp-25731	437	27	the	the	DET
bjp-25731	437	28	site	site	NOUN
bjp-25731	437	29	-	-	PUNCT
bjp-25731	437	30	by	by	ADP
bjp-25731	437	31	-	-	PUNCT
bjp-25731	437	32	site	site	NOUN
bjp-25731	437	33	modification	modification	NOUN
bjp-25731	437	34	of	of	ADP
bjp-25731	437	35	(	(	PUNCT
bjp-25731	437	36	r)-n’-benzyl	r)-n’-benzyl	NOUN
bjp-25731	437	37	2	2	NUM
bjp-25731	437	38	-	-	PUNCT
bjp-25731	437	39	amino-3	amino-3	NOUN
bjp-25731	437	40	-	-	PUNCT
bjp-25731	437	41	methylbutanamide	methylbutanamide	NOUN
bjp-25731	437	42	.	.	PUNCT
bjp-25731	438	1	j	j	PROPN
bjp-25731	438	2	med	med	PROPN
bjp-25731	438	3	chem	chem	NOUN
bjp-25731	438	4	.	.	PUNCT
bjp-25731	439	1	2011	2011	NUM
bjp-25731	439	2	;	;	PUNCT
bjp-25731	439	3	54	54	NUM
bjp-25731	439	4	:	:	SYM
bjp-25731	439	5	643242	643242	NUM
bjp-25731	439	6	.	.	PUNCT
bjp-25731	440	1	kolavenko	kolavenko	PROPN
bjp-25731	440	2	si	si	PROPN
bjp-25731	440	3	,	,	PUNCT
bjp-25731	440	4	nosulenko	nosulenko	PROPN
bjp-25731	440	5	is	be	AUX
bjp-25731	440	6	,	,	PUNCT
bjp-25731	440	7	voskoboynik	voskoboynik	PROPN
bjp-25731	440	8	ay	ay	PROPN
bjp-25731	440	9	,	,	PUNCT
bjp-25731	440	10	berest	ber	ADJ
bjp-25731	440	11	gg	gg	NOUN
bjp-25731	440	12	,	,	PUNCT
bjp-25731	440	13	antypenko	antypenko	PROPN
bjp-25731	440	14	ln	ln	NOUN
bjp-25731	440	15	.	.	PUNCT
bjp-25731	441	1	antypenko	antypenko	PROPN
bjp-25731	441	2	an	an	PROPN
bjp-25731	441	3	,	,	PUNCT
bjp-25731	441	4	katsev	katsev	PROPN
bjp-25731	441	5	am	am	NOUN
bjp-25731	441	6	.	.	PUNCT
bjp-25731	442	1	novel	novel	ADJ
bjp-25731	442	2	n	n	CCONJ
bjp-25731	442	3	-	-	PUNCT
bjp-25731	442	4	aryl	aryl	NOUN
bjp-25731	442	5	(	(	PUNCT
bjp-25731	442	6	alkaryl)-2-[(3	alkaryl)-2-[(3	NOUN
bjp-25731	442	7	-	-	PUNCT
bjp-25731	442	8	r-2	r-2	PROPN
bjp-25731	442	9	-	-	PUNCT
bjp-25731	442	10	oxo-2h-[1,2,4]triazino[2,3	oxo-2h-[1,2,4]triazino[2,3	NOUN
bjp-25731	442	11	-	-	PUNCT
bjp-25731	442	12	c]quinazoline-6yl)thio]acetamides	c]quinazoline-6yl)thio]acetamide	NOUN
bjp-25731	442	13	:	:	PUNCT
bjp-25731	442	14	synthesis	synthesis	NOUN
bjp-25731	442	15	,	,	PUNCT
bjp-25731	442	16	cytotoxicity	cytotoxicity	NOUN
bjp-25731	442	17	,	,	PUNCT
bjp-25731	442	18	anticancer	anticancer	NOUN
bjp-25731	442	19	activity	activity	NOUN
bjp-25731	442	20	,	,	PUNCT
bjp-25731	442	21	compare	compare	VERB
bjp-25731	442	22	analysis	analysis	NOUN
bjp-25731	442	23	and	and	CCONJ
bjp-25731	442	24	docking	docking	NOUN
bjp-25731	442	25	.	.	PUNCT
bjp-25731	443	1	med	med	ADJ
bjp-25731	443	2	chem	chem	NOUN
bjp-25731	443	3	res	re	NOUN
bjp-25731	443	4	.	.	PUNCT
bjp-25731	443	5	2013	2013	NUM
bjp-25731	443	6	;	;	PUNCT
bjp-25731	443	7	22	22	NUM
bjp-25731	443	8	:	:	PUNCT
bjp-25731	443	9	2610	2610	NUM
bjp-25731	443	10	-	-	SYM
bjp-25731	443	11	32	32	NUM
bjp-25731	443	12	.	.	PUNCT
bjp-25731	444	1	kramer	kramer	PROPN
bjp-25731	445	1	oh	oh	INTJ
bjp-25731	445	2	.	.	PUNCT
bjp-25731	446	1	hdac2	hdac2	NOUN
bjp-25731	446	2	:	:	PUNCT
bjp-25731	446	3	a	a	DET
bjp-25731	446	4	critical	critical	ADJ
bjp-25731	446	5	factor	factor	NOUN
bjp-25731	446	6	in	in	ADP
bjp-25731	446	7	health	health	NOUN
bjp-25731	446	8	and	and	CCONJ
bjp-25731	446	9	disease	disease	NOUN
bjp-25731	446	10	.	.	PUNCT
bjp-25731	447	1	trends	trend	NOUN
bjp-25731	447	2	pharmacol	pharmacol	PROPN
bjp-25731	447	3	sci	sci	PROPN
bjp-25731	447	4	.	.	PROPN
bjp-25731	447	5	2009	2009	NUM
bjp-25731	447	6	;	;	PUNCT
bjp-25731	447	7	30	30	NUM
bjp-25731	447	8	:	:	PUNCT
bjp-25731	447	9	647	647	NUM
bjp-25731	447	10	-	-	SYM
bjp-25731	447	11	55	55	NUM
bjp-25731	447	12	.	.	PUNCT
bjp-25731	448	1	kumar	kumar	PROPN
bjp-25731	448	2	a	a	PROPN
bjp-25731	448	3	,	,	PUNCT
bjp-25731	448	4	ito	ito	PROPN
bjp-25731	448	5	a	a	X
bjp-25731	448	6	,	,	PUNCT
bjp-25731	448	7	hirohama	hirohama	NOUN
bjp-25731	448	8	m	m	NOUN
bjp-25731	448	9	,	,	PUNCT
bjp-25731	448	10	yoshida	yoshida	PROPN
bjp-25731	448	11	m	m	PROPN
bjp-25731	448	12	,	,	PUNCT
bjp-25731	448	13	zhang	zhang	PROPN
bjp-25731	448	14	kyj	kyj	PROPN
bjp-25731	448	15	.	.	PUNCT
bjp-25731	449	1	identification	identification	NOUN
bjp-25731	449	2	of	of	ADP
bjp-25731	449	3	quinazolinyloxy	quinazolinyloxy	ADJ
bjp-25731	449	4	biarylurea	biarylurea	NOUN
bjp-25731	449	5	as	as	ADP
bjp-25731	449	6	a	a	DET
bjp-25731	449	7	new	new	ADJ
bjp-25731	449	8	class	class	NOUN
bjp-25731	449	9	of	of	ADP
bjp-25731	449	10	sumo	sumo	NOUN
bjp-25731	449	11	activating	activate	VERB
bjp-25731	449	12	enzyme	enzyme	NOUN
bjp-25731	449	13	1	1	NUM
bjp-25731	449	14	inhibitors	inhibitor	NOUN
bjp-25731	449	15	.	.	PUNCT
bjp-25731	450	1	bioorg	bioorg	PROPN
bjp-25731	450	2	med	med	PROPN
bjp-25731	450	3	chem	chem	NOUN
bjp-25731	450	4	lett	lett	PROPN
bjp-25731	450	5	.	.	PUNCT
bjp-25731	451	1	2013	2013	NUM
bjp-25731	451	2	;	;	PUNCT
bjp-25731	451	3	23	23	NUM
bjp-25731	451	4	:	:	PUNCT
bjp-25731	451	5	5145	5145	NUM
bjp-25731	451	6	-	-	SYM
bjp-25731	451	7	49	49	NUM
bjp-25731	451	8	.	.	PUNCT
bjp-25731	452	1	kumar	kumar	PROPN
bjp-25731	452	2	a	a	PROPN
bjp-25731	452	3	,	,	PUNCT
bjp-25731	452	4	sharma	sharma	PROPN
bjp-25731	452	5	s	s	PROPN
bjp-25731	452	6	,	,	PUNCT
bjp-25731	452	7	bajaj	bajaj	PROPN
bjp-25731	452	8	ak	ak	PROPN
bjp-25731	452	9	,	,	PUNCT
bjp-25731	452	10	sharma	sharma	PROPN
bjp-25731	452	11	s	s	PROPN
bjp-25731	452	12	,	,	PUNCT
bjp-25731	452	13	panwar	panwar	PROPN
bjp-25731	452	14	h	h	PROPN
bjp-25731	452	15	,	,	PUNCT
bjp-25731	452	16	singh	singh	PROPN
bjp-25731	452	17	t	t	PROPN
bjp-25731	452	18	,	,	PUNCT
bjp-25731	452	19	srivastava	srivastava	PROPN
bjp-25731	452	20	vk	vk	PROPN
bjp-25731	452	21	.	.	PUNCT
bjp-25731	453	1	some	some	DET
bjp-25731	453	2	new	new	ADJ
bjp-25731	453	3	2	2	NUM
bjp-25731	453	4	,	,	PUNCT
bjp-25731	453	5	3	3	NUM
bjp-25731	453	6	,	,	PUNCT
bjp-25731	453	7	6	6	NUM
bjp-25731	453	8	-	-	PUNCT
bjp-25731	453	9	trisubstituted	trisubstitute	VERB
bjp-25731	453	10	quinazolinones	quinazolinone	NOUN
bjp-25731	453	11	as	as	SCONJ
bjp-25731	453	12	potent	potent	ADJ
bjp-25731	453	13	anti	anti	ADJ
bjp-25731	453	14	-	-	ADJ
bjp-25731	453	15	inflammatory	inflammatory	ADJ
bjp-25731	453	16	,	,	PUNCT
bjp-25731	453	17	analgesic	analgesic	ADJ
bjp-25731	453	18	and	and	CCONJ
bjp-25731	453	19	cox	cox	PROPN
bjp-25731	453	20	-	-	PUNCT
bjp-25731	453	21	ii	ii	PROPN
bjp-25731	453	22	inhibitors	inhibitor	NOUN
bjp-25731	453	23	.	.	PUNCT
bjp-25731	454	1	bioorg	bioorg	PROPN
bjp-25731	454	2	med	med	PROPN
bjp-25731	454	3	chem	chem	NOUN
bjp-25731	454	4	.	.	PUNCT
bjp-25731	455	1	2003	2003	NUM
bjp-25731	455	2	;	;	PUNCT
bjp-25731	455	3	11	11	NUM
bjp-25731	455	4	:	:	SYM
bjp-25731	455	5	5293	5293	NUM
bjp-25731	455	6	-	-	SYM
bjp-25731	455	7	99	99	NUM
bjp-25731	455	8	.	.	PUNCT
bjp-25731	456	1	kumar	kumar	PROPN
bjp-25731	456	2	ks	ks	PROPN
bjp-25731	456	3	,	,	PUNCT
bjp-25731	456	4	ganguly	ganguly	NOUN
bjp-25731	456	5	s	s	PROPN
bjp-25731	456	6	,	,	PUNCT
bjp-25731	456	7	veerasamy	veerasamy	ADJ
bjp-25731	456	8	r	r	NOUN
bjp-25731	456	9	,	,	PUNCT
bjp-25731	456	10	de	de	PROPN
bjp-25731	456	11	clercq	clercq	PROPN
bjp-25731	456	12	e.	e.	PROPN
bjp-25731	456	13	synthesis	synthesis	PROPN
bjp-25731	456	14	,	,	PUNCT
bjp-25731	456	15	antiviral	antiviral	ADJ
bjp-25731	456	16	activity	activity	NOUN
bjp-25731	456	17	and	and	CCONJ
bjp-25731	456	18	cytotoxicity	cytotoxicity	NOUN
bjp-25731	456	19	evaluation	evaluation	NOUN
bjp-25731	456	20	of	of	ADP
bjp-25731	456	21	schiff	schiff	NOUN
bjp-25731	456	22	bases	basis	NOUN
bjp-25731	456	23	of	of	ADP
bjp-25731	456	24	some	some	DET
bjp-25731	456	25	2	2	NUM
bjp-25731	456	26	-	-	PUNCT
bjp-25731	456	27	phenyl	phenyl	NOUN
bjp-25731	456	28	quinazoline-4(3h)-ones	quinazoline-4(3h)-one	NOUN
bjp-25731	456	29	.	.	PUNCT
bjp-25731	457	1	eur	eur	PROPN
bjp-25731	457	2	j	j	PROPN
bjp-25731	457	3	med	med	PROPN
bjp-25731	457	4	chem	chem	NOUN
bjp-25731	457	5	.	.	PUNCT
bjp-25731	458	1	2010	2010	NUM
bjp-25731	458	2	;	;	PUNCT
bjp-25731	458	3	45	45	NUM
bjp-25731	458	4	:	:	SYM
bjp-25731	458	5	5474	5474	NUM
bjp-25731	458	6	-	-	SYM
bjp-25731	458	7	79	79	NUM
bjp-25731	458	8	.	.	PUNCT
bjp-25731	459	1	lim	lim	PROPN
bjp-25731	459	2	cj	cj	PROPN
bjp-25731	459	3	,	,	PUNCT
bjp-25731	459	4	oh	oh	INTJ
bjp-25731	459	5	ks	ks	NOUN
bjp-25731	459	6	,	,	PUNCT
bjp-25731	459	7	ha	ha	INTJ
bjp-25731	459	8	jd	jd	PROPN
bjp-25731	459	9	,	,	PUNCT
bjp-25731	459	10	lee	lee	PROPN
bjp-25731	459	11	jh	jh	PROPN
bjp-25731	459	12	,	,	PUNCT
bjp-25731	459	13	seo	seo	PROPN
bjp-25731	459	14	hw	hw	PROPN
bjp-25731	459	15	,	,	PUNCT
bjp-25731	459	16	chae	chae	PROPN
bjp-25731	459	17	ch	ch	PROPN
bjp-25731	459	18	,	,	PUNCT
bjp-25731	459	19	kim	kim	PROPN
bjp-25731	459	20	dg	dg	PROPN
bjp-25731	459	21	,	,	PUNCT
bjp-25731	459	22	lee	lee	PROPN
bjp-25731	459	23	mj	mj	PROPN
bjp-25731	459	24	,	,	PUNCT
bjp-25731	459	25	lee	lee	PROPN
bjp-25731	459	26	bh	bh	PROPN
bjp-25731	459	27	.	.	PROPN
bjp-25731	459	28	4	4	NUM
bjp-25731	459	29	-	-	PUNCT
bjp-25731	459	30	substituted	substitute	VERB
bjp-25731	459	31	quinazoline	quinazoline	NOUN
bjp-25731	459	32	derivatives	derivative	NOUN
bjp-25731	459	33	as	as	ADP
bjp-25731	459	34	novel	novel	ADJ
bjp-25731	459	35	epha2	epha2	NOUN
bjp-25731	459	36	receptor	receptor	NOUN
bjp-25731	459	37	tyrosine	tyrosine	NOUN
bjp-25731	459	38	kinase	kinase	PROPN
bjp-25731	459	39	inhibitors	inhibitor	NOUN
bjp-25731	459	40	.	.	PUNCT
bjp-25731	460	1	bioorg	bioorg	PROPN
bjp-25731	460	2	med	med	PROPN
bjp-25731	460	3	chem	chem	NOUN
bjp-25731	460	4	lett	lett	PROPN
bjp-25731	460	5	.	.	PUNCT
bjp-25731	461	1	2014	2014	NUM
bjp-25731	461	2	;	;	PUNCT
bjp-25731	461	3	24	24	NUM
bjp-25731	461	4	:	:	SYM
bjp-25731	461	5	4080	4080	NUM
bjp-25731	461	6	-	-	SYM
bjp-25731	461	7	83	83	NUM
bjp-25731	461	8	.	.	PUNCT
bjp-25731	462	1	lin	lin	PROPN
bjp-25731	462	2	z	z	PROPN
bjp-25731	462	3	,	,	PUNCT
bjp-25731	462	4	bishop	bishop	PROPN
bjp-25731	462	5	ks	ks	PROPN
bjp-25731	462	6	,	,	PUNCT
bjp-25731	462	7	sunderland	sunderland	PROPN
bjp-25731	462	8	h	h	PROPN
bjp-25731	462	9	,	,	PUNCT
bjp-25731	462	10	marlow	marlow	ADJ
bjp-25731	462	11	g	g	PROPN
bjp-25731	462	12	,	,	PUNCT
bjp-25731	462	13	murray	murray	PROPN
bjp-25731	462	14	p	p	X
bjp-25731	462	15	,	,	PUNCT
bjp-25731	462	16	dennya	dennya	PROPN
bjp-25731	462	17	wa	wa	PROPN
bjp-25731	462	18	,	,	PUNCT
bjp-25731	462	19	ferguson	ferguson	PROPN
bjp-25731	462	20	lr	lr	PROPN
bjp-25731	462	21	.	.	PROPN
bjp-25731	462	22	aquinazoline	aquinazoline	PROPN
bjp-25731	462	23	-	-	PUNCT
bjp-25731	462	24	based	base	VERB
bjp-25731	462	25	hdac	hdac	PROPN
bjp-25731	462	26	inhibitor	inhibitor	NOUN
bjp-25731	462	27	affects	affect	VERB
bjp-25731	462	28	gene	gene	NOUN
bjp-25731	462	29	expression	expression	NOUN
bjp-25731	462	30	pathways	pathway	NOUN
bjp-25731	462	31	involved	involve	VERB
bjp-25731	462	32	in	in	ADP
bjp-25731	462	33	cholesterol	cholesterol	NOUN
bjp-25731	462	34	biosynthesis	biosynthesis	NOUN
bjp-25731	462	35	and	and	CCONJ
bjp-25731	462	36	mevalonate	mevalonate	VERB
bjp-25731	462	37	in	in	ADP
bjp-25731	462	38	prostate	prostate	NOUN
bjp-25731	462	39	cancer	cancer	NOUN
bjp-25731	462	40	cells	cell	NOUN
bjp-25731	462	41	.	.	PUNCT
bjp-25731	463	1	mol	mol	ADP
bjp-25731	463	2	biosyst	biosyst	NOUN
bjp-25731	463	3	.	.	PUNCT
bjp-25731	464	1	2016	2016	NUM
bjp-25731	464	2	;	;	PUNCT
bjp-25731	464	3	12	12	NUM
bjp-25731	464	4	:	:	PUNCT
bjp-25731	464	5	839	839	NUM
bjp-25731	464	6	-	-	SYM
bjp-25731	464	7	49	49	NUM
bjp-25731	464	8	.	.	PUNCT
bjp-25731	465	1	lin	lin	PROPN
bjp-25731	465	2	z	z	PROPN
bjp-25731	465	3	,	,	PUNCT
bjp-25731	465	4	murray	murray	PROPN
bjp-25731	465	5	pm	pm	PROPN
bjp-25731	465	6	,	,	PUNCT
bjp-25731	465	7	ding	de	VERB
bjp-25731	465	8	y	y	PROPN
bjp-25731	465	9	,	,	PUNCT
bjp-25731	465	10	denny	denny	PROPN
bjp-25731	465	11	wa	wa	PROPN
bjp-25731	465	12	,	,	PUNCT
bjp-25731	465	13	ferguson	ferguson	PROPN
bjp-25731	465	14	lr	lr	PROPN
bjp-25731	465	15	.	.	PROPN
bjp-25731	465	16	quinazolines	quinazoline	NOUN
bjp-25731	465	17	as	as	ADP
bjp-25731	465	18	novel	novel	ADJ
bjp-25731	465	19	anti	anti	ADJ
bjp-25731	465	20	-	-	ADJ
bjp-25731	465	21	inflammatoryhistone	inflammatoryhistone	ADJ
bjp-25731	465	22	deacetylase	deacetylase	NOUN
bjp-25731	465	23	inhibitors	inhibitor	NOUN
bjp-25731	465	24	.	.	PUNCT
bjp-25731	466	1	mutation	mutation	NOUN
bjp-25731	466	2	res	re	NOUN
bjp-25731	466	3	.	.	PUNCT
bjp-25731	466	4	2010	2010	NUM
bjp-25731	466	5	;	;	PUNCT
bjp-25731	466	6	690	690	NUM
bjp-25731	466	7	:	:	PUNCT
bjp-25731	466	8	81	81	NUM
bjp-25731	466	9	-	-	SYM
bjp-25731	466	10	88	88	NUM
bjp-25731	466	11	.	.	PUNCT
bjp-25731	467	1	liu	liu	PROPN
bjp-25731	467	2	j	j	PROPN
bjp-25731	467	3	,	,	PUNCT
bjp-25731	467	4	xie	xie	PROPN
bjp-25731	467	5	yq	yq	PROPN
bjp-25731	467	6	,	,	PUNCT
bjp-25731	467	7	lin	lin	PROPN
bjp-25731	467	8	q	q	PROPN
bjp-25731	467	9	,	,	PUNCT
bjp-25731	467	10	shi	shi	PROPN
bjp-25731	467	11	bb	bb	PROPN
bjp-25731	467	12	,	,	PUNCT
bjp-25731	467	13	zhang	zhang	PROPN
bjp-25731	467	14	p	p	PROPN
bjp-25731	467	15	,	,	PUNCT
bjp-25731	467	16	zhang	zhang	PROPN
bjp-25731	467	17	ym	ym	PROPN
bjp-25731	467	18	,	,	PUNCT
bjp-25731	467	19	wei	wei	PROPN
bjp-25731	467	20	tb	tb	PROPN
bjp-25731	467	21	.	.	PUNCT
bjp-25731	467	22	dipodal	dipodal	ADJ
bjp-25731	467	23	fluorescent	fluorescent	ADJ
bjp-25731	467	24	chemosensor	chemosensor	NOUN
bjp-25731	467	25	for	for	ADP
bjp-25731	467	26	fe3	fe3	PROPN
bjp-25731	467	27	+	+	CCONJ
bjp-25731	467	28	and	and	CCONJ
bjp-25731	467	29	resultant	resultant	VERB
bjp-25731	467	30	complex	complex	NOUN
bjp-25731	467	31	as	as	ADP
bjp-25731	467	32	a	a	DET
bjp-25731	467	33	chemosensor	chemosensor	NOUN
bjp-25731	467	34	for	for	ADP
bjp-25731	467	35	fluoride	fluoride	NOUN
bjp-25731	467	36	.	.	PUNCT
bjp-25731	468	1	sensor	sensor	NOUN
bjp-25731	468	2	actuator	actuator	NOUN
bjp-25731	468	3	b	b	PROPN
bjp-25731	468	4	chem	chem	NOUN
bjp-25731	468	5	.	.	PUNCT
bjp-25731	469	1	2013	2013	NUM
bjp-25731	469	2	;	;	PUNCT
bjp-25731	469	3	186	186	NUM
bjp-25731	469	4	:	:	PUNCT
bjp-25731	469	5	657	657	NUM
bjp-25731	469	6	-	-	SYM
bjp-25731	469	7	65	65	NUM
bjp-25731	469	8	.	.	PUNCT
bjp-25731	470	1	liu	liu	PROPN
bjp-25731	470	2	y	y	PROPN
bjp-25731	470	3	,	,	PUNCT
bjp-25731	470	4	li	li	PROPN
bjp-25731	470	5	xm	xm	PROPN
bjp-25731	470	6	,	,	PUNCT
bjp-25731	470	7	meng	meng	PROPN
bjp-25731	470	8	lh	lh	PROPN
bjp-25731	470	9	,	,	PUNCT
bjp-25731	470	10	wang	wang	PROPN
bjp-25731	470	11	bg	bg	PROPN
bjp-25731	470	12	.	.	PROPN
bjp-25731	470	13	n	n	CCONJ
bjp-25731	470	14	-	-	PUNCT
bjp-25731	470	15	formyllapatin	formyllapatin	NOUN
bjp-25731	470	16	a	a	ADP
bjp-25731	470	17	,	,	PUNCT
bjp-25731	470	18	a	a	DET
bjp-25731	470	19	new	new	ADJ
bjp-25731	470	20	n	n	CCONJ
bjp-25731	470	21	-	-	PUNCT
bjp-25731	470	22	formylspiro	formylspiro	NOUN
bjp-25731	470	23	quinazoline	quinazoline	NOUN
bjp-25731	470	24	derivative	derivative	NOUN
bjp-25731	470	25	from	from	ADP
bjp-25731	470	26	the	the	DET
bjp-25731	470	27	marinederived	marinederived	ADJ
bjp-25731	470	28	fungus	fungus	NOUN
bjp-25731	470	29	penicillium	penicillium	NOUN
bjp-25731	470	30	adametzioides	adametzioide	VERB
bjp-25731	470	31	as-53	as-53	NOUN
bjp-25731	470	32	.	.	PUNCT
bjp-25731	471	1	phytochem	phytochem	PROPN
bjp-25731	471	2	lett	lett	PROPN
bjp-25731	471	3	.	.	PUNCT
bjp-25731	472	1	2014	2014	NUM
bjp-25731	472	2	;	;	PUNCT
bjp-25731	472	3	10	10	NUM
bjp-25731	472	4	:	:	SYM
bjp-25731	472	5	145	145	NUM
bjp-25731	472	6	-	-	SYM
bjp-25731	472	7	48	48	NUM
bjp-25731	472	8	.	.	PUNCT
bjp-25731	473	1	luo	luo	PROPN
bjp-25731	473	2	h	h	PROPN
bjp-25731	473	3	,	,	PUNCT
bjp-25731	473	4	yang	yang	PROPN
bjp-25731	473	5	s	s	PROPN
bjp-25731	473	6	,	,	PUNCT
bjp-25731	473	7	cai	cai	PROPN
bjp-25731	473	8	y	y	PROPN
bjp-25731	473	9	,	,	PUNCT
bjp-25731	473	10	peng	peng	PROPN
bjp-25731	473	11	z	z	PROPN
bjp-25731	473	12	,	,	PUNCT
bjp-25731	473	13	liu	liu	PROPN
bjp-25731	473	14	t.	t.	PROPN
bjp-25731	473	15	synthesis	synthesis	NOUN
bjp-25731	473	16	and	and	CCONJ
bjp-25731	473	17	biological	biological	ADJ
bjp-25731	473	18	evaluation	evaluation	NOUN
bjp-25731	473	19	of	of	ADP
bjp-25731	473	20	novel	novel	ADJ
bjp-25731	473	21	6	6	NUM
bjp-25731	473	22	-	-	PUNCT
bjp-25731	473	23	chloro	chloro	NOUN
bjp-25731	473	24	-	-	PUNCT
bjp-25731	473	25	quinazoline	quinazoline	NOUN
bjp-25731	473	26	derivatives	derivative	NOUN
bjp-25731	473	27	as	as	ADP
bjp-25731	473	28	potential	potential	ADJ
bjp-25731	473	29	antitumor	antitumor	PROPN
bjp-25731	473	30	agents	agent	NOUN
bjp-25731	473	31	.	.	PUNCT
bjp-25731	474	1	eur	eur	PROPN
bjp-25731	474	2	j	j	PROPN
bjp-25731	474	3	med	med	PROPN
bjp-25731	474	4	chem	chem	NOUN
bjp-25731	474	5	.	.	PUNCT
bjp-25731	475	1	2014	2014	NUM
bjp-25731	475	2	;	;	PUNCT
bjp-25731	475	3	84	84	NUM
bjp-25731	475	4	:	:	SYM
bjp-25731	475	5	746	746	NUM
bjp-25731	475	6	52	52	NUM
bjp-25731	475	7	.	.	PUNCT
bjp-25731	476	1	magyar	magyar	PROPN
bjp-25731	476	2	k	k	PROPN
bjp-25731	476	3	,	,	PUNCT
bjp-25731	476	4	deres	dere	VERB
bjp-25731	476	5	l	l	PROPN
bjp-25731	476	6	,	,	PUNCT
bjp-25731	476	7	eros	eros	PROPN
bjp-25731	476	8	k	k	PROPN
bjp-25731	476	9	,	,	PUNCT
bjp-25731	476	10	bruszt	bruszt	NOUN
bjp-25731	476	11	k	k	PROPN
bjp-25731	476	12	,	,	PUNCT
bjp-25731	476	13	seress	seress	PROPN
bjp-25731	476	14	l	l	PROPN
bjp-25731	476	15	,	,	PUNCT
bjp-25731	476	16	hamar	hamar	PROPN
bjp-25731	476	17	j	j	PROPN
bjp-25731	476	18	,	,	PUNCT
bjp-25731	476	19	hideg	hideg	PROPN
bjp-25731	476	20	k	k	PROPN
bjp-25731	476	21	,	,	PUNCT
bjp-25731	476	22	balogh	balogh	PROPN
bjp-25731	476	23	a	a	PROPN
bjp-25731	476	24	,	,	PUNCT
bjp-25731	476	25	gallyas	gallyas	PROPN
bjp-25731	476	26	jr	jr	PROPN
bjp-25731	476	27	,	,	PUNCT
bjp-25731	476	28	f	f	PROPN
bjp-25731	476	29	,	,	PUNCT
bjp-25731	476	30	sumegi	sumegi	PROPN
bjp-25731	476	31	b	b	PROPN
bjp-25731	476	32	,	,	PUNCT
bjp-25731	476	33	toth	toth	PROPN
bjp-25731	476	34	k	k	PROPN
bjp-25731	476	35	,	,	PUNCT
bjp-25731	476	36	halmosi	halmosi	NOUN
bjp-25731	476	37	r.	r.	VERB
bjp-25731	476	38	a	a	DET
bjp-25731	476	39	quinazoline	quinazoline	NOUN
bjp-25731	476	40	-	-	PUNCT
bjp-25731	476	41	derivative	derivative	NOUN
bjp-25731	476	42	compound	compound	NOUN
bjp-25731	476	43	with	with	ADP
bjp-25731	476	44	parp	parp	ADJ
bjp-25731	476	45	inhibitory	inhibitory	ADJ
bjp-25731	476	46	effect	effect	NOUN
bjp-25731	476	47	suppresses	suppress	VERB
bjp-25731	476	48	hypertension	hypertension	NOUN
bjp-25731	476	49	-	-	PUNCT
bjp-25731	476	50	induced	induce	VERB
bjp-25731	476	51	vascular	vascular	ADJ
bjp-25731	476	52	alterations	alteration	NOUN
bjp-25731	476	53	in	in	ADP
bjp-25731	476	54	spontaneously	spontaneously	ADV
bjp-25731	476	55	hypertensive	hypertensive	ADJ
bjp-25731	476	56	rats	rat	NOUN
bjp-25731	476	57	.	.	PUNCT
bjp-25731	477	1	biochim	biochim	PROPN
bjp-25731	477	2	biophys	biophy	NOUN
bjp-25731	477	3	acta	acta	PROPN
bjp-25731	477	4	mol	mol	ADP
bjp-25731	477	5	basis	basis	NOUN
bjp-25731	477	6	dis	dis	PROPN
bjp-25731	477	7	.	.	PUNCT
bjp-25731	477	8	2014	2014	NUM
bjp-25731	477	9	;	;	PUNCT
bjp-25731	477	10	1842	1842	NUM
bjp-25731	477	11	:	:	PUNCT
bjp-25731	477	12	935	935	NUM
bjp-25731	477	13	-	-	SYM
bjp-25731	477	14	44	44	NUM
bjp-25731	477	15	.	.	PUNCT
bjp-25731	478	1	mahato	mahato	PROPN
bjp-25731	478	2	ak	ak	PROPN
bjp-25731	478	3	,	,	PUNCT
bjp-25731	478	4	srivastava	srivastava	PROPN
bjp-25731	478	5	b	b	PROPN
bjp-25731	478	6	,	,	PUNCT
bjp-25731	478	7	nithya	nithya	PROPN
bjp-25731	478	8	s.	s.	PROPN
bjp-25731	478	9	chemistry	chemistry	PROPN
bjp-25731	478	10	,	,	PUNCT
bjp-25731	478	11	structure	structure	NOUN
bjp-25731	478	12	activity	activity	NOUN
bjp-25731	478	13	relationship	relationship	NOUN
bjp-25731	478	14	and	and	CCONJ
bjp-25731	478	15	biological	biological	ADJ
bjp-25731	478	16	activity	activity	NOUN
bjp-25731	478	17	of	of	ADP
bjp-25731	478	18	quinazoline-4	quinazoline-4	PROPN
bjp-25731	478	19	(	(	PUNCT
bjp-25731	478	20	3h)-one	3h)-one	NUM
bjp-25731	478	21	derivatives	derivative	NOUN
bjp-25731	478	22	.	.	PUNCT
bjp-25731	479	1	inventi	inventi	PROPN
bjp-25731	479	2	rapid	rapid	ADJ
bjp-25731	479	3	med	med	ADJ
bjp-25731	479	4	chem	chem	NOUN
bjp-25731	479	5	.	.	PUNCT
bjp-25731	480	1	2011	2011	NUM
bjp-25731	480	2	;	;	PUNCT
bjp-25731	480	3	2	2	X
bjp-25731	480	4	.	.	X
bjp-25731	480	5	maheswari	maheswari	PROPN
bjp-25731	480	6	cu	cu	PROPN
bjp-25731	480	7	,	,	PUNCT
bjp-25731	480	8	kumar	kumar	PROPN
bjp-25731	480	9	gs	gs	PROPN
bjp-25731	480	10	,	,	PUNCT
bjp-25731	480	11	venkateshwar	venkateshwar	PROPN
bjp-25731	480	12	m	m	PROPN
bjp-25731	480	13	,	,	PUNCT
bjp-25731	480	14	kumar	kumar	PROPN
bjp-25731	480	15	ra	ra	PROPN
bjp-25731	480	16	,	,	PUNCT
bjp-25731	480	17	kantam	kantam	PROPN
bjp-25731	480	18	ml	ml	PROPN
bjp-25731	480	19	,	,	PUNCT
bjp-25731	480	20	reddy	reddy	PROPN
bjp-25731	480	21	kr	kr	PROPN
bjp-25731	480	22	.	.	PROPN
bjp-25731	481	1	highly	highly	ADV
bjp-25731	481	2	efficient	efficient	ADJ
bjp-25731	481	3	one‐pot	one‐pot	NOUN
bjp-25731	481	4	synthesis	synthesis	NOUN
bjp-25731	481	5	of	of	ADP
bjp-25731	481	6	2‐substituted	2‐substitute	VERB
bjp-25731	481	7	quinazolines	quinazoline	NOUN
bjp-25731	481	8	and	and	CCONJ
bjp-25731	481	9	4h‐benzo[d][1,3]oxazines	4h‐benzo[d][1,3]oxazine	NOUN
bjp-25731	481	10	via	via	ADP
bjp-25731	481	11	cross	cross	PROPN
bjp-25731	481	12	dehydrogenative	dehydrogenative	ADJ
bjp-25731	481	13	coupling	coupling	NOUN
bjp-25731	481	14	using	use	VERB
bjp-25731	481	15	sodium	sodium	NOUN
bjp-25731	481	16	hypochlorite	hypochlorite	NOUN
bjp-25731	481	17	.	.	PUNCT
bjp-25731	482	1	adv	adv	PROPN
bjp-25731	482	2	syn	syn	PROPN
bjp-25731	482	3	catal	catal	PROPN
bjp-25731	482	4	.	.	PUNCT
bjp-25731	483	1	2010	2010	NUM
bjp-25731	483	2	;	;	PUNCT
bjp-25731	483	3	352	352	NUM
bjp-25731	483	4	:	:	PUNCT
bjp-25731	483	5	341	341	NUM
bjp-25731	483	6	-	-	SYM
bjp-25731	483	7	46	46	NUM
bjp-25731	483	8	manasa	manasa	PROPN
bjp-25731	483	9	k	k	PROPN
bjp-25731	483	10	,	,	PUNCT
bjp-25731	483	11	sidhaye	sidhaye	VERB
bjp-25731	483	12	rv	rv	PROPN
bjp-25731	483	13	,	,	PUNCT
bjp-25731	483	14	radhika	radhika	PROPN
bjp-25731	483	15	g	g	PROPN
bjp-25731	483	16	,	,	PUNCT
bjp-25731	483	17	nalini	nalini	PROPN
bjp-25731	483	18	cn	cn	PROPN
bjp-25731	483	19	.	.	PUNCT
bjp-25731	483	20	synthesis	synthesis	NOUN
bjp-25731	483	21	,	,	PUNCT
bjp-25731	483	22	antioxidant	antioxidant	ADJ
bjp-25731	483	23	and	and	CCONJ
bjp-25731	483	24	anti	anti	ADJ
bjp-25731	483	25	-	-	ADJ
bjp-25731	483	26	cancer	cancer	ADJ
bjp-25731	483	27	activity	activity	NOUN
bjp-25731	483	28	of	of	ADP
bjp-25731	483	29	quinazoline	quinazoline	NOUN
bjp-25731	483	30	derivatives	derivative	NOUN
bjp-25731	483	31	.	.	PUNCT
bjp-25731	484	1	curr	curr	PROPN
bjp-25731	484	2	pharma	pharma	PROPN
bjp-25731	484	3	res	re	NOUN
bjp-25731	484	4	.	.	PROPN
bjp-25731	484	5	2011	2011	NUM
bjp-25731	484	6	;	;	PUNCT
bjp-25731	484	7	1	1	NUM
bjp-25731	484	8	:	:	SYM
bjp-25731	484	9	101	101	NUM
bjp-25731	484	10	-	-	SYM
bjp-25731	484	11	05	05	NUM
bjp-25731	484	12	.	.	PUNCT
bjp-25731	484	13	maskey	maskey	PROPN
bjp-25731	484	14	rp	rp	PROPN
bjp-25731	484	15	,	,	PUNCT
bjp-25731	484	16	shaaban	shaaban	PROPN
bjp-25731	484	17	m	m	PROPN
bjp-25731	484	18	,	,	PUNCT
bjp-25731	484	19	grün	grün	PROPN
bjp-25731	484	20	-	-	PUNCT
bjp-25731	484	21	wollny	wollny	PROPN
bjp-25731	484	22	i	i	PROPN
bjp-25731	484	23	,	,	PUNCT
bjp-25731	485	1	laatsch	laatsch	PROPN
bjp-25731	485	2	h.	h.	PROPN
bjp-25731	485	3	quinazolin	quinazolin	PROPN
bjp-25731	485	4	-4	-4	PROPN
bjp-25731	485	5	-	-	PUNCT
bjp-25731	485	6	one	one	NUM
bjp-25731	485	7	derivatives	derivative	NOUN
bjp-25731	485	8	from	from	ADP
bjp-25731	485	9	streptomyces	streptomyce	NOUN
bjp-25731	485	10	isolates	isolate	NOUN
bjp-25731	485	11	.	.	PUNCT
bjp-25731	486	1	j	j	PROPN
bjp-25731	486	2	nat	nat	PROPN
bjp-25731	486	3	prod	prod	NOUN
bjp-25731	486	4	.	.	PUNCT
bjp-25731	486	5	2004	2004	NUM
bjp-25731	486	6	;	;	PUNCT
bjp-25731	486	7	67	67	NUM
bjp-25731	486	8	:	:	SYM
bjp-25731	486	9	1131	1131	NUM
bjp-25731	486	10	-	-	SYM
bjp-25731	486	11	34	34	NUM
bjp-25731	486	12	.	.	PUNCT
bjp-25731	487	1	mathew	mathew	PROPN
bjp-25731	487	2	b	b	PROPN
bjp-25731	487	3	,	,	PUNCT
bjp-25731	487	4	ross	ross	PROPN
bjp-25731	487	5	l	l	PROPN
bjp-25731	487	6	,	,	PUNCT
bjp-25731	487	7	reynolds	reynolds	PROPN
bjp-25731	487	8	rc	rc	PROPN
bjp-25731	487	9	.	.	PUNCT
bjp-25731	488	1	a	a	DET
bjp-25731	488	2	novel	novel	ADJ
bjp-25731	488	3	quinoline	quinoline	NOUN
bjp-25731	488	4	derivative	derivative	NOUN
bjp-25731	488	5	that	that	PRON
bjp-25731	488	6	inhibits	inhibit	VERB
bjp-25731	488	7	mycobacterial	mycobacterial	ADJ
bjp-25731	488	8	ftsz	ftsz	NOUN
bjp-25731	488	9	.	.	PUNCT
bjp-25731	489	1	tuberculosis	tuberculosis	NOUN
bjp-25731	489	2	2013	2013	NUM
bjp-25731	489	3	;	;	PUNCT
bjp-25731	489	4	93	93	NUM
bjp-25731	489	5	:	:	SYM
bjp-25731	489	6	398400	398400	NUM
bjp-25731	489	7	.	.	PUNCT
bjp-25731	490	1	maurya	maurya	PROPN
bjp-25731	490	2	hk	hk	PROPN
bjp-25731	490	3	,	,	PUNCT
bjp-25731	490	4	verma	verma	PROPN
bjp-25731	490	5	r	r	PROPN
bjp-25731	490	6	,	,	PUNCT
bjp-25731	490	7	alam	alam	PROPN
bjp-25731	490	8	s	s	PROPN
bjp-25731	490	9	,	,	PUNCT
bjp-25731	490	10	pandey	pandey	PROPN
bjp-25731	490	11	s	s	PROPN
bjp-25731	490	12	,	,	PUNCT
bjp-25731	490	13	pathak	pathak	PROPN
bjp-25731	490	14	v	v	PROPN
bjp-25731	490	15	,	,	PUNCT
bjp-25731	490	16	sharma	sharma	PROPN
bjp-25731	490	17	s	s	PROPN
bjp-25731	490	18	,	,	PUNCT
bjp-25731	490	19	srivastava	srivastava	PROPN
bjp-25731	490	20	kk	kk	PROPN
bjp-25731	490	21	,	,	PUNCT
bjp-25731	490	22	negi	negi	PROPN
bjp-25731	490	23	as	as	ADP
bjp-25731	490	24	,	,	PUNCT
bjp-25731	490	25	gupta	gupta	PROPN
bjp-25731	490	26	a.	a.	NOUN
bjp-25731	490	27	studies	study	NOUN
bjp-25731	490	28	on	on	ADP
bjp-25731	490	29	substituted	substitute	VERB
bjp-25731	490	30	benzo[h]quinazolines	benzo[h]quinazoline	NOUN
bjp-25731	490	31	,	,	PUNCT
bjp-25731	490	32	benzo[g]indazoles	benzo[g]indazole	NOUN
bjp-25731	490	33	,	,	PUNCT
bjp-25731	490	34	pyrazoles	pyrazole	VERB
bjp-25731	490	35	,	,	PUNCT
bjp-25731	490	36	2,6diaryl	2,6diaryl	NUM
bjp-25731	490	37	pyridines	pyridine	NOUN
bjp-25731	490	38	as	as	ADP
bjp-25731	490	39	anti	anti	ADJ
bjp-25731	490	40	-	-	ADJ
bjp-25731	490	41	tubercular	tubercular	ADJ
bjp-25731	490	42	agents	agent	NOUN
bjp-25731	490	43	.	.	PUNCT
bjp-25731	491	1	bioorg	bioorg	PROPN
bjp-25731	491	2	med	med	PROPN
bjp-25731	491	3	chem	chem	NOUN
bjp-25731	491	4	lett	lett	PROPN
bjp-25731	491	5	.	.	PUNCT
bjp-25731	492	1	2013	2013	NUM
bjp-25731	492	2	;	;	PUNCT
bjp-25731	492	3	23	23	NUM
bjp-25731	492	4	:	:	SYM
bjp-25731	492	5	5844	5844	NUM
bjp-25731	492	6	-	-	SYM
bjp-25731	492	7	49	49	NUM
bjp-25731	492	8	.	.	PUNCT
bjp-25731	493	1	mclaughlin	mclaughlin	PROPN
bjp-25731	493	2	np	np	PROPN
bjp-25731	493	3	,	,	PUNCT
bjp-25731	493	4	evans	evans	PROPN
bjp-25731	493	5	p	p	PROPN
bjp-25731	493	6	,	,	PUNCT
bjp-25731	493	7	pines	pine	NOUN
bjp-25731	493	8	m.	m.	NOUN
bjp-25731	493	9	the	the	DET
bjp-25731	493	10	chemistry	chemistry	NOUN
bjp-25731	493	11	and	and	CCONJ
bjp-25731	493	12	biology	biology	NOUN
bjp-25731	493	13	of	of	ADP
bjp-25731	493	14	febrifugine	febrifugine	NOUN
bjp-25731	493	15	and	and	CCONJ
bjp-25731	493	16	halofuginone	halofuginone	PROPN
bjp-25731	493	17	.	.	PUNCT
bjp-25731	494	1	bioorg	bioorg	PROPN
bjp-25731	494	2	med	med	PROPN
bjp-25731	494	3	chem	chem	NOUN
bjp-25731	494	4	.	.	PUNCT
bjp-25731	495	1	2014	2014	NUM
bjp-25731	495	2	;	;	PUNCT
bjp-25731	495	3	2	2	NUM
bjp-25731	495	4	:	:	SYM
bjp-25731	495	5	1993	1993	NUM
bjp-25731	495	6	-	-	SYM
bjp-25731	495	7	2004	2004	NUM
bjp-25731	495	8	.	.	PUNCT
bjp-25731	496	1	mendoza	mendoza	PROPN
bjp-25731	496	2	-	-	PUNCT
bjp-25731	496	3	martínez	martínez	PROPN
bjp-25731	496	4	c	c	NOUN
bjp-25731	496	5	,	,	PUNCT
bjp-25731	496	6	galindo	galindo	PROPN
bjp-25731	496	7	-	-	PUNCT
bjp-25731	496	8	sevilla	sevilla	PROPN
bjp-25731	496	9	n	n	CCONJ
bjp-25731	496	10	,	,	PUNCT
bjp-25731	496	11	correa	correa	PROPN
bjp-25731	496	12	-	-	PUNCT
bjp-25731	496	13	basurto	basurto	PROPN
bjp-25731	496	14	j	j	PROPN
bjp-25731	496	15	,	,	PUNCT
bjp-25731	496	16	ugalde	ugalde	PROPN
bjp-25731	496	17	-	-	PUNCT
bjp-25731	496	18	saldivar	saldivar	PROPN
bjp-25731	496	19	vm	vm	PROPN
bjp-25731	496	20	,	,	PUNCT
bjp-25731	496	21	rodríguez	rodríguez	NOUN
bjp-25731	496	22	-	-	PUNCT
bjp-25731	496	23	delgado	delgado	NOUN
bjp-25731	496	24	rg	rg	PROPN
bjp-25731	496	25	,	,	PUNCT
bjp-25731	496	26	hernándezpineda	hernándezpineda	PROPN
bjp-25731	496	27	j	j	PROPN
bjp-25731	496	28	,	,	PUNCT
bjp-25731	496	29	padierna	padierna	NOUN
bjp-25731	496	30	-	-	PUNCT
bjp-25731	496	31	mota	mota	NOUN
bjp-25731	496	32	c	c	X
bjp-25731	496	33	,	,	PUNCT
bjp-25731	496	34	flores	flores	PROPN
bjp-25731	496	35	-	-	PUNCT
bjp-25731	496	36	alamo	alamo	PROPN
bjp-25731	496	37	m	m	PROPN
bjp-25731	496	38	,	,	PUNCT
bjp-25731	496	39	hernándezluis	hernándezluis	VERB
bjp-25731	496	40	f.	f.	NOUN
bjp-25731	496	41	antileishmanial	antileishmanial	ADJ
bjp-25731	496	42	activity	activity	NOUN
bjp-25731	496	43	of	of	ADP
bjp-25731	496	44	quinazoline	quinazoline	ADJ
bjp-25731	496	45	derivatives	derivative	NOUN
bjp-25731	496	46	:	:	PUNCT
bjp-25731	496	47	synthesis	synthesis	NOUN
bjp-25731	496	48	,	,	PUNCT
bjp-25731	496	49	docking	dock	VERB
bjp-25731	496	50	screens	screen	NOUN
bjp-25731	496	51	,	,	PUNCT
bjp-25731	496	52	molecular	molecular	ADJ
bjp-25731	496	53	dynamic	dynamic	ADJ
bjp-25731	496	54	simulations	simulation	NOUN
bjp-25731	496	55	and	and	CCONJ
bjp-25731	496	56	electrochemical	electrochemical	ADJ
bjp-25731	496	57	studies	study	NOUN
bjp-25731	496	58	.	.	PUNCT
bjp-25731	497	1	eur	eur	PROPN
bjp-25731	497	2	j	j	PROPN
bjp-25731	497	3	med	med	PROPN
bjp-25731	497	4	chem	chem	NOUN
bjp-25731	497	5	.	.	PUNCT
bjp-25731	498	1	2015	2015	NUM
bjp-25731	498	2	;	;	PUNCT
bjp-25731	498	3	92	92	NUM
bjp-25731	498	4	:	:	SYM
bjp-25731	498	5	31431	31431	NUM
bjp-25731	498	6	.	.	PUNCT
bjp-25731	499	1	mhaske	mhaske	PROPN
bjp-25731	499	2	sb	sb	PROPN
bjp-25731	499	3	,	,	PUNCT
bjp-25731	499	4	argade	argade	VERB
bjp-25731	499	5	np	np	INTJ
bjp-25731	499	6	.	.	PUNCT
bjp-25731	500	1	the	the	DET
bjp-25731	500	2	chemistry	chemistry	NOUN
bjp-25731	500	3	of	of	ADP
bjp-25731	500	4	recently	recently	ADV
bjp-25731	500	5	isolated	isolate	VERB
bjp-25731	500	6	naturally	naturally	ADV
bjp-25731	500	7	occurring	occur	VERB
bjp-25731	500	8	quinazolinone	quinazolinone	NOUN
bjp-25731	500	9	alkaloids	alkaloid	NOUN
bjp-25731	500	10	.	.	PUNCT
bjp-25731	500	11	tetrahedron	tetrahedron	PROPN
bjp-25731	500	12	2006	2006	NUM
bjp-25731	500	13	;	;	PUNCT
bjp-25731	500	14	62	62	NUM
bjp-25731	500	15	:	:	SYM
bjp-25731	500	16	9787	9787	NUM
bjp-25731	500	17	-	-	SYM
bjp-25731	500	18	826	826	NUM
bjp-25731	500	19	.	.	PUNCT
bjp-25731	501	1	minkovsky	minkovsky	PROPN
bjp-25731	501	2	n	n	CCONJ
bjp-25731	501	3	,	,	PUNCT
bjp-25731	501	4	berezov	berezov	NOUN
bjp-25731	501	5	a.	a.	PROPN
bjp-25731	501	6	bibw-2992	bibw-2992	PROPN
bjp-25731	501	7	,	,	PUNCT
bjp-25731	501	8	a	a	DET
bjp-25731	501	9	dual	dual	ADJ
bjp-25731	501	10	receptor	receptor	NOUN
bjp-25731	501	11	tyrosine	tyrosine	NOUN
bjp-25731	501	12	kinase	kinase	PROPN
bjp-25731	501	13	inhibitor	inhibitor	NOUN
bjp-25731	501	14	for	for	ADP
bjp-25731	501	15	the	the	DET
bjp-25731	501	16	treatment	treatment	NOUN
bjp-25731	501	17	of	of	ADP
bjp-25731	501	18	solid	solid	ADJ
bjp-25731	501	19	tumors	tumor	NOUN
bjp-25731	501	20	.	.	PUNCT
bjp-25731	502	1	curr	curr	PROPN
bjp-25731	502	2	opin	opin	PROPN
bjp-25731	502	3	invest	invest	NOUN
bjp-25731	502	4	drug	drug	NOUN
bjp-25731	502	5	.	.	PUNCT
bjp-25731	503	1	2008	2008	NUM
bjp-25731	503	2	;	;	PUNCT
bjp-25731	503	3	9	9	NUM
bjp-25731	503	4	:	:	SYM
bjp-25731	503	5	1336	1336	NUM
bjp-25731	503	6	-	-	SYM
bjp-25731	503	7	46	46	NUM
bjp-25731	503	8	.	.	PUNCT
bjp-25731	504	1	miolo	miolo	ADV
bjp-25731	504	2	g	g	PROPN
bjp-25731	504	3	,	,	PUNCT
bjp-25731	504	4	salvador	salvador	PROPN
bjp-25731	504	5	a	a	PRON
bjp-25731	504	6	,	,	PUNCT
bjp-25731	504	7	mazzoli	mazzoli	NOUN
bjp-25731	504	8	a	a	PRON
bjp-25731	504	9	,	,	PUNCT
bjp-25731	504	10	spalletti	spalletti	PROPN
bjp-25731	504	11	a	a	NOUN
bjp-25731	504	12	,	,	PUNCT
bjp-25731	504	13	marzaro	marzaro	NOUN
bjp-25731	504	14	g	g	NOUN
bjp-25731	504	15	,	,	PUNCT
bjp-25731	504	16	chilin	chilin	NOUN
bjp-25731	504	17	a.	a.	NOUN
bjp-25731	504	18	photochemical	photochemical	ADJ
bjp-25731	504	19	and	and	CCONJ
bjp-25731	504	20	photobiological	photobiological	ADJ
bjp-25731	504	21	studies	study	NOUN
bjp-25731	504	22	on	on	ADP
bjp-25731	504	23	furoquinazolines	furoquinazoline	NOUN
bjp-25731	504	24	as	as	ADP
bjp-25731	504	25	new	new	ADJ
bjp-25731	504	26	psoralen	psoralen	ADJ
bjp-25731	504	27	analogs	analog	NOUN
bjp-25731	504	28	.	.	PUNCT
bjp-25731	505	1	j	j	PROPN
bjp-25731	505	2	photochem	photochem	PROPN
bjp-25731	505	3	photobiol	photobiol	PROPN
bjp-25731	505	4	b	b	PROPN
bjp-25731	505	5	biol	biol	PROPN
bjp-25731	505	6	.	.	PUNCT
bjp-25731	506	1	2014	2014	NUM
bjp-25731	506	2	;	;	PUNCT
bjp-25731	506	3	138	138	NUM
bjp-25731	506	4	:	:	SYM
bjp-25731	506	5	43	43	NUM
bjp-25731	506	6	-	-	SYM
bjp-25731	506	7	54	54	NUM
bjp-25731	506	8	.	.	PUNCT
bjp-25731	507	1	modh	modh	PROPN
bjp-25731	507	2	rp	rp	PROPN
bjp-25731	507	3	,	,	PUNCT
bjp-25731	507	4	de	de	X
bjp-25731	507	5	clercq	clercq	PROPN
bjp-25731	507	6	e	e	NOUN
bjp-25731	507	7	,	,	PUNCT
bjp-25731	507	8	pannecouque	pannecouque	ADJ
bjp-25731	507	9	c	c	NOUN
bjp-25731	507	10	,	,	PUNCT
bjp-25731	507	11	chikhalia	chikhalia	PROPN
bjp-25731	507	12	kh	kh	PROPN
bjp-25731	507	13	design	design	PROPN
bjp-25731	507	14	,	,	PUNCT
bjp-25731	507	15	synthesis	synthesis	NOUN
bjp-25731	507	16	,	,	PUNCT
bjp-25731	507	17	antimicrobial	antimicrobial	ADJ
bjp-25731	507	18	activity	activity	NOUN
bjp-25731	507	19	and	and	CCONJ
bjp-25731	507	20	anti	anti	ADJ
bjp-25731	507	21	-	-	ADJ
bjp-25731	507	22	hiv	hiv	ADJ
bjp-25731	507	23	activity	activity	NOUN
bjp-25731	507	24	evaluation	evaluation	NOUN
bjp-25731	507	25	of	of	ADP
bjp-25731	507	26	novel	novel	ADJ
bjp-25731	507	27	hybrid	hybrid	ADJ
bjp-25731	507	28	quinazoline	quinazoline	NOUN
bjp-25731	507	29	-	-	PUNCT
bjp-25731	507	30	triazine	triazine	NOUN
bjp-25731	507	31	derivatives	derivative	NOUN
bjp-25731	507	32	.	.	PUNCT
bjp-25731	508	1	j	j	PROPN
bjp-25731	508	2	enzyme	enzyme	NOUN
bjp-25731	508	3	inhib	inhib	VERB
bjp-25731	508	4	med	med	ADJ
bjp-25731	508	5	chem	chem	NOUN
bjp-25731	508	6	.	.	PUNCT
bjp-25731	509	1	2014	2014	NUM
bjp-25731	509	2	;	;	PUNCT
bjp-25731	509	3	29	29	NUM
bjp-25731	509	4	:	:	SYM
bjp-25731	509	5	100	100	NUM
bjp-25731	509	6	-	-	SYM
bjp-25731	509	7	08	08	NUM
bjp-25731	509	8	.	.	PUNCT
bjp-25731	510	1	mohamed	mohamed	PROPN
bjp-25731	510	2	ha	ha	PROPN
bjp-25731	510	3	,	,	PUNCT
bjp-25731	510	4	lake	lake	PROPN
bjp-25731	510	5	br	br	PROPN
bjp-25731	510	6	,	,	PUNCT
bjp-25731	510	7	laing	laing	PROPN
bjp-25731	510	8	t	t	PROPN
bjp-25731	510	9	,	,	PUNCT
bjp-25731	510	10	phillips	phillips	PROPN
bjp-25731	510	11	rm	rm	PROPN
bjp-25731	510	12	,	,	PUNCT
bjp-25731	510	13	willans	willans	PROPN
bjp-25731	510	14	ce	ce	PROPN
bjp-25731	510	15	.	.	PROPN
bjp-25731	510	16	synthesis	synthesis	NOUN
bjp-25731	510	17	and	and	CCONJ
bjp-25731	510	18	anti	anti	ADJ
bjp-25731	510	19	-	-	ADJ
bjp-25731	510	20	cancer	cancer	ADJ
bjp-25731	510	21	activity	activity	NOUN
bjp-25731	510	22	of	of	ADP
bjp-25731	510	23	silver(i)-n	silver(i)-n	ADJ
bjp-25731	510	24	-	-	PUNCT
bjp-25731	510	25	heterocyclic	heterocyclic	ADJ
bjp-25731	510	26	carbene	carbene	NOUN
bjp-25731	510	27	complexes	complex	NOUN
bjp-25731	510	28	derived	derive	VERB
bjp-25731	510	29	from	from	ADP
bjp-25731	510	30	the	the	DET
bjp-25731	510	31	natural	natural	ADJ
bjp-25731	510	32	xanthine	xanthine	NOUN
bjp-25731	510	33	products	product	NOUN
bjp-25731	510	34	caffeine	caffeine	NOUN
bjp-25731	510	35	,	,	PUNCT
bjp-25731	510	36	theophylline	theophylline	NOUN
bjp-25731	510	37	and	and	CCONJ
bjp-25731	510	38	theobromine	theobromine	NOUN
bjp-25731	510	39	.	.	PUNCT
bjp-25731	511	1	dalton	dalton	PROPN
bjp-25731	511	2	trans	trans	PROPN
bjp-25731	511	3	.	.	PROPN
bjp-25731	511	4	2015	2015	NUM
bjp-25731	511	5	;	;	PUNCT
bjp-25731	511	6	44	44	NUM
bjp-25731	511	7	:	:	SYM
bjp-25731	511	8	7563	7563	NUM
bjp-25731	511	9	-	-	SYM
bjp-25731	511	10	69	69	NUM
bjp-25731	511	11	.	.	PUNCT
bjp-25731	512	1	mohamed	mohamed	PROPN
bjp-25731	512	2	ma	ma	PROPN
bjp-25731	512	3	,	,	PUNCT
bjp-25731	512	4	ghanem	ghanem	PROPN
bjp-25731	512	5	hm	hm	INTJ
bjp-25731	512	6	,	,	PUNCT
bjp-25731	512	7	abd	abd	PROPN
bjp-25731	512	8	el	el	PROPN
bjp-25731	512	9	-	-	PROPN
bjp-25731	512	10	ghaffar	ghaffar	PROPN
bjp-25731	512	11	nf	nf	PROPN
bjp-25731	512	12	,	,	PUNCT
bjp-25731	512	13	mohamed	mohamed	PROPN
bjp-25731	512	14	ss	ss	PROPN
bjp-25731	512	15	.	.	PUNCT
bjp-25731	512	16	biological	biological	ADJ
bjp-25731	512	17	evaluation	evaluation	NOUN
bjp-25731	512	18	and	and	CCONJ
bjp-25731	512	19	molecular	molecular	ADJ
bjp-25731	512	20	docking	docking	NOUN
bjp-25731	512	21	of	of	ADP
bjp-25731	512	22	substituted	substitute	VERB
bjp-25731	512	23	quinazolinones	quinazolinone	NOUN
bjp-25731	512	24	as	as	ADP
bjp-25731	512	25	antimicrobial	antimicrobial	ADJ
bjp-25731	512	26	agents	agent	NOUN
bjp-25731	512	27	.	.	PUNCT
bjp-25731	513	1	aust	aust	PROPN
bjp-25731	513	2	j	j	PROPN
bjp-25731	513	3	basic	basic	ADJ
bjp-25731	513	4	appl	appl	PROPN
bjp-25731	513	5	sci	sci	PROPN
bjp-25731	513	6	.	.	PROPN
bjp-25731	513	7	2013	2013	NUM
bjp-25731	513	8	;	;	PUNCT
bjp-25731	513	9	7	7	NUM
bjp-25731	513	10	:	:	SYM
bjp-25731	513	11	263	263	NUM
bjp-25731	513	12	-	-	SYM
bjp-25731	513	13	74	74	NUM
bjp-25731	513	14	.	.	PUNCT
bjp-25731	514	1	mohamed	mohamed	PROPN
bjp-25731	514	2	ya	ya	PROPN
bjp-25731	514	3	,	,	PUNCT
bjp-25731	514	4	amr	amr	PROPN
bjp-25731	514	5	aee	aee	PROPN
bjp-25731	514	6	,	,	PUNCT
bjp-25731	514	7	mohamed	mohamed	PROPN
bjp-25731	514	8	sf	sf	PROPN
bjp-25731	514	9	,	,	PUNCT
bjp-25731	514	10	abdalla	abdalla	PROPN
bjp-25731	514	11	mm	mm	PROPN
bjp-25731	514	12	,	,	PUNCT
bjp-25731	514	13	al	al	PROPN
bjp-25731	514	14	bangladesh	bangladesh	PROPN
bjp-25731	514	15	j	j	PROPN
bjp-25731	514	16	pharmacol	pharmacol	PROPN
bjp-25731	514	17	2016	2016	NUM
bjp-25731	514	18	;	;	PUNCT
bjp-25731	514	19	11	11	NUM
bjp-25731	514	20	:	:	PUNCT
bjp-25731	514	21	716	716	NUM
bjp-25731	514	22	-	-	SYM
bjp-25731	514	23	733	733	NUM
bjp-25731	514	24	731	731	NUM
bjp-25731	514	25	https://www.researchgate.net/publication/236109900_novel_n-arylalkaryl-2-3-r-2-oxo-2h-124triazino23-cquinazoline-6-_ylthioacetamides_synthesis_cytotoxicity_anticancer_activity_compare_analysis_and_docking?_sg=czkz3ejorrcxc9r76gk42h5kbqtil8fgpvvnrxot9bspml-kpm	https://www.researchgate.net/publication/236109900_novel_n-arylalkaryl-2-3-r-2-oxo-2h-124triazino23-cquinazoline-6-_ylthioacetamides_synthesis_cytotoxicity_anticancer_activity_compare_analysis_and_docking?_sg=czkz3ejorrcxc9r76gk42h5kbqtil8fgpvvnrxot9bspml-kpm	NOUN
bjp-25731	514	26	https://www.researchgate.net/publication/236109900_novel_n-arylalkaryl-2-3-r-2-oxo-2h-124triazino23-cquinazoline-6-_ylthioacetamides_synthesis_cytotoxicity_anticancer_activity_compare_analysis_and_docking?_sg=czkz3ejorrcxc9r76gk42h5kbqtil8fgpvvnrxot9bspml-kpm	https://www.researchgate.net/publication/236109900_novel_n-arylalkaryl-2-3-r-2-oxo-2h-124triazino23-cquinazoline-6-_ylthioacetamides_synthesis_cytotoxicity_anticancer_activity_compare_analysis_and_docking?_sg=czkz3ejorrcxc9r76gk42h5kbqtil8fgpvvnrxot9bspml-kpm	NOUN
bjp-25731	514	27	https://www.researchgate.net/publication/236109900_novel_n-arylalkaryl-2-3-r-2-oxo-2h-124triazino23-cquinazoline-6-_ylthioacetamides_synthesis_cytotoxicity_anticancer_activity_compare_analysis_and_docking?_sg=czkz3ejorrcxc9r76gk42h5kbqtil8fgpvvnrxot9bspml-kpm	https://www.researchgate.net/publication/236109900_novel_n-arylalkaryl-2-3-r-2-oxo-2h-124triazino23-cquinazoline-6-_ylthioacetamides_synthesis_cytotoxicity_anticancer_activity_compare_analysis_and_docking?_sg=czkz3ejorrcxc9r76gk42h5kbqtil8fgpvvnrxot9bspml-kpm	NOUN
bjp-25731	514	28	https://www.researchgate.net/publication/236109900_novel_n-arylalkaryl-2-3-r-2-oxo-2h-124triazino23-cquinazoline-6-_ylthioacetamides_synthesis_cytotoxicity_anticancer_activity_compare_analysis_and_docking?_sg=czkz3ejorrcxc9r76gk42h5kbqtil8fgpvvnrxot9bspml-kpm	https://www.researchgate.net/publication/236109900_novel_n-arylalkaryl-2-3-r-2-oxo-2h-124triazino23-cquinazoline-6-_ylthioacetamides_synthesis_cytotoxicity_anticancer_activity_compare_analysis_and_docking?_sg=czkz3ejorrcxc9r76gk42h5kbqtil8fgpvvnrxot9bspml-kpm	NOUN
bjp-25731	514	29	omar	omar	PROPN
bjp-25731	514	30	ma	ma	PROPN
bjp-25731	514	31	,	,	PUNCT
bjp-25731	514	32	shfik	shfik	VERB
bjp-25731	514	33	sh	sh	PROPN
bjp-25731	514	34	.	.	PROPN
bjp-25731	514	35	cytotoxicity	cytotoxicity	NOUN
bjp-25731	514	36	and	and	CCONJ
bjp-25731	514	37	anti	anti	ADJ
bjp-25731	514	38	-	-	ADJ
bjp-25731	514	39	hiv	hiv	ADJ
bjp-25731	514	40	evaluations	evaluation	NOUN
bjp-25731	514	41	of	of	ADP
bjp-25731	514	42	some	some	DET
bjp-25731	514	43	new	new	ADJ
bjp-25731	514	44	synthesized	synthesize	VERB
bjp-25731	514	45	quinazoline	quinazoline	NOUN
bjp-25731	514	46	and	and	CCONJ
bjp-25731	514	47	thioxopyrimidine	thioxopyrimidine	VERB
bjp-25731	514	48	derivatives	derivative	NOUN
bjp-25731	514	49	using	use	VERB
bjp-25731	514	50	4-(thiophen-2	4-(thiophen-2	NOUN
bjp-25731	514	51	-	-	PUNCT
bjp-25731	514	52	yl)-3,4,5,6	yl)-3,4,5,6	NOUN
bjp-25731	514	53	-	-	PUNCT
bjp-25731	514	54	tetrahydrobenzo	tetrahydrobenzo	NOUN
bjp-25731	514	55	[	[	X
bjp-25731	514	56	h]quinazoline-2(1h)-thione	h]quinazoline-2(1h)-thione	NOUN
bjp-25731	514	57	as	as	ADP
bjp-25731	514	58	synthon	synthon	ADJ
bjp-25731	514	59	.	.	PUNCT
bjp-25731	515	1	j	j	PROPN
bjp-25731	515	2	chem	chem	PROPN
bjp-25731	515	3	sci	sci	PROPN
bjp-25731	515	4	.	.	PROPN
bjp-25731	515	5	2012	2012	NUM
bjp-25731	515	6	;	;	PUNCT
bjp-25731	515	7	124	124	NUM
bjp-25731	515	8	:	:	PUNCT
bjp-25731	515	9	693	693	NUM
bjp-25731	515	10	-	-	SYM
bjp-25731	515	11	702	702	NUM
bjp-25731	515	12	.	.	PUNCT
bjp-25731	516	1	murgan	murgan	PROPN
bjp-25731	516	2	v	v	PROPN
bjp-25731	516	3	,	,	PUNCT
bjp-25731	516	4	thomas	thomas	PROPN
bjp-25731	516	5	cc	cc	PROPN
bjp-25731	516	6	,	,	PUNCT
bjp-25731	516	7	rama	rama	PROPN
bjp-25731	516	8	b	b	PROPN
bjp-25731	516	9	,	,	PUNCT
bjp-25731	516	10	sarma	sarma	PROPN
bjp-25731	516	11	gvs	gvs	PROPN
bjp-25731	516	12	,	,	PUNCT
bjp-25731	516	13	kumar	kumar	PROPN
bjp-25731	516	14	ep	ep	PROPN
bjp-25731	516	15	.	.	PUNCT
bjp-25731	517	1	synthesis	synthesis	NOUN
bjp-25731	517	2	of	of	ADP
bjp-25731	517	3	2	2	NUM
bjp-25731	517	4	-	-	PUNCT
bjp-25731	517	5	substituted	substitute	VERB
bjp-25731	517	6	quinazolin-4(3h)-ones	quinazolin-4(3h)-one	NOUN
bjp-25731	517	7	as	as	ADP
bjp-25731	517	8	a	a	DET
bjp-25731	517	9	new	new	ADJ
bjp-25731	517	10	class	class	NOUN
bjp-25731	517	11	of	of	ADP
bjp-25731	517	12	anti	anti	ADJ
bjp-25731	517	13	-	-	ADJ
bjp-25731	517	14	cancer	cancer	ADJ
bjp-25731	517	15	agents	agent	NOUN
bjp-25731	517	16	.	.	PUNCT
bjp-25731	518	1	indian	indian	PROPN
bjp-25731	518	2	j	j	PROPN
bjp-25731	518	3	pharm	pharm	PROPN
bjp-25731	518	4	sci	sci	PROPN
bjp-25731	518	5	.	.	PROPN
bjp-25731	518	6	2003	2003	NUM
bjp-25731	518	7	;	;	PUNCT
bjp-25731	518	8	65	65	NUM
bjp-25731	518	9	:	:	SYM
bjp-25731	518	10	38689	38689	NUM
bjp-25731	518	11	.	.	PUNCT
bjp-25731	519	1	nayyar	nayyar	PROPN
bjp-25731	519	2	ap	ap	PROPN
bjp-25731	519	3	,	,	PUNCT
bjp-25731	519	4	arpanarana	arpanarana	PROPN
bjp-25731	519	5	m.	m.	NOUN
bjp-25731	519	6	an	an	DET
bjp-25731	519	7	updated	update	VERB
bjp-25731	519	8	review	review	NOUN
bjp-25731	519	9	:	:	PUNCT
bjp-25731	519	10	newer	new	ADJ
bjp-25731	519	11	quinazoline	quinazoline	NOUN
bjp-25731	519	12	derivatives	derivative	NOUN
bjp-25731	519	13	under	under	ADP
bjp-25731	519	14	clinical	clinical	ADJ
bjp-25731	519	15	trial	trial	NOUN
bjp-25731	519	16	.	.	PUNCT
bjp-25731	520	1	int	int	NOUN
bjp-25731	521	1	j	j	PROPN
bjp-25731	521	2	pharm	pharm	PROPN
bjp-25731	521	3	biol	biol	PROPN
bjp-25731	521	4	arch	arch	VERB
bjp-25731	521	5	.	.	PUNCT
bjp-25731	522	1	2011	2011	NUM
bjp-25731	522	2	;	;	PUNCT
bjp-25731	522	3	2	2	NUM
bjp-25731	522	4	:	:	SYM
bjp-25731	522	5	1651	1651	NUM
bjp-25731	522	6	-	-	SYM
bjp-25731	522	7	57	57	NUM
bjp-25731	522	8	.	.	PUNCT
bjp-25731	523	1	olliaro	olliaro	NOUN
bjp-25731	523	2	p	p	NOUN
bjp-25731	523	3	,	,	PUNCT
bjp-25731	523	4	wells	wells	PROPN
bjp-25731	523	5	tn	tn	PROPN
bjp-25731	523	6	.	.	PUNCT
bjp-25731	524	1	the	the	DET
bjp-25731	524	2	global	global	ADJ
bjp-25731	524	3	portfolio	portfolio	NOUN
bjp-25731	524	4	of	of	ADP
bjp-25731	524	5	new	new	ADJ
bjp-25731	524	6	antimalarial	antimalarial	ADJ
bjp-25731	524	7	medicines	medicine	NOUN
bjp-25731	524	8	under	under	ADP
bjp-25731	524	9	development	development	NOUN
bjp-25731	524	10	.	.	PUNCT
bjp-25731	525	1	clin	clin	PROPN
bjp-25731	525	2	pharmacol	pharmacol	PROPN
bjp-25731	525	3	ther	ther	ADV
bjp-25731	525	4	.	.	PUNCT
bjp-25731	526	1	2009	2009	NUM
bjp-25731	526	2	;	;	PUNCT
bjp-25731	526	3	85	85	NUM
bjp-25731	526	4	:	:	PUNCT
bjp-25731	526	5	584	584	NUM
bjp-25731	526	6	-	-	SYM
bjp-25731	526	7	95	95	NUM
bjp-25731	526	8	.	.	PUNCT
bjp-25731	527	1	omori	omori	PROPN
bjp-25731	527	2	k	k	PROPN
bjp-25731	527	3	,	,	PUNCT
bjp-25731	527	4	kotera	kotera	PROPN
bjp-25731	527	5	j.	j.	PROPN
bjp-25731	527	6	overview	overview	PROPN
bjp-25731	527	7	of	of	ADP
bjp-25731	527	8	pdes	pde	NOUN
bjp-25731	527	9	and	and	CCONJ
bjp-25731	527	10	their	their	PRON
bjp-25731	527	11	regulation	regulation	NOUN
bjp-25731	527	12	.	.	PUNCT
bjp-25731	528	1	circ	circ	PROPN
bjp-25731	528	2	res	re	NOUN
bjp-25731	528	3	.	.	PUNCT
bjp-25731	528	4	2007	2007	NUM
bjp-25731	528	5	;	;	PUNCT
bjp-25731	528	6	100	100	NUM
bjp-25731	528	7	:	:	PUNCT
bjp-25731	528	8	309	309	NUM
bjp-25731	528	9	-	-	SYM
bjp-25731	528	10	27	27	NUM
bjp-25731	528	11	.	.	PUNCT
bjp-25731	529	1	ouahrouch	ouahrouch	PROPN
bjp-25731	529	2	a	a	PRON
bjp-25731	529	3	,	,	PUNCT
bjp-25731	529	4	taourirte	taourirte	NOUN
bjp-25731	529	5	m	m	PROPN
bjp-25731	529	6	,	,	PUNCT
bjp-25731	529	7	engels	engels	PROPN
bjp-25731	529	8	jw	jw	PROPN
bjp-25731	529	9	,	,	PUNCT
bjp-25731	529	10	benjelloun	benjelloun	PROPN
bjp-25731	529	11	s	s	PROPN
bjp-25731	529	12	,	,	PUNCT
bjp-25731	529	13	lazre	lazre	VERB
bjp-25731	529	14	hb	hb	PROPN
bjp-25731	529	15	.	.	PUNCT
bjp-25731	529	16	synthesis	synthesis	NOUN
bjp-25731	529	17	of	of	ADP
bjp-25731	529	18	new	new	ADJ
bjp-25731	529	19	1,2,3	1,2,3	NUM
bjp-25731	529	20	-	-	PUNCT
bjp-25731	529	21	triazol-4	triazol-4	NUM
bjp-25731	529	22	-	-	PUNCT
bjp-25731	529	23	yl	yl	NOUN
bjp-25731	529	24	-	-	PUNCT
bjp-25731	529	25	quinazoline	quinazoline	NOUN
bjp-25731	529	26	nucleoside	nucleoside	NOUN
bjp-25731	529	27	and	and	CCONJ
bjp-25731	529	28	acyclonucleoside	acyclonucleoside	ADJ
bjp-25731	529	29	analogues	analogue	NOUN
bjp-25731	529	30	.	.	PUNCT
bjp-25731	530	1	molecules	molecule	NOUN
bjp-25731	530	2	2014	2014	NUM
bjp-25731	530	3	;	;	PUNCT
bjp-25731	530	4	19	19	NUM
bjp-25731	530	5	:	:	SYM
bjp-25731	530	6	3638	3638	NUM
bjp-25731	530	7	-	-	SYM
bjp-25731	530	8	53	53	NUM
bjp-25731	530	9	.	.	PUNCT
bjp-25731	531	1	palop	palop	PROPN
bjp-25731	531	2	ja	ja	PROPN
bjp-25731	531	3	,	,	PUNCT
bjp-25731	531	4	plano	plano	PROPN
bjp-25731	531	5	d	d	PROPN
bjp-25731	531	6	,	,	PUNCT
bjp-25731	531	7	moreno	moreno	PROPN
bjp-25731	531	8	e	e	PROPN
bjp-25731	531	9	,	,	PUNCT
bjp-25731	531	10	sanmartín	sanmartín	PROPN
bjp-25731	531	11	c.	c.	PROPN
bjp-25731	531	12	novel	novel	PROPN
bjp-25731	531	13	quinazoline	quinazoline	NOUN
bjp-25731	531	14	and	and	CCONJ
bjp-25731	531	15	pyrido[2,3	pyrido[2,3	PROPN
bjp-25731	531	16	-	-	ADJ
bjp-25731	531	17	d]pyrimidine	d]pyrimidine	ADJ
bjp-25731	531	18	derivatives	derivative	NOUN
bjp-25731	531	19	and	and	CCONJ
bjp-25731	531	20	their	their	PRON
bjp-25731	531	21	hydroselenite	hydroselenite	ADJ
bjp-25731	531	22	salts	salt	NOUN
bjp-25731	531	23	as	as	ADP
bjp-25731	531	24	antitumoral	antitumoral	ADJ
bjp-25731	531	25	agents	agent	NOUN
bjp-25731	531	26	.	.	PUNCT
bjp-25731	532	1	arkivoc	arkivoc	NOUN
bjp-25731	532	2	2013	2013	NUM
bjp-25731	532	3	;	;	PUNCT
bjp-25731	532	4	ii	ii	PROPN
bjp-25731	532	5	:	:	PUNCT
bjp-25731	532	6	187	187	NUM
bjp-25731	532	7	-	-	SYM
bjp-25731	532	8	206	206	NUM
bjp-25731	532	9	.	.	PUNCT
bjp-25731	533	1	patel	patel	PROPN
bjp-25731	533	2	nb	nb	PROPN
bjp-25731	533	3	,	,	PUNCT
bjp-25731	533	4	patel	patel	PROPN
bjp-25731	533	5	jc	jc	PROPN
bjp-25731	533	6	.	.	PROPN
bjp-25731	533	7	synthesis	synthesis	NOUN
bjp-25731	533	8	and	and	CCONJ
bjp-25731	533	9	antimicrobial	antimicrobial	ADJ
bjp-25731	533	10	activity	activity	NOUN
bjp-25731	533	11	of	of	ADP
bjp-25731	533	12	schiff	schiff	NOUN
bjp-25731	533	13	bases	basis	NOUN
bjp-25731	533	14	and	and	CCONJ
bjp-25731	533	15	2	2	NUM
bjp-25731	533	16	-	-	PUNCT
bjp-25731	533	17	azetidinones	azetidinone	NOUN
bjp-25731	533	18	derived	derive	VERB
bjp-25731	533	19	from	from	ADP
bjp-25731	533	20	quinazolin-4	quinazolin-4	PROPN
bjp-25731	533	21	(	(	PUNCT
bjp-25731	533	22	3h)-one	3h)-one	NUM
bjp-25731	533	23	.	.	PUNCT
bjp-25731	533	24	arabian	arabian	PROPN
bjp-25731	533	25	j	j	PROPN
bjp-25731	533	26	chem	chem	NOUN
bjp-25731	533	27	.	.	PUNCT
bjp-25731	534	1	2011	2011	NUM
bjp-25731	534	2	;	;	PUNCT
bjp-25731	534	3	4	4	NUM
bjp-25731	534	4	:	:	SYM
bjp-25731	534	5	403	403	NUM
bjp-25731	534	6	-	-	SYM
bjp-25731	534	7	11	11	NUM
bjp-25731	534	8	.	.	PUNCT
bjp-25731	535	1	pathak	pathak	PROPN
bjp-25731	535	2	sr	sr	PROPN
bjp-25731	535	3	,	,	PUNCT
bjp-25731	535	4	malhotra	malhotra	PROPN
bjp-25731	535	5	v	v	PROPN
bjp-25731	535	6	,	,	PUNCT
bjp-25731	535	7	nath	nath	NOUN
bjp-25731	535	8	r	r	NOUN
bjp-25731	535	9	,	,	PUNCT
bjp-25731	535	10	shanker	shanker	PROPN
bjp-25731	535	11	k.	k.	PROPN
bjp-25731	535	12	synthesis	synthesis	PROPN
bjp-25731	535	13	and	and	CCONJ
bjp-25731	535	14	antihypertensive	antihypertensive	ADJ
bjp-25731	535	15	activity	activity	NOUN
bjp-25731	535	16	of	of	ADP
bjp-25731	535	17	novel	novel	ADJ
bjp-25731	535	18	quinazolin-4(3h)-one	quinazolin-4(3h)-one	NOUN
bjp-25731	535	19	derivatives	derivative	NOUN
bjp-25731	535	20	.	.	PUNCT
bjp-25731	536	1	cent	cent	NOUN
bjp-25731	536	2	nerv	nerv	PROPN
bjp-25731	536	3	syst	syst	PROPN
bjp-25731	536	4	agents	agents	PROPN
bjp-25731	536	5	med	med	PROPN
bjp-25731	536	6	chem	chem	NOUN
bjp-25731	536	7	.	.	PUNCT
bjp-25731	537	1	2014	2014	NUM
bjp-25731	537	2	;	;	PUNCT
bjp-25731	537	3	14	14	NUM
bjp-25731	537	4	:	:	SYM
bjp-25731	537	5	3438	3438	NUM
bjp-25731	537	6	.	.	PUNCT
bjp-25731	538	1	pathania	pathania	NOUN
bjp-25731	538	2	d	d	PROPN
bjp-25731	538	3	,	,	PUNCT
bjp-25731	538	4	sechi	sechi	PROPN
bjp-25731	538	5	m	m	PROPN
bjp-25731	538	6	,	,	PUNCT
bjp-25731	538	7	palomba	palomba	NOUN
bjp-25731	538	8	m	m	PROPN
bjp-25731	538	9	,	,	PUNCT
bjp-25731	538	10	sanna	sanna	PROPN
bjp-25731	538	11	v	v	NOUN
bjp-25731	538	12	,	,	PUNCT
bjp-25731	538	13	berrettini	berrettini	PROPN
bjp-25731	538	14	f	f	PROPN
bjp-25731	538	15	,	,	PUNCT
bjp-25731	538	16	sias	sias	PROPN
bjp-25731	538	17	a	a	PRON
bjp-25731	538	18	,	,	PUNCT
bjp-25731	538	19	taheri	taheri	PROPN
bjp-25731	538	20	l	l	NOUN
bjp-25731	538	21	,	,	PUNCT
bjp-25731	538	22	neamati	neamati	PROPN
bjp-25731	538	23	n.	n.	PROPN
bjp-25731	538	24	design	design	PROPN
bjp-25731	538	25	and	and	CCONJ
bjp-25731	538	26	discovery	discovery	NOUN
bjp-25731	538	27	of	of	ADP
bjp-25731	538	28	novel	novel	ADJ
bjp-25731	538	29	quinazolinedione	quinazolinedione	NOUN
bjp-25731	538	30	-	-	PUNCT
bjp-25731	538	31	based	base	VERB
bjp-25731	538	32	redox	redox	NOUN
bjp-25731	538	33	modulators	modulator	NOUN
bjp-25731	538	34	as	as	ADP
bjp-25731	538	35	therapies	therapy	NOUN
bjp-25731	538	36	for	for	ADP
bjp-25731	538	37	pancreatic	pancreatic	ADJ
bjp-25731	538	38	cancer	cancer	NOUN
bjp-25731	538	39	.	.	PUNCT
bjp-25731	539	1	biochim	biochim	PROPN
bjp-25731	539	2	biophys	biophy	NOUN
bjp-25731	539	3	acta	acta	PROPN
bjp-25731	539	4	.	.	PUNCT
bjp-25731	540	1	2014	2014	NUM
bjp-25731	540	2	;	;	PUNCT
bjp-25731	540	3	1840	1840	NUM
bjp-25731	540	4	:	:	PUNCT
bjp-25731	540	5	332	332	NUM
bjp-25731	540	6	-	-	SYM
bjp-25731	540	7	43	43	NUM
bjp-25731	540	8	.	.	PUNCT
bjp-25731	541	1	pickup	pickup	PROPN
bjp-25731	541	2	m	m	PROPN
bjp-25731	541	3	,	,	PUNCT
bjp-25731	541	4	novitskiy	novitskiy	PROPN
bjp-25731	541	5	s	s	PROPN
bjp-25731	541	6	,	,	PUNCT
bjp-25731	541	7	moses	moses	PROPN
bjp-25731	541	8	hl	hl	VERB
bjp-25731	541	9	.	.	PUNCT
bjp-25731	542	1	the	the	DET
bjp-25731	542	2	role	role	NOUN
bjp-25731	542	3	of	of	ADP
bjp-25731	542	4	tgf	tgf	PROPN
bjp-25731	542	5	in	in	ADP
bjp-25731	542	6	the	the	DET
bjp-25731	542	7	tumour	tumour	NOUN
bjp-25731	542	8	microenvironment	microenvironment	NOUN
bjp-25731	542	9	.	.	PUNCT
bjp-25731	543	1	nat	nat	PROPN
bjp-25731	543	2	rev	rev	PROPN
bjp-25731	543	3	cancer	cancer	NOUN
bjp-25731	543	4	.	.	PUNCT
bjp-25731	544	1	2013	2013	NUM
bjp-25731	544	2	;	;	PUNCT
bjp-25731	544	3	13	13	NUM
bjp-25731	544	4	:	:	SYM
bjp-25731	544	5	788	788	NUM
bjp-25731	544	6	-	-	SYM
bjp-25731	544	7	99	99	NUM
bjp-25731	544	8	.	.	PUNCT
bjp-25731	545	1	popkin	popkin	PROPN
bjp-25731	545	2	,	,	PUNCT
bjp-25731	545	3	bm	bm	PROPN
bjp-25731	545	4	,	,	PUNCT
bjp-25731	545	5	adair	adair	PROPN
bjp-25731	545	6	ls	ls	PROPN
bjp-25731	545	7	,	,	PUNCT
bjp-25731	545	8	ng	ng	PROPN
bjp-25731	545	9	sw	sw	PROPN
bjp-25731	545	10	.	.	PUNCT
bjp-25731	546	1	global	global	PROPN
bjp-25731	546	2	nutrition	nutrition	PROPN
bjp-25731	546	3	transition	transition	NOUN
bjp-25731	546	4	and	and	CCONJ
bjp-25731	546	5	the	the	DET
bjp-25731	546	6	pandemic	pandemic	NOUN
bjp-25731	546	7	of	of	ADP
bjp-25731	546	8	obesity	obesity	NOUN
bjp-25731	546	9	in	in	ADP
bjp-25731	546	10	developing	develop	VERB
bjp-25731	546	11	countries	country	NOUN
bjp-25731	546	12	.	.	PUNCT
bjp-25731	547	1	nutr	nutr	PROPN
bjp-25731	547	2	rev	rev	PROPN
bjp-25731	547	3	.	.	PROPN
bjp-25731	547	4	2012	2012	NUM
bjp-25731	547	5	;	;	PUNCT
bjp-25731	547	6	70	70	NUM
bjp-25731	547	7	:	:	SYM
bjp-25731	547	8	3	3	NUM
bjp-25731	547	9	-	-	SYM
bjp-25731	547	10	21	21	NUM
bjp-25731	547	11	.	.	PUNCT
bjp-25731	547	12	portela	portela	PROPN
bjp-25731	547	13	-	-	PUNCT
bjp-25731	547	14	cubillo	cubillo	ADJ
bjp-25731	547	15	f	f	PROPN
bjp-25731	547	16	,	,	PUNCT
bjp-25731	547	17	scott	scott	PROPN
bjp-25731	547	18	js	js	PROPN
bjp-25731	547	19	,	,	PUNCT
bjp-25731	547	20	walton	walton	PROPN
bjp-25731	547	21	jc	jc	PROPN
bjp-25731	547	22	.	.	PROPN
bjp-25731	547	23	microwave	microwave	NOUN
bjp-25731	547	24	-	-	PUNCT
bjp-25731	547	25	promoted	promote	VERB
bjp-25731	547	26	syntheses	synthesis	NOUN
bjp-25731	547	27	of	of	ADP
bjp-25731	547	28	quinazolines	quinazoline	NOUN
bjp-25731	547	29	and	and	CCONJ
bjp-25731	547	30	dihydroquinazolines	dihydroquinazoline	NOUN
bjp-25731	547	31	from	from	ADP
bjp-25731	547	32	2aminoarylalkanone	2aminoarylalkanone	NUM
bjp-25731	547	33	o	o	ADJ
bjp-25731	547	34	-	-	ADJ
bjp-25731	547	35	phenyl	phenyl	ADJ
bjp-25731	547	36	oxime	oxime	NOUN
bjp-25731	547	37	.	.	PUNCT
bjp-25731	548	1	j	j	PROPN
bjp-25731	548	2	org	org	PROPN
bjp-25731	548	3	chem	chem	PROPN
bjp-25731	548	4	.	.	PUNCT
bjp-25731	549	1	2009	2009	NUM
bjp-25731	549	2	;	;	PUNCT
bjp-25731	549	3	74	74	NUM
bjp-25731	549	4	:	:	SYM
bjp-25731	549	5	4934	4934	NUM
bjp-25731	549	6	-	-	SYM
bjp-25731	549	7	42	42	NUM
bjp-25731	549	8	.	.	PUNCT
bjp-25731	550	1	radnai	radnai	PROPN
bjp-25731	550	2	b	b	NOUN
bjp-25731	550	3	,	,	PUNCT
bjp-25731	550	4	antus	antus	NOUN
bjp-25731	550	5	c	c	NOUN
bjp-25731	550	6	,	,	PUNCT
bjp-25731	550	7	racz	racz	NOUN
bjp-25731	550	8	b	b	PROPN
bjp-25731	550	9	,	,	PUNCT
bjp-25731	550	10	engelmann	engelmann	PROPN
bjp-25731	550	11	p	p	X
bjp-25731	550	12	,	,	PUNCT
bjp-25731	550	13	priber	priber	PROPN
bjp-25731	550	14	jk	jk	PROPN
bjp-25731	550	15	,	,	PUNCT
bjp-25731	550	16	et	et	PROPN
bjp-25731	550	17	al	al	PROPN
bjp-25731	550	18	.	.	PROPN
bjp-25731	550	19	,	,	PUNCT
bjp-25731	550	20	protective	protective	ADJ
bjp-25731	550	21	effect	effect	NOUN
bjp-25731	550	22	of	of	ADP
bjp-25731	550	23	the	the	DET
bjp-25731	550	24	poly	poly	ADJ
bjp-25731	550	25	(	(	PUNCT
bjp-25731	550	26	adp	adp	PROPN
bjp-25731	550	27	-	-	PUNCT
bjp-25731	550	28	ribose	ribose	NOUN
bjp-25731	550	29	)	)	PUNCT
bjp-25731	550	30	polymerase	polymerase	NOUN
bjp-25731	550	31	inhibitor	inhibitor	NOUN
bjp-25731	550	32	pj34	pj34	PROPN
bjp-25731	550	33	on	on	ADP
bjp-25731	550	34	mitochondrial	mitochondrial	ADJ
bjp-25731	550	35	depolarization	depolarization	NOUN
bjp-25731	550	36	-	-	PUNCT
bjp-25731	550	37	mediated	mediate	VERB
bjp-25731	550	38	cell	cell	NOUN
bjp-25731	550	39	death	death	NOUN
bjp-25731	550	40	in	in	ADP
bjp-25731	550	41	hepatocellular	hepatocellular	ADJ
bjp-25731	550	42	carcinoma	carcinoma	NOUN
bjp-25731	550	43	cells	cell	NOUN
bjp-25731	550	44	involves	involve	VERB
bjp-25731	550	45	attenuation	attenuation	NOUN
bjp-25731	550	46	of	of	ADP
bjp-25731	550	47	c	c	PROPN
bjp-25731	550	48	-	-	PUNCT
bjp-25731	550	49	jun	jun	PROPN
bjp-25731	550	50	n	n	CCONJ
bjp-25731	550	51	-	-	PUNCT
bjp-25731	550	52	terminal	terminal	ADJ
bjp-25731	550	53	kinase-2	kinase-2	PROPN
bjp-25731	550	54	and	and	CCONJ
bjp-25731	550	55	protein	protein	NOUN
bjp-25731	550	56	kinase	kinase	PROPN
bjp-25731	550	57	b	b	PROPN
bjp-25731	550	58	/	/	SYM
bjp-25731	550	59	akt	akt	PROPN
bjp-25731	550	60	activation	activation	NOUN
bjp-25731	550	61	.	.	PUNCT
bjp-25731	551	1	mol	mol	ADP
bjp-25731	551	2	cancer	cancer	NOUN
bjp-25731	551	3	.	.	PUNCT
bjp-25731	552	1	2012	2012	NUM
bjp-25731	552	2	;	;	PUNCT
bjp-25731	552	3	11	11	NUM
bjp-25731	552	4	:	:	SYM
bjp-25731	552	5	34	34	NUM
bjp-25731	552	6	-	-	SYM
bjp-25731	552	7	45	45	NUM
bjp-25731	552	8	.	.	PUNCT
bjp-25731	553	1	raghav	raghav	PROPN
bjp-25731	553	2	n	n	CCONJ
bjp-25731	553	3	,	,	PUNCT
bjp-25731	553	4	singh	singh	PROPN
bjp-25731	553	5	m.	m.	NOUN
bjp-25731	553	6	design	design	NOUN
bjp-25731	553	7	,	,	PUNCT
bjp-25731	553	8	synthesis	synthesis	NOUN
bjp-25731	553	9	and	and	CCONJ
bjp-25731	553	10	docking	dock	VERB
bjp-25731	553	11	studies	study	NOUN
bjp-25731	553	12	of	of	ADP
bjp-25731	553	13	bischalcones	bischalcone	NOUN
bjp-25731	553	14	based	base	VERB
bjp-25731	553	15	quinazoline-2(1h)-ones	quinazoline-2(1h)-one	NOUN
bjp-25731	553	16	and	and	CCONJ
bjp-25731	553	17	quinazoline2(1h)-thiones	quinazoline2(1h)-thiones	ADJ
bjp-25731	553	18	derivatives	derivative	NOUN
bjp-25731	553	19	as	as	ADP
bjp-25731	553	20	novel	novel	ADJ
bjp-25731	553	21	inhibitors	inhibitor	NOUN
bjp-25731	553	22	of	of	ADP
bjp-25731	553	23	cathepsin	cathepsin	NOUN
bjp-25731	553	24	b	b	PROPN
bjp-25731	553	25	and	and	CCONJ
bjp-25731	553	26	cathepsin	cathepsin	PROPN
bjp-25731	553	27	h.	h.	PROPN
bjp-25731	553	28	eur	eur	PROPN
bjp-25731	553	29	j	j	PROPN
bjp-25731	553	30	pharm	pharm	PROPN
bjp-25731	553	31	sci	sci	PROPN
bjp-25731	553	32	.	.	PROPN
bjp-25731	553	33	2014	2014	NUM
bjp-25731	553	34	;	;	PUNCT
bjp-25731	553	35	54	54	NUM
bjp-25731	553	36	:	:	SYM
bjp-25731	553	37	28	28	NUM
bjp-25731	553	38	-	-	SYM
bjp-25731	553	39	39	39	NUM
bjp-25731	553	40	.	.	PUNCT
bjp-25731	554	1	rajput	rajput	PROPN
bjp-25731	554	2	r	r	PROPN
bjp-25731	554	3	,	,	PUNCT
bjp-25731	554	4	mishra	mishra	PROPN
bjp-25731	554	5	ap	ap	PROPN
bjp-25731	554	6	.	.	PUNCT
bjp-25731	555	1	a	a	DET
bjp-25731	555	2	review	review	NOUN
bjp-25731	555	3	on	on	ADP
bjp-25731	555	4	biological	biological	ADJ
bjp-25731	555	5	activity	activity	NOUN
bjp-25731	555	6	of	of	ADP
bjp-25731	555	7	quinazolinones	quinazolinone	NOUN
bjp-25731	555	8	.	.	PUNCT
bjp-25731	556	1	int	int	PROPN
bjp-25731	556	2	j	j	PROPN
bjp-25731	556	3	pharm	pharm	PROPN
bjp-25731	556	4	pharm	pharm	PROPN
bjp-25731	556	5	sci	sci	PROPN
bjp-25731	556	6	.	.	PROPN
bjp-25731	556	7	2012	2012	NUM
bjp-25731	556	8	;	;	PUNCT
bjp-25731	556	9	4	4	NUM
bjp-25731	556	10	:	:	SYM
bjp-25731	556	11	66	66	NUM
bjp-25731	556	12	-	-	SYM
bjp-25731	556	13	70	70	NUM
bjp-25731	556	14	.	.	PUNCT
bjp-25731	557	1	redondo	redondo	PROPN
bjp-25731	557	2	m	m	PROPN
bjp-25731	557	3	,	,	PUNCT
bjp-25731	557	4	zarruk	zarruk	PROPN
bjp-25731	557	5	jg	jg	PROPN
bjp-25731	557	6	,	,	PUNCT
bjp-25731	557	7	ceballos	ceballos	PROPN
bjp-25731	557	8	p	p	PROPN
bjp-25731	557	9	,	,	PUNCT
bjp-25731	557	10	pérez	pérez	NOUN
bjp-25731	557	11	di	di	NOUN
bjp-25731	557	12	,	,	PUNCT
bjp-25731	557	13	pérez	pérez	NOUN
bjp-25731	557	14	c	c	PROPN
bjp-25731	557	15	,	,	PUNCT
bjp-25731	557	16	perezcastillo	perezcastillo	PROPN
bjp-25731	557	17	a	a	PROPN
bjp-25731	557	18	,	,	PUNCT
bjp-25731	557	19	moro	moro	PROPN
bjp-25731	557	20	ma	ma	PROPN
bjp-25731	557	21	,	,	PUNCT
bjp-25731	557	22	brea	brea	PROPN
bjp-25731	557	23	j	j	PROPN
bjp-25731	557	24	,	,	PUNCT
bjp-25731	557	25	val	val	PROPN
bjp-25731	557	26	c	c	X
bjp-25731	557	27	,	,	PUNCT
bjp-25731	557	28	cadavid	cadavid	PROPN
bjp-25731	557	29	mi	mi	PROPN
bjp-25731	557	30	,	,	PUNCT
bjp-25731	557	31	loza	loza	PROPN
bjp-25731	557	32	mi	mi	PROPN
bjp-25731	557	33	,	,	PUNCT
bjp-25731	557	34	campillo	campillo	PROPN
bjp-25731	557	35	ne	ne	PROPN
bjp-25731	557	36	,	,	PUNCT
bjp-25731	557	37	martínez	martínez	PROPN
bjp-25731	557	38	a	a	NOUN
bjp-25731	557	39	,	,	PUNCT
bjp-25731	557	40	gil	gil	PROPN
bjp-25731	557	41	c.	c.	PROPN
bjp-25731	557	42	neuroprotective	neuroprotective	ADJ
bjp-25731	557	43	efficacy	efficacy	NOUN
bjp-25731	557	44	of	of	ADP
bjp-25731	557	45	quinazoline	quinazoline	NOUN
bjp-25731	557	46	type	type	NOUN
bjp-25731	557	47	phosphodiesterase	phosphodiesterase	NOUN
bjp-25731	557	48	7	7	NUM
bjp-25731	557	49	inhibitors	inhibitor	NOUN
bjp-25731	557	50	in	in	ADP
bjp-25731	557	51	cellular	cellular	ADJ
bjp-25731	557	52	cultures	culture	NOUN
bjp-25731	557	53	and	and	CCONJ
bjp-25731	557	54	experimental	experimental	ADJ
bjp-25731	557	55	stroke	stroke	NOUN
bjp-25731	557	56	model	model	NOUN
bjp-25731	557	57	.	.	PUNCT
bjp-25731	558	1	eur	eur	PROPN
bjp-25731	558	2	j	j	PROPN
bjp-25731	558	3	med	med	PROPN
bjp-25731	558	4	chem	chem	NOUN
bjp-25731	558	5	.	.	PUNCT
bjp-25731	559	1	2012	2012	NUM
bjp-25731	559	2	;	;	PUNCT
bjp-25731	559	3	47	47	NUM
bjp-25731	559	4	:	:	SYM
bjp-25731	559	5	175	175	NUM
bjp-25731	559	6	-	-	SYM
bjp-25731	559	7	85	85	NUM
bjp-25731	559	8	.	.	PUNCT
bjp-25731	560	1	rojas	rojas	PROPN
bjp-25731	560	2	-	-	PUNCT
bjp-25731	560	3	aguirre	aguirre	PROPN
bjp-25731	560	4	y	y	PROPN
bjp-25731	560	5	,	,	PUNCT
bjp-25731	560	6	hernández	hernández	PROPN
bjp-25731	560	7	-	-	PUNCT
bjp-25731	560	8	luis	luis	PROPN
bjp-25731	560	9	f	f	PROPN
bjp-25731	560	10	,	,	PUNCT
bjp-25731	560	11	mendoza	mendoza	PROPN
bjp-25731	560	12	-	-	PUNCT
bjp-25731	560	13	martínez	martínez	PROPN
bjp-25731	560	14	c	c	PROPN
bjp-25731	560	15	,	,	PUNCT
bjp-25731	560	16	sotomayor	sotomayor	PROPN
bjp-25731	560	17	cp	cp	PROPN
bjp-25731	560	18	,	,	PUNCT
bjp-25731	560	19	aguilar	aguilar	PROPN
bjp-25731	560	20	lf	lf	PROPN
bjp-25731	560	21	,	,	PUNCT
bjp-25731	560	22	villena	villena	PROPN
bjp-25731	560	23	,	,	PUNCT
bjp-25731	560	24	f	f	PROPN
bjp-25731	560	25	,	,	PUNCT
bjp-25731	560	26	castillo	castillo	PROPN
bjp-25731	560	27	i	i	PROPN
bjp-25731	560	28	,	,	PUNCT
bjp-25731	560	29	hernández	hernández	PROPN
bjp-25731	560	30	dj	dj	PROPN
bjp-25731	560	31	,	,	PUNCT
bjp-25731	560	32	suwalsky	suwalsky	ADJ
bjp-25731	560	33	m.	m.	NOUN
bjp-25731	560	34	effects	effect	NOUN
bjp-25731	560	35	of	of	ADP
bjp-25731	560	36	an	an	DET
bjp-25731	560	37	antimalarial	antimalarial	ADJ
bjp-25731	560	38	quinazoline	quinazoline	NOUN
bjp-25731	560	39	derivative	derivative	NOUN
bjp-25731	560	40	on	on	ADP
bjp-25731	560	41	human	human	ADJ
bjp-25731	560	42	erythrocytes	erythrocyte	NOUN
bjp-25731	560	43	and	and	CCONJ
bjp-25731	560	44	on	on	ADP
bjp-25731	560	45	cell	cell	NOUN
bjp-25731	560	46	membrane	membrane	NOUN
bjp-25731	560	47	molecular	molecular	ADJ
bjp-25731	560	48	models	model	NOUN
bjp-25731	560	49	.	.	PUNCT
bjp-25731	561	1	biochim	biochim	PROPN
bjp-25731	561	2	biophys	biophy	NOUN
bjp-25731	561	3	acta	acta	PROPN
bjp-25731	561	4	.	.	PUNCT
bjp-25731	562	1	2012	2012	NUM
bjp-25731	562	2	;	;	PUNCT
bjp-25731	562	3	1818	1818	NUM
bjp-25731	562	4	:	:	PUNCT
bjp-25731	563	1	738	738	NUM
bjp-25731	563	2	-	-	SYM
bjp-25731	563	3	46	46	NUM
bjp-25731	563	4	.	.	PUNCT
bjp-25731	564	1	ryu	ryu	VERB
bjp-25731	564	2	ck	ck	PROPN
bjp-25731	564	3	,	,	PUNCT
bjp-25731	564	4	kim	kim	PROPN
bjp-25731	564	5	yh	yh	PROPN
bjp-25731	564	6	,	,	PUNCT
bjp-25731	564	7	i	i	PRON
bjp-25731	564	8	m	m	VERB
bjp-25731	564	9	ha	ha	INTJ
bjp-25731	564	10	,	,	PUNCT
bjp-25731	564	11	kim	kim	PROPN
bjp-25731	564	12	jy	jy	PROPN
bjp-25731	564	13	,	,	PUNCT
bjp-25731	564	14	yoon	yoon	PROPN
bjp-25731	564	15	jh	jh	PROPN
bjp-25731	564	16	,	,	PUNCT
bjp-25731	564	17	kim	kim	PROPN
bjp-25731	564	18	a.	a.	NOUN
bjp-25731	564	19	synthesis	synthesis	NOUN
bjp-25731	564	20	and	and	CCONJ
bjp-25731	564	21	antifungal	antifungal	ADJ
bjp-25731	564	22	activity	activity	NOUN
bjp-25731	564	23	of	of	ADP
bjp-25731	564	24	6,7	6,7	NUM
bjp-25731	564	25	-	-	PUNCT
bjp-25731	564	26	bis(arylthio)-quinazoline-5,8diones	bis(arylthio)-quinazoline-5,8dione	NOUN
bjp-25731	564	27	and	and	CCONJ
bjp-25731	564	28	furo[2,3	furo[2,3	NOUN
bjp-25731	564	29	-	-	PUNCT
bjp-25731	564	30	f]quinazolin-5	f]quinazolin-5	NOUN
bjp-25731	564	31	-	-	PUNCT
bjp-25731	564	32	ols	ol	NOUN
bjp-25731	564	33	.	.	PUNCT
bjp-25731	565	1	bioorg	bioorg	PROPN
bjp-25731	565	2	med	med	PROPN
bjp-25731	565	3	chem	chem	NOUN
bjp-25731	565	4	lett	lett	PROPN
bjp-25731	565	5	.	.	PUNCT
bjp-25731	566	1	2012	2012	NUM
bjp-25731	566	2	;	;	PUNCT
bjp-25731	566	3	22	22	NUM
bjp-25731	566	4	:	:	SYM
bjp-25731	566	5	500	500	NUM
bjp-25731	566	6	-	-	SYM
bjp-25731	566	7	03	03	NUM
bjp-25731	566	8	.	.	PUNCT
bjp-25731	567	1	sasmal	sasmal	PROPN
bjp-25731	567	2	s	s	PROPN
bjp-25731	567	3	,	,	PUNCT
bjp-25731	567	4	balaji	balaji	PROPN
bjp-25731	567	5	g	g	PROPN
bjp-25731	567	6	,	,	PUNCT
bjp-25731	567	7	kanna	kanna	PROPN
bjp-25731	567	8	rhr	rhr	PROPN
bjp-25731	567	9	,	,	PUNCT
bjp-25731	567	10	balasubrahmanyam	balasubrahmanyam	NOUN
bjp-25731	567	11	d	d	NOUN
bjp-25731	567	12	,	,	PUNCT
bjp-25731	567	13	srinivas	srinivas	PROPN
bjp-25731	567	14	g	g	PROPN
bjp-25731	567	15	,	,	PUNCT
bjp-25731	567	16	kyasa	kyasa	PROPN
bjp-25731	567	17	s	s	PROPN
bjp-25731	567	18	,	,	PUNCT
bjp-25731	567	19	sasmal	sasmal	ADJ
bjp-25731	567	20	pk	pk	NOUN
bjp-25731	567	21	,	,	PUNCT
bjp-25731	567	22	khanna	khanna	PROPN
bjp-25731	567	23	i	i	PROPN
bjp-25731	567	24	,	,	PUNCT
bjp-25731	567	25	talwar	talwar	PROPN
bjp-25731	567	26	r	r	PROPN
bjp-25731	567	27	,	,	PUNCT
bjp-25731	567	28	suresh	suresh	PROPN
bjp-25731	567	29	j	j	PROPN
bjp-25731	567	30	,	,	PUNCT
bjp-25731	567	31	jadhav	jadhav	PROPN
bjp-25731	567	32	vp	vp	PROPN
bjp-25731	567	33	,	,	PUNCT
bjp-25731	567	34	muzeeb	muzeeb	NOUN
bjp-25731	567	35	s	s	NOUN
bjp-25731	567	36	,	,	PUNCT
bjp-25731	567	37	shashikumar	shashikumar	PROPN
bjp-25731	567	38	d	d	PROPN
bjp-25731	567	39	,	,	PUNCT
bjp-25731	567	40	harinder	harinder	PROPN
bjp-25731	567	41	rk	rk	NOUN
bjp-25731	567	42	,	,	PUNCT
bjp-25731	567	43	sebastian	sebastian	PROPN
bjp-25731	567	44	vj	vj	PROPN
bjp-25731	567	45	,	,	PUNCT
bjp-25731	567	46	frimurer	frimurer	ADP
bjp-25731	567	47	tm	tm	PROPN
bjp-25731	567	48	,	,	PUNCT
bjp-25731	567	49	rist	rist	PROPN
bjp-25731	567	50	ø	ø	PROPN
bjp-25731	567	51	,	,	PUNCT
bjp-25731	567	52	elster	elster	PROPN
bjp-25731	567	53	l	l	PROPN
bjp-25731	567	54	,	,	PUNCT
bjp-25731	567	55	högberg	högberg	PROPN
bjp-25731	567	56	t.	t.	PROPN
bjp-25731	567	57	design	design	NOUN
bjp-25731	567	58	and	and	CCONJ
bjp-25731	567	59	optimization	optimization	NOUN
bjp-25731	567	60	of	of	ADP
bjp-25731	567	61	quinazoline	quinazoline	NOUN
bjp-25731	567	62	derivatives	derivative	NOUN
bjp-25731	567	63	as	as	ADP
bjp-25731	567	64	melanin	melanin	NOUN
bjp-25731	567	65	concentrating	concentrate	VERB
bjp-25731	567	66	hormone	hormone	NOUN
bjp-25731	567	67	receptor	receptor	NOUN
bjp-25731	567	68	1	1	NUM
bjp-25731	567	69	(	(	PUNCT
bjp-25731	567	70	mchr1	mchr1	NOUN
bjp-25731	567	71	)	)	PUNCT
bjp-25731	567	72	antagonists	antagonist	NOUN
bjp-25731	567	73	.	.	PUNCT
bjp-25731	568	1	bioorg	bioorg	PROPN
bjp-25731	568	2	med	med	PROPN
bjp-25731	568	3	chem	chem	NOUN
bjp-25731	568	4	lett	lett	PROPN
bjp-25731	568	5	.	.	PUNCT
bjp-25731	569	1	2012	2012	NUM
bjp-25731	569	2	;	;	PUNCT
bjp-25731	569	3	22	22	NUM
bjp-25731	569	4	:	:	PUNCT
bjp-25731	569	5	3157	3157	NUM
bjp-25731	569	6	-	-	SYM
bjp-25731	569	7	62	62	NUM
bjp-25731	569	8	.	.	PUNCT
bjp-25731	570	1	sánchez	sánchez	PROPN
bjp-25731	570	2	ai	ai	PROPN
bjp-25731	570	3	,	,	PUNCT
bjp-25731	570	4	martínez	martínez	PROPN
bjp-25731	570	5	-	-	PUNCT
bjp-25731	570	6	barrasa	barrasa	PROPN
bjp-25731	570	7	v	v	PROPN
bjp-25731	570	8	,	,	PUNCT
bjp-25731	570	9	burgos	burgos	PROPN
bjp-25731	570	10	c	c	PROPN
bjp-25731	570	11	,	,	PUNCT
bjp-25731	570	12	vaquero	vaquero	PROPN
bjp-25731	570	13	jj	jj	PROPN
bjp-25731	570	14	,	,	PUNCT
bjp-25731	570	15	alvarez	alvarez	PROPN
bjp-25731	570	16	-	-	PUNCT
bjp-25731	570	17	builla	builla	PROPN
bjp-25731	570	18	j	j	PROPN
bjp-25731	570	19	,	,	PUNCT
bjp-25731	570	20	terricabras	terricabras	NOUN
bjp-25731	570	21	e	e	NOUN
bjp-25731	570	22	,	,	PUNCT
bjp-25731	570	23	segarra	segarra	ADJ
bjp-25731	570	24	v.	v.	ADP
bjp-25731	570	25	synthesis	synthesis	NOUN
bjp-25731	570	26	and	and	CCONJ
bjp-25731	570	27	evaluation	evaluation	NOUN
bjp-25731	570	28	of	of	ADP
bjp-25731	570	29	quinazoline	quinazoline	NOUN
bjp-25731	570	30	derivatives	derivative	NOUN
bjp-25731	570	31	as	as	ADP
bjp-25731	570	32	phosphodiesterase	phosphodiesterase	NOUN
bjp-25731	570	33	7	7	NUM
bjp-25731	570	34	inhibitors	inhibitor	NOUN
bjp-25731	570	35	.	.	PUNCT
bjp-25731	571	1	bioorg	bioorg	PROPN
bjp-25731	571	2	med	med	PROPN
bjp-25731	571	3	chem	chem	NOUN
bjp-25731	571	4	.	.	PUNCT
bjp-25731	572	1	2013	2013	NUM
bjp-25731	572	2	;	;	PUNCT
bjp-25731	572	3	21	21	NUM
bjp-25731	572	4	:	:	SYM
bjp-25731	572	5	2370	2370	NUM
bjp-25731	572	6	-	-	SYM
bjp-25731	572	7	78	78	NUM
bjp-25731	572	8	.	.	PUNCT
bjp-25731	573	1	sangshetti	sangshetti	PROPN
bjp-25731	573	2	jn	jn	PROPN
bjp-25731	573	3	,	,	PUNCT
bjp-25731	573	4	khan	khan	PROPN
bjp-25731	573	5	fak	fak	PROPN
bjp-25731	573	6	,	,	PUNCT
bjp-25731	573	7	kulkarni	kulkarni	PROPN
bjp-25731	573	8	aa	aa	PROPN
bjp-25731	573	9	,	,	PUNCT
bjp-25731	573	10	aroteb	aroteb	PROPN
bjp-25731	573	11	r	r	NOUN
bjp-25731	573	12	,	,	PUNCT
bjp-25731	573	13	patil	patil	PROPN
bjp-25731	573	14	rh	rh	PROPN
bjp-25731	573	15	.	.	PROPN
bjp-25731	573	16	antileishmanial	antileishmanial	ADJ
bjp-25731	573	17	drug	drug	NOUN
bjp-25731	573	18	discovery	discovery	NOUN
bjp-25731	573	19	:	:	PUNCT
bjp-25731	573	20	comprehensive	comprehensive	ADJ
bjp-25731	573	21	review	review	NOUN
bjp-25731	573	22	of	of	ADP
bjp-25731	573	23	the	the	DET
bjp-25731	573	24	last	last	ADJ
bjp-25731	573	25	10	10	NUM
bjp-25731	573	26	years	year	NOUN
bjp-25731	573	27	.	.	PUNCT
bjp-25731	574	1	rsc	rsc	PROPN
bjp-25731	574	2	adv	adv	PROPN
bjp-25731	574	3	.	.	PROPN
bjp-25731	574	4	2015	2015	NUM
bjp-25731	574	5	;	;	PUNCT
bjp-25731	574	6	5	5	NUM
bjp-25731	574	7	:	:	SYM
bjp-25731	574	8	32376	32376	NUM
bjp-25731	574	9	-	-	SYM
bjp-25731	574	10	415	415	NUM
bjp-25731	574	11	.	.	PUNCT
bjp-25731	575	1	selvam	selvam	PROPN
bjp-25731	575	2	p	p	X
bjp-25731	575	3	,	,	PUNCT
bjp-25731	575	4	sridharan	sridharan	ADJ
bjp-25731	575	5	d	d	NOUN
bjp-25731	575	6	,	,	PUNCT
bjp-25731	575	7	murugesh	murugesh	ADJ
bjp-25731	575	8	n	n	CCONJ
bjp-25731	575	9	,	,	PUNCT
bjp-25731	575	10	chandramohan	chandramohan	PROPN
bjp-25731	575	11	m	m	PROPN
bjp-25731	575	12	,	,	PUNCT
bjp-25731	575	13	witurouw	witurouw	PROPN
bjp-25731	575	14	m.	m.	NOUN
bjp-25731	575	15	synthesis	synthesis	NOUN
bjp-25731	575	16	and	and	CCONJ
bjp-25731	575	17	anti	anti	ADJ
bjp-25731	575	18	-	-	ADJ
bjp-25731	575	19	hiv	hiv	ADJ
bjp-25731	575	20	activity	activity	NOUN
bjp-25731	575	21	of	of	ADP
bjp-25731	575	22	some	some	DET
bjp-25731	575	23	novel	novel	ADJ
bjp-25731	575	24	2,3	2,3	NUM
bjp-25731	575	25	-	-	PUNCT
bjp-25731	575	26	disubstituted	disubstitute	VERB
bjp-25731	575	27	quinazolin-4(3h)-ones	quinazolin-4(3h)-one	NOUN
bjp-25731	575	28	.	.	PUNCT
bjp-25731	576	1	int	int	PROPN
bjp-25731	576	2	j	j	PROPN
bjp-25731	576	3	chem	chem	PROPN
bjp-25731	576	4	sci	sci	PROPN
bjp-25731	576	5	.	.	PROPN
bjp-25731	576	6	2008	2008	NUM
bjp-25731	576	7	;	;	PUNCT
bjp-25731	576	8	6	6	NUM
bjp-25731	576	9	:	:	SYM
bjp-25731	576	10	1196	1196	NUM
bjp-25731	576	11	-	-	SYM
bjp-25731	576	12	201	201	NUM
bjp-25731	576	13	.	.	PUNCT
bjp-25731	577	1	selvam	selvam	PROPN
bjp-25731	577	2	tp	tp	PROPN
bjp-25731	577	3	,	,	PUNCT
bjp-25731	577	4	kumar	kumar	PROPN
bjp-25731	577	5	pv	pv	PROPN
bjp-25731	577	6	.	.	PUNCT
bjp-25731	578	1	quinazoline	quinazoline	PROPN
bjp-25731	578	2	marketed	market	VERB
bjp-25731	578	3	drugs	drug	NOUN
bjp-25731	578	4	–	–	PUNCT
bjp-25731	578	5	a	a	DET
bjp-25731	578	6	review	review	NOUN
bjp-25731	578	7	.	.	PUNCT
bjp-25731	579	1	res	re	NOUN
bjp-25731	579	2	pharm	pharm	PROPN
bjp-25731	579	3	.	.	PUNCT
bjp-25731	580	1	2011	2011	NUM
bjp-25731	580	2	;	;	PUNCT
bjp-25731	580	3	1	1	NUM
bjp-25731	580	4	:	:	SYM
bjp-25731	580	5	1	1	NUM
bjp-25731	580	6	-	-	SYM
bjp-25731	580	7	21	21	NUM
bjp-25731	580	8	.	.	PUNCT
bjp-25731	581	1	sergey	sergey	PROPN
bjp-25731	581	2	i	i	PRON
bjp-25731	581	3	,	,	PUNCT
bjp-25731	581	4	igor	igor	PROPN
bjp-25731	581	5	f	f	PROPN
bjp-25731	581	6	,	,	PUNCT
bjp-25731	581	7	vadim	vadim	PROPN
bjp-25731	581	8	v	v	PROPN
bjp-25731	581	9	,	,	PUNCT
bjp-25731	581	10	oksana	oksana	PROPN
bjp-25731	581	11	v.	v.	ADP
bjp-25731	581	12	synthesis	synthesis	NOUN
bjp-25731	581	13	of	of	ADP
bjp-25731	581	14	2-(3,4dihydro-3	2-(3,4dihydro-3	NUM
bjp-25731	581	15	-	-	PUNCT
bjp-25731	581	16	oxo-2h-[1,2,4]triazino[4,3	oxo-2h-[1,2,4]triazino[4,3	NOUN
bjp-25731	581	17	-	-	PUNCT
bjp-25731	581	18	c]quinazolin-4	c]quinazolin-4	NOUN
bjp-25731	581	19	-	-	ADJ
bjp-25731	581	20	yl)acetic	yl)acetic	ADJ
bjp-25731	581	21	acid	acid	NOUN
bjp-25731	581	22	derivatives	derivative	NOUN
bjp-25731	581	23	as	as	ADP
bjp-25731	581	24	potential	potential	ADJ
bjp-25731	581	25	anti	anti	NOUN
bjp-25731	581	26	-	-	NOUN
bjp-25731	581	27	oxidants	oxidant	NOUN
bjp-25731	581	28	in	in	ADP
bjp-25731	581	29	nitrosative	nitrosative	ADJ
bjp-25731	581	30	stress	stress	NOUN
bjp-25731	581	31	model	model	NOUN
bjp-25731	581	32	.	.	PUNCT
bjp-25731	582	1	farmacia	farmacia	PROPN
bjp-25731	582	2	2010	2010	NUM
bjp-25731	582	3	;	;	PUNCT
bjp-25731	582	4	58	58	NUM
bjp-25731	582	5	:	:	PUNCT
bjp-25731	582	6	145	145	NUM
bjp-25731	582	7	-	-	SYM
bjp-25731	582	8	57	57	NUM
bjp-25731	582	9	.	.	PUNCT
bjp-25731	583	1	serya	serya	ADJ
bjp-25731	583	2	rat	rat	PROPN
bjp-25731	583	3	,	,	PUNCT
bjp-25731	583	4	abbas	abbas	PROPN
bjp-25731	583	5	ah	ah	INTJ
bjp-25731	583	6	,	,	PUNCT
bjp-25731	583	7	ismail	ismail	PROPN
bjp-25731	583	8	nsm	nsm	PROPN
bjp-25731	583	9	,	,	PUNCT
bjp-25731	583	10	esmat	esmat	NOUN
bjp-25731	583	11	a	a	X
bjp-25731	583	12	,	,	PUNCT
bjp-25731	583	13	el	el	PROPN
bjp-25731	583	14	ella	ella	PROPN
bjp-25731	583	15	daa	daa	PROPN
bjp-25731	583	16	.	.	PUNCT
bjp-25731	583	17	design	design	NOUN
bjp-25731	583	18	,	,	PUNCT
bjp-25731	583	19	synthesis	synthesis	NOUN
bjp-25731	583	20	and	and	CCONJ
bjp-25731	583	21	biological	biological	ADJ
bjp-25731	583	22	evaluation	evaluation	NOUN
bjp-25731	583	23	of	of	ADP
bjp-25731	583	24	novel	novel	ADJ
bjp-25731	583	25	quinazoline	quinazoline	NOUN
bjp-25731	583	26	-	-	PUNCT
bjp-25731	583	27	based	base	VERB
bjp-25731	583	28	anti	anti	ADJ
bjp-25731	583	29	-	-	ADJ
bjp-25731	583	30	inflammatory	inflammatory	ADJ
bjp-25731	583	31	agents	agent	NOUN
bjp-25731	583	32	acting	act	VERB
bjp-25731	583	33	as	as	ADP
bjp-25731	583	34	pde4b	pde4b	PROPN
bjp-25731	583	35	inhibitors	inhibitor	NOUN
bjp-25731	583	36	.	.	PUNCT
bjp-25731	584	1	chem	chem	NOUN
bjp-25731	584	2	pharm	pharm	NOUN
bjp-25731	584	3	bull	bull	PROPN
bjp-25731	584	4	.	.	PUNCT
bjp-25731	585	1	2015	2015	NUM
bjp-25731	585	2	;	;	PUNCT
bjp-25731	585	3	63	63	NUM
bjp-25731	585	4	:	:	SYM
bjp-25731	585	5	102	102	NUM
bjp-25731	585	6	-	-	SYM
bjp-25731	585	7	16	16	NUM
bjp-25731	585	8	.	.	PUNCT
bjp-25731	586	1	sharma	sharma	PROPN
bjp-25731	586	2	a	a	DET
bjp-25731	586	3	,	,	PUNCT
bjp-25731	586	4	luxami	luxami	NOUN
bjp-25731	586	5	v	v	NOUN
bjp-25731	586	6	,	,	PUNCT
bjp-25731	586	7	paul	paul	PROPN
bjp-25731	586	8	k.	k.	PROPN
bjp-25731	586	9	synthesis	synthesis	PROPN
bjp-25731	586	10	,	,	PUNCT
bjp-25731	586	11	single	single	ADJ
bjp-25731	586	12	crystal	crystal	NOUN
bjp-25731	586	13	and	and	CCONJ
bjp-25731	586	14	antitumor	antitumor	PROPN
bjp-25731	586	15	activities	activity	NOUN
bjp-25731	586	16	of	of	ADP
bjp-25731	586	17	benzimidazole	benzimidazole	ADJ
bjp-25731	586	18	–	–	PUNCT
bjp-25731	586	19	quinazoline	quinazoline	NOUN
bjp-25731	586	20	hybrids	hybrid	NOUN
bjp-25731	586	21	.	.	PUNCT
bjp-25731	587	1	bioorg	bioorg	PROPN
bjp-25731	587	2	med	med	PROPN
bjp-25731	587	3	chem	chem	NOUN
bjp-25731	587	4	lett	lett	PROPN
bjp-25731	587	5	.	.	PUNCT
bjp-25731	588	1	2013a	2013a	NUM
bjp-25731	588	2	;	;	PUNCT
bjp-25731	588	3	23	23	NUM
bjp-25731	588	4	:	:	SYM
bjp-25731	588	5	3288	3288	NUM
bjp-25731	588	6	-	-	SYM
bjp-25731	588	7	94	94	NUM
bjp-25731	588	8	.	.	PUNCT
bjp-25731	589	1	sharma	sharma	PROPN
bjp-25731	589	2	a	a	DET
bjp-25731	589	3	,	,	PUNCT
bjp-25731	589	4	luxami	luxami	NOUN
bjp-25731	589	5	v	v	NOUN
bjp-25731	589	6	,	,	PUNCT
bjp-25731	589	7	saxena	saxena	PROPN
bjp-25731	589	8	s	s	PROPN
bjp-25731	589	9	,	,	PUNCT
bjp-25731	589	10	paul	paul	PROPN
bjp-25731	589	11	k.	k.	PROPN
bjp-25731	589	12	benzimidazole	benzimidazole	PROPN
bjp-25731	589	13	-	-	PUNCT
bjp-25731	589	14	based	base	VERB
bjp-25731	589	15	quinazolines	quinazoline	NOUN
bjp-25731	589	16	:	:	PUNCT
bjp-25731	589	17	in	in	ADP
bjp-25731	589	18	vitro	vitro	X
bjp-25731	589	19	evaluation	evaluation	NOUN
bjp-25731	589	20	,	,	PUNCT
bjp-25731	589	21	quantitative	quantitative	ADJ
bjp-25731	589	22	structureactivity	structureactivity	NOUN
bjp-25731	589	23	relationship	relationship	NOUN
bjp-25731	589	24	,	,	PUNCT
bjp-25731	589	25	and	and	CCONJ
bjp-25731	589	26	molecular	molecular	ADJ
bjp-25731	589	27	modeling	modeling	NOUN
bjp-25731	589	28	as	as	ADP
bjp-25731	589	29	aurora	aurora	PROPN
bjp-25731	589	30	kinase	kinase	PROPN
bjp-25731	589	31	inhibitors	inhibitor	NOUN
bjp-25731	589	32	.	.	PUNCT
bjp-25731	590	1	arch	arch	ADJ
bjp-25731	590	2	pharm	pharm	PROPN
bjp-25731	590	3	.	.	PUNCT
bjp-25731	591	1	2016	2016	NUM
bjp-25731	591	2	;	;	PUNCT
bjp-25731	591	3	349	349	NUM
bjp-25731	591	4	:	:	SYM
bjp-25731	591	5	193	193	NUM
bjp-25731	591	6	-	-	SYM
bjp-25731	591	7	201	201	NUM
bjp-25731	591	8	.	.	PUNCT
bjp-25731	592	1	špulák	špulák	PROPN
bjp-25731	592	2	m	m	PROPN
bjp-25731	592	3	,	,	PUNCT
bjp-25731	592	4	pourová	pourová	PROPN
bjp-25731	592	5	j	j	PROPN
bjp-25731	592	6	,	,	PUNCT
bjp-25731	592	7	vopršálová	vopršálová	PROPN
bjp-25731	592	8	m	m	PROPN
bjp-25731	592	9	,	,	PUNCT
bjp-25731	592	10	mikušek	mikušek	VERB
bjp-25731	592	11	j	j	PROPN
bjp-25731	592	12	,	,	PUNCT
bjp-25731	592	13	kuneš	kuneš	PROPN
bjp-25731	592	14	j	j	PROPN
bjp-25731	592	15	,	,	PUNCT
bjp-25731	592	16	vacek	vacek	PROPN
bjp-25731	592	17	j	j	PROPN
bjp-25731	592	18	,	,	PUNCT
bjp-25731	592	19	ghavre	ghavre	VERB
bjp-25731	592	20	m	m	PROPN
bjp-25731	592	21	,	,	PUNCT
bjp-25731	592	22	gathergood	gathergood	PROPN
bjp-25731	592	23	n	n	CCONJ
bjp-25731	592	24	,	,	PUNCT
bjp-25731	592	25	pour	pour	ADJ
bjp-25731	592	26	m.	m.	NOUN
bjp-25731	592	27	novel	novel	NOUN
bjp-25731	592	28	bronchodilatory	bronchodilatory	ADJ
bjp-25731	592	29	quinazolines	quinazoline	NOUN
bjp-25731	592	30	and	and	CCONJ
bjp-25731	592	31	quinoxalines	quinoxaline	NOUN
bjp-25731	592	32	:	:	PUNCT
bjp-25731	592	33	synthesis	synthesis	NOUN
bjp-25731	592	34	and	and	CCONJ
bjp-25731	592	35	biological	biological	ADJ
bjp-25731	592	36	evaluation	evaluation	NOUN
bjp-25731	592	37	.	.	PUNCT
bjp-25731	593	1	eur	eur	PROPN
bjp-25731	593	2	j	j	PROPN
bjp-25731	593	3	med	med	PROPN
bjp-25731	593	4	chem	chem	NOUN
bjp-25731	593	5	.	.	PUNCT
bjp-25731	594	1	2014	2014	NUM
bjp-25731	594	2	;	;	PUNCT
bjp-25731	595	1	74	74	NUM
bjp-25731	595	2	:	:	SYM
bjp-25731	595	3	65	65	NUM
bjp-25731	595	4	-	-	SYM
bjp-25731	595	5	72	72	NUM
bjp-25731	595	6	.	.	PUNCT
bjp-25731	596	1	srivastav	srivastav	PROPN
bjp-25731	596	2	mk	mk	PROPN
bjp-25731	596	3	,	,	PUNCT
bjp-25731	596	4	shantakumar	shantakumar	PROPN
bjp-25731	596	5	sm	sm	PROPN
bjp-25731	596	6	.	.	PUNCT
bjp-25731	596	7	design	design	NOUN
bjp-25731	596	8	and	and	CCONJ
bjp-25731	596	9	synthesis	synthesis	NOUN
bjp-25731	596	10	of	of	ADP
bjp-25731	596	11	novel	novel	ADJ
bjp-25731	596	12	2	2	NUM
bjp-25731	596	13	-	-	PUNCT
bjp-25731	596	14	trichloromethyl-4	trichloromethyl-4	NUM
bjp-25731	596	15	-	-	PUNCT
bjp-25731	596	16	substituted	substitute	VERB
bjp-25731	596	17	quinazoline	quinazoline	NOUN
bjp-25731	596	18	derivatives	derivative	NOUN
bjp-25731	596	19	as	as	ADP
bjp-25731	596	20	anti	anti	ADJ
bjp-25731	596	21	-	-	ADJ
bjp-25731	596	22	tubercular	tubercular	ADJ
bjp-25731	596	23	agents	agent	NOUN
bjp-25731	596	24	.	.	PUNCT
bjp-25731	597	1	chem	chem	NOUN
bjp-25731	597	2	sci	sci	PROPN
bjp-25731	597	3	trans	trans	PROPN
bjp-25731	597	4	.	.	PROPN
bjp-25731	598	1	2013	2013	NUM
bjp-25731	598	2	;	;	PUNCT
bjp-25731	598	3	2	2	NUM
bjp-25731	598	4	:	:	SYM
bjp-25731	598	5	1056	1056	NUM
bjp-25731	598	6	-	-	SYM
bjp-25731	598	7	62	62	NUM
bjp-25731	598	8	.	.	PUNCT
bjp-25731	599	1	732	732	NUM
bjp-25731	599	2	bangladesh	bangladesh	PROPN
bjp-25731	599	3	j	j	PROPN
bjp-25731	599	4	pharmacol	pharmacol	PROPN
bjp-25731	599	5	2016	2016	NUM
bjp-25731	599	6	;	;	PUNCT
bjp-25731	599	7	11	11	NUM
bjp-25731	599	8	:	:	PUNCT
bjp-25731	599	9	716	716	NUM
bjp-25731	599	10	-	-	SYM
bjp-25731	599	11	733	733	NUM
bjp-25731	599	12	author	author	NOUN
bjp-25731	599	13	info	info	NOUN
bjp-25731	599	14	olayinka	olayinka	ADJ
bjp-25731	599	15	oyewale	oyewale	PROPN
bjp-25731	599	16	ajani	ajani	PROPN
bjp-25731	599	17	(	(	PUNCT
bjp-25731	599	18	principal	principal	ADJ
bjp-25731	599	19	contact	contact	NOUN
bjp-25731	599	20	)	)	PUNCT
bjp-25731	599	21	e	e	NOUN
bjp-25731	599	22	-	-	NOUN
bjp-25731	599	23	mail	mail	NOUN
bjp-25731	599	24	:	:	PUNCT
bjp-25731	599	25	ola.ajani@covenantuniversity.edu.ng	ola.ajani@covenantuniversity.edu.ng	ADV
bjp-25731	599	26	susín	susín	NOUN
bjp-25731	599	27	c	c	NOUN
bjp-25731	599	28	,	,	PUNCT
bjp-25731	599	29	morales	morales	PROPN
bjp-25731	599	30	-	-	PUNCT
bjp-25731	599	31	garcia	garcia	PROPN
bjp-25731	599	32	ja	ja	PROPN
bjp-25731	599	33	,	,	PUNCT
bjp-25731	599	34	aguilar	aguilar	PROPN
bjp-25731	599	35	-	-	PUNCT
bjp-25731	599	36	morante	morante	NOUN
bjp-25731	599	37	d	d	NOUN
bjp-25731	599	38	,	,	PUNCT
bjp-25731	599	39	palomo	palomo	PROPN
bjp-25731	599	40	v	v	NOUN
bjp-25731	599	41	,	,	PUNCT
bjp-25731	599	42	sanz	sanz	PROPN
bjp-25731	599	43	-	-	PUNCT
bjp-25731	599	44	sancristobal	sancristobal	PROPN
bjp-25731	599	45	m	m	PROPN
bjp-25731	599	46	,	,	PUNCT
bjp-25731	599	47	alonso	alonso	PROPN
bjp-25731	599	48	-	-	NOUN
bjp-25731	599	49	gil	gil	PROPN
bjp-25731	599	50	s	s	PROPN
bjp-25731	599	51	,	,	PUNCT
bjp-25731	599	52	gil	gil	PROPN
bjp-25731	599	53	c	c	PROPN
bjp-25731	599	54	,	,	PUNCT
bjp-25731	599	55	santos	santos	PROPN
bjp-25731	599	56	a	a	PRON
bjp-25731	599	57	,	,	PUNCT
bjp-25731	599	58	martinez	martinez	PROPN
bjp-25731	599	59	a	a	X
bjp-25731	599	60	,	,	PUNCT
bjp-25731	599	61	perez	perez	PROPN
bjp-25731	599	62	-	-	PUNCT
bjp-25731	599	63	castillo	castillo	PROPN
bjp-25731	599	64	a.	a.	NOUN
bjp-25731	600	1	the	the	DET
bjp-25731	600	2	new	new	ADJ
bjp-25731	600	3	iminothiadiazole	iminothiadiazole	NOUN
bjp-25731	600	4	derivative	derivative	NOUN
bjp-25731	600	5	vp1.14	vp1.14	NOUN
bjp-25731	600	6	ameliorates	ameliorate	VERB
bjp-25731	600	7	hippocampal	hippocampal	ADJ
bjp-25731	600	8	damage	damage	NOUN
bjp-25731	600	9	after	after	ADP
bjp-25731	600	10	an	an	DET
bjp-25731	600	11	excitotoxic	excitotoxic	ADJ
bjp-25731	600	12	injury	injury	NOUN
bjp-25731	600	13	.	.	PUNCT
bjp-25731	601	1	j	j	PROPN
bjp-25731	601	2	neurochem	neurochem	PROPN
bjp-25731	601	3	.	.	PUNCT
bjp-25731	602	1	2012	2012	NUM
bjp-25731	602	2	;	;	PUNCT
bjp-25731	602	3	122	122	NUM
bjp-25731	602	4	:	:	SYM
bjp-25731	602	5	1193	1193	NUM
bjp-25731	602	6	-	-	SYM
bjp-25731	602	7	202	202	NUM
bjp-25731	602	8	.	.	PUNCT
bjp-25731	603	1	takase	takase	PROPN
bjp-25731	603	2	y	y	PROPN
bjp-25731	603	3	,	,	PUNCT
bjp-25731	603	4	saeki	saeki	PROPN
bjp-25731	603	5	t	t	PROPN
bjp-25731	603	6	,	,	PUNCT
bjp-25731	603	7	watanabe	watanabe	PROPN
bjp-25731	603	8	n	n	PROPN
bjp-25731	603	9	,	,	PUNCT
bjp-25731	603	10	saito	saito	PROPN
bjp-25731	603	11	i.	i.	PROPN
bjp-25731	603	12	cyclic	cyclic	PROPN
bjp-25731	603	13	gmp	gmp	PROPN
bjp-25731	603	14	phosphodiesterase	phosphodiesterase	NOUN
bjp-25731	603	15	inhibitors	inhibitor	NOUN
bjp-25731	603	16	.	.	PUNCT
bjp-25731	604	1	2	2	X
bjp-25731	604	2	.	.	X
bjp-25731	604	3	requirement	requirement	NOUN
bjp-25731	604	4	of	of	ADP
bjp-25731	604	5	6	6	NUM
bjp-25731	604	6	-	-	PUNCT
bjp-25731	604	7	substitution	substitution	NOUN
bjp-25731	604	8	of	of	ADP
bjp-25731	604	9	quinazoline	quinazoline	ADJ
bjp-25731	604	10	derivatives	derivative	NOUN
bjp-25731	604	11	for	for	ADP
bjp-25731	604	12	potent	potent	ADJ
bjp-25731	604	13	and	and	CCONJ
bjp-25731	604	14	selective	selective	ADJ
bjp-25731	604	15	inhibitory	inhibitory	ADJ
bjp-25731	604	16	activity	activity	NOUN
bjp-25731	604	17	.	.	PUNCT
bjp-25731	605	1	j	j	PROPN
bjp-25731	605	2	med	med	PROPN
bjp-25731	605	3	chem	chem	NOUN
bjp-25731	605	4	.	.	PUNCT
bjp-25731	605	5	1994	1994	NUM
bjp-25731	605	6	;	;	PUNCT
bjp-25731	605	7	37	37	NUM
bjp-25731	605	8	:	:	PUNCT
bjp-25731	605	9	2106	2106	NUM
bjp-25731	605	10	-	-	SYM
bjp-25731	605	11	11	11	NUM
bjp-25731	605	12	.	.	PUNCT
bjp-25731	606	1	tan	tan	PROPN
bjp-25731	606	2	f	f	PROPN
bjp-25731	606	3	,	,	PUNCT
bjp-25731	606	4	shen	shen	PROPN
bjp-25731	606	5	x	x	PROPN
bjp-25731	606	6	,	,	PUNCT
bjp-25731	606	7	wang	wang	PROPN
bjp-25731	606	8	d	d	PROPN
bjp-25731	606	9	,	,	PUNCT
bjp-25731	606	10	xie	xie	PROPN
bjp-25731	606	11	g	g	PROPN
bjp-25731	606	12	,	,	PUNCT
bjp-25731	606	13	zhang	zhang	PROPN
bjp-25731	606	14	x	x	PROPN
bjp-25731	606	15	,	,	PUNCT
bjp-25731	606	16	ding	ding	PROPN
bjp-25731	606	17	l	l	PROPN
bjp-25731	606	18	,	,	PUNCT
bjp-25731	606	19	hu	hu	PROPN
bjp-25731	606	20	y	y	PROPN
bjp-25731	606	21	,	,	PUNCT
bjp-25731	606	22	he	he	PRON
bjp-25731	606	23	w	w	PROPN
bjp-25731	606	24	,	,	PUNCT
bjp-25731	606	25	wang	wang	PROPN
bjp-25731	606	26	y	y	PROPN
bjp-25731	606	27	,	,	PUNCT
bjp-25731	606	28	wang	wang	PROPN
bjp-25731	606	29	y.	y.	PROPN
bjp-25731	606	30	icotinib	icotinib	PROPN
bjp-25731	606	31	(	(	PUNCT
bjp-25731	606	32	bpi-2009h	bpi-2009h	NOUN
bjp-25731	606	33	)	)	PUNCT
bjp-25731	606	34	,	,	PUNCT
bjp-25731	606	35	a	a	DET
bjp-25731	606	36	novel	novel	ADJ
bjp-25731	606	37	egfr	egfr	NOUN
bjp-25731	606	38	tyrosine	tyrosine	PROPN
bjp-25731	606	39	kinase	kinase	PROPN
bjp-25731	606	40	inhibitor	inhibitor	PROPN
bjp-25731	606	41	,	,	PUNCT
bjp-25731	606	42	displays	display	NOUN
bjp-25731	606	43	potent	potent	ADJ
bjp-25731	606	44	efficacy	efficacy	NOUN
bjp-25731	606	45	in	in	ADP
bjp-25731	606	46	preclinical	preclinical	ADJ
bjp-25731	606	47	studies	study	NOUN
bjp-25731	606	48	.	.	PUNCT
bjp-25731	607	1	lung	lung	NOUN
bjp-25731	607	2	cancer	cancer	NOUN
bjp-25731	607	3	.	.	PUNCT
bjp-25731	608	1	2012	2012	NUM
bjp-25731	608	2	;	;	PUNCT
bjp-25731	608	3	76	76	NUM
bjp-25731	608	4	:	:	SYM
bjp-25731	608	5	177	177	NUM
bjp-25731	608	6	-	-	SYM
bjp-25731	608	7	82	82	NUM
bjp-25731	608	8	.	.	PUNCT
bjp-25731	608	9	tang	tang	PROPN
bjp-25731	609	1	l	l	PROPN
bjp-25731	609	2	,	,	PUNCT
bjp-25731	609	3	zhou	zhou	PROPN
bjp-25731	609	4	p	p	PROPN
bjp-25731	609	5	,	,	PUNCT
bjp-25731	609	6	zhong	zhong	PROPN
bjp-25731	609	7	k	k	PROPN
bjp-25731	609	8	,	,	PUNCT
bjp-25731	609	9	hou	hou	PROPN
bjp-25731	609	10	s.	s.	PROPN
bjp-25731	609	11	fluorescence	fluorescence	PROPN
bjp-25731	609	12	relay	relay	PROPN
bjp-25731	609	13	enhancement	enhancement	NOUN
bjp-25731	609	14	sequential	sequential	ADJ
bjp-25731	609	15	recognition	recognition	NOUN
bjp-25731	609	16	of	of	ADP
bjp-25731	609	17	cu2	cu2	NOUN
bjp-25731	609	18	+	+	CCONJ
bjp-25731	609	19	and	and	CCONJ
bjp-25731	609	20	cn−	cn−	PROPN
bjp-25731	609	21	by	by	ADP
bjp-25731	609	22	a	a	DET
bjp-25731	609	23	new	new	ADJ
bjp-25731	609	24	quinazoline	quinazoline	NOUN
bjp-25731	609	25	derivative	derivative	NOUN
bjp-25731	609	26	.	.	PUNCT
bjp-25731	610	1	sensor	sensor	NOUN
bjp-25731	610	2	actuator	actuator	NOUN
bjp-25731	610	3	.	.	PUNCT
bjp-25731	611	1	b.	b.	PROPN
bjp-25731	611	2	2013	2013	NUM
bjp-25731	611	3	;	;	PUNCT
bjp-25731	611	4	182	182	NUM
bjp-25731	611	5	:	:	PUNCT
bjp-25731	611	6	439	439	NUM
bjp-25731	611	7	-	-	SYM
bjp-25731	611	8	45	45	NUM
bjp-25731	611	9	.	.	PUNCT
bjp-25731	612	1	tinker	tinker	PROPN
bjp-25731	612	2	ac	ac	PROPN
bjp-25731	612	3	,	,	PUNCT
bjp-25731	612	4	beaton	beaton	PROPN
bjp-25731	612	5	hg	hg	PROPN
bjp-25731	612	6	,	,	PUNCT
bjp-25731	612	7	smith	smith	PROPN
bjp-25731	612	8	nb	nb	PROPN
bjp-25731	612	9	,	,	PUNCT
bjp-25731	612	10	cook	cook	VERB
bjp-25731	612	11	tr	tr	VERB
bjp-25731	612	12	,	,	PUNCT
bjp-25731	612	13	cooper	cooper	PROPN
bjp-25731	612	14	sl	sl	PROPN
bjp-25731	612	15	,	,	PUNCT
bjp-25731	612	16	rae	rae	PROPN
bjp-25731	612	17	lf	lf	PROPN
bjp-25731	612	18	,	,	PUNCT
bjp-25731	612	19	hallam	hallam	PROPN
bjp-25731	612	20	k	k	PROPN
bjp-25731	612	21	,	,	PUNCT
bjp-25731	612	22	hamley	hamley	PROPN
bjp-25731	612	23	p	p	NOUN
bjp-25731	612	24	,	,	PUNCT
bjp-25731	612	25	mcinally	mcinally	ADV
bjp-25731	612	26	t	t	PROPN
bjp-25731	612	27	,	,	PUNCT
bjp-25731	612	28	nicholls	nicholls	PROPN
bjp-25731	612	29	dj	dj	PROPN
bjp-25731	612	30	,	,	PUNCT
bjp-25731	612	31	pimm	pimm	NOUN
bjp-25731	612	32	ad	ad	NOUN
bjp-25731	612	33	,	,	PUNCT
bjp-25731	612	34	wallace	wallace	PROPN
bjp-25731	612	35	av	av	PROPN
bjp-25731	612	36	.	.	PUNCT
bjp-25731	613	1	1,2	1,2	NUM
bjp-25731	613	2	-	-	PUNCT
bjp-25731	613	3	dihydro-4	dihydro-4	NOUN
bjp-25731	613	4	-	-	PUNCT
bjp-25731	613	5	quinazolinamines	quinazolinamine	NOUN
bjp-25731	613	6	:	:	PUNCT
bjp-25731	613	7	  	  	SPACE
bjp-25731	613	8	potent	potent	ADJ
bjp-25731	613	9	,	,	PUNCT
bjp-25731	613	10	highly	highly	ADV
bjp-25731	613	11	selective	selective	ADJ
bjp-25731	613	12	inhibitors	inhibitor	NOUN
bjp-25731	613	13	of	of	ADP
bjp-25731	613	14	inducible	inducible	ADJ
bjp-25731	613	15	nitric	nitric	ADJ
bjp-25731	613	16	oxide	oxide	NOUN
bjp-25731	613	17	synthase	synthase	NOUN
bjp-25731	613	18	which	which	PRON
bjp-25731	613	19	show	show	VERB
bjp-25731	613	20	anti	anti	ADJ
bjp-25731	613	21	-	-	ADJ
bjp-25731	613	22	inflammatory	inflammatory	ADJ
bjp-25731	613	23	activity	activity	NOUN
bjp-25731	613	24	in	in	ADP
bjp-25731	613	25	vivo	vivo	NOUN
bjp-25731	613	26	.	.	PUNCT
bjp-25731	614	1	j	j	PROPN
bjp-25731	614	2	med	med	PROPN
bjp-25731	614	3	chem	chem	NOUN
bjp-25731	614	4	.	.	PUNCT
bjp-25731	615	1	2003	2003	NUM
bjp-25731	615	2	;	;	PUNCT
bjp-25731	615	3	46	46	NUM
bjp-25731	615	4	:	:	PUNCT
bjp-25731	615	5	913	913	NUM
bjp-25731	615	6	-	-	SYM
bjp-25731	615	7	16	16	NUM
bjp-25731	615	8	.	.	PUNCT
bjp-25731	616	1	tiumana	tiumana	NOUN
bjp-25731	616	2	ts	ts	PROPN
bjp-25731	616	3	,	,	PUNCT
bjp-25731	616	4	santos	santos	PROPN
bjp-25731	616	5	ao	ao	PROPN
bjp-25731	616	6	,	,	PUNCT
bjp-25731	616	7	ueda	ueda	PROPN
bjp-25731	616	8	-	-	PUNCT
bjp-25731	616	9	nakamuraa	nakamuraa	PROPN
bjp-25731	616	10	t	t	PROPN
bjp-25731	616	11	,	,	PUNCT
bjp-25731	616	12	dias	dias	PROPN
bjp-25731	616	13	filhoa	filhoa	PROPN
bjp-25731	616	14	bp	bp	PROPN
bjp-25731	616	15	,	,	PUNCT
bjp-25731	616	16	nakamuraa	nakamuraa	PROPN
bjp-25731	616	17	cv	cv	PROPN
bjp-25731	616	18	.	.	PUNCT
bjp-25731	617	1	recent	recent	ADJ
bjp-25731	617	2	advances	advance	NOUN
bjp-25731	617	3	in	in	ADP
bjp-25731	617	4	leishmaniasis	leishmaniasis	NOUN
bjp-25731	617	5	treatment	treatment	NOUN
bjp-25731	617	6	.	.	PUNCT
bjp-25731	618	1	int	int	PROPN
bjp-25731	618	2	j	j	PROPN
bjp-25731	618	3	infect	infect	VERB
bjp-25731	618	4	dis	dis	PROPN
bjp-25731	618	5	.	.	PUNCT
bjp-25731	619	1	2011	2011	NUM
bjp-25731	619	2	;	;	PUNCT
bjp-25731	619	3	15	15	NUM
bjp-25731	619	4	:	:	PUNCT
bjp-25731	619	5	e525	e525	PROPN
bjp-25731	619	6	-	-	PUNCT
bjp-25731	619	7	32	32	NUM
bjp-25731	619	8	.	.	PUNCT
bjp-25731	620	1	vagdevi	vagdevi	PROPN
bjp-25731	620	2	hm	hm	PROPN
bjp-25731	620	3	,	,	PUNCT
bjp-25731	620	4	lokesh	lokesh	PROPN
bjp-25731	620	5	mr	mr	PROPN
bjp-25731	620	6	,	,	PUNCT
bjp-25731	620	7	gowdarshivannanavar	gowdarshivannanavar	PROPN
bjp-25731	620	8	bc	bc	PROPN
bjp-25731	620	9	.	.	PROPN
bjp-25731	620	10	synthesis	synthesis	NOUN
bjp-25731	620	11	and	and	CCONJ
bjp-25731	620	12	anti	anti	ADJ
bjp-25731	620	13	-	-	ADJ
bjp-25731	620	14	oxidant	oxidant	ADJ
bjp-25731	620	15	activity	activity	NOUN
bjp-25731	620	16	of	of	ADP
bjp-25731	620	17	3	3	NUM
bjp-25731	620	18	-	-	PUNCT
bjp-25731	620	19	substituted	substitute	VERB
bjp-25731	620	20	schiff	schiff	NOUN
bjp-25731	620	21	bases	basis	NOUN
bjp-25731	620	22	of	of	ADP
bjp-25731	620	23	quinazoline-2,4	quinazoline-2,4	NOUN
bjp-25731	620	24	-	-	PUNCT
bjp-25731	620	25	diones	dione	NOUN
bjp-25731	620	26	.	.	PUNCT
bjp-25731	621	1	int	int	NOUN
bjp-25731	621	2	j	j	PROPN
bjp-25731	621	3	chem	chem	NOUN
bjp-25731	621	4	tech	tech	NOUN
bjp-25731	621	5	res	re	NOUN
bjp-25731	621	6	.	.	PUNCT
bjp-25731	621	7	2012	2012	NUM
bjp-25731	621	8	;	;	PUNCT
bjp-25731	621	9	4	4	NUM
bjp-25731	621	10	:	:	SYM
bjp-25731	621	11	152733	152733	NUM
bjp-25731	621	12	.	.	PUNCT
bjp-25731	622	1	vijayakumar	vijayakumar	PROPN
bjp-25731	622	2	k	k	PROPN
bjp-25731	622	3	,	,	PUNCT
bjp-25731	622	4	ahamed	ahamed	PROPN
bjp-25731	622	5	aj	aj	PROPN
bjp-25731	622	6	,	,	PUNCT
bjp-25731	622	7	thiruneelakandan	thiruneelakandan	PROPN
bjp-25731	622	8	g.	g.	PROPN
bjp-25731	622	9	synthesis	synthesis	PROPN
bjp-25731	622	10	,	,	PUNCT
bjp-25731	622	11	antimicrobial	antimicrobial	ADJ
bjp-25731	622	12	,	,	PUNCT
bjp-25731	622	13	and	and	CCONJ
bjp-25731	622	14	anti	anti	ADJ
bjp-25731	622	15	-	-	ADJ
bjp-25731	622	16	hiv1	hiv1	ADJ
bjp-25731	622	17	activity	activity	NOUN
bjp-25731	622	18	of	of	ADP
bjp-25731	622	19	quinazoline-4(3h)one	quinazoline-4(3h)one	PROPN
bjp-25731	622	20	derivatives	derivative	NOUN
bjp-25731	622	21	.	.	PUNCT
bjp-25731	623	1	j	j	PROPN
bjp-25731	623	2	appl	appl	PROPN
bjp-25731	623	3	chem	chem	PROPN
bjp-25731	623	4	.	.	PUNCT
bjp-25731	624	1	2013	2013	NUM
bjp-25731	624	2	:	:	PUNCT
bjp-25731	624	3	5	5	X
bjp-25731	624	4	.	.	X
bjp-25731	624	5	wan	wan	PROPN
bjp-25731	625	1	z	z	PROPN
bjp-25731	625	2	,	,	PUNCT
bjp-25731	625	3	hu	hu	PROPN
bjp-25731	626	1	d	d	PROPN
bjp-25731	626	2	,	,	PUNCT
bjp-25731	626	3	li	li	PROPN
bjp-25731	626	4	p	p	PROPN
bjp-25731	626	5	,	,	PUNCT
bjp-25731	626	6	xie	xie	PROPN
bjp-25731	627	1	d	d	PROPN
bjp-25731	627	2	,	,	PUNCT
bjp-25731	627	3	gan	gan	PROPN
bjp-25731	627	4	x.	x.	NOUN
bjp-25731	627	5	synthesis	synthesis	PROPN
bjp-25731	627	6	,	,	PUNCT
bjp-25731	627	7	antiviral	antiviral	ADJ
bjp-25731	627	8	bioactivity	bioactivity	NOUN
bjp-25731	627	9	of	of	ADP
bjp-25731	627	10	novel	novel	ADJ
bjp-25731	627	11	4	4	NUM
bjp-25731	627	12	-	-	PUNCT
bjp-25731	627	13	thioquinazoline	thioquinazoline	ADJ
bjp-25731	627	14	derivatives	derivative	NOUN
bjp-25731	627	15	containing	contain	VERB
bjp-25731	627	16	chalcone	chalcone	NOUN
bjp-25731	627	17	moiety	moiety	NOUN
bjp-25731	627	18	.	.	PUNCT
bjp-25731	628	1	molecules	molecule	NOUN
bjp-25731	628	2	2015	2015	NUM
bjp-25731	628	3	;	;	PUNCT
bjp-25731	628	4	20	20	NUM
bjp-25731	628	5	:	:	SYM
bjp-25731	628	6	11861	11861	NUM
bjp-25731	628	7	-	-	SYM
bjp-25731	628	8	74	74	NUM
bjp-25731	628	9	.	.	PUNCT
bjp-25731	629	1	wang	wang	PROPN
bjp-25731	629	2	c	c	PROPN
bjp-25731	629	3	,	,	PUNCT
bjp-25731	629	4	sun	sun	PROPN
bjp-25731	629	5	y	y	PROPN
bjp-25731	629	6	,	,	PUNCT
bjp-25731	629	7	zhu	zhu	PROPN
bjp-25731	629	8	x	x	X
bjp-25731	629	9	,	,	PUNCT
bjp-25731	629	10	wu	wu	PROPN
bjp-25731	629	11	b	b	PROPN
bjp-25731	629	12	,	,	PUNCT
bjp-25731	629	13	wang	wang	PROPN
bjp-25731	629	14	q	q	PROPN
bjp-25731	629	15	,	,	PUNCT
bjp-25731	629	16	zhen	zhen	PROPN
bjp-25731	629	17	y	y	PROPN
bjp-25731	629	18	,	,	PUNCT
bjp-25731	629	19	shu	shu	PROPN
bjp-25731	629	20	x	x	PROPN
bjp-25731	629	21	,	,	PUNCT
bjp-25731	629	22	liu	liu	PROPN
bjp-25731	629	23	k	k	PROPN
bjp-25731	629	24	,	,	PUNCT
bjp-25731	629	25	zhou	zhou	PROPN
bjp-25731	629	26	y	y	PROPN
bjp-25731	629	27	,	,	PUNCT
bjp-25731	629	28	ma	ma	PROPN
bjp-25731	629	29	x.	x.	PROPN
bjp-25731	629	30	novel	novel	PROPN
bjp-25731	629	31	quinazoline	quinazoline	NOUN
bjp-25731	629	32	bearing	bear	VERB
bjp-25731	629	33	various	various	ADJ
bjp-25731	629	34	4	4	NUM
bjp-25731	629	35	-	-	PUNCT
bjp-25731	629	36	aniline	aniline	NOUN
bjp-25731	629	37	moieties	moiety	NOUN
bjp-25731	629	38	as	as	ADP
bjp-25731	629	39	potent	potent	ADJ
bjp-25731	629	40	egfr	egfr	ADJ
bjp-25731	629	41	inhibitors	inhibitor	NOUN
bjp-25731	629	42	with	with	ADP
bjp-25731	629	43	enhanced	enhanced	ADJ
bjp-25731	629	44	activity	activity	NOUN
bjp-25731	629	45	against	against	ADP
bjp-25731	629	46	nsclc	nsclc	NOUN
bjp-25731	629	47	cell	cell	NOUN
bjp-25731	629	48	line	line	NOUN
bjp-25731	629	49	.	.	PUNCT
bjp-25731	630	1	cell	cell	NOUN
bjp-25731	630	2	biol	biol	PROPN
bjp-25731	630	3	drug	drug	PROPN
bjp-25731	630	4	des	des	PROPN
bjp-25731	630	5	.	.	PROPN
bjp-25731	630	6	2016	2016	NUM
bjp-25731	630	7	;	;	PUNCT
bjp-25731	630	8	87	87	NUM
bjp-25731	630	9	:	:	PUNCT
bjp-25731	630	10	635	635	NUM
bjp-25731	630	11	-	-	SYM
bjp-25731	630	12	43	43	NUM
bjp-25731	630	13	.	.	PUNCT
bjp-25731	631	1	wang	wang	PROPN
bjp-25731	631	2	d	d	PROPN
bjp-25731	631	3	,	,	PUNCT
bjp-25731	631	4	gao	gao	PROPN
bjp-25731	631	5	f.	f.	PROPN
bjp-25731	631	6	quinazoline	quinazoline	PROPN
bjp-25731	631	7	derivatives	derivative	NOUN
bjp-25731	631	8	:	:	PUNCT
bjp-25731	631	9	synthesis	synthesis	NOUN
bjp-25731	631	10	and	and	CCONJ
bjp-25731	631	11	bioactivities	bioactivitie	NOUN
bjp-25731	631	12	.	.	PUNCT
bjp-25731	632	1	chem	chem	NOUN
bjp-25731	632	2	central	central	PROPN
bjp-25731	632	3	j.	j.	PROPN
bjp-25731	632	4	2013	2013	NUM
bjp-25731	632	5	;	;	PUNCT
bjp-25731	632	6	7	7	NUM
bjp-25731	632	7	:	:	SYM
bjp-25731	632	8	95	95	NUM
bjp-25731	632	9	-	-	SYM
bjp-25731	632	10	115	115	NUM
bjp-25731	632	11	.	.	PUNCT
bjp-25731	633	1	wang	wang	PROPN
bjp-25731	633	2	x	x	PROPN
bjp-25731	633	3	,	,	PUNCT
bjp-25731	633	4	li	li	PROPN
bjp-25731	633	5	zn	zn	PROPN
bjp-25731	633	6	,	,	PUNCT
bjp-25731	633	7	yin	yin	PROPN
bjp-25731	633	8	j	j	PROPN
bjp-25731	633	9	,	,	PUNCT
bjp-25731	633	10	he	he	PRON
bjp-25731	633	11	m	m	PROPN
bjp-25731	633	12	,	,	PUNCT
bjp-25731	633	13	xue	xue	PROPN
bjp-25731	633	14	w	w	PROPN
bjp-25731	633	15	,	,	PUNCT
bjp-25731	633	16	chen	chen	PROPN
bjp-25731	633	17	zw	zw	PROPN
bjp-25731	633	18	,	,	PUNCT
bjp-25731	633	19	song	song	PROPN
bjp-25731	633	20	ba	ba	PROPN
bjp-25731	633	21	.	.	PUNCT
bjp-25731	633	22	synthesis	synthesis	NOUN
bjp-25731	633	23	and	and	CCONJ
bjp-25731	633	24	bioactivity	bioactivity	NOUN
bjp-25731	633	25	evaluation	evaluation	NOUN
bjp-25731	633	26	of	of	ADP
bjp-25731	633	27	novel	novel	ADJ
bjp-25731	633	28	arylimines	arylimine	NOUN
bjp-25731	633	29	containing	contain	VERB
bjp-25731	633	30	3	3	NUM
bjp-25731	633	31	-	-	PUNCT
bjp-25731	633	32	aminoethyl-2-[(p	aminoethyl-2-[(p	NOUN
bjp-25731	633	33	-	-	PUNCT
bjp-25731	633	34	trifluoromethoxy)anilino]-4	trifluoromethoxy)anilino]-4	NOUN
bjp-25731	633	35	(	(	PUNCT
bjp-25731	633	36	3h)-quinazolinone	3h)-quinazolinone	NUM
bjp-25731	633	37	moiety	moiety	NOUN
bjp-25731	633	38	.	.	PUNCT
bjp-25731	634	1	j	j	PROPN
bjp-25731	634	2	agric	agric	PROPN
bjp-25731	634	3	food	food	PROPN
bjp-25731	634	4	chem	chem	NOUN
bjp-25731	634	5	.	.	PUNCT
bjp-25731	635	1	2013	2013	NUM
bjp-25731	635	2	;	;	PUNCT
bjp-25731	635	3	61	61	NUM
bjp-25731	635	4	:	:	SYM
bjp-25731	635	5	9575	9575	NUM
bjp-25731	635	6	-	-	SYM
bjp-25731	635	7	958	958	NUM
bjp-25731	635	8	.	.	PUNCT
bjp-25731	636	1	wang	wang	PROPN
bjp-25731	636	2	x	x	PROPN
bjp-25731	636	3	,	,	PUNCT
bjp-25731	636	4	yin	yin	PROPN
bjp-25731	636	5	j	j	PROPN
bjp-25731	636	6	,	,	PUNCT
bjp-25731	636	7	shi	shi	PROPN
bjp-25731	636	8	l	l	PROPN
bjp-25731	636	9	,	,	PUNCT
bjp-25731	636	10	zhang	zhang	PROPN
bjp-25731	636	11	g	g	PROPN
bjp-25731	636	12	,	,	PUNCT
bjp-25731	636	13	song	song	PROPN
bjp-25731	636	14	b.	b.	PROPN
bjp-25731	636	15	design	design	PROPN
bjp-25731	636	16	,	,	PUNCT
bjp-25731	636	17	synthesis	synthesis	NOUN
bjp-25731	636	18	,	,	PUNCT
bjp-25731	636	19	and	and	CCONJ
bjp-25731	636	20	antibacterial	antibacterial	ADJ
bjp-25731	636	21	activity	activity	NOUN
bjp-25731	636	22	of	of	ADP
bjp-25731	636	23	novel	novel	ADJ
bjp-25731	636	24	schiff	schiff	NOUN
bjp-25731	636	25	base	base	NOUN
bjp-25731	636	26	derivatives	derivative	NOUN
bjp-25731	636	27	of	of	ADP
bjp-25731	636	28	quinazolin-4(3h)-one	quinazolin-4(3h)-one	NOUN
bjp-25731	636	29	.	.	PUNCT
bjp-25731	637	1	eur	eur	PROPN
bjp-25731	637	2	j	j	PROPN
bjp-25731	637	3	med	med	PROPN
bjp-25731	637	4	chem	chem	NOUN
bjp-25731	637	5	.	.	PUNCT
bjp-25731	638	1	2014	2014	NUM
bjp-25731	638	2	;	;	PUNCT
bjp-25731	638	3	77	77	NUM
bjp-25731	638	4	:	:	SYM
bjp-25731	638	5	65	65	NUM
bjp-25731	638	6	-	-	SYM
bjp-25731	638	7	74	74	NUM
bjp-25731	638	8	.	.	PUNCT
bjp-25731	639	1	werbel	werbel	PROPN
bjp-25731	639	2	lm	lm	PROPN
bjp-25731	639	3	,	,	PUNCT
bjp-25731	639	4	degnan	degnan	PROPN
bjp-25731	639	5	mj	mj	PROPN
bjp-25731	639	6	.	.	PUNCT
bjp-25731	639	7	synthesis	synthesis	NOUN
bjp-25731	639	8	and	and	CCONJ
bjp-25731	639	9	antimalarial	antimalarial	ADJ
bjp-25731	639	10	and	and	CCONJ
bjp-25731	639	11	antitumor	antitumor	PROPN
bjp-25731	639	12	effects	effect	NOUN
bjp-25731	639	13	of	of	ADP
bjp-25731	639	14	2	2	NUM
bjp-25731	639	15	-	-	PUNCT
bjp-25731	639	16	amino-4-(hydrazino	amino-4-(hydrazino	NOUN
bjp-25731	639	17	and	and	CCONJ
bjp-25731	639	18	hydroxyamino)-6-[(aryl)thio]quinazolines	hydroxyamino)-6-[(aryl)thio]quinazolines	PROPN
bjp-25731	639	19	.	.	PUNCT
bjp-25731	640	1	j	j	PROPN
bjp-25731	640	2	med	med	PROPN
bjp-25731	640	3	chem	chem	NOUN
bjp-25731	640	4	.	.	PUNCT
bjp-25731	641	1	1987	1987	NUM
bjp-25731	641	2	;	;	PUNCT
bjp-25731	641	3	30	30	NUM
bjp-25731	641	4	:	:	PUNCT
bjp-25731	641	5	2151	2151	NUM
bjp-25731	641	6	-	-	SYM
bjp-25731	641	7	54	54	NUM
bjp-25731	641	8	.	.	PUNCT
bjp-25731	642	1	who	who	PRON
bjp-25731	642	2	,	,	PUNCT
bjp-25731	642	3	world	world	PROPN
bjp-25731	642	4	health	health	NOUN
bjp-25731	642	5	organization	organization	NOUN
bjp-25731	642	6	.	.	PUNCT
bjp-25731	643	1	control	control	NOUN
bjp-25731	643	2	of	of	ADP
bjp-25731	643	3	the	the	DET
bjp-25731	643	4	leishmaniases	leishmaniase	NOUN
bjp-25731	643	5	.	.	PUNCT
bjp-25731	644	1	who	who	PRON
bjp-25731	644	2	technical	technical	ADJ
bjp-25731	644	3	report	report	NOUN
bjp-25731	644	4	series	series	NOUN
bjp-25731	644	5	.	.	PUNCT
bjp-25731	645	1	retrieved	retrieve	VERB
bjp-25731	645	2	online	online	ADV
bjp-25731	645	3	on	on	ADP
bjp-25731	645	4	february	february	PROPN
bjp-25731	645	5	7	7	NUM
bjp-25731	645	6	,	,	PUNCT
bjp-25731	645	7	2016	2016	NUM
bjp-25731	645	8	at	at	ADP
bjp-25731	645	9	http://www.who.int/leishmaniasis/	http://www.who.int/leishmaniasis/	PROPN
bjp-25731	645	10	resources	resource	NOUN
bjp-25731	645	11	/	/	SYM
bjp-25731	645	12	en	en	X
bjp-25731	645	13	.	.	PUNCT
bjp-25731	646	1	who	who	PRON
bjp-25731	646	2	,	,	PUNCT
bjp-25731	646	3	world	world	PROPN
bjp-25731	646	4	health	health	NOUN
bjp-25731	646	5	organization	organization	NOUN
bjp-25731	646	6	.	.	PUNCT
bjp-25731	647	1	hiv	hiv	PROPN
bjp-25731	647	2	/	/	SYM
bjp-25731	647	3	aids	aids	PROPN
bjp-25731	647	4	,	,	PUNCT
bjp-25731	647	5	fact	fact	NOUN
bjp-25731	647	6	sheet	sheet	NOUN
bjp-25731	647	7	n.	n.	NOUN
bjp-25731	647	8	360	360	NUM
bjp-25731	647	9	,	,	PUNCT
bjp-25731	647	10	updated	update	VERB
bjp-25731	647	11	nov	nov	PROPN
bjp-25731	647	12	.	.	PROPN
bjp-25731	647	13	2015	2015	NUM
bjp-25731	647	14	.	.	PUNCT
bjp-25731	648	1	retrieved	retrieve	VERB
bjp-25731	648	2	online	online	ADV
bjp-25731	648	3	on	on	ADP
bjp-25731	648	4	dec	dec	PROPN
bjp-25731	648	5	.	.	PROPN
bjp-25731	648	6	7	7	NUM
bjp-25731	648	7	,	,	PUNCT
bjp-25731	648	8	2015	2015	NUM
bjp-25731	648	9	at	at	ADP
bjp-25731	648	10	http://www.who.int/mediacentre/factsheets/fs360/en/	http://www.who.int/mediacentre/factsheets/fs360/en/	X
bjp-25731	648	11	williams	williams	PROPN
bjp-25731	648	12	ch	ch	PROPN
bjp-25731	648	13	,	,	PUNCT
bjp-25731	648	14	hong	hong	PROPN
bjp-25731	648	15	cc	cc	PROPN
bjp-25731	648	16	.	.	PUNCT
bjp-25731	648	17	making	make	VERB
bjp-25731	648	18	models	model	NOUN
bjp-25731	648	19	work	work	VERB
bjp-25731	648	20	:	:	PUNCT
bjp-25731	648	21	library	library	NOUN
bjp-25731	648	22	annotation	annotation	NOUN
bjp-25731	648	23	through	through	ADP
bjp-25731	648	24	phenoclustering	phenoclustere	VERB
bjp-25731	648	25	.	.	PUNCT
bjp-25731	649	1	drug	drug	NOUN
bjp-25731	649	2	discov	discov	PROPN
bjp-25731	649	3	today	today	NOUN
bjp-25731	649	4	dis	dis	PROPN
bjp-25731	649	5	model	model	PROPN
bjp-25731	649	6	.	.	PUNCT
bjp-25731	650	1	2013	2013	NUM
bjp-25731	650	2	;	;	PUNCT
bjp-25731	650	3	10	10	NUM
bjp-25731	650	4	:	:	PUNCT
bjp-25731	650	5	e5	e5	PROPN
bjp-25731	650	6	–	–	PUNCT
bjp-25731	650	7	e9	e9	PROPN
bjp-25731	650	8	.	.	PROPN
bjp-25731	650	9	yassen	yassen	PROPN
bjp-25731	650	10	asa	asa	PROPN
bjp-25731	650	11	,	,	PUNCT
bjp-25731	650	12	elshihawy	elshihawy	PROPN
bjp-25731	650	13	heaea	heaea	PROPN
bjp-25731	650	14	,	,	PUNCT
bjp-25731	650	15	said	say	VERB
bjp-25731	650	16	mma	mma	PROPN
bjp-25731	650	17	,	,	PUNCT
bjp-25731	650	18	abouzid	abouzid	PROPN
bjp-25731	650	19	kam	kam	PROPN
bjp-25731	650	20	.	.	PUNCT
bjp-25731	651	1	molecular	molecular	ADJ
bjp-25731	651	2	modelling	modelling	NOUN
bjp-25731	651	3	and	and	CCONJ
bjp-25731	651	4	synthesis	synthesis	NOUN
bjp-25731	651	5	of	of	ADP
bjp-25731	651	6	quinazoline	quinazoline	NOUN
bjp-25731	651	7	-	-	PUNCT
bjp-25731	651	8	based	base	VERB
bjp-25731	651	9	compounds	compound	NOUN
bjp-25731	651	10	as	as	ADP
bjp-25731	651	11	potential	potential	ADJ
bjp-25731	651	12	anti	anti	ADJ
bjp-25731	651	13	-	-	ADJ
bjp-25731	651	14	proliferative	proliferative	ADJ
bjp-25731	651	15	agents	agent	NOUN
bjp-25731	651	16	.	.	PUNCT
bjp-25731	652	1	chem	chem	NOUN
bjp-25731	652	2	pharm	pharm	NOUN
bjp-25731	652	3	bull	bull	PROPN
bjp-25731	652	4	.	.	PUNCT
bjp-25731	653	1	2014	2014	NUM
bjp-25731	653	2	;	;	PUNCT
bjp-25731	653	3	62	62	NUM
bjp-25731	653	4	:	:	PUNCT
bjp-25731	653	5	454	454	NUM
bjp-25731	653	6	-	-	SYM
bjp-25731	653	7	66	66	NUM
bjp-25731	653	8	.	.	PUNCT
bjp-25731	654	1	yu	yu	PROPN
bjp-25731	654	2	h	h	PROPN
bjp-25731	654	3	,	,	PUNCT
bjp-25731	654	4	li	li	PROPN
bjp-25731	654	5	y	y	PROPN
bjp-25731	654	6	,	,	PUNCT
bjp-25731	654	7	ge	ge	PROPN
bjp-25731	654	8	y	y	PROPN
bjp-25731	654	9	,	,	PUNCT
bjp-25731	654	10	song	song	NOUN
bjp-25731	654	11	z	z	PROPN
bjp-25731	654	12	,	,	PUNCT
bjp-25731	654	13	wang	wang	PROPN
bjp-25731	654	14	c.	c.	PROPN
bjp-25731	654	15	,	,	PUNCT
bjp-25731	654	16	huang	huang	PROPN
bjp-25731	654	17	s	s	PROPN
bjp-25731	654	18	,	,	PUNCT
bjp-25731	654	19	jin	jin	PROPN
bjp-25731	654	20	y	y	PROPN
bjp-25731	654	21	,	,	PUNCT
bjp-25731	654	22	han	han	PROPN
bjp-25731	654	23	x	x	PROPN
bjp-25731	654	24	,	,	PUNCT
bjp-25731	654	25	zhen	zhen	PROPN
bjp-25731	654	26	y	y	PROPN
bjp-25731	654	27	,	,	PUNCT
bjp-25731	654	28	liu	liu	PROPN
bjp-25731	654	29	k	k	PROPN
bjp-25731	654	30	,	,	PUNCT
bjp-25731	654	31	zhou	zhou	PROPN
bjp-25731	654	32	y	y	PROPN
bjp-25731	654	33	,	,	PUNCT
bjp-25731	654	34	ma	ma	PROPN
bjp-25731	654	35	x.	x.	PROPN
bjp-25731	654	36	novel	novel	VERB
bjp-25731	654	37	4	4	NUM
bjp-25731	654	38	-	-	PUNCT
bjp-25731	654	39	anilinoquinazoline	anilinoquinazoline	NOUN
bjp-25731	654	40	derivatives	derivative	NOUN
bjp-25731	654	41	featuring	feature	VERB
bjp-25731	654	42	an	an	DET
bjp-25731	654	43	1	1	NUM
bjp-25731	654	44	-	-	PUNCT
bjp-25731	654	45	adamantyl	adamantyl	ADJ
bjp-25731	654	46	moiety	moiety	NOUN
bjp-25731	654	47	as	as	ADP
bjp-25731	654	48	potent	potent	ADJ
bjp-25731	654	49	egfr	egfr	ADJ
bjp-25731	654	50	inhibitors	inhibitor	NOUN
bjp-25731	654	51	with	with	ADP
bjp-25731	654	52	enhanced	enhanced	ADJ
bjp-25731	654	53	activity	activity	NOUN
bjp-25731	654	54	against	against	ADP
bjp-25731	654	55	nsclc	nsclc	NOUN
bjp-25731	654	56	cell	cell	NOUN
bjp-25731	654	57	lines	line	NOUN
bjp-25731	654	58	.	.	PUNCT
bjp-25731	655	1	eur	eur	PROPN
bjp-25731	655	2	j	j	PROPN
bjp-25731	655	3	med	med	PROPN
bjp-25731	655	4	chem	chem	NOUN
bjp-25731	655	5	.	.	PUNCT
bjp-25731	656	1	2016	2016	NUM
bjp-25731	656	2	;	;	PUNCT
bjp-25731	656	3	110	110	NUM
bjp-25731	656	4	:	:	SYM
bjp-25731	656	5	195	195	NUM
bjp-25731	656	6	-	-	SYM
bjp-25731	656	7	203	203	NUM
bjp-25731	656	8	.	.	PUNCT
bjp-25731	657	1	yves	yve	NOUN
bjp-25731	657	2	lj	lj	PROPN
bjp-25731	657	3	.	.	PUNCT
bjp-25731	658	1	antituberculosis	antituberculosis	PROPN
bjp-25731	658	2	drugs	drug	NOUN
bjp-25731	658	3	:	:	PUNCT
bjp-25731	658	4	ten	ten	NUM
bjp-25731	658	5	years	year	NOUN
bjp-25731	658	6	of	of	ADP
bjp-25731	658	7	research	research	NOUN
bjp-25731	658	8	.	.	PUNCT
bjp-25731	659	1	bioorg	bioorg	PROPN
bjp-25731	659	2	med	med	PROPN
bjp-25731	659	3	chem	chem	NOUN
bjp-25731	659	4	.	.	PUNCT
bjp-25731	660	1	2007	2007	NUM
bjp-25731	660	2	;	;	PUNCT
bjp-25731	660	3	15	15	NUM
bjp-25731	660	4	:	:	SYM
bjp-25731	660	5	2479	2479	NUM
bjp-25731	660	6	-	-	SYM
bjp-25731	660	7	513	513	NUM
bjp-25731	660	8	.	.	PUNCT
bjp-25731	661	1	zayed	zayed	PROPN
bjp-25731	661	2	mf	mf	PROPN
bjp-25731	661	3	.	.	PROPN
bjp-25731	661	4	new	new	ADJ
bjp-25731	661	5	fluorinated	fluorinate	VERB
bjp-25731	661	6	quinazolinone	quinazolinone	NOUN
bjp-25731	661	7	derivatives	derivative	NOUN
bjp-25731	661	8	as	as	ADP
bjp-25731	661	9	anticonvulsant	anticonvulsant	ADJ
bjp-25731	661	10	agents	agent	NOUN
bjp-25731	661	11	.	.	PUNCT
bjp-25731	662	1	j	j	PROPN
bjp-25731	662	2	taibah	taibah	PROPN
bjp-25731	662	3	univ	univ	PROPN
bjp-25731	662	4	med	med	PROPN
bjp-25731	662	5	sci	sci	PROPN
bjp-25731	662	6	.	.	PROPN
bjp-25731	662	7	2014	2014	NUM
bjp-25731	662	8	;	;	PUNCT
bjp-25731	662	9	9	9	NUM
bjp-25731	662	10	:	:	SYM
bjp-25731	662	11	10409	10409	NUM
bjp-25731	662	12	.	.	PUNCT
bjp-25731	663	1	zhang	zhang	PROPN
bjp-25731	663	2	j	j	PROPN
bjp-25731	663	3	,	,	PUNCT
bjp-25731	663	4	liu	liu	PROPN
bjp-25731	663	5	j	j	PROPN
bjp-25731	663	6	,	,	PUNCT
bjp-25731	663	7	ma	ma	PROPN
bjp-25731	663	8	y	y	PROPN
bjp-25731	663	9	,	,	PUNCT
bjp-25731	663	10	ren	ren	PROPN
bjp-25731	663	11	d	d	PROPN
bjp-25731	663	12	,	,	PUNCT
bjp-25731	663	13	cheng	cheng	PROPN
bjp-25731	663	14	p	p	PROPN
bjp-25731	663	15	,	,	PUNCT
bjp-25731	663	16	zhao	zhao	PROPN
bjp-25731	663	17	j	j	PROPN
bjp-25731	663	18	,	,	PUNCT
bjp-25731	663	19	zhang	zhang	PROPN
bjp-25731	663	20	f	f	PROPN
bjp-25731	663	21	,	,	PUNCT
bjp-25731	663	22	yao	yao	PROPN
bjp-25731	663	23	y.	y.	PROPN
bjp-25731	663	24	one	one	NUM
bjp-25731	663	25	-	-	PUNCT
bjp-25731	663	26	pot	pot	NOUN
bjp-25731	663	27	synthesis	synthesis	NOUN
bjp-25731	663	28	and	and	CCONJ
bjp-25731	663	29	antifungal	antifungal	ADJ
bjp-25731	663	30	activity	activity	NOUN
bjp-25731	663	31	against	against	ADP
bjp-25731	663	32	plant	plant	NOUN
bjp-25731	663	33	pathogens	pathogen	NOUN
bjp-25731	663	34	of	of	ADP
bjp-25731	663	35	quinazolinone	quinazolinone	NOUN
bjp-25731	663	36	derivatives	derivative	NOUN
bjp-25731	663	37	containing	contain	VERB
bjp-25731	663	38	an	an	DET
bjp-25731	663	39	amide	amide	NOUN
bjp-25731	663	40	moiety	moiety	NOUN
bjp-25731	663	41	.	.	PUNCT
bjp-25731	664	1	bioorg	bioorg	PROPN
bjp-25731	664	2	med	med	PROPN
bjp-25731	664	3	chem	chem	NOUN
bjp-25731	664	4	lett	lett	PROPN
bjp-25731	664	5	.	.	PROPN
bjp-25731	665	1	2016	2016	NUM
bjp-25731	665	2	;	;	PUNCT
bjp-25731	665	3	26	26	NUM
bjp-25731	665	4	:	:	PUNCT
bjp-25731	665	5	2273	2273	NUM
bjp-25731	665	6	-	-	SYM
bjp-25731	665	7	77	77	NUM
bjp-25731	665	8	.	.	PUNCT
bjp-25731	666	1	zhang	zhang	PROPN
bjp-25731	666	2	x	x	PROPN
bjp-25731	666	3	,	,	PUNCT
bjp-25731	666	4	peng	peng	PROPN
bjp-25731	666	5	t	t	PROPN
bjp-25731	666	6	,	,	PUNCT
bjp-25731	666	7	ji	ji	PROPN
bjp-25731	666	8	x	x	PROPN
bjp-25731	666	9	,	,	PUNCT
bjp-25731	666	10	li	li	PROPN
bjp-25731	666	11	j	j	PROPN
bjp-25731	666	12	,	,	PUNCT
bjp-25731	666	13	tong	tong	PROPN
bjp-25731	666	14	l	l	PROPN
bjp-25731	666	15	,	,	PUNCT
bjp-25731	666	16	li	li	PROPN
bjp-25731	666	17	z	z	PROPN
bjp-25731	666	18	,	,	PUNCT
bjp-25731	666	19	yang	yang	PROPN
bjp-25731	666	20	w	w	PROPN
bjp-25731	666	21	,	,	PUNCT
bjp-25731	666	22	xu	xu	PROPN
bjp-25731	666	23	y	y	PROPN
bjp-25731	666	24	,	,	PUNCT
bjp-25731	666	25	li	li	PROPN
bjp-25731	666	26	m	m	PROPN
bjp-25731	666	27	,	,	PUNCT
bjp-25731	666	28	ding	ding	PROPN
bjp-25731	666	29	j	j	PROPN
bjp-25731	666	30	,	,	PUNCT
bjp-25731	666	31	jiang	jiang	PROPN
bjp-25731	666	32	h	h	PROPN
bjp-25731	666	33	,	,	PUNCT
bjp-25731	666	34	xie	xie	PROPN
bjp-25731	666	35	h	h	PROPN
bjp-25731	666	36	,	,	PUNCT
bjp-25731	666	37	liu	liu	PROPN
bjp-25731	666	38	h.	h.	PROPN
bjp-25731	666	39	design	design	PROPN
bjp-25731	666	40	,	,	PUNCT
bjp-25731	666	41	synthesis	synthesis	NOUN
bjp-25731	666	42	and	and	CCONJ
bjp-25731	666	43	biological	biological	ADJ
bjp-25731	666	44	evaluation	evaluation	NOUN
bjp-25731	666	45	of	of	ADP
bjp-25731	666	46	novel	novel	ADJ
bjp-25731	666	47	4	4	NUM
bjp-25731	666	48	-	-	NOUN
bjp-25731	666	49	anilinoquinazolines	anilinoquinazoline	NOUN
bjp-25731	666	50	with	with	ADP
bjp-25731	666	51	c-6	c-6	NOUN
bjp-25731	666	52	urea	urea	NOUN
bjp-25731	666	53	-	-	PUNCT
bjp-25731	666	54	linked	link	VERB
bjp-25731	666	55	side	side	NOUN
bjp-25731	666	56	chains	chain	NOUN
bjp-25731	666	57	as	as	ADP
bjp-25731	666	58	inhibitors	inhibitor	NOUN
bjp-25731	666	59	of	of	ADP
bjp-25731	666	60	the	the	DET
bjp-25731	666	61	epidermal	epidermal	ADJ
bjp-25731	666	62	growth	growth	NOUN
bjp-25731	666	63	factor	factor	NOUN
bjp-25731	666	64	receptor	receptor	NOUN
bjp-25731	666	65	.	.	PUNCT
bjp-25731	667	1	bioorg	bioorg	PROPN
bjp-25731	667	2	med	med	PROPN
bjp-25731	667	3	chem	chem	NOUN
bjp-25731	667	4	.	.	PUNCT
bjp-25731	667	5	2013a	2013a	NUM
bjp-25731	667	6	;	;	PUNCT
bjp-25731	667	7	21	21	NUM
bjp-25731	667	8	:	:	PUNCT
bjp-25731	667	9	7988	7988	NUM
bjp-25731	667	10	-	-	SYM
bjp-25731	667	11	98	98	NUM
bjp-25731	667	12	.	.	PUNCT
bjp-25731	668	1	zhang	zhang	PROPN
bjp-25731	668	2	x	x	PROPN
bjp-25731	668	3	,	,	PUNCT
bjp-25731	668	4	su	su	PROPN
bjp-25731	668	5	s	s	PROPN
bjp-25731	668	6	,	,	PUNCT
bjp-25731	668	7	chen	chen	PROPN
bjp-25731	668	8	y	y	PROPN
bjp-25731	668	9	,	,	PUNCT
bjp-25731	668	10	li	li	PROPN
bjp-25731	668	11	j	j	PROPN
bjp-25731	668	12	,	,	PUNCT
bjp-25731	668	13	lu	lu	PROPN
bjp-25731	668	14	w.	w.	PROPN
bjp-25731	668	15	the	the	DET
bjp-25731	668	16	design	design	NOUN
bjp-25731	668	17	and	and	CCONJ
bjp-25731	668	18	synthesis	synthesis	NOUN
bjp-25731	668	19	of	of	ADP
bjp-25731	668	20	a	a	DET
bjp-25731	668	21	new	new	ADJ
bjp-25731	668	22	class	class	NOUN
bjp-25731	668	23	of	of	ADP
bjp-25731	668	24	rtk/	rtk/	PROPN
bjp-25731	668	25	hdac	hdac	NOUN
bjp-25731	668	26	dual	dual	ADV
bjp-25731	668	27	-	-	PUNCT
bjp-25731	668	28	targeted	target	VERB
bjp-25731	668	29	inhibitors	inhibitor	NOUN
bjp-25731	668	30	.	.	PUNCT
bjp-25731	669	1	molecules	molecule	NOUN
bjp-25731	669	2	2013b	2013b	NUM
bjp-25731	669	3	;	;	PUNCT
bjp-25731	669	4	18	18	NUM
bjp-25731	669	5	:	:	SYM
bjp-25731	669	6	6491	6491	NUM
bjp-25731	669	7	-	-	SYM
bjp-25731	669	8	503	503	NUM
bjp-25731	669	9	.	.	PUNCT
bjp-25731	670	1	bangladesh	bangladesh	PROPN
bjp-25731	670	2	j	j	PROPN
bjp-25731	670	3	pharmacol	pharmacol	PROPN
bjp-25731	670	4	2016	2016	NUM
bjp-25731	670	5	;	;	PUNCT
bjp-25731	670	6	11	11	NUM
bjp-25731	670	7	:	:	PUNCT
bjp-25731	670	8	716	716	NUM
bjp-25731	670	9	-	-	SYM
bjp-25731	670	10	733	733	NUM
bjp-25731	670	11	733	733	NUM
bjp-25731	670	12	http://www.who.int/leishmaniasis/resources/en	http://www.who.int/leishmaniasis/resources/en	PROPN
bjp-25731	670	13	http://www.who.int/leishmaniasis/resources/en	http://www.who.int/leishmaniasis/resources/en	PROPN
bjp-25731	670	14	http://www.who.int/mediacentre/factsheets/fs360/en/	http://www.who.int/mediacentre/factsheets/fs360/en/	VERB
bjp-25731	670	15	your	your	PRON
bjp-25731	670	16	feedback	feedback	NOUN
bjp-25731	670	17	about	about	ADP
bjp-25731	670	18	this	this	DET
bjp-25731	670	19	paper	paper	NOUN
bjp-25731	670	20	1	1	NUM
bjp-25731	670	21	.	.	PUNCT
bjp-25731	670	22	number	number	NOUN
bjp-25731	670	23	of	of	ADP
bjp-25731	670	24	times	time	NOUN
bjp-25731	670	25	you	you	PRON
bjp-25731	670	26	have	have	AUX
bjp-25731	670	27	read	read	VERB
bjp-25731	670	28	this	this	DET
bjp-25731	670	29	paper	paper	NOUN
bjp-25731	670	30	2	2	NUM
bjp-25731	670	31	.	.	PUNCT
bjp-25731	670	32	quality	quality	NOUN
bjp-25731	670	33	of	of	ADP
bjp-25731	670	34	paper	paper	NOUN
bjp-25731	670	35	3	3	X
bjp-25731	670	36	.	.	PUNCT
bjp-25731	671	1	your	your	PRON
bjp-25731	671	2	comments	comment	NOUN
bjp-25731	671	3	dateprinted	dateprinte	VERB
bjp-25731	671	4	:	:	PUNCT
bjp-25731	671	5	this	this	DET
bjp-25731	671	6	article	article	NOUN
bjp-25731	671	7	was	be	AUX
bjp-25731	671	8	downloaded	download	VERB
bjp-25731	671	9	by	by	ADP
bjp-25731	671	10	you	you	PRON
bjp-25731	671	11	on	on	ADP
bjp-25731	671	12	:	:	PUNCT
bjp-25731	671	13	aug	aug	PROPN
bjp-25731	671	14	27	27	NUM
bjp-25731	671	15	,	,	PUNCT
bjp-25731	671	16	2016	2016	NUM
bjp-25731	671	17	text2	text2	NOUN
bjp-25731	671	18	:	:	PUNCT
bjp-25731	671	19	dropdown3	dropdown3	PROPN
bjp-25731	671	20	:	:	PUNCT
bjp-25731	672	1	[	[	X
bjp-25731	672	2	click	click	NOUN
bjp-25731	672	3	]	]	PUNCT
bjp-25731	672	4	dropdown4	dropdown4	PROPN
bjp-25731	672	5	:	:	PUNCT
bjp-25731	673	1	[	[	X
bjp-25731	673	2	0	0	X
bjp-25731	673	3	]	]	PUNCT